data_1g90_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1g90 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -130.25 127.06 38.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.298 1.039 . . . . 0.0 108.355 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -82.62 157.95 23.21 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.023 1.329 . . . . 0.0 110.654 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.414 ' CZ ' ' HA3' ' A' ' 42' ' ' GLY . 43.2 p90 -151.68 164.54 36.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.761 2.025 . . . . 0.0 109.7 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -130.98 167.38 19.13 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.176 1.39 . . . . 0.0 108.486 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.82 175.39 40.78 Favored Glycine 0 C--N 1.334 0.435 0 O-C-N 121.474 -0.766 . . . . 0.0 112.087 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.33 147.89 31.81 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.291 1.036 . . . . 0.0 109.267 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.535 ' HE2' ' CE1' ' A' ' 40' ' ' PHE . 40.4 mtmt -132.64 164.83 25.83 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.842 1.257 . . . . 0.0 112.308 -169.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.16 150.09 41.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 128.451 2.7 . . . . 0.0 106.363 159.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.77 163.66 29.07 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 119.366 0.985 . . . . 0.0 114.006 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -143.53 136.85 28.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.002 2.121 . . . . 0.0 109.338 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.7 m . . . . . 0 C--O 1.242 0.669 0 C-N-CA 125.219 1.408 . . . . 0.0 110.791 -176.568 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.742 0.306 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.54 -176.75 44.05 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.79 171.96 13.65 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.366 1.867 . . . . 0.0 108.171 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.61 170.18 38.09 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.906 -1.14 . . . . 0.0 114.695 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.42 137.5 30.43 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.098 1.759 . . . . 0.0 109.059 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.535 ' CE1' ' HE2' ' A' ' 12' ' ' LYS . 46.3 m-85 -139.57 151.8 46.36 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.025 1.33 . . . . 0.0 111.159 -166.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.69 157.91 16.47 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 126.946 2.213 . . . . 0.0 107.884 163.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.414 ' HA3' ' CZ ' ' A' ' 8' ' ' TYR . . . -168.57 166.86 39.9 Favored Glycine 0 N--CA 1.449 -0.438 0 O-C-N 121.344 -1.092 . . . . 0.0 111.054 -174.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -140.34 165.85 26.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.209 0.505 . . . . 0.0 110.837 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -115.18 162.61 16.81 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.815 1.646 . . . . 0.0 107.883 162.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 159.229 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.28 -164.79 19.19 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -139.96 163.04 33.73 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.71 1.604 . . . . 0.0 110.13 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -149.85 127.85 11.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.441 1.896 . . . . 0.0 107.613 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -134.78 125.58 27.21 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.422 1.889 . . . . 0.0 108.211 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.515 ' HA3' ' CD2' ' A' ' 40' ' ' PHE . . . -170.59 -179.22 41.82 Favored Glycine 0 C--N 1.333 0.366 0 O-C-N 121.697 -0.627 . . . . 0.0 113.027 -175.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 125.388 1.475 . . . . 0.0 107.646 -175.105 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.694 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -138.21 141.37 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -122.95 132.66 54.26 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 167.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.61 110.68 10.06 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.151 1.381 . . . . 0.0 107.439 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.9 p -137.17 143.03 42.2 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.31 0.644 . . . . 0.0 111.693 -161.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.01 149.24 25.72 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 160.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.08 156.64 45.95 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.667 0.787 . . . . 0.0 111.759 -171.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.7 tp -133.78 125.38 28.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.959 2.504 . . . . 0.0 105.773 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.82 137.85 9.57 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 106.954 -2.458 . . . . 0.0 106.954 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -138.2 133.92 17.51 Favored Pre-proline 0 C--O 1.237 0.397 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.459 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.1 143.95 67.42 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.434 2.756 . . . . 0.0 110.536 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.468 0.428 0 C-N-CA 123.195 0.598 . . . . 0.0 111.368 168.067 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.238 0.451 0 CA-C-O 121.962 0.887 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.18 149.05 36.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.717 2.807 . . . . 0.0 108.826 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -90.68 137.17 22.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 163.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -127.88 144.66 51.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.682 1.193 . . . . 0.0 110.791 -162.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 48.9 m -154.7 148.38 25.39 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.564 1.146 . . . . 0.0 108.462 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -147.76 155.56 41.83 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.666 0.786 . . . . 0.0 110.57 175.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -153.46 158.68 41.72 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.314 1.045 . . . . 0.0 111.003 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.97 -130.92 2.35 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.56 162.5 18.73 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.175 0.893 . . . . 0.0 112.479 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -143.88 149.94 37.68 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.595 1.558 . . . . 0.0 109.783 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.66 150.12 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.504 1.921 . . . . 0.0 107.754 168.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -150.85 143.09 24.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.598 1.159 . . . . 0.0 111.061 -165.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.523 1.129 . . . . 0.0 110.538 167.285 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 119.468 -0.301 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -64.83 163.28 28.6 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.544 1.496 . . . . 0.0 109.306 158.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.1 p -147.54 159.1 8.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 121.702 -0.624 . . . . 0.0 109.741 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -147.57 164.74 32.5 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.063 1.345 . . . . 0.0 109.42 168.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.62 165.77 35.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.705 1.202 . . . . 0.0 108.293 161.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -163.72 170.42 39.04 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 112.049 -0.42 . . . . 0.0 112.049 169.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 158.31 -116.36 0.71 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.1 157.51 28.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 117.94 0.87 . . . . 0.0 111.009 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -128.74 149.96 50.48 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 167.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.21 127.83 18.07 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.352 -0.842 . . . . 0.0 108.965 -158.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.37 136.55 37.7 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.89 -37.01 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.1 0.56 . . . . 0.0 109.656 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 47.3 m -159.83 156.25 23.97 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 103.021 -2.955 . . . . 0.0 103.021 164.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -57.14 -4.35 1.01 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 N-CA-C 118.836 2.591 . . . . 0.0 118.836 -163.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.18 0.26 10.64 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.373 1.869 . . . . 0.0 113.489 173.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.4 tt -134.7 141.96 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.621 1.569 . . . . 0.0 110.595 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.14 170.33 15.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.575 -0.703 . . . . 0.0 109.836 -168.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.3 p -128.12 160.18 32.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.157 0.983 . . . . 0.0 108.655 159.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -140.11 159.24 42.62 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.635 -0.666 . . . . 0.0 110.27 164.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.42 119.85 15.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -138.61 154.68 48.69 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.779 0.8 . . . . 0.0 111.151 -173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -141.83 148.68 39.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.723 2.009 . . . . 0.0 108.484 -162.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -142.4 119.2 11.17 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.142 0 C-N-CA 125.236 1.414 . . . . 0.0 110.134 -167.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.85 0 CA-C-O 121.559 0.533 . . . . 0.0 113.301 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 23.4 ptp -75.95 154.13 36.1 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 169.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -137.29 148.3 46.29 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.424 1.089 . . . . 0.0 108.929 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.3 p -143.1 158.23 43.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.901 0.48 . . . . 0.0 110.136 166.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -145.15 150.36 36.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.49 1.116 . . . . 0.0 109.149 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.17 175.09 40.31 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.66 160.28 3.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 126.735 2.014 . . . . 0.0 109.418 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.37 159.67 41.74 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.042 0.537 . . . . 0.0 109.616 167.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -140.62 140.67 35.1 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.972 1.309 . . . . 0.0 108.138 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.4 mtm105 -89.86 155.29 19.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.267 0.556 . . . . 0.0 110.721 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 67.8 t80 . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 167.148 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.0 t -157.03 174.33 15.68 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 159.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -133.48 168.11 19.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.474 1.909 . . . . 0.0 109.07 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -139.46 155.9 47.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 109.717 -168.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.3 p -133.45 126.94 32.26 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.504 1.921 . . . . 0.0 107.015 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.56 -159.37 13.03 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 119.038 0.835 . . . . 0.0 113.565 -161.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.9 162.24 36.0 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.182 1.393 . . . . 0.0 109.916 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HE2' ' CE2' ' A' ' 40' ' ' PHE . 9.2 ttmm -141.65 143.56 33.69 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.803 1.641 . . . . 0.0 107.149 174.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 pp -145.77 145.07 30.68 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.532 0.733 . . . . 0.0 109.462 166.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.65 174.49 29.14 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 124.704 1.145 . . . . 0.0 112.932 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -149.36 167.23 26.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.538 0.735 . . . . 0.0 110.316 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.24 0.569 0 C-N-CA 125.194 1.397 . . . . 0.0 107.992 165.602 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.64 144.73 12.58 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 160.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.05 121.65 2.43 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.94 170.05 39.84 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 121.702 0.612 . . . . 0.0 114.368 -172.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.77 139.93 30.6 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.419 ' CE2' ' HE2' ' A' ' 12' ' ' LYS . 8.0 m-85 -135.62 165.4 25.63 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.242 1.017 . . . . 0.0 110.758 -167.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.67 162.54 25.84 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.64 165.35 25.86 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -146.18 134.44 21.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.393 1.877 . . . . 0.0 106.284 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.09 118.89 29.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 159.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -160.451 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.417 0.627 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.6 -168.42 26.52 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.943 1.735 . . . . 0.0 110.544 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -148.44 162.54 39.4 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.862 1.265 . . . . 0.0 108.543 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HG2' HH22 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -151.56 157.86 42.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.116 0.966 . . . . 0.0 110.42 171.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 64.5 mtt -146.48 152.76 39.53 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 125.799 1.639 . . . . 0.0 107.46 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.02 173.06 44.08 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 119.186 0.903 . . . . 0.0 113.178 170.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 . . . . . 0 N--CA 1.452 -0.348 0 C-N-CA 126.543 1.937 . . . . 0.0 107.954 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.491 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.16 146.03 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 126.458 1.903 . . . . 0.0 107.106 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -130.11 147.75 51.89 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.694 1.598 . . . . 0.0 108.012 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.34 125.79 10.18 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.961 0.904 . . . . 0.0 109.025 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.5 p -141.99 154.07 44.75 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.846 0.355 . . . . 0.0 111.255 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.53 142.77 29.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 164.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -115.41 102.93 10.28 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 mp -92.83 107.44 19.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.09 166.79 39.98 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 117.819 0.281 . . . . 0.0 112.545 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -157.7 157.6 29.9 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.023 0.929 . . . . 0.0 110.341 -171.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.79 125.96 12.15 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.205 2.603 . . . . 0.0 110.443 169.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.1 mm . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.391 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 C--O 1.233 0.188 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -86.94 139.57 30.47 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 20.2 tt -120.09 141.27 41.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -147.83 170.62 17.23 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 123.19 1.471 . . . . 0.0 113.793 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.0 m -137.41 128.05 26.9 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.666 1.986 . . . . 0.0 106.433 163.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -104.85 146.56 28.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.898 0.879 . . . . 0.0 108.734 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 tt -149.83 139.4 21.59 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.772 0.829 . . . . 0.0 109.402 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.16 -128.21 1.6 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.8 174.31 28.47 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-O 122.072 0.818 . . . . 0.0 113.085 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -150.31 162.12 41.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.132 1.373 . . . . 0.0 109.746 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 t -137.09 137.35 46.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -131.73 158.33 41.46 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.379 0.671 . . . . 0.0 110.988 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 . . . . . 0 N--CA 1.452 -0.364 0 C-N-CA 127.113 2.165 . . . . 0.0 106.826 176.729 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.36 161.45 44.75 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.955 1.77 . . . . 0.0 110.042 164.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -148.53 144.29 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -148.2 153.05 38.25 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.632 1.173 . . . . 0.0 108.971 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.9 167.64 29.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.746 1.218 . . . . 0.0 109.477 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -108.73 169.7 14.24 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.67 -173.79 45.94 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 118.747 1.273 . . . . 0.0 113.968 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.0 156.8 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.779 1.231 . . . . 0.0 109.536 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -134.34 151.56 51.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.042 1.337 . . . . 0.0 108.885 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.42 108.66 4.6 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.914 0.886 . . . . 0.0 109.747 -164.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.71 81.36 5.02 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.033 0.833 . . . . 0.0 110.202 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.3 mm -51.2 -39.05 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.489 1.516 . . . . 0.0 110.793 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 51.2 p -135.65 165.66 34.42 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 159.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.58 43.82 0.68 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 122.907 2.405 . . . . 0.0 110.839 164.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -149.25 -45.24 0.14 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.427 2.691 . . . . 0.0 109.531 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.7 tt -137.57 145.16 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 118.973 0.806 . . . . 0.0 110.464 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.66 137.76 30.16 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.93 0.892 . . . . 0.0 109.93 -165.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 53.2 m -93.91 152.93 18.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.37 1.468 . . . . 0.0 109.236 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.426 HH22 ' HG2' ' A' ' 52' ' ' GLU . 37.9 mtp180 -124.02 149.12 46.42 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.215 1.806 . . . . 0.0 107.793 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.98 144.21 41.04 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.476 1.91 . . . . 0.0 106.033 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -144.5 146.94 32.68 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.375 1.47 . . . . 0.0 109.448 -171.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -137.03 121.09 17.76 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 127.079 2.152 . . . . 0.0 107.525 172.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.59 165.88 19.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.994 2.118 . . . . 0.0 108.391 -170.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 122.514 1.149 . . . . 0.0 110.303 -173.871 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 14.6 ttt -72.33 140.39 48.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -138.73 152.03 47.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.28 163.55 32.64 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 123.883 0.739 . . . . 0.0 109.91 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.89 166.77 22.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.494 1.118 . . . . 0.0 108.938 164.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -158.73 172.96 35.66 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.7 t -142.34 145.73 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.21 113.24 4.52 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -159.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.81 132.56 35.16 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 145.3 25.38 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.615 0.643 . . . . 0.0 112.151 -171.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 45.5 t80 . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 124.924 1.29 . . . . 0.0 111.411 171.35 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 p -149.17 162.36 40.14 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.082 0.953 . . . . 0.0 110.822 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -128.25 153.07 47.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.159 1.784 . . . . 0.0 109.113 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -144.92 152.3 40.0 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.288 1.835 . . . . 0.0 108.065 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -150.05 148.34 28.91 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.323 -0.86 . . . . 0.0 111.216 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.64 -104.78 0.2 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 125.687 1.613 . . . . 0.0 109.425 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.37 169.12 25.45 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 118.204 1.002 . . . . 0.0 113.526 -166.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.456 ' HE3' ' CE1' ' A' ' 40' ' ' PHE . 17.0 ptpt -142.52 166.19 25.34 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.705 1.202 . . . . 0.0 109.212 158.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 tt -131.03 115.98 17.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 163.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.87 146.46 20.55 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -150.8 142.24 23.43 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.526 1.53 . . . . 0.0 111.08 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.1 p . . . . . 0 N--CA 1.454 -0.26 0 C-N-CA 124.34 1.056 . . . . 0.0 109.769 161.749 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.14 96.3 0.19 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 106.991 -2.443 . . . . 0.0 106.991 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.88 129.92 46.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.953 1.301 . . . . 0.0 108.264 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.92 169.5 39.59 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 114.69 0.636 . . . . 0.0 114.69 -169.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.83 154.52 17.21 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.68 1.192 . . . . 0.0 108.951 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.456 ' CE1' ' HE3' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -146.63 155.52 42.52 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.217 1.007 . . . . 0.0 111.799 -171.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.3 158.22 25.85 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 163.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.73 166.2 39.21 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 117.418 0.609 . . . . 0.0 111.743 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -145.05 145.93 31.66 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.418 1.087 . . . . 0.0 110.535 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -87.9 110.9 20.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 162.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 CA--C 1.536 0.415 0 CA-C-N 118.527 0.603 . . . . 0.0 110.244 173.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -179.59 -165.72 34.11 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 121.105 -0.997 . . . . 0.0 112.758 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -142.16 160.82 39.46 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.548 1.139 . . . . 0.0 109.311 170.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.61 149.92 35.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.295 1.838 . . . . 0.0 107.954 168.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 53.5 mtt -148.71 153.31 38.04 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.6 1.16 . . . . 0.0 108.193 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.06 173.34 44.12 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-O 119.655 -0.525 . . . . 0.0 111.954 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.0 p90 . . . . . 0 C--O 1.233 0.209 0 C-N-CA 124.024 0.93 . . . . 0.0 109.83 -175.782 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.241 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.3 125.6 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.22 1.408 . . . . 0.0 107.923 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -95.87 144.07 26.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.769 2.428 . . . . 0.0 108.382 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -141.83 125.42 16.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.329 1.052 . . . . 0.0 108.915 169.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.61 123.93 19.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.4 1.08 . . . . 0.0 108.449 -167.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.54 138.47 32.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -99.78 129.22 45.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.323 1.049 . . . . 0.0 108.645 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.08 137.53 52.18 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 158.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.22 -172.45 43.47 Favored Glycine 0 C--O 1.226 -0.363 0 CA-C-O 119.191 -0.783 . . . . 0.0 111.448 -165.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -155.67 157.93 31.65 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.672 1.189 . . . . 0.0 109.253 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -62.2 141.9 89.75 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.882 1.721 . . . . 0.0 109.274 161.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.4 tp . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 123.79 0.836 . . . . 0.0 110.455 171.066 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--O 1.239 0.513 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -140.46 127.01 20.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.399 1.479 . . . . 0.0 109.865 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 pp -99.09 153.98 4.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.751 1.621 . . . . 0.0 109.579 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -150.15 157.6 43.27 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 122.15 0.976 . . . . 0.0 113.415 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.6 m -114.07 121.7 44.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 158.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -105.81 109.22 21.1 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 tt -125.85 128.24 47.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.98 0.809 . . . . 0.0 110.154 -168.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.48 -98.33 0.14 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.04 -162.43 36.23 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.758 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -145.95 159.36 43.35 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.502 1.121 . . . . 0.0 109.872 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.14 151.25 35.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.598 1.159 . . . . 0.0 108.138 168.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -136.04 145.02 45.57 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.809 0.844 . . . . 0.0 111.171 -170.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 . . . . . 0 C--O 1.233 0.231 0 C-N-CA 129.014 2.926 . . . . 0.0 106.809 -177.719 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.71 117.86 5.22 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.992 2.461 . . . . 0.0 108.329 170.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.34 171.15 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.476 0.71 . . . . 0.0 110.227 -172.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -138.55 162.59 34.18 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 165.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.53 163.3 29.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.411 1.884 . . . . 0.0 108.488 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -108.8 151.45 17.08 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 106.969 -2.453 . . . . 0.0 106.969 162.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -174.55 -174.32 41.2 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 117.9 0.85 . . . . 0.0 112.723 -173.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.1 p -146.57 159.52 10.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 124.571 1.149 . . . . 0.0 108.659 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.2 145.08 49.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.049 2.14 . . . . 0.0 107.164 160.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -142.94 106.1 4.56 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.285 1.834 . . . . 0.0 107.534 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.58 81.97 7.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.841 1.256 . . . . 0.0 108.296 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -25.18 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.099 0.56 . . . . 0.0 111.512 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.1 p -137.03 143.65 43.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 158.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.58 -18.57 59.48 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.763 2.308 . . . . 0.0 114.015 -166.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -62.95 -24.26 67.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.73 2.012 . . . . 0.0 112.249 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.27 164.83 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 125.28 1.432 . . . . 0.0 109.806 -167.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.46 150.56 49.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 162.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.4 p -106.92 150.42 26.45 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 158.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -143.79 147.53 34.27 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.097 0.862 . . . . 0.0 110.109 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.49 159.33 42.12 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.206 1.803 . . . . 0.0 107.771 -175.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -163.38 151.99 14.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.457 0.703 . . . . 0.0 111.483 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -145.58 139.84 26.98 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.582 1.153 . . . . 0.0 109.74 160.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -132.46 175.69 9.08 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.058 1.743 . . . . 0.0 108.915 163.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 CA--C 1.536 0.433 0 C-N-CA 124.223 1.009 . . . . 0.0 110.632 169.679 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 19.0 ttm -148.65 118.09 6.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 158.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.01 154.2 31.69 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 165.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.27 155.05 50.88 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 118.887 0.767 . . . . 0.0 109.78 159.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.76 153.52 51.13 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.77 1.628 . . . . 0.0 107.496 168.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.24 175.49 40.31 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 118.696 0.68 . . . . 0.0 112.843 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.4 m -141.33 164.0 20.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.465 1.106 . . . . 0.0 109.946 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 58.8 m -155.93 161.2 40.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.214 -0.928 . . . . 0.0 110.809 166.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -100.76 155.61 17.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.68 1.592 . . . . 0.0 107.233 159.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.1 ptm85 -90.03 158.68 17.22 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 42.5 t80 . . . . . 0 C--O 1.239 0.517 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 158.078 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.8 m -153.06 122.44 6.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -81.62 160.09 23.87 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 170.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -148.27 160.73 42.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.424 1.89 . . . . 0.0 108.022 171.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 t -148.93 161.54 41.68 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.89 -160.49 26.18 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -165.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.59 153.37 40.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.422 ' HE3' ' CZ ' ' A' ' 40' ' ' PHE . 28.0 mtmt -131.0 155.0 47.58 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.903 0.881 . . . . 0.0 109.929 172.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.3 tp -114.19 151.91 32.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.538 2.335 . . . . 0.0 106.074 164.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.91 169.06 29.39 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 118.878 0.763 . . . . 0.0 113.497 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -141.21 136.62 31.92 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.679 1.991 . . . . 0.0 109.068 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.24 0.578 0 C-N-CA 125.109 1.364 . . . . 0.0 110.508 -176.483 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.698 0.285 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.73 159.2 27.88 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 165.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.74 121.87 3.77 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.12 1.768 . . . . 0.0 107.286 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.79 165.56 35.19 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.878 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.33 146.52 24.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.102 1.361 . . . . 0.0 108.129 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.422 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 39.4 m-85 -130.3 154.72 47.34 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.074 0.949 . . . . 0.0 110.322 -171.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.11 137.43 5.81 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.04 166.83 39.73 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -166.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -139.88 168.06 20.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.402 0.601 . . . . 0.0 110.833 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -117.68 151.67 36.77 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.528 1.931 . . . . 0.0 108.049 163.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 164.823 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.465 0.3 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.64 -161.32 13.42 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -138.59 158.66 43.83 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.126 1.37 . . . . 0.0 109.79 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -139.71 120.3 14.17 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.803 2.441 . . . . 0.0 106.853 169.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -118.9 166.02 13.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.798 1.639 . . . . 0.0 107.854 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.91 173.32 41.5 Favored Glycine 0 N--CA 1.452 -0.281 0 O-C-N 121.792 -0.568 . . . . 0.0 111.982 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 . . . . . 0 N--CA 1.448 -0.546 0 C-N-CA 126.711 2.004 . . . . 0.0 106.535 -177.642 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.501 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 t -138.24 123.51 23.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -95.2 145.03 25.33 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 171.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.0 107.81 4.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.6 p -138.03 144.45 41.05 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.091 0.556 . . . . 0.0 111.717 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.91 152.65 23.38 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 162.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 157.08 47.73 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.399 0.679 . . . . 0.0 112.007 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.3 tp -140.78 136.66 32.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.926 2.49 . . . . 0.0 105.891 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.04 158.75 29.1 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 166.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.91 141.65 18.94 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.907 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.27 145.1 70.98 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.506 2.804 . . . . 0.0 110.385 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 123.053 0.541 . . . . 0.0 111.419 167.209 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.237 0.418 0 CA-C-O 121.895 0.855 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.73 146.65 35.94 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.862 2.865 . . . . 0.0 108.763 175.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.8 mt -90.64 137.76 20.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 163.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -134.35 147.34 50.52 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.364 1.066 . . . . 0.0 111.57 -159.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.9 m -155.07 150.15 26.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.047 1.339 . . . . 0.0 109.41 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -147.44 154.25 40.58 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.34 1.056 . . . . 0.0 110.275 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -152.69 156.55 39.4 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.578 1.151 . . . . 0.0 111.557 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.35 -119.49 0.91 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.27 170.18 26.72 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 118.331 1.066 . . . . 0.0 113.624 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -145.75 126.52 14.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.519 1.528 . . . . 0.0 107.745 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.06 142.26 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.42 146.55 42.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.631 1.572 . . . . 0.0 108.348 -172.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.2 ttp85 . . . . . 0 C--O 1.236 0.366 0 C-N-CA 124.458 1.103 . . . . 0.0 109.961 174.098 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -65.48 159.68 46.59 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 N-CA-C 108.396 -1.425 . . . . 0.0 108.396 158.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.41 157.13 8.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 O-C-N 121.659 -0.651 . . . . 0.0 109.663 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.74 165.06 30.77 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.989 1.316 . . . . 0.0 108.54 165.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.55 162.36 39.92 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 162.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.28 165.86 32.97 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 112.125 -0.39 . . . . 0.0 112.125 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 160.56 -118.65 0.84 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.8 m -138.83 158.45 30.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 117.876 0.838 . . . . 0.0 111.435 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -129.55 141.63 50.93 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 166.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.2 126.26 18.34 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.177 0.991 . . . . 0.0 108.946 -158.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.94 140.44 45.58 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.709 0.686 . . . . 0.0 109.984 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 44.4 mm -117.14 -33.72 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.491 0.716 . . . . 0.0 109.962 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 20.7 m -161.87 157.9 21.02 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 172.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.9 -2.65 0.84 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.749 2.299 . . . . 0.0 116.618 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.23 -10.11 13.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.065 1.746 . . . . 0.0 113.773 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.6 tt -148.28 149.09 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 120.049 1.295 . . . . 0.0 111.833 -171.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.14 169.94 16.77 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.273 1.429 . . . . 0.0 108.333 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.0 p -120.04 160.31 23.06 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.989 1.315 . . . . 0.0 108.369 162.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -141.55 159.38 42.34 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 121.58 -0.7 . . . . 0.0 110.114 165.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.38 120.04 12.52 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.16 155.46 43.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.951 0.881 . . . . 0.0 111.778 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.96 152.74 43.77 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.227 1.811 . . . . 0.0 109.829 -159.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -143.75 115.07 7.99 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.096 1.358 . . . . 0.0 108.059 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.2 t80 . . . . . 0 CA--C 1.529 0.169 0 C-N-CA 125.166 1.387 . . . . 0.0 109.98 179.056 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.894 0 CA-C-O 121.158 0.31 . . . . 0.0 113.121 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 23.7 ptp -80.74 155.3 26.79 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 122.336 -0.508 . . . . 0.0 109.747 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.0 tt -139.45 149.41 44.0 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.603 1.161 . . . . 0.0 109.339 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.2 p -136.84 161.72 35.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.633 0.73 . . . . 0.0 111.491 160.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.21 151.45 34.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.125 1.37 . . . . 0.0 109.411 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.41 175.45 40.45 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 114.911 0.725 . . . . 0.0 114.911 -172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 10.4 m -110.31 152.33 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 127.456 2.302 . . . . 0.0 108.953 172.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.3 t -151.0 113.53 4.65 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.877 0.762 . . . . 0.0 109.145 -172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -96.26 142.52 28.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.181 1.792 . . . . 0.0 109.305 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -89.67 155.32 19.31 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.546 0.612 . . . . 0.0 111.161 -175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 60.7 t80 . . . . . 0 C--O 1.237 0.429 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 166.31 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.178 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -112.09 154.39 25.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.547 0.739 . . . . 0.0 110.141 -159.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -134.03 156.65 47.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 158.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -135.23 146.92 49.1 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.576 1.55 . . . . 0.0 106.829 -171.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 m -150.01 148.01 28.54 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.186 -0.946 . . . . 0.0 109.307 165.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.45 -142.53 7.69 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.218 0.914 . . . . 0.0 111.93 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.88 159.3 15.02 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.086 1.755 . . . . 0.0 111.829 -168.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -147.99 144.36 27.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.323 1.449 . . . . 0.0 109.903 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -133.59 148.51 51.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.94 1.696 . . . . 0.0 107.658 164.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.67 158.22 23.36 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.022 1.296 . . . . 0.0 109.876 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -154.75 143.24 20.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.369 1.084 . . . . 0.0 110.588 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.234 0.268 0 C-N-CA 124.137 0.975 . . . . 0.0 108.636 160.588 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.16 156.98 21.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 168.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.64 122.02 3.43 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.915 1.286 . . . . 0.0 107.938 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.16 -121.12 0.84 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.32 169.62 16.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.93 0.892 . . . . 0.0 111.58 -167.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -145.74 151.4 37.92 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.903 2.081 . . . . 0.0 107.831 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.94 156.79 27.84 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 160.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.15 166.02 39.18 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 117.748 0.774 . . . . 0.0 111.859 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -123.66 134.64 53.72 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.63 1.972 . . . . 0.0 108.065 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -122.43 118.33 28.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.679 1.992 . . . . 0.0 109.249 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 122.187 0.994 . . . . 0.0 108.608 173.423 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.81 -175.25 40.57 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.861 1.219 . . . . 0.0 111.691 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -140.6 148.19 40.54 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.916 1.286 . . . . 0.0 107.898 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.75 158.76 43.66 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.234 1.413 . . . . 0.0 109.119 -174.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 75.9 mtp -129.1 159.11 37.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.255 1.422 . . . . 0.0 109.809 167.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.47 165.68 16.13 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.2 t80 . . . . . 0 C--O 1.235 0.333 0 C-N-CA 125.505 1.522 . . . . 0.0 107.687 -173.439 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 107.489 -2.245 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.09 165.46 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.044 0.938 . . . . 0.0 109.267 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -128.1 154.27 45.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.275 1.43 . . . . 0.0 107.981 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -141.55 139.4 33.18 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.405 1.082 . . . . 0.0 109.073 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.55 133.46 12.29 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.466 0.706 . . . . 0.0 110.033 -161.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.95 150.7 24.75 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 160.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.473 ' HE3' ' CD2' ' A' ' 94' ' ' TYR . 14.1 tmtt? -131.5 131.33 43.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.765 1.226 . . . . 0.0 109.05 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.2 148.54 26.81 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 159.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 174.1 169.38 36.2 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 119.454 -1.355 . . . . 0.0 114.142 167.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -148.53 133.73 9.31 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.219 -164.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -71.12 135.39 27.12 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.824 3.016 . . . . 0.0 110.467 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.9 tp . . . . . 0 CA--C 1.539 0.547 0 C-N-CA 123.053 0.541 . . . . 0.0 111.421 177.484 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--O 1.233 0.229 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -101.31 125.63 47.97 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.886 1.274 . . . . 0.0 108.491 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.1 mt -90.7 117.38 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.473 ' CD2' ' HE3' ' A' ' 82' ' ' LYS . 4.4 m-85 -98.45 141.12 31.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.446 1.899 . . . . 0.0 109.788 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.3 m -134.02 115.25 14.1 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 162.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -130.06 148.69 51.94 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 123.774 0.83 . . . . 0.0 110.449 -170.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.37 148.21 27.86 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.974 0.91 . . . . 0.0 110.742 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.07 -121.8 1.05 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.75 167.41 34.7 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 117.861 0.831 . . . . 0.0 113.69 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 36.2 mtm -101.38 150.84 22.6 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.618 1.967 . . . . 0.0 106.975 163.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.3 137.47 50.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -149.71 131.11 14.7 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.293 0 C-N-CA 124.981 1.312 . . . . 0.0 109.45 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.02 144.38 47.2 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.428 2.086 . . . . 0.0 110.863 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.93 164.31 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.13 0.972 . . . . 0.0 110.078 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -147.59 165.54 30.07 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.919 1.688 . . . . 0.0 108.495 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.78 160.41 42.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.32 0.509 . . . . 0.0 110.298 165.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -109.35 159.06 14.22 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 106.131 -2.788 . . . . 0.0 106.131 158.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.79 -173.87 46.09 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 118.539 1.169 . . . . 0.0 112.008 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.21 145.16 31.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -103.05 150.97 23.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.258 1.423 . . . . 0.0 107.544 158.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.39 165.37 28.69 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.533 1.133 . . . . 0.0 109.08 163.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -130.85 88.52 2.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.028 1.731 . . . . 0.0 110.486 -163.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.12 -29.64 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 125.147 1.379 . . . . 0.0 111.118 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.4 t -141.98 146.14 39.19 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 159.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.48 -15.53 49.05 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.501 2.134 . . . . 0.0 114.9 -167.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.97 -41.76 97.02 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.217 0.917 . . . . 0.0 111.004 168.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.0 pt -110.64 163.9 7.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 124.179 0.992 . . . . 0.0 111.188 -164.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.8 158.75 43.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.8 t -141.52 152.78 44.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 158.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -135.33 153.98 51.67 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 123.124 0.569 . . . . 0.0 111.168 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.55 137.32 41.91 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -144.74 154.12 42.4 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.851 1.26 . . . . 0.0 109.803 -164.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -151.02 146.02 25.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.252 1.421 . . . . 0.0 110.735 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -132.13 115.51 15.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.902 2.481 . . . . 0.0 105.965 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.0 t80 . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 168.582 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.706 0 CA-C-O 121.588 0.549 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 26.0 ttt -142.0 156.28 45.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.624 1.97 . . . . 0.0 107.237 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.13 161.78 33.93 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.606 1.162 . . . . 0.0 108.79 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.2 p -147.28 166.4 27.2 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.342 0.591 . . . . 0.0 110.419 166.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.71 165.69 31.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 108.745 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.35 175.14 40.44 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 121.485 -0.388 . . . . 0.0 113.377 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 62.1 t -134.51 146.73 30.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 126.661 1.984 . . . . 0.0 105.709 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.5 m -156.45 174.87 14.79 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 119.934 -1.729 . . . . 0.0 110.433 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -143.72 166.06 25.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 122.926 0.49 . . . . 0.0 111.37 166.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -106.55 158.8 16.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.655 2.382 . . . . 0.0 110.446 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.2 p90 . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 163.722 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.614 0.721 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.9 m -145.2 115.34 7.47 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 119.64 -1.913 . . . . 0.0 108.863 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -114.7 131.53 56.72 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.771 1.628 . . . . 0.0 108.717 -172.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.495 ' CZ ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER -130.78 155.81 46.05 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.193 0.997 . . . . 0.0 111.741 -170.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 m -143.01 144.91 32.48 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.156 2.183 . . . . 0.0 107.633 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.3 -159.49 22.52 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 118.747 0.703 . . . . 0.0 113.522 -169.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.49 157.91 45.28 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.965 1.306 . . . . 0.0 110.629 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.6 163.75 35.63 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.02 0.928 . . . . 0.0 112.794 -175.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mp -141.34 165.78 26.56 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.542 2.337 . . . . 0.0 109.37 171.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.3 171.04 29.54 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.075 0.845 . . . . 0.0 112.249 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -158.57 150.07 20.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.829 0.852 . . . . 0.0 112.101 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 126.264 1.826 . . . . 0.0 108.246 162.841 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.27 165.24 25.5 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 171.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.1 174.66 11.1 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.565 1.946 . . . . 0.0 107.904 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.04 -164.89 31.53 Favored Glycine 0 C--N 1.332 0.338 0 O-C-N 121.848 -0.532 . . . . 0.0 112.675 163.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.29 160.63 14.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -135.74 155.14 50.84 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.653 1.581 . . . . 0.0 107.653 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.26 172.41 40.05 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' A' ' 8' ' ' TYR . . . -168.78 166.73 39.87 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 121.553 -0.969 . . . . 0.0 113.099 166.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -137.68 106.09 5.81 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -95.91 132.87 40.75 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.465 0.302 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.356 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 121.767 0.794 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.05 -116.26 0.81 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 167.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -136.4 159.72 40.9 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.942 1.353 . . . . 0.0 111.908 -171.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -144.81 151.86 39.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 128.534 2.733 . . . . 0.0 106.263 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 66.4 mtt -152.65 170.94 19.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.728 1.211 . . . . 0.0 109.458 -162.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.27 179.95 42.14 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.172 0.892 . . . . 0.0 110.921 170.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 4.5 t80 . . . . . 0 C--O 1.235 0.311 0 C-N-CA 123.656 0.782 . . . . 0.0 109.474 178.011 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.745 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.87 131.83 38.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -95.43 132.2 40.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.35 132.53 20.46 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.001 0.92 . . . . 0.0 108.786 175.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.23 142.75 19.64 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.665 -172.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.64 147.14 26.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.966 1.306 . . . . 0.0 108.512 165.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.496 ' HE2' ' CE1' ' A' ' 94' ' ' TYR . 81.2 tttt -143.52 135.17 26.34 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.375 1.47 . . . . 0.0 109.204 -165.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.8 tp -144.28 129.45 18.69 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.729 1.612 . . . . 0.0 107.394 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.73 179.13 19.16 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 117.965 0.348 . . . . 0.0 112.994 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -143.42 138.55 15.58 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.344 1.058 . . . . 0.0 109.298 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.45 117.08 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.798 2.332 . . . . 0.0 109.073 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.7 tt . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 123.023 0.529 . . . . 0.0 110.78 -176.328 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.353 0 CA-C-O 121.5 0.667 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -132.36 136.56 46.91 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.678 1.991 . . . . 0.0 107.917 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.93 110.58 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.496 ' CE1' ' HE2' ' A' ' 82' ' ' LYS . 10.4 m-85 -111.5 118.43 35.74 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.526 1.931 . . . . 0.0 110.613 -171.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.4 m -96.97 154.6 17.21 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.315 1.846 . . . . 0.0 108.183 171.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.98 165.05 35.86 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.4 tt -138.54 151.13 47.06 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.718 2.007 . . . . 0.0 107.552 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.35 -139.8 8.34 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 119.129 0.877 . . . . 0.0 111.21 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.0 177.9 44.45 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 117.517 0.659 . . . . 0.0 112.448 172.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.2 108.37 19.54 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 125.012 1.325 . . . . 0.0 107.433 168.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.02 122.76 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -88.82 150.7 22.79 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? . . . . . 0 C--O 1.232 0.153 0 C-N-CA 124.307 1.043 . . . . 0.0 109.706 171.593 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -67.04 148.14 81.04 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.639 1.559 . . . . 0.0 109.678 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.8 169.8 19.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.521 1.128 . . . . 0.0 110.192 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.05 154.0 51.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.503 1.521 . . . . 0.0 107.128 168.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.94 171.47 18.29 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.103 0.961 . . . . 0.0 109.08 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -152.63 161.94 29.73 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 169.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.19 -140.96 6.18 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.2 t -132.57 158.3 43.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 117.532 0.666 . . . . 0.0 109.738 -167.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -123.08 137.22 54.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 158.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -120.16 113.57 20.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.641 1.576 . . . . 0.0 107.624 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.0 81.58 1.89 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.855 1.262 . . . . 0.0 108.868 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.9 tp -70.53 -41.13 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 167.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.55 115.57 60.12 Favored Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 126.413 1.885 . . . . 0.0 106.486 161.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -59.1 -23.31 68.39 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 CA-C-N 121.021 1.4 . . . . 0.0 111.45 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -68.03 -39.99 82.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.208 1.803 . . . . 0.0 112.895 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.9 tt -146.42 130.77 10.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 119.527 1.058 . . . . 0.0 108.468 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.97 145.66 31.62 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 123.579 0.55 . . . . 0.0 109.525 -160.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.4 m -94.97 151.56 19.07 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.15 152.97 49.89 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 125.053 1.341 . . . . 0.0 109.803 173.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 pp -141.61 154.65 45.54 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.191 1.396 . . . . 0.0 108.824 163.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -145.68 155.46 43.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.678 1.591 . . . . 0.0 108.92 171.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -133.68 149.35 51.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.946 1.698 . . . . 0.0 107.733 166.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -135.12 167.81 20.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.454 1.502 . . . . 0.0 108.857 167.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 18.0 t80 . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 168.228 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.839 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 18.5 ttt -104.64 148.06 26.96 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 169.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.8 pp -130.64 160.81 33.13 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.334 0.654 . . . . 0.0 111.4 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.39 158.11 44.92 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.589 1.155 . . . . 0.0 108.531 163.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 pp -149.54 156.03 41.29 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.326 1.451 . . . . 0.0 108.712 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.16 175.19 40.29 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 112.271 -0.332 . . . . 0.0 112.271 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.25 145.07 27.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 170.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.8 p -154.18 151.66 29.47 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.275 0.943 . . . . 0.0 110.743 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -106.15 149.83 26.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.342 1.857 . . . . 0.0 108.961 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.12 156.13 46.69 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 127.211 2.204 . . . . 0.0 109.949 171.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 44.6 t80 . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 159.386 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.41 ' H ' ' ND2' ' A' ' 5' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 121.221 0.534 . . . . 0.0 112.047 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.5 p -154.13 161.59 41.77 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.516 1.926 . . . . 0.0 109.226 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -134.86 149.37 50.31 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.385 1.474 . . . . 0.0 107.462 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -134.85 144.77 47.75 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.79 2.036 . . . . 0.0 108.802 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -150.08 135.16 17.88 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.906 -1.121 . . . . 0.0 108.682 171.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.09 -155.42 11.53 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.717 0.675 . . . . 0.0 112.748 -160.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.77 162.88 33.64 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.843 1.257 . . . . 0.0 111.0 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -139.5 142.22 37.3 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.76 1.624 . . . . 0.0 108.83 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.1 139.32 53.88 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.512 1.925 . . . . 0.0 106.524 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.92 148.27 19.0 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.615 1.102 . . . . 0.0 111.43 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -137.78 129.44 28.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.012 2.125 . . . . 0.0 107.493 -167.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.24 0.592 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.105 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 CA--C 1.523 -0.077 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.41 -169.59 42.6 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.9 170.55 18.54 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.371 1.068 . . . . 0.0 108.741 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.36 -179.14 43.02 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.67 159.09 15.23 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -144.16 156.65 44.42 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.287 0.635 . . . . 0.0 111.113 -162.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.15 171.9 39.83 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 170.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.12 166.3 39.38 Favored Glycine 0 C--N 1.331 0.261 0 CA-C-N 117.778 0.789 . . . . 0.0 111.546 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -148.8 133.37 17.72 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.022 0.929 . . . . 0.0 109.318 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -121.76 154.84 36.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.235 0.333 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.835 -172.606 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 t . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.894 0.378 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.48 -161.43 11.47 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.082 1.325 . . . . 0.0 112.163 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -136.44 155.83 49.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.696 1.198 . . . . 0.0 109.021 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -147.38 149.06 32.02 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.72 1.208 . . . . 0.0 108.223 -169.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 73.3 mtp -151.16 171.9 16.64 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.995 0.918 . . . . 0.0 110.898 -162.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.51 179.02 40.13 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 119.523 -0.598 . . . . 0.0 111.959 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 71.9 t80 . . . . . 0 CA--C 1.535 0.396 0 C-N-CA 126.047 1.739 . . . . 0.0 110.29 -175.162 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.375 0 N-CA-C 113.849 0.3 . . . . 0.0 113.849 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 m -146.15 164.7 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.819 2.047 . . . . 0.0 110.058 173.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -120.62 146.4 46.41 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 163.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.54 116.54 7.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.289 1.436 . . . . 0.0 108.518 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.84 145.67 27.61 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.809 -0.557 . . . . 0.0 110.376 -169.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.48 22.69 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.967 0.907 . . . . 0.0 108.978 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.528 ' HE2' ' CE1' ' A' ' 94' ' ' TYR . 86.7 tttt -142.16 138.31 31.48 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.752 1.221 . . . . 0.0 108.69 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.89 146.55 34.17 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 123.113 0.565 . . . . 0.0 109.505 169.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.402 ' HA3' ' CD1' ' A' ' 94' ' ' TYR . . . 168.5 170.22 32.91 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 118.409 0.549 . . . . 0.0 113.623 -174.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -157.97 157.2 29.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.285 1.034 . . . . 0.0 111.607 -166.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.01 131.12 13.92 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.463 2.775 . . . . 0.0 110.521 172.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 pt . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 124.511 1.125 . . . . 0.0 112.865 -178.466 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.6 tp . . . . . 0 C--O 1.234 0.247 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -106.85 111.9 24.62 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.244 1.018 . . . . 0.0 108.531 -170.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.66 143.91 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 121.85 -0.531 . . . . 0.0 110.002 -166.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.528 ' CE1' ' HE2' ' A' ' 82' ' ' LYS . 77.5 m-85 -137.89 158.86 43.48 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.707 0.765 . . . . 0.0 112.869 -166.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.7 m -124.43 147.09 48.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 128.429 2.692 . . . . 0.0 106.179 166.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.28 144.22 31.38 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.059 0.944 . . . . 0.0 108.996 -171.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.1 tt -149.07 147.48 28.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.339 1.056 . . . . 0.0 109.188 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.9 -140.68 7.68 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.19 176.42 28.83 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-O 122.222 0.901 . . . . 0.0 112.789 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -140.0 157.44 45.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.31 1.044 . . . . 0.0 109.087 169.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.5 t -130.26 128.29 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -150.72 110.11 3.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 71.3 p . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.43 155.76 36.54 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.76 2.307 . . . . 0.0 110.086 166.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.8 124.54 2.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 124.913 1.285 . . . . 0.0 108.288 169.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -133.35 145.86 50.76 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 167.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.89 170.78 21.57 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.923 0.889 . . . . 0.0 110.468 -164.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -126.34 165.2 19.63 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 161.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.16 175.5 43.5 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 118.149 0.974 . . . . 0.0 113.187 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.0 m -133.44 140.64 46.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.242 1.417 . . . . 0.0 107.43 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.41 ' CD ' ' HE ' ' A' ' 138' ' ' ARG . 40.4 mt-10 -136.63 148.01 47.21 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.591 1.157 . . . . 0.0 108.092 -169.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -149.97 166.14 30.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.917 0.887 . . . . 0.0 110.385 -168.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.82 143.81 51.11 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 125.159 1.383 . . . . 0.0 109.603 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.56 -26.81 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.012 0.525 . . . . 0.0 110.104 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 91.0 m 139.06 -64.46 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.776 1 C-N-CA 132.894 4.478 . . . . 0.0 106.879 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -67.35 179.81 2.27 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.833 1.689 . . . . 0.0 109.943 159.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -52.81 -3.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 130.542 3.537 . . . . 0.0 117.914 -165.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 68.5 mt -87.61 138.08 19.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.95 161.52 34.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.719 0.808 . . . . 0.0 109.682 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.5 m -135.28 148.91 49.68 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.474 1.509 . . . . 0.0 107.799 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.41 ' HE ' ' CD ' ' A' ' 128' ' ' GLU . 33.5 mtp-105 -135.32 146.13 48.14 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.708 1.203 . . . . 0.0 108.928 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.6 125.66 38.67 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 164.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -140.01 123.58 17.2 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -169.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -120.68 138.03 54.16 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.149 1.78 . . . . 0.0 109.842 -172.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.14 114.97 16.99 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.621 1.968 . . . . 0.0 107.867 -167.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.5 t80 . . . . . 0 CA--C 1.533 0.298 0 C-N-CA 124.422 1.089 . . . . 0.0 109.346 179.228 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -152.44 141.83 21.6 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.965 0.883 . . . . 0.0 109.391 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.0 tp -118.82 154.33 33.05 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.553 1.941 . . . . 0.0 107.484 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.9 p -153.77 162.1 41.52 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.299 -0.875 . . . . 0.0 111.785 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 7.0 tt -132.52 149.82 52.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.192 2.197 . . . . 0.0 106.767 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.01 162.77 27.8 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 170.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.6 t -139.79 142.75 31.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 8.0 t -151.46 167.92 26.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.711 0.687 . . . . 0.0 110.734 -167.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -115.81 127.71 55.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.016 2.126 . . . . 0.0 106.303 167.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -89.63 137.59 32.2 Favored 'General case' 0 C--N 1.337 0.063 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 170.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 . . . . . 0 C--O 1.236 0.381 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -178.103 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.2 m -121.71 155.32 35.47 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.11 1.364 . . . . 0.0 108.795 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -121.37 129.6 53.14 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.294 1.438 . . . . 0.0 108.01 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -113.13 143.34 44.52 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.993 1.317 . . . . 0.0 107.95 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 t -150.35 158.2 43.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.384 0.993 . . . . 0.0 111.514 159.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.04 -141.59 6.41 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 125.4 1.476 . . . . 0.0 110.041 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.67 155.29 44.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.95 0.375 . . . . 0.0 111.606 -164.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.44 159.81 41.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.144 0.978 . . . . 0.0 111.617 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp -109.75 158.96 17.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.204 1.802 . . . . 0.0 106.411 164.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -129.89 165.35 22.36 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 124.966 1.27 . . . . 0.0 109.933 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -148.3 148.34 30.31 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.462 0.169 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.744 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 121.929 0.871 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.2 175.68 36.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.841 2.162 . . . . 0.0 109.127 170.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.03 166.3 32.88 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.026 0.93 . . . . 0.0 110.399 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.37 175.69 44.84 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.482 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.81 157.34 16.78 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.635 1.174 . . . . 0.0 107.883 164.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -151.44 166.2 31.8 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.729 0.776 . . . . 0.0 111.796 175.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.25 171.85 39.9 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.62 166.2 39.18 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -121.06 119.84 33.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 173.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.13 160.34 25.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.414 0.685 . . . . 0.0 109.428 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 124.364 1.066 . . . . 0.0 111.387 -170.578 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.14 -162.3 30.38 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 118.756 0.707 . . . . 0.0 113.695 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -126.68 155.3 42.85 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.997 1.319 . . . . 0.0 108.113 166.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -149.16 158.12 43.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.863 1.265 . . . . 0.0 108.455 -169.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.0 mtt -146.1 152.56 39.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.124 1.77 . . . . 0.0 108.731 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -136.73 157.69 23.79 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 103.183 -2.895 . . . . 0.0 103.183 -177.492 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.227 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -143.43 163.05 16.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 123.138 0.575 . . . . 0.0 110.33 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -147.29 155.97 42.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.564 1.145 . . . . 0.0 109.808 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 pp -143.73 144.44 31.84 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.238 1.415 . . . . 0.0 107.797 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 t -154.03 153.16 31.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.588 0.709 . . . . 0.0 111.401 -169.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.71 151.67 24.26 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 158.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -135.74 135.46 40.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.303 1.441 . . . . 0.0 108.622 -171.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.3 tp -133.52 168.29 18.9 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 128.023 2.529 . . . . 0.0 107.478 -176.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.53 -176.9 39.71 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -143.8 142.21 20.15 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 168.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.42 157.58 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.053 1.835 . . . . 0.0 112.909 -161.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--N 1.346 0.42 0 C-N-CA 131.447 3.899 . . . . 0.0 110.637 162.775 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 121.526 0.679 . . . . 0.0 112.41 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.97 148.3 25.38 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 tp -90.91 144.04 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 167.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -137.09 134.91 36.98 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.694 1.598 . . . . 0.0 108.519 -164.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.8 m -137.62 147.18 44.78 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -151.67 142.78 23.19 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.881 -0.512 . . . . 0.0 110.687 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 mp -141.59 140.29 33.33 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.518 1.127 . . . . 0.0 108.826 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.96 -150.27 8.22 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 117.757 0.253 . . . . 0.0 113.006 -164.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.83 161.63 24.34 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.653 1.12 . . . . 0.0 112.017 170.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.6 ptm -141.6 149.67 41.03 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.567 1.547 . . . . 0.0 109.973 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.1 127.06 19.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 125.295 1.438 . . . . 0.0 107.664 -167.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -138.47 135.68 35.41 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 117.789 0.268 . . . . 0.0 110.504 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.167 0 C-N-CA 124.174 0.99 . . . . 0.0 109.515 172.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.213 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.538 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.14 167.18 27.5 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.8 2.334 . . . . 0.0 109.925 164.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.25 153.24 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 165.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -143.37 152.34 41.49 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.465 1.506 . . . . 0.0 106.986 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.92 168.64 19.16 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.142 0.577 . . . . 0.0 110.051 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.12 164.46 32.36 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 170.79 -133.21 2.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -173.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.73 162.21 35.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 118.471 1.135 . . . . 0.0 111.615 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -139.93 144.57 37.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.136 1.774 . . . . 0.0 109.048 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -153.17 164.68 37.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.132 0.573 . . . . 0.0 110.925 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.41 143.06 43.76 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 161.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 tp -113.07 -2.93 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.18 0.992 . . . . 0.0 111.084 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.8 m -161.58 136.97 5.66 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 102.806 -3.035 . . . . 0.0 102.806 168.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.72 -23.93 69.25 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.894 1.729 . . . . 0.0 113.905 -161.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.68 -2.07 49.13 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 36.5 pt -127.38 163.39 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.87 0.868 . . . . 0.0 109.79 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.61 169.22 18.05 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.882 0.873 . . . . 0.0 109.127 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.1 m -149.46 138.69 21.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -137.91 145.89 42.65 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.852 1.261 . . . . 0.0 107.63 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.91 140.15 25.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 167.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -136.42 161.09 36.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.95 1.3 . . . . 0.0 110.803 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -136.51 152.35 50.43 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.279 2.232 . . . . 0.0 108.995 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -141.86 148.33 38.62 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.438 2.295 . . . . 0.0 107.35 172.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 C--O 1.237 0.396 0 C-N-CA 125.503 1.521 . . . . 0.0 107.617 172.239 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 CA-C-O 121.993 0.774 . . . . 0.0 113.205 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 54.5 ttm -144.67 151.67 39.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.143 1.777 . . . . 0.0 107.558 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.9 pp -139.68 162.41 35.17 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.128 0.971 . . . . 0.0 110.04 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.1 m -139.16 155.93 47.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.774 0.829 . . . . 0.0 109.741 165.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 16.1 tp -149.96 119.3 6.85 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.708 2.003 . . . . 0.0 107.4 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -152.89 171.22 31.96 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 121.718 0.621 . . . . 0.0 114.26 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.08 160.38 33.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 126.278 1.831 . . . . 0.0 109.282 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.0 m -152.46 161.99 41.82 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 121.52 -0.738 . . . . 0.0 111.504 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -97.49 152.45 18.98 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.062 1.745 . . . . 0.0 107.365 161.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.83 116.18 27.55 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.21 1.004 . . . . 0.0 110.485 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 64.1 t80 . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 124.522 1.129 . . . . 0.0 113.154 -171.829 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.312 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 m -117.7 124.51 48.69 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -104.14 156.42 17.9 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -142.71 156.94 45.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.944 1.698 . . . . 0.0 109.131 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.0 t -150.27 158.64 44.38 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.89 0.768 . . . . 0.0 111.519 162.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.65 -134.34 3.1 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.105 0.86 . . . . 0.0 112.296 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.09 147.74 50.54 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.236 1.014 . . . . 0.0 110.627 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -129.36 139.52 51.68 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.0 mp -115.12 159.5 20.81 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.472 1.909 . . . . 0.0 107.311 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.77 157.52 27.31 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -138.35 149.85 46.0 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.537 1.135 . . . . 0.0 108.358 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.6 p . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 125.0 1.32 . . . . 0.0 108.248 176.755 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.3 tp . . . . . 0 N--CA 1.464 0.258 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.2 -167.26 39.74 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 119.584 1.084 . . . . 0.0 113.625 -174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.07 169.22 19.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.154 1.382 . . . . 0.0 109.908 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.41 170.21 38.74 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.072 0.844 . . . . 0.0 112.048 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.46 143.76 26.52 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 171.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -144.97 165.2 28.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.76 152.56 20.33 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 127.309 2.385 . . . . 0.0 109.322 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.89 151.93 19.21 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -148.35 105.72 3.65 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -172.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -122.59 142.14 50.95 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.743 0.701 . . . . 0.0 111.097 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 123.812 0.845 . . . . 0.0 112.24 -164.909 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 122.178 0.99 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.55 -166.9 18.55 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 127.663 2.554 . . . . 0.0 109.087 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -135.53 163.66 29.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.171 1.388 . . . . 0.0 108.886 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -148.04 152.38 37.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.364 1.066 . . . . 0.0 108.304 164.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 50.4 mtt -149.49 157.11 42.99 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.534 1.134 . . . . 0.0 108.068 -169.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.47 176.52 43.4 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 119.06 0.846 . . . . 0.0 113.08 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.7 t80 . . . . . 0 C--O 1.236 0.394 0 C-N-CA 125.572 1.549 . . . . 0.0 109.376 -172.393 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.323 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.7 p -143.87 148.5 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -132.05 130.23 41.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.386 1.874 . . . . 0.0 107.013 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -120.38 150.32 40.95 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 159.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -154.98 132.24 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 120.598 -1.314 . . . . 0.0 109.08 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.12 140.03 31.27 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 164.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -117.72 114.36 23.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.21 136.64 40.09 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.867 0.758 . . . . 0.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.93 -148.53 17.14 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 118.582 -1.121 . . . . 0.0 110.634 -166.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -159.32 157.43 27.24 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 118.508 1.154 . . . . 0.0 112.415 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.33 153.54 69.73 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.323 2.682 . . . . 0.0 111.911 161.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 124.832 1.253 . . . . 0.0 108.5 171.118 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -134.93 164.02 28.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.024 2.13 . . . . 0.0 109.544 -172.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.39 129.2 73.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.657 1.583 . . . . 0.0 106.899 173.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -137.98 153.36 49.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.085 0.945 . . . . 0.0 111.768 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 51.9 m -96.9 132.41 42.69 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 159.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -99.31 108.93 21.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 167.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tt -98.96 107.53 19.99 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.07 142.01 15.39 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.113 0.863 . . . . 0.0 112.502 -164.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.66 95.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 105.929 -2.868 . . . . 0.0 105.929 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.1 ptp -134.23 157.04 47.29 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.275 0.63 . . . . 0.0 110.304 -171.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.2 p -148.25 150.38 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -117.62 156.17 28.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.602 1.961 . . . . 0.0 107.319 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 . . . . . 0 N--CA 1.452 -0.373 0 C-N-CA 123.378 0.671 . . . . 0.0 109.698 175.726 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 C--O 1.236 0.393 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.5 158.08 24.6 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.019 1.146 . . . . 0.0 109.708 158.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.2 p -167.24 -178.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.192 1.797 . . . . 0.0 107.752 -172.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -139.01 164.8 28.8 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.596 -1.315 . . . . 0.0 109.694 163.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.77 160.6 40.99 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.199 1.8 . . . . 0.0 108.403 172.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -124.36 145.94 16.04 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.24 -162.37 29.15 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 117.915 0.857 . . . . 0.0 114.615 -169.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.97 158.51 30.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 127.301 2.24 . . . . 0.0 108.38 -169.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -135.56 146.55 48.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.157 1.383 . . . . 0.0 107.568 165.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -150.16 122.88 8.63 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.811 0.844 . . . . 0.0 110.077 -162.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -135.75 82.43 1.95 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.787 2.035 . . . . 0.0 109.201 -172.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.64 -31.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.129 0.972 . . . . 0.0 112.931 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.0 p -136.65 155.08 76.95 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.972 1.309 . . . . 0.0 107.832 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.05 60.76 6.99 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.152 3.234 . . . . 0.0 111.33 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -148.07 -33.54 0.24 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.468 2.307 . . . . 0.0 111.395 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.16 149.58 21.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 127.21 2.204 . . . . 0.0 108.131 -166.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.0 109.12 5.24 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.138 0.881 . . . . 0.0 108.871 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.65 149.03 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.435 1.894 . . . . 0.0 106.99 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.6 157.75 46.04 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.277 0.944 . . . . 0.0 110.592 168.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 37.7 tp -154.44 119.52 5.0 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 125.67 1.588 . . . . 0.0 107.266 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.34 156.45 45.84 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.365 1.066 . . . . 0.0 111.423 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -134.01 152.96 52.06 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.474 1.51 . . . . 0.0 109.801 -173.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -145.15 158.34 43.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.555 1.542 . . . . 0.0 109.915 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 60.1 t80 . . . . . 0 CA--C 1.534 0.339 0 C-N-CA 126.089 1.755 . . . . 0.0 107.372 -177.693 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.837 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -140.96 157.76 44.89 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 pp -140.22 162.37 35.42 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.434 0.694 . . . . 0.0 111.136 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.3 m -135.02 155.85 50.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 160.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 158.64 44.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 169.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -163.6 170.14 38.85 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.25 136.78 41.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.5 p -144.43 166.78 24.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -117.21 154.07 31.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 166.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 -89.76 158.65 17.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.221 0.534 . . . . 0.0 111.56 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 47.2 t80 . . . . . 0 CA--C 1.537 0.45 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.92 161.509 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.341 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.5 m -130.94 122.13 26.39 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 165.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -102.13 157.99 16.49 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -146.16 159.8 42.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.117 1.367 . . . . 0.0 109.253 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -149.86 161.58 41.99 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 159.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.37 -151.41 20.15 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.06 158.75 42.79 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.307 0.643 . . . . 0.0 110.543 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HE3' ' CZ ' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -136.66 150.38 48.47 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.026 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.79 162.85 32.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.812 1.645 . . . . 0.0 107.957 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.38 157.52 22.34 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 119.198 -0.779 . . . . 0.0 112.105 -170.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -144.11 152.23 40.66 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.906 1.282 . . . . 0.0 110.902 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 127.669 2.388 . . . . 0.0 112.023 173.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.11 167.79 28.34 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.568 0.604 . . . . 0.0 112.167 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.3 153.44 29.05 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.641 1.576 . . . . 0.0 110.078 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.79 163.4 32.34 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.298 1.427 . . . . 0.0 111.253 168.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.4 140.34 49.22 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.011 1.724 . . . . 0.0 108.574 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -134.66 158.91 42.85 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -159.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.99 143.39 14.83 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 127.302 2.382 . . . . 0.0 107.801 160.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.38 161.65 26.51 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.931 0.866 . . . . 0.0 112.102 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -149.1 143.97 26.36 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.067 1.347 . . . . 0.0 109.771 -171.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -122.04 123.21 41.08 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 158.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -158.752 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t . . . . . 0 C--O 1.238 0.491 0 CA-C-O 121.994 0.902 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.48 -179.57 26.37 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.009 0.814 . . . . 0.0 111.805 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.25 163.27 34.98 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.533 1.533 . . . . 0.0 108.835 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -151.82 159.94 43.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 162.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 77.6 mtm -143.44 156.39 44.64 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -155.4 170.68 33.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.878 -0.201 . . . . 0.0 112.608 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.496 0 C-N-CA 124.483 1.113 . . . . 0.0 110.027 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.308 0 CA-C-O 117.618 -1.657 . . . . 0.0 114.03 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.83 155.36 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.983 1.392 . . . . 0.0 110.934 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -133.75 148.26 51.39 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.968 2.107 . . . . 0.0 108.178 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 pp -143.14 152.11 41.44 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.209 1.003 . . . . 0.0 110.961 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 m -155.68 152.07 28.18 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.706 1.202 . . . . 0.0 112.36 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.23 136.08 54.85 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.717 2.407 . . . . 0.0 106.975 159.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -118.56 153.54 34.06 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.977 0.911 . . . . 0.0 110.147 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.14 133.47 52.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 161.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.7 164.98 10.11 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -167.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -161.24 168.87 10.73 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.142 -163.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -62.96 95.46 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 124.154 3.236 . . . . 0.0 110.74 168.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.7 tt . . . . . 0 CA--C 1.533 0.308 0 C-N-CA 123.077 0.551 . . . . 0.0 110.895 -172.729 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.7 mt . . . . . 0 C--O 1.233 0.194 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.72 111.79 21.03 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 166.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.6 137.17 41.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -153.5 166.73 31.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.551 1.167 . . . . 0.0 113.784 -170.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.6 t -129.73 153.45 48.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 158.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.28 155.73 41.68 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.996 -0.44 . . . . 0.0 110.34 -166.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.6 tt -127.8 138.12 52.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.13 -160.1 15.13 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -170.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.99 176.38 47.93 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-O 121.341 0.412 . . . . 0.0 112.299 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -116.33 144.64 43.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.238 1.815 . . . . 0.0 107.699 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.1 t -129.28 94.17 2.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 160.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -129.13 138.73 51.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 N--CA 1.451 -0.386 0 O-C-N 121.767 -0.583 . . . . 0.0 110.867 -174.183 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -79.28 168.89 19.64 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.931 2.42 . . . . 0.0 110.74 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.4 t -136.33 139.86 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.087 1.355 . . . . 0.0 107.879 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -127.77 118.69 24.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.711 2.004 . . . . 0.0 106.307 160.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.11 166.47 24.56 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.661 -0.649 . . . . 0.0 111.909 -168.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -120.75 158.51 15.65 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 166.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.79 175.23 47.43 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 118.361 1.081 . . . . 0.0 113.412 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.7 m -138.97 135.35 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.463 1.105 . . . . 0.0 108.73 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -105.83 110.74 23.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.534 2.734 . . . . 0.0 105.347 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.91 110.46 22.13 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.16 81.46 1.79 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 47.1 pt -69.36 -3.62 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.154 0.982 . . . . 0.0 112.632 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 45.0 m -154.43 149.71 20.78 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 163.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.54 -7.8 9.62 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.306 2.004 . . . . 0.0 115.855 -171.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -111.49 -12.54 13.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.16 1.384 . . . . 0.0 113.577 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 pp -139.34 147.94 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 121.764 2.075 . . . . 0.0 111.379 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.7 161.1 37.4 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.38 0.672 . . . . 0.0 109.293 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 73.9 m -130.96 135.97 48.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.439 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 6.0 ptp180 -122.19 159.54 27.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 pp -135.02 145.06 47.69 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 125.112 1.508 . . . . 0.0 107.311 159.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.54 162.08 41.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.884 1.274 . . . . 0.0 109.664 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -154.56 154.84 33.73 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.12 0.568 . . . . 0.0 111.118 -165.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -138.22 160.05 40.45 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.301 1.84 . . . . 0.0 107.288 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 . . . . . 0 CA--C 1.53 0.202 0 C-N-CA 124.953 1.301 . . . . 0.0 108.455 -179.245 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -105.65 159.28 16.09 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.042 0.937 . . . . 0.0 110.034 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.73 117.37 17.75 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 164.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.2 m -129.39 160.86 31.77 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.6 pp -144.39 167.08 23.31 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.941 1.296 . . . . 0.0 110.294 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.63 175.24 40.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.814 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.32 148.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 124.592 1.157 . . . . 0.0 108.484 163.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 70.8 m -145.6 118.69 8.84 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -169.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -82.57 123.83 29.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 171.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -90.14 124.95 35.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.82 1.648 . . . . 0.0 106.74 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 70.1 t80 . . . . . 0 C--O 1.235 0.303 0 C-N-CA 123.591 0.756 . . . . 0.0 110.858 -175.474 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.34 68.1 5.21 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.715 2.943 . . . . 0.0 110.107 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -123.26 29.82 6.55 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.518 1.927 . . . . 0.0 109.667 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -43.91 -51.2 7.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 128.31 2.644 . . . . 0.0 110.165 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -77.59 112.06 13.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 166.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -130.25 127.06 38.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.298 1.039 . . . . 0.0 108.355 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -82.62 157.95 23.21 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.023 1.329 . . . . 0.0 110.654 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.414 ' CZ ' ' HA3' ' A' ' 42' ' ' GLY . 43.2 p90 -151.68 164.54 36.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.761 2.025 . . . . 0.0 109.7 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -130.98 167.38 19.13 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.176 1.39 . . . . 0.0 108.486 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.82 175.39 40.78 Favored Glycine 0 C--N 1.334 0.435 0 O-C-N 121.474 -0.766 . . . . 0.0 112.087 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.33 147.89 31.81 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.291 1.036 . . . . 0.0 109.267 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.535 ' HE2' ' CE1' ' A' ' 40' ' ' PHE . 40.4 mtmt -132.64 164.83 25.83 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.842 1.257 . . . . 0.0 112.308 -169.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.16 150.09 41.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 128.451 2.7 . . . . 0.0 106.363 159.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.77 163.66 29.07 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 119.366 0.985 . . . . 0.0 114.006 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -143.53 136.85 28.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.002 2.121 . . . . 0.0 109.338 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.7 m -142.16 85.02 1.9 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 125.219 1.408 . . . . 0.0 110.791 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 141.26 50.03 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 158.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -169.27 101.98 0.36 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.6 150.49 31.31 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 158.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t70 134.92 -29.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 130.798 3.639 . . . . 0.0 107.864 -158.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 69.2 p -129.35 102.25 6.34 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 162.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.93 -130.15 1.11 Allowed Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.44 0.563 . . . . 0.0 112.291 -170.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -153.2 4.18 0.32 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.621 1.568 . . . . 0.0 114.357 -167.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.308 7.8 pt 58.61 130.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 130.093 3.357 . . . . 0.0 114.096 -164.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.43 170.5 15.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.625 1.17 . . . . 0.0 110.063 168.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -85.46 -112.53 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 166.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -60.04 153.82 20.65 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.928 1.24 . . . . 0.0 108.684 158.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 139.17 99.55 0.45 Allowed Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -170.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.12 65.17 5.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.668 2.912 . . . . 0.0 109.966 174.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.3 m -60.1 146.45 43.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.423 1.489 . . . . 0.0 109.615 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -150.54 141.76 23.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.185 -160.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.407 ' OE1' ' HE2' ' A' ' 73' ' ' LYS . 1.8 tm-20 -85.98 -74.78 0.4 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 166.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -27.87 44.23 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.315 -172.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 69.78 -73.78 0.09 Allowed 'General case' 0 C--N 1.347 0.457 0 C-N-CA 125.984 1.714 . . . . 0.0 110.786 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 pp -159.0 169.49 24.18 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.557 1.143 . . . . 0.0 110.299 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.54 -176.75 44.05 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.79 171.96 13.65 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.366 1.867 . . . . 0.0 108.171 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.61 170.18 38.09 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.906 -1.14 . . . . 0.0 114.695 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.42 137.5 30.43 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.098 1.759 . . . . 0.0 109.059 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.535 ' CE1' ' HE2' ' A' ' 12' ' ' LYS . 46.3 m-85 -139.57 151.8 46.36 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.025 1.33 . . . . 0.0 111.159 -166.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.69 157.91 16.47 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 126.946 2.213 . . . . 0.0 107.884 163.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' HA3' ' CZ ' ' A' ' 8' ' ' TYR . . . -168.57 166.86 39.9 Favored Glycine 0 N--CA 1.449 -0.438 0 O-C-N 121.344 -1.092 . . . . 0.0 111.054 -174.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -140.34 165.85 26.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.209 0.505 . . . . 0.0 110.837 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -115.18 162.61 16.81 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.815 1.646 . . . . 0.0 107.883 162.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 p -126.59 91.94 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 159.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 57.3 176.73 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 127.54 2.336 . . . . 0.0 112.742 -167.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.9 74.4 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.558 2.172 . . . . 0.0 109.371 160.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -143.96 -72.97 0.27 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.388 1.475 . . . . 0.0 109.127 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.5 m -141.95 166.13 17.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.972 0.909 . . . . 0.0 109.315 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.28 -164.79 19.19 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -139.96 163.04 33.73 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.71 1.604 . . . . 0.0 110.13 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -149.85 127.85 11.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.441 1.896 . . . . 0.0 107.613 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -134.78 125.58 27.21 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.422 1.889 . . . . 0.0 108.211 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.515 ' HA3' ' CD2' ' A' ' 40' ' ' PHE . . . -170.59 -179.22 41.82 Favored Glycine 0 C--N 1.333 0.366 0 O-C-N 121.697 -0.627 . . . . 0.0 113.027 -175.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -119.13 115.76 24.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.388 1.475 . . . . 0.0 107.646 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -98.04 133.31 42.68 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 158.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -161.35 176.63 10.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.242 1.017 . . . . 0.0 110.714 -173.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.5 tp -126.71 101.45 6.63 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.733 1.613 . . . . 0.0 106.908 170.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.37 58.97 1.97 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.753 1.168 . . . . 0.0 112.085 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 58.22 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.905 2.482 . . . . 0.0 110.728 -171.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.7 mtm -138.16 110.76 8.46 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 160.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.63 -12.31 33.09 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.346 2.031 . . . . 0.0 112.83 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.21 -28.01 56.77 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.643 1.577 . . . . 0.0 112.569 165.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 61.45 -15.82 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.558 2.343 . . . . 0.0 115.522 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.28 79.83 0.22 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 166.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 t 70.58 178.02 0.26 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.511 1.924 . . . . 0.0 110.786 -161.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.3 m -143.0 161.95 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 126.13 1.772 . . . . 0.0 109.103 -172.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -67.02 153.96 42.36 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.38 1.085 . . . . 0.0 108.171 167.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.04 -28.79 35.25 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.888 2.075 . . . . 0.0 113.305 -170.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 167.39 178.22 39.46 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.001 1.762 . . . . 0.0 109.689 -168.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 59.41 -8.53 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.763 2.825 . . . . 0.0 116.616 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -57.3 150.03 18.96 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.292 1.837 . . . . 0.0 111.409 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.407 ' HE2' ' OE1' ' A' ' 32' ' ' GLU . 9.0 mptt -76.71 70.51 3.21 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.824 1.25 . . . . 0.0 110.547 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.06 -56.13 4.23 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 126.44 1.896 . . . . 0.0 114.534 -167.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -161.1 165.49 29.55 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 121.664 0.745 . . . . 0.0 111.32 -170.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.57 177.21 46.78 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -138.21 141.37 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -122.95 132.66 54.26 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 167.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.61 110.68 10.06 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.151 1.381 . . . . 0.0 107.439 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.9 p -137.17 143.03 42.2 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.31 0.644 . . . . 0.0 111.693 -161.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.01 149.24 25.72 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 160.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.08 156.64 45.95 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.667 0.787 . . . . 0.0 111.759 -171.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.7 tp -133.78 125.38 28.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.959 2.504 . . . . 0.0 105.773 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.82 137.85 9.57 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 106.954 -2.458 . . . . 0.0 106.954 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -138.2 133.92 17.51 Favored Pre-proline 0 C--O 1.237 0.397 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.459 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -67.1 143.95 67.42 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.434 2.756 . . . . 0.0 110.536 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.37 -4.34 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.195 0.598 . . . . 0.0 111.368 168.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.8 m -160.57 165.17 31.24 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.593 2.757 . . . . 0.0 104.101 166.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -70.34 50.76 0.12 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.283 1.833 . . . . 0.0 110.48 168.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -151.31 -56.17 0.15 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.858 2.063 . . . . 0.0 109.368 -170.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 pp -143.34 158.06 43.95 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.962 0.887 . . . . 0.0 112.643 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -114.18 149.05 36.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.717 2.807 . . . . 0.0 108.826 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -90.68 137.17 22.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 163.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -127.88 144.66 51.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.682 1.193 . . . . 0.0 110.791 -162.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 48.9 m -154.7 148.38 25.39 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.564 1.146 . . . . 0.0 108.462 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -147.76 155.56 41.83 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.666 0.786 . . . . 0.0 110.57 175.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -153.46 158.68 41.72 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.314 1.045 . . . . 0.0 111.003 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.97 -130.92 2.35 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.56 162.5 18.73 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.175 0.893 . . . . 0.0 112.479 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -143.88 149.94 37.68 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.595 1.558 . . . . 0.0 109.783 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.66 150.12 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.504 1.921 . . . . 0.0 107.754 168.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -150.85 143.09 24.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.598 1.159 . . . . 0.0 111.061 -165.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -143.3 148.34 36.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.523 1.129 . . . . 0.0 110.538 167.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.55 126.84 12.2 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.343 1.457 . . . . 0.0 110.796 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.64 103.46 3.04 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.695 0.798 . . . . 0.0 110.43 -165.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.53 16.12 5.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -159.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -53.79 109.76 0.5 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 162.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.2 t -162.73 -166.23 1.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.522 1.929 . . . . 0.0 107.187 -170.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -68.24 44.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.043 2.537 . . . . 0.0 112.519 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.7 t 50.89 -87.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 128.527 2.731 . . . . 0.0 111.333 -172.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -74.58 -30.22 61.63 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.779 1.231 . . . . 0.0 111.462 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -82.05 74.86 2.42 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.9 pttp -133.86 166.56 22.38 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.542 1.137 . . . . 0.0 112.292 -171.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -72.66 168.96 17.62 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.75 2.42 . . . . 0.0 111.921 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -68.2 119.56 12.96 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 158.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -85.23 -26.4 26.72 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.591 1.156 . . . . 0.0 113.747 -172.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.4 m -149.37 153.83 38.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -170.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -165.19 160.29 33.58 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 166.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.2 p -150.97 139.55 14.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 167.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.2 m -169.96 169.32 4.02 Favored Pre-proline 0 N--CA 1.467 0.375 0 C-N-CA 123.72 0.808 . . . . 0.0 110.513 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -64.83 163.28 28.6 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.544 1.496 . . . . 0.0 109.306 158.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.1 p -147.54 159.1 8.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 121.702 -0.624 . . . . 0.0 109.741 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -147.57 164.74 32.5 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.063 1.345 . . . . 0.0 109.42 168.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.62 165.77 35.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.705 1.202 . . . . 0.0 108.293 161.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -163.72 170.42 39.04 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 112.049 -0.42 . . . . 0.0 112.049 169.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 158.31 -116.36 0.71 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.1 157.51 28.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 117.94 0.87 . . . . 0.0 111.009 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -128.74 149.96 50.48 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 167.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.21 127.83 18.07 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.352 -0.842 . . . . 0.0 108.965 -158.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.37 136.55 37.7 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.89 -37.01 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.1 0.56 . . . . 0.0 109.656 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 47.3 m -159.83 156.25 23.97 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 103.021 -2.955 . . . . 0.0 103.021 164.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -57.14 -4.35 1.01 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 N-CA-C 118.836 2.591 . . . . 0.0 118.836 -163.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.18 0.26 10.64 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.373 1.869 . . . . 0.0 113.489 173.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.4 tt -134.7 141.96 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.621 1.569 . . . . 0.0 110.595 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.14 170.33 15.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.575 -0.703 . . . . 0.0 109.836 -168.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.3 p -128.12 160.18 32.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.157 0.983 . . . . 0.0 108.655 159.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -140.11 159.24 42.62 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.635 -0.666 . . . . 0.0 110.27 164.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.42 119.85 15.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -138.61 154.68 48.69 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.779 0.8 . . . . 0.0 111.151 -173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -141.83 148.68 39.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.723 2.009 . . . . 0.0 108.484 -162.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -142.4 119.2 11.17 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.88 154.13 49.49 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.236 1.414 . . . . 0.0 110.134 -167.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.3 t -150.26 167.27 27.44 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 158.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -77.63 81.04 4.09 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -44.89 141.18 2.27 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.335 1.854 . . . . 0.0 111.047 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mt -84.91 51.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -50.19 110.9 0.97 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 127.273 2.368 . . . . 0.0 113.656 -168.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.9 109.48 1.47 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.991 1.316 . . . . 0.0 109.848 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.27 170.11 23.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.272 -0.893 . . . . 0.0 110.68 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -57.66 126.49 27.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 158.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 26.2 m 50.59 73.14 0.29 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.032 1.333 . . . . 0.0 110.648 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.6 pt -55.88 -2.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 128.949 2.9 . . . . 0.0 116.756 -168.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.33 95.72 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 159.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.03 94.88 3.5 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.593 1.957 . . . . 0.0 108.412 -173.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.1 mtm105 -132.11 159.57 71.59 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 126.69 1.996 . . . . 0.0 107.129 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.67 -16.11 30.17 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.615 1.543 . . . . 0.0 112.466 171.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 47.81 28.27 1.3 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.232 1.813 . . . . 0.0 112.509 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -111.62 127.97 55.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.404 1.082 . . . . 0.0 109.217 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -73.04 179.92 37.91 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.267 1.413 . . . . 0.0 113.301 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 23.4 ptp -75.95 154.13 36.1 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 169.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -137.29 148.3 46.29 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.424 1.089 . . . . 0.0 108.929 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.3 p -143.1 158.23 43.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.901 0.48 . . . . 0.0 110.136 166.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -145.15 150.36 36.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.49 1.116 . . . . 0.0 109.149 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.17 175.09 40.31 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.66 160.28 3.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 126.735 2.014 . . . . 0.0 109.418 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.37 159.67 41.74 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.042 0.537 . . . . 0.0 109.616 167.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -140.62 140.67 35.1 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.972 1.309 . . . . 0.0 108.138 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.4 mtm105 -89.86 155.29 19.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.267 0.556 . . . . 0.0 110.721 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -69.4 115.96 9.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 167.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.49 -164.26 14.14 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.614 1.102 . . . . 0.0 112.266 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 66.19 159.8 0.13 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.244 2.218 . . . . 0.0 113.156 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 59.41 32.72 73.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.338 0.97 . . . . 0.0 112.958 176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -134.06 145.7 49.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.404 1.082 . . . . 0.0 109.063 -164.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -156.29 158.71 37.96 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.694 1.597 . . . . 0.0 108.247 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.503 1.521 . . . . 0.0 111.196 176.39 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -70.76 164.63 34.84 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.039 1.826 . . . . 0.0 110.704 171.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' HZ3' ' C ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -148.01 143.26 27.13 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 164.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -130.97 115.55 16.64 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -162.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.39 161.66 41.6 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.128 0.571 . . . . 0.0 111.711 -162.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.0 t -157.03 174.33 15.68 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 159.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -133.48 168.11 19.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.474 1.909 . . . . 0.0 109.07 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -139.46 155.9 47.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 109.717 -168.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.3 p -133.45 126.94 32.26 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.504 1.921 . . . . 0.0 107.015 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.56 -159.37 13.03 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 119.038 0.835 . . . . 0.0 113.565 -161.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.9 162.24 36.0 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.182 1.393 . . . . 0.0 109.916 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HE2' ' CE2' ' A' ' 40' ' ' PHE . 9.2 ttmm -141.65 143.56 33.69 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.803 1.641 . . . . 0.0 107.149 174.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 pp -145.77 145.07 30.68 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.532 0.733 . . . . 0.0 109.462 166.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.65 174.49 29.14 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 124.704 1.145 . . . . 0.0 112.932 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -149.36 167.23 26.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.538 0.735 . . . . 0.0 110.316 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 t -126.93 150.01 49.54 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.194 1.397 . . . . 0.0 107.992 165.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -72.49 170.46 14.28 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.796 1.238 . . . . 0.0 110.724 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -62.68 151.16 39.05 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 158.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.402 ' HA ' ' CE1' ' A' ' 31' ' ' HIS . 4.4 t-80 39.23 79.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.697 2.399 . . . . 0.0 113.639 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.65 -168.16 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.207 1.003 . . . . 0.0 111.719 163.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 t -56.29 -25.52 48.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.006 1.722 . . . . 0.0 113.2 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.92 -159.84 2.6 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.638 1.59 . . . . 0.0 112.347 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -139.89 166.13 25.46 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.473 -1.016 . . . . 0.0 108.58 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.9 pt -61.75 152.06 6.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 123.097 0.559 . . . . 0.0 110.256 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -78.48 79.48 4.91 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 121.903 -0.498 . . . . 0.0 110.5 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 62.33 -66.4 0.08 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.2 2.6 . . . . 0.0 114.286 161.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.19 -3.21 12.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.251 1.82 . . . . 0.0 111.659 -176.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.31 170.68 35.67 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 119.747 1.158 . . . . 0.0 112.117 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.91 -56.28 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.437 2.758 . . . . 0.0 113.257 -165.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p 56.57 -75.15 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.194 1.798 . . . . 0.0 112.691 -159.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.402 ' CE1' ' HA ' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -76.8 55.77 1.11 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.356 1.462 . . . . 0.0 113.106 -172.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.98 -17.09 33.89 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.947 0.899 . . . . 0.0 112.211 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -173.44 162.13 4.22 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.39 1.876 . . . . 0.0 108.079 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.27 157.22 46.86 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 158.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.98 153.51 46.89 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.034 1.334 . . . . 0.0 109.787 -174.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.64 144.73 12.58 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 160.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.05 121.65 2.43 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.94 170.05 39.84 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 121.702 0.612 . . . . 0.0 114.368 -172.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.77 139.93 30.6 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.419 ' CE2' ' HE2' ' A' ' 12' ' ' LYS . 8.0 m-85 -135.62 165.4 25.63 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.242 1.017 . . . . 0.0 110.758 -167.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.67 162.54 25.84 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.64 165.35 25.86 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -146.18 134.44 21.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.393 1.877 . . . . 0.0 106.284 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.09 118.89 29.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 159.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.72 -1.42 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -160.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -141.54 167.62 16.46 Favored Pre-proline 0 C--O 1.235 0.327 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.08 133.98 50.2 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 N-CA-C 107.059 -1.939 . . . . 0.0 107.059 158.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 63.32 -9.42 0.12 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 t -136.54 103.99 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 121.84 2.109 . . . . 0.0 111.127 -169.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.6 -168.42 26.52 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.943 1.735 . . . . 0.0 110.544 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -148.44 162.54 39.4 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.862 1.265 . . . . 0.0 108.543 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HG2' HH22 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -151.56 157.86 42.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.116 0.966 . . . . 0.0 110.42 171.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 64.5 mtt -146.48 152.76 39.53 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 125.799 1.639 . . . . 0.0 107.46 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.02 173.06 44.08 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 119.186 0.903 . . . . 0.0 113.178 170.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -126.51 116.25 20.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.543 1.937 . . . . 0.0 107.954 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.21 148.66 26.61 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 125.797 1.639 . . . . 0.0 108.907 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -144.97 118.86 9.29 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.41 -35.61 76.19 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 112.15 -167.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.42 150.4 12.07 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.48 118.07 15.99 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 90.0 mtp -60.5 147.82 82.13 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 118.906 -0.569 . . . . 0.0 109.784 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.82 69.47 4.52 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.681 2.921 . . . . 0.0 109.382 171.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -62.13 -28.12 69.42 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.193 0.997 . . . . 0.0 113.564 -162.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? 60.52 -61.32 0.07 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.641 3.176 . . . . 0.0 113.392 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.49 42.34 0.02 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 128.337 2.875 . . . . 0.0 108.034 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.6 m -70.99 167.88 18.23 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.129 0.972 . . . . 0.0 110.867 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.83 170.33 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.926 1.69 . . . . 0.0 107.192 168.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.259 9.5 pt-20 51.47 -24.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 130.691 3.596 . . . . 0.0 117.288 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -68.16 82.25 0.23 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.544 1.538 . . . . 0.0 109.669 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.9 -172.33 13.04 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.007 1.765 . . . . 0.0 110.809 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 59.99 172.47 0.09 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.814 2.046 . . . . 0.0 113.702 -173.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -73.48 131.16 41.48 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.828 1.251 . . . . 0.0 112.131 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -149.94 157.39 43.12 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.412 1.485 . . . . 0.0 110.075 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 41.12 60.22 2.08 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.457 2.303 . . . . 0.0 112.714 172.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -155.14 -179.55 8.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.785 0.834 . . . . 0.0 111.466 -166.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -160.44 -178.31 34.32 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 123.512 0.577 . . . . 0.0 111.851 172.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.16 146.03 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 126.458 1.903 . . . . 0.0 107.106 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -130.11 147.75 51.89 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.694 1.598 . . . . 0.0 108.012 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.34 125.79 10.18 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.961 0.904 . . . . 0.0 109.025 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.5 p -141.99 154.07 44.75 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.846 0.355 . . . . 0.0 111.255 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.53 142.77 29.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 164.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -115.41 102.93 10.28 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 mp -92.83 107.44 19.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.09 166.79 39.98 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 117.819 0.281 . . . . 0.0 112.545 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -157.7 157.6 29.9 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.023 0.929 . . . . 0.0 110.341 -171.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.79 125.96 12.15 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.205 2.603 . . . . 0.0 110.443 169.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.1 mm -62.39 -47.23 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 t -159.12 179.52 8.96 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.377 1.871 . . . . 0.0 106.554 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 25.97 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 130.497 3.519 . . . . 0.0 113.447 163.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -142.04 94.94 2.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.822 1.249 . . . . 0.0 108.974 167.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -163.89 105.89 0.93 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 127.016 2.127 . . . . 0.0 105.423 158.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -86.94 139.57 30.47 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 20.2 tt -120.09 141.27 41.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -147.83 170.62 17.23 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 123.19 1.471 . . . . 0.0 113.793 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.0 m -137.41 128.05 26.9 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.666 1.986 . . . . 0.0 106.433 163.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -104.85 146.56 28.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.898 0.879 . . . . 0.0 108.734 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 tt -149.83 139.4 21.59 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.772 0.829 . . . . 0.0 109.402 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.16 -128.21 1.6 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.8 174.31 28.47 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-O 122.072 0.818 . . . . 0.0 113.085 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -150.31 162.12 41.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.132 1.373 . . . . 0.0 109.746 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 t -137.09 137.35 46.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -131.73 158.33 41.46 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.379 0.671 . . . . 0.0 110.988 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -140.42 104.05 4.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 127.113 2.165 . . . . 0.0 106.826 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.1 107.64 19.13 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 171.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.19 103.44 4.62 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-O 121.264 0.554 . . . . 0.0 110.212 -173.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 t -166.53 171.31 11.91 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.779 2.032 . . . . 0.0 106.719 165.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -77.8 76.49 4.33 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 167.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.8 t -57.53 101.68 0.08 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.836 1.254 . . . . 0.0 111.318 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -161.84 -165.8 1.33 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.219 1.807 . . . . 0.0 108.22 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.6 t 58.99 69.18 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.528 1.531 . . . . 0.0 108.895 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -62.02 5.98 0.08 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.801 2.44 . . . . 0.0 116.244 -163.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.53 -17.32 79.23 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.441 1.019 . . . . 0.0 111.796 163.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.49 165.27 11.65 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.283 1.433 . . . . 0.0 107.203 161.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -144.98 152.91 40.9 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.88 70.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.676 2.79 . . . . 0.0 104.344 -172.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -51.66 -64.27 0.87 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.846 2.058 . . . . 0.0 112.746 -158.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.5 m 65.9 146.65 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.763 2.025 . . . . 0.0 111.672 -167.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.21 -174.38 15.51 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.246 0.927 . . . . 0.0 112.101 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.6 p -88.33 148.72 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.817 1.647 . . . . 0.0 109.637 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.3 t -153.09 152.75 28.58 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.319 1.048 . . . . 0.0 108.999 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.36 161.45 44.75 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.955 1.77 . . . . 0.0 110.042 164.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -148.53 144.29 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -148.2 153.05 38.25 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.632 1.173 . . . . 0.0 108.971 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.9 167.64 29.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.746 1.218 . . . . 0.0 109.477 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -108.73 169.7 14.24 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.67 -173.79 45.94 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 118.747 1.273 . . . . 0.0 113.968 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.0 156.8 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.779 1.231 . . . . 0.0 109.536 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -134.34 151.56 51.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.042 1.337 . . . . 0.0 108.885 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.42 108.66 4.6 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.914 0.886 . . . . 0.0 109.747 -164.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.71 81.36 5.02 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.033 0.833 . . . . 0.0 110.202 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.3 mm -51.2 -39.05 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.489 1.516 . . . . 0.0 110.793 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 51.2 p -135.65 165.66 34.42 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 159.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.58 43.82 0.68 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 122.907 2.405 . . . . 0.0 110.839 164.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -149.25 -45.24 0.14 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.427 2.691 . . . . 0.0 109.531 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.7 tt -137.57 145.16 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 118.973 0.806 . . . . 0.0 110.464 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.66 137.76 30.16 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.93 0.892 . . . . 0.0 109.93 -165.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 53.2 m -93.91 152.93 18.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.37 1.468 . . . . 0.0 109.236 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.426 HH22 ' HG2' ' A' ' 52' ' ' GLU . 37.9 mtp180 -124.02 149.12 46.42 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.215 1.806 . . . . 0.0 107.793 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.98 144.21 41.04 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.476 1.91 . . . . 0.0 106.033 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -144.5 146.94 32.68 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.375 1.47 . . . . 0.0 109.448 -171.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -137.03 121.09 17.76 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 127.079 2.152 . . . . 0.0 107.525 172.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.59 165.88 19.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.994 2.118 . . . . 0.0 108.391 -170.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -83.39 164.26 20.06 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 122.514 1.149 . . . . 0.0 110.303 -173.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.0 m -151.31 96.37 2.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 102.005 -3.331 . . . . 0.0 102.005 166.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 53.71 -176.14 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.558 1.543 . . . . 0.0 111.457 -158.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -157.22 144.72 18.81 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.857 1.263 . . . . 0.0 107.965 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 32.6 mt 45.48 68.09 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.377 2.271 . . . . 0.0 110.628 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.0 -82.18 1.62 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 166.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 150' ' ' ALA . 6.8 p-10 -38.89 -89.39 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 131.193 3.797 . . . . 0.0 115.367 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.457 ' H ' ' CG ' ' A' ' 149' ' ' ASP . . . -73.63 70.15 1.32 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.488 1.515 . . . . 0.0 108.526 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -54.97 121.72 9.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.641 0.776 . . . . 0.0 112.43 -161.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.0 p 66.16 -1.15 1.23 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.719 2.408 . . . . 0.0 115.043 -175.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 75.6 mt -103.45 -34.59 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.216 1.406 . . . . 0.0 109.313 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -163.23 175.15 39.56 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 118.93 0.786 . . . . 0.0 112.229 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 11.7 t -132.37 102.15 5.63 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.444 1.898 . . . . 0.0 106.16 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 15.3 mtp-105 -130.63 96.32 23.99 Favored Pre-proline 0 CA--C 1.533 0.318 0 O-C-N 121.468 -0.77 . . . . 0.0 109.998 -170.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -78.84 178.28 7.72 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.269 1.979 . . . . 0.0 108.576 158.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.62 -55.42 20.35 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 159.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -145.55 152.16 39.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -69.47 -168.14 5.95 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 170.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 14.6 ttt -72.33 140.39 48.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -138.73 152.03 47.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.28 163.55 32.64 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 123.883 0.739 . . . . 0.0 109.91 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.89 166.77 22.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.494 1.118 . . . . 0.0 108.938 164.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -158.73 172.96 35.66 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.7 t -142.34 145.73 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.21 113.24 4.52 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -159.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.81 132.56 35.16 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 145.3 25.38 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.615 0.643 . . . . 0.0 112.151 -171.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -76.98 149.78 35.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.924 1.29 . . . . 0.0 111.411 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.72 166.08 36.58 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 106.953 -2.459 . . . . 0.0 106.953 159.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.51 35.46 2.04 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.221 1.008 . . . . 0.0 109.111 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 78.48 -62.81 3.77 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -164.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -72.47 170.82 13.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.538 0.735 . . . . 0.0 110.519 160.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -86.98 -3.36 59.08 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.69 1.196 . . . . 0.0 113.193 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.443 ' C ' ' HZ3' ' A' ' 3' ' ' LYS . . . . . . . . 0 C--O 1.25 1.084 0 C-N-CA 126.295 1.838 . . . . 0.0 109.481 -159.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -69.72 170.77 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.239 1.96 . . . . 0.0 110.506 167.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 -159.03 0.94 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.681 1.193 . . . . 0.0 108.053 171.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -48.92 178.15 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.648 1.579 . . . . 0.0 112.926 161.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -60.51 2.23 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.827 -1.17 . . . . 0.0 109.943 170.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 p -149.17 162.36 40.14 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.082 0.953 . . . . 0.0 110.822 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -128.25 153.07 47.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.159 1.784 . . . . 0.0 109.113 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -144.92 152.3 40.0 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.288 1.835 . . . . 0.0 108.065 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -150.05 148.34 28.91 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.323 -0.86 . . . . 0.0 111.216 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.64 -104.78 0.2 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 125.687 1.613 . . . . 0.0 109.425 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.37 169.12 25.45 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 118.204 1.002 . . . . 0.0 113.526 -166.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.456 ' HE3' ' CE1' ' A' ' 40' ' ' PHE . 17.0 ptpt -142.52 166.19 25.34 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.705 1.202 . . . . 0.0 109.212 158.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 tt -131.03 115.98 17.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 163.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.87 146.46 20.55 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -150.8 142.24 23.43 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.526 1.53 . . . . 0.0 111.08 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.1 p -154.2 172.73 17.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.34 1.056 . . . . 0.0 109.769 161.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 171.77 2.18 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 158.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -110.2 -53.15 2.71 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.798 1.239 . . . . 0.0 110.872 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -130.07 -54.8 1.12 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.654 0.782 . . . . 0.0 109.942 172.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 165.6 -49.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 129.873 3.269 . . . . 0.0 107.138 -176.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -143.73 30.95 1.31 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.28 1.832 . . . . 0.0 108.468 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.35 -144.23 48.24 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.095 -1.628 . . . . 0.0 109.176 -168.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -78.19 50.59 0.92 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.602 -0.94 . . . . 0.0 109.922 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 mm 47.21 46.35 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.28 1.832 . . . . 0.0 109.598 -167.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -62.05 94.41 0.05 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 128.158 2.583 . . . . 0.0 110.663 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -126.65 146.77 50.06 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.755 1.622 . . . . 0.0 107.404 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.2 -38.89 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.656 2.382 . . . . 0.0 113.668 -167.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.81 82.87 0.32 Allowed Glycine 0 CA--C 1.531 1.092 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 162.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -69.54 173.2 11.12 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.444 2.763 . . . . 0.0 111.697 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 t -146.12 176.31 9.83 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -71.95 -12.81 61.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.124 1.37 . . . . 0.0 113.26 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 51.72 -164.63 0.06 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.574 1.15 . . . . 0.0 109.501 -159.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 72.71 156.34 0.17 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.677 1.991 . . . . 0.0 114.714 163.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -135.85 142.85 44.83 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 170.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.1 169.56 17.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.37 0.268 . . . . 0.0 110.35 170.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.14 96.3 0.19 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 106.991 -2.443 . . . . 0.0 106.991 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.88 129.92 46.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.953 1.301 . . . . 0.0 108.264 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.92 169.5 39.59 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 114.69 0.636 . . . . 0.0 114.69 -169.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.83 154.52 17.21 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.68 1.192 . . . . 0.0 108.951 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.456 ' CE1' ' HE3' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -146.63 155.52 42.52 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.217 1.007 . . . . 0.0 111.799 -171.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.3 158.22 25.85 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 163.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.73 166.2 39.21 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 117.418 0.609 . . . . 0.0 111.743 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -145.05 145.93 31.66 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.418 1.087 . . . . 0.0 110.535 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -87.9 110.9 20.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 162.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -75.59 -23.21 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 118.527 0.603 . . . . 0.0 110.244 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.36 166.44 15.15 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 126.938 2.095 . . . . 0.0 106.687 169.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.22 6.4 0.66 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.817 2.345 . . . . 0.0 114.433 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -137.83 1.01 2.26 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.614 1.566 . . . . 0.0 113.513 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 t -143.85 149.58 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 119.549 1.068 . . . . 0.0 109.057 -174.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -179.59 -165.72 34.11 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 121.105 -0.997 . . . . 0.0 112.758 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -142.16 160.82 39.46 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.548 1.139 . . . . 0.0 109.311 170.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.61 149.92 35.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.295 1.838 . . . . 0.0 107.954 168.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 53.5 mtt -148.71 153.31 38.04 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.6 1.16 . . . . 0.0 108.193 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.06 173.34 44.12 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-O 119.655 -0.525 . . . . 0.0 111.954 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -135.06 136.4 42.02 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.024 0.93 . . . . 0.0 109.83 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.67 166.67 25.15 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.756 1.222 . . . . 0.0 112.241 -166.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -155.38 173.81 16.13 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.203 1.001 . . . . 0.0 110.102 162.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 tp -59.26 -29.69 67.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.723 1.609 . . . . 0.0 111.701 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.87 176.91 50.15 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.875 1.226 . . . . 0.0 111.839 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -160.03 176.11 12.21 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.103 1.761 . . . . 0.0 106.961 169.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 tmm? 25.11 77.65 0.24 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 129.034 2.933 . . . . 0.0 113.163 169.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.52 65.33 8.07 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.837 3.025 . . . . 0.0 111.501 -172.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 52.67 -161.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.662 1.985 . . . . 0.0 111.336 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.0 mttp 75.61 -52.43 0.64 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.167 2.187 . . . . 0.0 110.114 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.22 120.52 22.32 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 160.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -71.59 -10.1 59.26 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.4 t -140.98 156.5 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.379 1.872 . . . . 0.0 106.079 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -122.7 132.26 54.17 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 171.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -80.02 73.72 6.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.836 1.255 . . . . 0.0 109.69 -174.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.4 91.63 1.74 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -171.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.46 -62.41 1.89 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.279 1.432 . . . . 0.0 112.09 -173.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -61.98 155.49 23.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.549 0.74 . . . . 0.0 109.617 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.89 174.79 12.7 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.288 0.635 . . . . 0.0 110.402 -169.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.18 155.72 4.64 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.561 161.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -170.61 168.31 7.63 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 124.321 1.048 . . . . 0.0 109.896 -170.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.8 171.79 27.46 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.3 125.6 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.22 1.408 . . . . 0.0 107.923 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -95.87 144.07 26.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.769 2.428 . . . . 0.0 108.382 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -141.83 125.42 16.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.329 1.052 . . . . 0.0 108.915 169.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.61 123.93 19.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.4 1.08 . . . . 0.0 108.449 -167.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.54 138.47 32.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -99.78 129.22 45.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.323 1.049 . . . . 0.0 108.645 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.08 137.53 52.18 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 158.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.22 -172.45 43.47 Favored Glycine 0 C--O 1.226 -0.363 0 CA-C-O 119.191 -0.783 . . . . 0.0 111.448 -165.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -155.67 157.93 31.65 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.672 1.189 . . . . 0.0 109.253 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -62.2 141.9 89.75 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.882 1.721 . . . . 0.0 109.274 161.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.4 tp -107.73 -4.68 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.79 0.836 . . . . 0.0 110.455 171.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.8 m -149.92 -87.53 0.08 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 159.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -152.52 -44.02 0.1 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.173 1.789 . . . . 0.0 106.83 159.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.14 -20.41 53.45 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.915 2.486 . . . . 0.0 112.645 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.67 138.88 51.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.878 1.671 . . . . 0.0 108.483 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -140.46 127.01 20.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.399 1.479 . . . . 0.0 109.865 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 pp -99.09 153.98 4.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.751 1.621 . . . . 0.0 109.579 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -150.15 157.6 43.27 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 122.15 0.976 . . . . 0.0 113.415 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.6 m -114.07 121.7 44.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 158.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -105.81 109.22 21.1 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 tt -125.85 128.24 47.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.98 0.809 . . . . 0.0 110.154 -168.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.48 -98.33 0.14 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.04 -162.43 36.23 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.758 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -145.95 159.36 43.35 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.502 1.121 . . . . 0.0 109.872 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.14 151.25 35.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.598 1.159 . . . . 0.0 108.138 168.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -136.04 145.02 45.57 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.809 0.844 . . . . 0.0 111.171 -170.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -119.35 111.19 17.85 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 129.014 2.926 . . . . 0.0 106.809 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.34 107.4 17.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 165.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -91.86 119.22 31.45 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.2 m 69.67 -39.92 0.44 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.912 2.085 . . . . 0.0 113.454 168.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.458 ' HZ3' ' CG ' ' A' ' 116' ' ' ASP . 6.0 ptmm? -73.51 175.3 7.16 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.052 1.341 . . . . 0.0 111.381 170.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.5 m -152.51 -75.22 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 159.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 41.51 62.35 1.56 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.336 1.855 . . . . 0.0 113.45 165.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 m -135.67 154.5 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -71.0 -27.7 63.89 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.058 0.943 . . . . 0.0 112.151 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.82 76.09 1.02 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -162.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -138.99 -65.45 0.49 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.494 1.518 . . . . 0.0 106.986 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.27 178.5 8.7 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 128.741 2.816 . . . . 0.0 104.414 159.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -148.58 150.5 33.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.458 ' CG ' ' HZ3' ' A' ' 107' ' ' LYS . 5.3 p-10 -70.51 29.97 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.463 2.305 . . . . 0.0 112.315 169.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.05 153.58 46.83 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 162.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.78 -161.02 25.81 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 p -129.64 145.53 35.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 126.361 1.864 . . . . 0.0 107.025 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.3 t -140.85 96.98 7.27 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.71 117.86 5.22 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.992 2.461 . . . . 0.0 108.329 170.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.34 171.15 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.476 0.71 . . . . 0.0 110.227 -172.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -138.55 162.59 34.18 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 165.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.53 163.3 29.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.411 1.884 . . . . 0.0 108.488 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -108.8 151.45 17.08 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 106.969 -2.453 . . . . 0.0 106.969 162.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -174.55 -174.32 41.2 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 117.9 0.85 . . . . 0.0 112.723 -173.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.1 p -146.57 159.52 10.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 124.571 1.149 . . . . 0.0 108.659 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.2 145.08 49.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.049 2.14 . . . . 0.0 107.164 160.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -142.94 106.1 4.56 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.285 1.834 . . . . 0.0 107.534 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.58 81.97 7.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.841 1.256 . . . . 0.0 108.296 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -25.18 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.099 0.56 . . . . 0.0 111.512 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.1 p -137.03 143.65 43.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 158.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.58 -18.57 59.48 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.763 2.308 . . . . 0.0 114.015 -166.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -62.95 -24.26 67.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.73 2.012 . . . . 0.0 112.249 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.27 164.83 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 125.28 1.432 . . . . 0.0 109.806 -167.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.46 150.56 49.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 162.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.4 p -106.92 150.42 26.45 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 158.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -143.79 147.53 34.27 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.097 0.862 . . . . 0.0 110.109 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.49 159.33 42.12 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.206 1.803 . . . . 0.0 107.771 -175.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -163.38 151.99 14.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.457 0.703 . . . . 0.0 111.483 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -145.58 139.84 26.98 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.582 1.153 . . . . 0.0 109.74 160.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -132.46 175.69 9.08 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.058 1.743 . . . . 0.0 108.915 163.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -93.03 164.28 13.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.223 1.009 . . . . 0.0 110.632 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.5 m -131.5 118.74 20.59 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.067 1.747 . . . . 0.0 106.812 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -62.05 138.37 58.37 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t30 37.07 59.65 1.08 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.966 2.106 . . . . 0.0 112.224 -172.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.0 tp -63.17 90.26 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.501 1.12 . . . . 0.0 108.689 165.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 146.05 -172.94 26.54 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.247 1.403 . . . . 0.0 110.439 -171.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -148.26 171.87 15.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.193 1.797 . . . . 0.0 107.303 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 47.73 36.13 5.36 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.543 1.937 . . . . 0.0 112.353 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 48.82 13.46 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 129.315 3.046 . . . . 0.0 115.73 -170.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.271 1.2 p 41.51 -89.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.535 2.334 . . . . 0.0 111.777 -161.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.5 tp -139.26 49.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 122.506 1.146 . . . . 0.0 108.588 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.02 -57.18 4.34 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -172.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 13.8 t -79.59 158.69 27.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 111.08 166.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.0 mtt85 -130.95 159.48 71.21 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 129.249 3.02 . . . . 0.0 108.01 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -64.72 -179.19 0.88 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.744 1.63 . . . . 0.0 109.961 159.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -134.91 121.22 20.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 160.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.02 -3.05 11.61 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.016 1.726 . . . . 0.0 109.905 163.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 38.21 -115.63 0.42 Allowed Glycine 0 C--N 1.342 0.903 0 C-N-CA 126.748 2.118 . . . . 0.0 111.146 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 19.0 ttm -148.65 118.09 6.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 158.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.01 154.2 31.69 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 165.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.27 155.05 50.88 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 118.887 0.767 . . . . 0.0 109.78 159.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.76 153.52 51.13 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.77 1.628 . . . . 0.0 107.496 168.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.24 175.49 40.31 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 118.696 0.68 . . . . 0.0 112.843 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.4 m -141.33 164.0 20.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.465 1.106 . . . . 0.0 109.946 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 58.8 m -155.93 161.2 40.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.214 -0.928 . . . . 0.0 110.809 166.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -100.76 155.61 17.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.68 1.592 . . . . 0.0 107.233 159.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.1 ptm85 -90.03 158.68 17.22 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -73.55 116.0 13.6 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 158.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 151.86 150.7 5.42 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 123.909 0.766 . . . . 0.0 111.299 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 67.04 -63.35 0.28 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 128.635 2.774 . . . . 0.0 111.832 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -75.62 42.78 1.54 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.41 1.481 . . . . 0.0 111.838 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -80.53 61.05 4.12 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.306 1.842 . . . . 0.0 109.365 -174.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 57.64 -168.67 0.12 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.516 1.926 . . . . 0.0 112.004 -166.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 C-N-CA 127.79 2.436 . . . . 0.0 106.391 174.786 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.93 170.6 19.79 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.206 1.937 . . . . 0.0 110.614 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -141.18 77.18 1.58 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 170.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.92 -7.7 18.15 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.693 1.597 . . . . 0.0 115.06 -161.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.07 145.95 46.51 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 163.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.8 m -153.06 122.44 6.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -81.62 160.09 23.87 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 170.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -148.27 160.73 42.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.424 1.89 . . . . 0.0 108.022 171.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 t -148.93 161.54 41.68 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.89 -160.49 26.18 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -165.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.59 153.37 40.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.422 ' HE3' ' CZ ' ' A' ' 40' ' ' PHE . 28.0 mtmt -131.0 155.0 47.58 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.903 0.881 . . . . 0.0 109.929 172.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.3 tp -114.19 151.91 32.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.538 2.335 . . . . 0.0 106.074 164.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.91 169.06 29.39 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 118.878 0.763 . . . . 0.0 113.497 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -141.21 136.62 31.92 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.679 1.991 . . . . 0.0 109.068 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -143.2 80.91 1.69 Allowed 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.109 1.364 . . . . 0.0 110.508 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.29 146.08 50.83 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 158.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -169.48 107.43 0.4 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -128.61 153.96 46.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 158.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 153.41 -49.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.48 2.712 . . . . 0.0 108.088 -159.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.7 m -135.38 96.79 3.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.07 -109.95 0.27 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.872 -0.404 . . . . 0.0 113.079 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -157.09 2.15 0.13 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.315 1.446 . . . . 0.0 114.548 -166.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.298 9.4 pt 57.22 140.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 131.268 3.827 . . . . 0.0 115.038 -167.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.04 172.66 12.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.049 1.339 . . . . 0.0 109.663 167.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -88.32 -111.82 0.06 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -60.37 153.64 22.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.822 1.192 . . . . 0.0 108.383 158.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.27 98.01 0.27 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -170.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.15 63.18 5.18 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.931 3.087 . . . . 0.0 110.093 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.3 m -62.28 147.21 48.83 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.946 1.698 . . . . 0.0 109.93 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -151.78 148.72 28.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.823 -161.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.65 -82.57 0.2 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 164.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -28.34 59.57 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.008 -171.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 71.26 -62.43 0.45 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 126.309 1.844 . . . . 0.0 110.135 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 pp -146.63 174.24 11.62 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.941 1.296 . . . . 0.0 110.736 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.73 159.2 27.88 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 165.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.74 121.87 3.77 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.12 1.768 . . . . 0.0 107.286 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.79 165.56 35.19 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.878 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.33 146.52 24.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.102 1.361 . . . . 0.0 108.129 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.422 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 39.4 m-85 -130.3 154.72 47.34 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.074 0.949 . . . . 0.0 110.322 -171.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.11 137.43 5.81 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.04 166.83 39.73 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -166.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -139.88 168.06 20.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.402 0.601 . . . . 0.0 110.833 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -117.68 151.67 36.77 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.528 1.931 . . . . 0.0 108.049 163.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 p -116.74 90.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 164.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 58.21 176.96 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 127.207 2.203 . . . . 0.0 112.56 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.63 75.05 0.82 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.529 2.152 . . . . 0.0 109.231 162.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -147.73 -75.82 0.18 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.298 1.439 . . . . 0.0 109.438 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.63 166.46 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.911 0.884 . . . . 0.0 109.242 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.64 -161.32 13.42 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -177.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -138.59 158.66 43.83 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.126 1.37 . . . . 0.0 109.79 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -139.71 120.3 14.17 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.803 2.441 . . . . 0.0 106.853 169.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -118.9 166.02 13.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.798 1.639 . . . . 0.0 107.854 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.91 173.32 41.5 Favored Glycine 0 N--CA 1.452 -0.281 0 O-C-N 121.792 -0.568 . . . . 0.0 111.982 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -134.67 115.85 14.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.711 2.004 . . . . 0.0 106.535 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.27 139.5 30.68 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.609 1.563 . . . . 0.0 107.73 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -158.47 136.66 10.75 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.993 0.425 . . . . 0.0 111.25 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.5 tp -140.92 113.73 8.31 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.492 1.517 . . . . 0.0 108.11 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.42 39.22 1.89 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.292 0.949 . . . . 0.0 113.158 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? 56.46 -72.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.552 2.341 . . . . 0.0 110.716 -159.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.5 mtm -122.48 97.01 45.29 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 173.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.5 -11.53 28.98 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.468 2.112 . . . . 0.0 112.789 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -53.03 -26.49 15.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.497 1.919 . . . . 0.0 112.799 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 77.8 tttt 63.18 -7.82 0.15 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.434 2.294 . . . . 0.0 114.984 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.0 77.61 0.22 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 165.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 t 69.2 173.76 0.29 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.447 2.299 . . . . 0.0 111.58 -164.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.5 m -149.74 172.45 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 128.042 2.537 . . . . 0.0 107.245 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -89.04 151.51 22.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.476 1.131 . . . . 0.0 108.556 164.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.32 -53.13 31.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.693 2.397 . . . . 0.0 112.262 171.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 171.54 -146.44 9.48 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 119.953 1.251 . . . . 0.0 111.828 -171.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 63.02 -29.77 0.09 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 130.405 3.482 . . . . 0.0 115.335 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.96 170.6 2.05 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.693 1.597 . . . . 0.0 111.717 169.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -93.98 130.77 39.97 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.558 0.743 . . . . 0.0 110.011 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.55 -52.81 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -160.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -162.5 169.75 19.82 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.498 0.59 . . . . 0.0 111.688 -167.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.03 175.63 42.19 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 t -138.24 123.51 23.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -95.2 145.03 25.33 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 171.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.0 107.81 4.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.6 p -138.03 144.45 41.05 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.091 0.556 . . . . 0.0 111.717 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.91 152.65 23.38 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 162.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 157.08 47.73 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.399 0.679 . . . . 0.0 112.007 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.3 tp -140.78 136.66 32.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.926 2.49 . . . . 0.0 105.891 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.04 158.75 29.1 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 166.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.91 141.65 18.94 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.907 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -67.27 145.1 70.98 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.506 2.804 . . . . 0.0 110.385 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -112.57 -4.92 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.053 0.541 . . . . 0.0 111.419 167.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 53.6 m -162.05 165.05 27.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.908 2.883 . . . . 0.0 103.947 167.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -70.16 51.2 0.12 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.276 1.83 . . . . 0.0 110.501 167.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -150.0 -54.13 0.16 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.946 2.098 . . . . 0.0 109.519 -170.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -144.69 156.0 43.86 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.895 0.855 . . . . 0.0 112.546 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.73 146.65 35.94 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.862 2.865 . . . . 0.0 108.763 175.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.8 mt -90.64 137.76 20.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 163.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -134.35 147.34 50.52 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.364 1.066 . . . . 0.0 111.57 -159.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.9 m -155.07 150.15 26.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.047 1.339 . . . . 0.0 109.41 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -147.44 154.25 40.58 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.34 1.056 . . . . 0.0 110.275 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -152.69 156.55 39.4 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.578 1.151 . . . . 0.0 111.557 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.35 -119.49 0.91 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.27 170.18 26.72 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 118.331 1.066 . . . . 0.0 113.624 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -145.75 126.52 14.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.519 1.528 . . . . 0.0 107.745 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.06 142.26 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.42 146.55 42.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.631 1.572 . . . . 0.0 108.348 -172.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.2 ttp85 -141.24 148.74 40.36 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.458 1.103 . . . . 0.0 109.961 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.09 137.37 36.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.966 2.106 . . . . 0.0 108.369 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -75.83 103.05 5.73 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -85.29 24.94 1.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -162.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -74.52 62.68 1.03 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.91 1.684 . . . . 0.0 111.763 -174.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.4 t -80.7 -160.98 0.35 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.215 1.406 . . . . 0.0 108.275 159.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -129.79 160.99 31.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.721 1.209 . . . . 0.0 109.813 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 51.75 -151.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.008 1.323 . . . . 0.0 109.456 -174.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -77.2 -3.92 42.08 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.981 -1.074 . . . . 0.0 112.39 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.04 60.8 4.65 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 124.196 0.903 . . . . 0.0 111.449 -168.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -114.46 164.75 13.54 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 122.024 0.916 . . . . 0.0 112.1 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -76.31 171.72 14.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.779 2.431 . . . . 0.0 111.982 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -66.3 115.27 6.07 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 159.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -80.96 -31.31 34.93 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.302 1.441 . . . . 0.0 113.724 -174.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.9 m -145.72 156.65 43.76 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -167.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -153.11 157.7 27.49 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 165.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.66 30.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.071 1.348 . . . . 0.0 109.613 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 m -66.92 157.35 84.67 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.668 1.587 . . . . 0.0 112.796 -169.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -65.48 159.68 46.59 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 N-CA-C 108.396 -1.425 . . . . 0.0 108.396 158.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.41 157.13 8.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 O-C-N 121.659 -0.651 . . . . 0.0 109.663 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.74 165.06 30.77 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.989 1.316 . . . . 0.0 108.54 165.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.55 162.36 39.92 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 162.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.28 165.86 32.97 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 112.125 -0.39 . . . . 0.0 112.125 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 160.56 -118.65 0.84 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.8 m -138.83 158.45 30.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 117.876 0.838 . . . . 0.0 111.435 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -129.55 141.63 50.93 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 166.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.2 126.26 18.34 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.177 0.991 . . . . 0.0 108.946 -158.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.94 140.44 45.58 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.709 0.686 . . . . 0.0 109.984 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 44.4 mm -117.14 -33.72 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.491 0.716 . . . . 0.0 109.962 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 20.7 m -161.87 157.9 21.02 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 172.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.9 -2.65 0.84 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.749 2.299 . . . . 0.0 116.618 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.23 -10.11 13.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.065 1.746 . . . . 0.0 113.773 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.6 tt -148.28 149.09 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 120.049 1.295 . . . . 0.0 111.833 -171.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.14 169.94 16.77 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.273 1.429 . . . . 0.0 108.333 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.0 p -120.04 160.31 23.06 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.989 1.315 . . . . 0.0 108.369 162.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -141.55 159.38 42.34 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 121.58 -0.7 . . . . 0.0 110.114 165.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.38 120.04 12.52 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.16 155.46 43.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.951 0.881 . . . . 0.0 111.778 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.96 152.74 43.77 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.227 1.811 . . . . 0.0 109.829 -159.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -143.75 115.07 7.99 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.096 1.358 . . . . 0.0 108.059 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -107.38 154.22 21.63 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.166 1.387 . . . . 0.0 109.98 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.6 t -145.73 165.0 30.06 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 159.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -79.32 69.93 5.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.682 0.793 . . . . 0.0 110.083 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -52.16 111.87 0.7 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.856 1.662 . . . . 0.0 111.001 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.1 mt -82.57 42.84 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 125.382 1.473 . . . . 0.0 108.878 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -19.19 97.41 0.01 OUTLIER Glycine 0 C--N 1.339 0.732 0 C-N-CA 130.22 3.771 . . . . 0.0 116.271 -173.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.59 105.84 0.49 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.879 1.272 . . . . 0.0 109.597 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -164.21 173.8 11.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.636 1.174 . . . . 0.0 110.316 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.412 ' CD2' ' HG1' ' A' ' 152' ' ' THR . 55.9 t60 -57.33 128.13 35.49 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 158.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.412 ' HG1' ' CD2' ' A' ' 151' ' ' HIS . 24.1 m 50.63 70.15 0.55 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.586 1.554 . . . . 0.0 111.626 174.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 37.6 pt -55.94 1.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 128.407 2.683 . . . . 0.0 116.601 -171.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.32 -49.56 65.1 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 120.318 -1.489 . . . . 0.0 109.588 161.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.3 m -74.97 95.68 3.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 127.052 2.141 . . . . 0.0 109.4 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -131.72 159.46 71.84 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 126.108 1.763 . . . . 0.0 107.899 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -66.11 -18.41 56.44 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.77 1.647 . . . . 0.0 111.426 165.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.8 t0 50.01 40.58 21.59 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.53 2.332 . . . . 0.0 112.893 166.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -137.49 143.07 41.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.104 1.362 . . . . 0.0 109.272 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -80.59 -178.39 52.06 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.988 1.756 . . . . 0.0 113.121 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 23.7 ptp -80.74 155.3 26.79 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 122.336 -0.508 . . . . 0.0 109.747 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.0 tt -139.45 149.41 44.0 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.603 1.161 . . . . 0.0 109.339 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.2 p -136.84 161.72 35.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.633 0.73 . . . . 0.0 111.491 160.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.21 151.45 34.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.125 1.37 . . . . 0.0 109.411 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.41 175.45 40.45 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 114.911 0.725 . . . . 0.0 114.911 -172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 10.4 m -110.31 152.33 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 127.456 2.302 . . . . 0.0 108.953 172.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.3 t -151.0 113.53 4.65 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.877 0.762 . . . . 0.0 109.145 -172.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -96.26 142.52 28.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.181 1.792 . . . . 0.0 109.305 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -89.67 155.32 19.31 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.546 0.612 . . . . 0.0 111.161 -175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -70.36 115.22 9.29 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 166.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.07 176.99 42.7 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.794 1.188 . . . . 0.0 110.556 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 63.65 168.34 0.15 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.456 1.502 . . . . 0.0 110.232 -165.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 54.36 47.32 69.31 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -170.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -147.75 151.95 36.92 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.328 1.451 . . . . 0.0 107.508 -168.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -160.05 -173.63 4.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.225 1.81 . . . . 0.0 107.552 -177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.934 1.694 . . . . 0.0 106.695 171.45 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.71 105.02 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.513 2.142 . . . . 0.0 108.894 169.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt 55.86 81.11 0.13 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.875 1.67 . . . . 0.0 110.169 -166.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.57 157.43 2.94 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.466 171.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.67 146.17 55.14 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 160.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -112.09 154.39 25.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.547 0.739 . . . . 0.0 110.141 -159.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -134.03 156.65 47.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 158.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -135.23 146.92 49.1 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.576 1.55 . . . . 0.0 106.829 -171.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 m -150.01 148.01 28.54 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.186 -0.946 . . . . 0.0 109.307 165.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.45 -142.53 7.69 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.218 0.914 . . . . 0.0 111.93 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.88 159.3 15.02 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.086 1.755 . . . . 0.0 111.829 -168.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -147.99 144.36 27.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.323 1.449 . . . . 0.0 109.903 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -133.59 148.51 51.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.94 1.696 . . . . 0.0 107.658 164.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.67 158.22 23.36 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.022 1.296 . . . . 0.0 109.876 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -154.75 143.24 20.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.369 1.084 . . . . 0.0 110.588 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -148.22 140.92 24.57 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.137 0.975 . . . . 0.0 108.636 160.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -71.87 69.93 0.71 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 160.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -67.15 -30.09 69.98 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.497 0.719 . . . . 0.0 112.234 -170.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -107.65 147.37 30.78 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 158.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -124.29 154.97 39.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 158.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 69.6 p 50.36 -105.67 0.2 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.583 1.153 . . . . 0.0 109.38 -158.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.01 -178.62 20.59 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 127.306 2.384 . . . . 0.0 109.095 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -54.77 128.58 33.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.786 1.234 . . . . 0.0 111.241 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt 47.71 55.4 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.028 1.731 . . . . 0.0 109.664 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.308 0.0 OUTLIER 56.31 12.67 1.06 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.916 2.886 . . . . 0.0 115.051 -174.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 73.35 -63.48 0.43 Allowed 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 128.268 2.627 . . . . 0.0 110.815 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 73.7 -21.09 0.27 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.904 2.482 . . . . 0.0 111.512 -167.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.61 175.64 54.27 Favored Glycine 0 CA--C 1.538 1.473 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 158.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.74 150.9 50.99 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.321 2.014 . . . . 0.0 111.21 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -69.95 89.24 0.59 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.22 1.01 . . . . 0.0 109.08 172.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -131.23 -2.05 3.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.914 1.286 . . . . 0.0 112.399 -177.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -75.72 45.81 0.34 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.115 2.166 . . . . 0.0 112.538 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -60.66 162.43 6.57 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.886 1.674 . . . . 0.0 111.034 162.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -129.01 160.08 33.89 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 161.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 pp -147.1 166.37 27.1 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.165 0.986 . . . . 0.0 109.779 -174.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.16 156.98 21.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 168.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.64 122.02 3.43 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.915 1.286 . . . . 0.0 107.938 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.16 -121.12 0.84 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.32 169.62 16.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.93 0.892 . . . . 0.0 111.58 -167.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -145.74 151.4 37.92 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.903 2.081 . . . . 0.0 107.831 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.94 156.79 27.84 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 160.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.15 166.02 39.18 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 117.748 0.774 . . . . 0.0 111.859 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -123.66 134.64 53.72 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.63 1.972 . . . . 0.0 108.065 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -122.43 118.33 28.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.679 1.992 . . . . 0.0 109.249 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.25 79.77 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 122.187 0.994 . . . . 0.0 108.608 173.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.411 ' HB3' ' CD ' ' A' ' 47' ' ' PRO 0.322 5.0 m120 63.89 -163.71 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 125.282 1.433 . . . . 0.0 109.857 167.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.411 ' CD ' ' HB3' ' A' ' 46' ' ' ASN . 47.9 Cg_endo -80.29 60.3 7.79 Favored 'Trans proline' 0 C--N 1.357 1.011 0 CA-C-N 124.393 2.605 . . . . 0.0 111.071 -169.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -143.17 -77.19 0.24 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.905 0.882 . . . . 0.0 111.139 -176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.0 p -150.54 165.72 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.911 0.884 . . . . 0.0 109.08 -160.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.81 -175.25 40.57 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.861 1.219 . . . . 0.0 111.691 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -140.6 148.19 40.54 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.916 1.286 . . . . 0.0 107.898 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.75 158.76 43.66 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.234 1.413 . . . . 0.0 109.119 -174.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 75.9 mtp -129.1 159.11 37.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.255 1.422 . . . . 0.0 109.809 167.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.47 165.68 16.13 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -149.82 150.04 31.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.505 1.522 . . . . 0.0 107.687 -173.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -126.24 142.6 51.46 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.363 1.065 . . . . 0.0 109.469 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -67.74 -72.05 0.19 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.898 0.879 . . . . 0.0 110.986 -175.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mp 46.33 -147.46 0.15 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.041 0.936 . . . . 0.0 109.082 -161.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.56 -48.95 2.98 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.432 1.015 . . . . 0.0 115.11 166.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.94 65.98 3.49 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.549 1.175 . . . . 0.0 110.337 -176.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.7 mtp -61.92 164.42 10.37 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.652 1.181 . . . . 0.0 109.154 161.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.8 -37.71 53.73 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.052 1.835 . . . . 0.0 112.66 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 61.41 -57.8 0.1 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.525 2.73 . . . . 0.0 114.755 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt 55.25 30.7 15.14 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.534 1.534 . . . . 0.0 113.123 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.93 -129.48 1.65 Allowed Glycine 0 C--N 1.336 0.549 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.6 p -64.5 -177.47 0.31 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 159.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.5 m -60.58 158.31 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 158.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.38 149.13 30.36 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 57.37 -44.5 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 128.768 2.827 . . . . 0.0 113.668 -160.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 169.92 167.29 30.2 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 127.272 2.367 . . . . 0.0 108.635 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.24 60.74 1.11 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.82 0.848 . . . . 0.0 109.439 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.515 ' CE2' ' HE3' ' A' ' 107' ' ' LYS . 8.2 m-85 -81.09 62.21 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.483 1.135 . . . . 0.0 113.376 -160.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -70.24 91.93 0.75 Allowed 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 158.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.58 151.31 24.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 122.662 0.385 . . . . 0.0 109.986 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -78.79 119.85 22.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.4 101.73 0.22 Allowed Glycine 0 C--N 1.333 0.379 0 N-CA-C 107.489 -2.245 . . . . 0.0 107.489 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.09 165.46 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.044 0.938 . . . . 0.0 109.267 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -128.1 154.27 45.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.275 1.43 . . . . 0.0 107.981 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -141.55 139.4 33.18 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.405 1.082 . . . . 0.0 109.073 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.55 133.46 12.29 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.466 0.706 . . . . 0.0 110.033 -161.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.95 150.7 24.75 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 160.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.473 ' HE3' ' CD2' ' A' ' 94' ' ' TYR . 14.1 tmtt? -131.5 131.33 43.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.765 1.226 . . . . 0.0 109.05 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.2 148.54 26.81 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 159.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 174.1 169.38 36.2 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 119.454 -1.355 . . . . 0.0 114.142 167.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -148.53 133.73 9.31 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.219 -164.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -71.12 135.39 27.12 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.824 3.016 . . . . 0.0 110.467 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.18 -30.47 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 123.053 0.541 . . . . 0.0 111.421 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.6 m -163.5 -48.3 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.518 2.327 . . . . 0.0 106.145 160.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -149.41 -179.11 6.81 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.482 2.313 . . . . 0.0 105.956 167.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.3 t0 65.85 -65.32 0.18 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.556 2.342 . . . . 0.0 113.216 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 mp -101.36 106.17 17.3 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -166.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -101.31 125.63 47.97 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.886 1.274 . . . . 0.0 108.491 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.1 mt -90.7 117.38 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.473 ' CD2' ' HE3' ' A' ' 82' ' ' LYS . 4.4 m-85 -98.45 141.12 31.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.446 1.899 . . . . 0.0 109.788 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.3 m -134.02 115.25 14.1 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 162.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -130.06 148.69 51.94 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 123.774 0.83 . . . . 0.0 110.449 -170.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.37 148.21 27.86 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.974 0.91 . . . . 0.0 110.742 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.07 -121.8 1.05 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.75 167.41 34.7 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 117.861 0.831 . . . . 0.0 113.69 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 36.2 mtm -101.38 150.84 22.6 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.618 1.967 . . . . 0.0 106.975 163.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.3 137.47 50.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -149.71 131.11 14.7 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.83 111.05 7.87 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.981 1.312 . . . . 0.0 109.45 171.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -122.23 124.47 43.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 158.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.56 115.02 10.25 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.605 1.162 . . . . 0.0 108.135 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 82.5 p -75.61 63.19 1.52 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.38 2.272 . . . . 0.0 109.38 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.515 ' HE3' ' CE2' ' A' ' 72' ' ' TYR . 1.8 pttm -69.12 47.57 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.962 2.905 . . . . 0.0 113.318 -174.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.8 m -160.84 162.85 32.34 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 120.238 -1.539 . . . . 0.0 109.258 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.43 77.1 2.49 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.66 167.73 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.005 1.322 . . . . 0.0 109.636 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -67.49 25.27 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.578 2.351 . . . . 0.0 114.314 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.25 -59.88 2.75 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.25 1.405 . . . . 0.0 110.762 -172.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.7 tptt 60.75 -11.94 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.363 2.665 . . . . 0.0 116.115 173.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -59.33 97.68 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.114 1.325 . . . . 0.0 108.294 163.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -64.72 -17.43 64.12 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.777 0.831 . . . . 0.0 113.158 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -129.52 131.09 46.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 159.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.78 158.53 41.05 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 163.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.84 -99.96 0.73 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 106.749 -2.54 . . . . 0.0 106.749 -163.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.6 144.28 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.645 1.578 . . . . 0.0 109.442 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.8 m -138.03 128.47 15.45 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.855 1.262 . . . . 0.0 108.838 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.02 144.38 47.2 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.428 2.086 . . . . 0.0 110.863 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.93 164.31 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.13 0.972 . . . . 0.0 110.078 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -147.59 165.54 30.07 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.919 1.688 . . . . 0.0 108.495 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.78 160.41 42.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.32 0.509 . . . . 0.0 110.298 165.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -109.35 159.06 14.22 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 106.131 -2.788 . . . . 0.0 106.131 158.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.79 -173.87 46.09 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 118.539 1.169 . . . . 0.0 112.008 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.21 145.16 31.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -103.05 150.97 23.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.258 1.423 . . . . 0.0 107.544 158.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.39 165.37 28.69 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.533 1.133 . . . . 0.0 109.08 163.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -130.85 88.52 2.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.028 1.731 . . . . 0.0 110.486 -163.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.12 -29.64 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 125.147 1.379 . . . . 0.0 111.118 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.4 t -141.98 146.14 39.19 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 159.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.48 -15.53 49.05 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.501 2.134 . . . . 0.0 114.9 -167.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.97 -41.76 97.02 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.217 0.917 . . . . 0.0 111.004 168.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.0 pt -110.64 163.9 7.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 124.179 0.992 . . . . 0.0 111.188 -164.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.8 158.75 43.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.8 t -141.52 152.78 44.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 158.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -135.33 153.98 51.67 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 123.124 0.569 . . . . 0.0 111.168 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.55 137.32 41.91 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -144.74 154.12 42.4 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.851 1.26 . . . . 0.0 109.803 -164.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -151.02 146.02 25.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.252 1.421 . . . . 0.0 110.735 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -132.13 115.51 15.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.902 2.481 . . . . 0.0 105.965 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -84.12 164.22 19.33 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 168.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . 0.281 4.9 t 57.64 -171.18 0.1 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.745 2.418 . . . . 0.0 111.94 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.413 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 34.0 t30 55.51 -161.27 0.17 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.76 1.224 . . . . 0.0 109.784 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.413 ' H ' ' CG ' ' A' ' 145' ' ' ASN . 34.2 m-80 62.87 45.7 5.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.41 1.484 . . . . 0.0 114.163 158.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.5 tt -140.1 157.26 25.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 119.154 0.888 . . . . 0.0 110.885 169.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.27 -17.02 0.46 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.619 1.581 . . . . 0.0 113.649 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -150.39 147.53 27.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.022 1.911 . . . . 0.0 110.313 171.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -169.89 87.84 0.15 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 130.871 3.668 . . . . 0.0 106.054 174.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -74.83 79.2 2.1 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.44 -0.788 . . . . 0.0 110.325 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.2 m 67.79 -29.53 0.16 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.363 2.665 . . . . 0.0 114.354 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.7 pt -128.01 174.81 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.199 1.799 . . . . 0.0 109.129 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.26 -152.71 21.39 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -167.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.3 m -69.58 158.38 35.37 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.61 1.164 . . . . 0.0 109.368 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.5 mtp-105 -68.62 158.77 84.48 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.754 1.221 . . . . 0.0 109.107 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.06 34.5 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.868 3.712 . . . . 0.0 112.6 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -155.97 99.11 1.95 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 129.468 3.107 . . . . 0.0 103.485 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -121.45 -130.76 0.28 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.171 0.988 . . . . 0.0 110.494 -158.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 179.42 176.33 46.98 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-N 119.153 0.888 . . . . 0.0 112.443 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 26.0 ttt -142.0 156.28 45.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.624 1.97 . . . . 0.0 107.237 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.13 161.78 33.93 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.606 1.162 . . . . 0.0 108.79 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.2 p -147.28 166.4 27.2 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.342 0.591 . . . . 0.0 110.419 166.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.71 165.69 31.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 108.745 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.35 175.14 40.44 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 121.485 -0.388 . . . . 0.0 113.377 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 62.1 t -134.51 146.73 30.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 126.661 1.984 . . . . 0.0 105.709 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.5 m -156.45 174.87 14.79 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 119.934 -1.729 . . . . 0.0 110.433 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -143.72 166.06 25.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 122.926 0.49 . . . . 0.0 111.37 166.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -106.55 158.8 16.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.655 2.382 . . . . 0.0 110.446 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -53.93 155.05 3.61 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 163.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 85.12 17.07 63.58 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.341 -0.699 . . . . 0.0 112.511 -167.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -53.86 122.01 9.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.529 1.132 . . . . 0.0 109.217 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 89.84 3.64 73.55 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.001 1.286 . . . . 0.0 113.543 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.68 -159.77 0.31 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.959 1.704 . . . . 0.0 110.886 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 62.33 -56.75 0.14 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.467 2.707 . . . . 0.0 113.915 -168.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 C-N-CA 127.513 2.325 . . . . 0.0 112.046 -172.89 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.6 150.73 83.77 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.212 1.942 . . . . 0.0 110.465 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.43 178.14 8.67 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.169 0.988 . . . . 0.0 108.369 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.87 -163.08 0.2 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -158.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.71 -177.38 1.24 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.298 1.439 . . . . 0.0 110.481 170.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.9 m -145.2 115.34 7.47 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 119.64 -1.913 . . . . 0.0 108.863 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -114.7 131.53 56.72 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.771 1.628 . . . . 0.0 108.717 -172.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.495 ' CZ ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER -130.78 155.81 46.05 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.193 0.997 . . . . 0.0 111.741 -170.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 m -143.01 144.91 32.48 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.156 2.183 . . . . 0.0 107.633 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.3 -159.49 22.52 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 118.747 0.703 . . . . 0.0 113.522 -169.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.49 157.91 45.28 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.965 1.306 . . . . 0.0 110.629 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HZ2' ' CG ' ' A' ' 56' ' ' ASP . 0.0 OUTLIER -147.6 163.75 35.63 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.02 0.928 . . . . 0.0 112.794 -175.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mp -141.34 165.78 26.56 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.542 2.337 . . . . 0.0 109.37 171.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.3 171.04 29.54 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.075 0.845 . . . . 0.0 112.249 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -158.57 150.07 20.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.829 0.852 . . . . 0.0 112.101 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 t -151.47 146.12 25.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.264 1.826 . . . . 0.0 108.246 162.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -89.54 -21.64 22.8 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.928 0.491 . . . . 0.0 111.932 167.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 54.0 6.81 0.1 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.245 2.218 . . . . 0.0 116.196 -170.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -158.86 179.6 8.93 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.886 3.274 . . . . 0.0 106.496 163.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -138.26 156.15 47.94 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.242 -0.911 . . . . 0.0 111.152 160.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.263 12.8 t 44.19 -158.71 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.119 1.767 . . . . 0.0 111.855 -172.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.29 154.92 46.72 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.091 -1.006 . . . . 0.0 111.427 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -137.0 94.02 2.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 164.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.332 0.3 OUTLIER 44.32 -141.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 126.773 2.029 . . . . 0.0 110.255 -176.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.407 ' ND2' ' H ' ' A' ' 26' ' ' ASN . 18.5 t30 48.49 -106.17 0.17 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.602 1.961 . . . . 0.0 110.246 -176.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.407 ' H ' ' ND2' ' A' ' 25' ' ' ASN . 1.7 p-10 -135.34 11.66 3.52 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.017 2.127 . . . . 0.0 110.302 172.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 t30 135.54 153.68 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.588 1 C-N-CA 133.022 4.529 . . . . 0.0 105.33 -158.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.51 -157.38 28.44 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.968 1.271 . . . . 0.0 112.328 -168.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.467 ' C ' ' H ' ' A' ' 31' ' ' HIS . 73.7 Cg_endo -63.34 -11.93 28.04 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.97 1.78 . . . . 0.0 111.592 167.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.53 16.65 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 130.421 3.488 . . . . 0.0 114.994 160.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.467 ' H ' ' C ' ' A' ' 29' ' ' PRO . 66.3 m80 -80.69 -20.2 43.45 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.4 -1.438 . . . . 0.0 109.286 158.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -122.66 176.5 5.91 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.908 1.683 . . . . 0.0 109.236 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -159.38 179.65 8.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.439 2.296 . . . . 0.0 106.535 175.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -128.97 142.4 50.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.09 163.81 20.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.753 1.221 . . . . 0.0 108.559 163.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.27 165.24 25.5 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 171.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.1 174.66 11.1 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.565 1.946 . . . . 0.0 107.904 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.04 -164.89 31.53 Favored Glycine 0 C--N 1.332 0.338 0 O-C-N 121.848 -0.532 . . . . 0.0 112.675 163.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.29 160.63 14.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -135.74 155.14 50.84 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.653 1.581 . . . . 0.0 107.653 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.26 172.41 40.05 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA3' ' CZ ' ' A' ' 8' ' ' TYR . . . -168.78 166.73 39.87 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 121.553 -0.969 . . . . 0.0 113.099 166.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -137.68 106.09 5.81 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -95.91 132.87 40.75 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.2 m -67.28 -27.47 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.35 145.31 14.91 Favored Pre-proline 0 C--O 1.233 0.185 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 158.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.88 99.73 0.28 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.282 2.655 . . . . 0.0 109.145 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.6 t80 158.48 -51.67 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 129.64 3.176 . . . . 0.0 107.569 -159.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -150.79 151.29 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.767 0.794 . . . . 0.0 111.86 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.05 -116.26 0.81 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 167.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -136.4 159.72 40.9 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.942 1.353 . . . . 0.0 111.908 -171.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -144.81 151.86 39.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 128.534 2.733 . . . . 0.0 106.263 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 66.4 mtt -152.65 170.94 19.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.728 1.211 . . . . 0.0 109.458 -162.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.27 179.95 42.14 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.172 0.892 . . . . 0.0 110.921 170.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -139.23 146.59 40.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.656 0.782 . . . . 0.0 109.474 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.401 ' CG ' ' HZ2' ' A' ' 12' ' ' LYS . 1.5 m-20 -127.72 112.58 14.97 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.493 1.517 . . . . 0.0 107.655 -171.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -158.07 179.44 9.17 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.707 1.603 . . . . 0.0 107.349 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -73.18 46.08 0.17 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.547 1.939 . . . . 0.0 112.636 -176.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.75 -140.48 30.13 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.135 1.35 . . . . 0.0 111.422 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.09 79.39 1.23 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.6 tpp -45.08 125.43 5.44 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.117 1.367 . . . . 0.0 108.573 165.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.7 -24.69 61.98 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.136 1.891 . . . . 0.0 112.921 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.6 t80 71.02 8.95 6.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.192 2.197 . . . . 0.0 116.85 158.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -98.54 -84.66 0.39 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.061 1.755 . . . . 0.0 112.059 -172.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.58 103.33 0.6 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 124.704 1.145 . . . . 0.0 111.662 -169.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.7 m 52.62 31.77 10.7 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.039 0.936 . . . . 0.0 111.835 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.2 19.8 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 126.015 1.726 . . . . 0.0 111.968 -174.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 50.43 36.66 13.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.208 2.203 . . . . 0.0 113.989 167.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -144.31 177.13 8.84 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.461 1.904 . . . . 0.0 107.739 169.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.47 -100.59 0.14 Allowed Glycine 0 C--N 1.339 0.706 0 CA-C-O 118.918 -0.935 . . . . 0.0 111.267 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.74 69.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.811 0.805 . . . . 0.0 111.538 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -63.28 118.79 8.49 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -147.47 80.5 1.51 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.67 156.33 41.11 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 122.813 0.445 . . . . 0.0 111.789 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -146.71 -178.97 6.46 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.699 2.4 . . . . 0.0 107.59 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.58 170.17 35.13 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 165.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.87 131.83 38.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -95.43 132.2 40.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.35 132.53 20.46 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.001 0.92 . . . . 0.0 108.786 175.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.23 142.75 19.64 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.665 -172.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.64 147.14 26.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.966 1.306 . . . . 0.0 108.512 165.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.496 ' HE2' ' CE1' ' A' ' 94' ' ' TYR . 81.2 tttt -143.52 135.17 26.34 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.375 1.47 . . . . 0.0 109.204 -165.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.8 tp -144.28 129.45 18.69 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.729 1.612 . . . . 0.0 107.394 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.73 179.13 19.16 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 117.965 0.348 . . . . 0.0 112.994 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -143.42 138.55 15.58 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.344 1.058 . . . . 0.0 109.298 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.45 117.08 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.798 2.332 . . . . 0.0 109.073 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.7 tt -90.86 -10.55 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.023 0.529 . . . . 0.0 110.78 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 48.3 m -151.05 -78.79 0.12 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 158.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -152.54 -59.76 0.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.771 0.828 . . . . 0.0 109.369 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -78.29 1.47 21.61 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.202 1.801 . . . . 0.0 113.012 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.43 147.39 45.34 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.145 1.378 . . . . 0.0 110.213 171.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -132.36 136.56 46.91 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.678 1.991 . . . . 0.0 107.917 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.93 110.58 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.496 ' CE1' ' HE2' ' A' ' 82' ' ' LYS . 10.4 m-85 -111.5 118.43 35.74 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.526 1.931 . . . . 0.0 110.613 -171.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.4 m -96.97 154.6 17.21 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.315 1.846 . . . . 0.0 108.183 171.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.98 165.05 35.86 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.4 tt -138.54 151.13 47.06 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.718 2.007 . . . . 0.0 107.552 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.35 -139.8 8.34 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 119.129 0.877 . . . . 0.0 111.21 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.0 177.9 44.45 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 117.517 0.659 . . . . 0.0 112.448 172.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.2 108.37 19.54 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 125.012 1.325 . . . . 0.0 107.433 168.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.02 122.76 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -88.82 150.7 22.79 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -143.28 109.48 5.32 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.307 1.043 . . . . 0.0 109.706 171.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.51 170.61 11.75 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 161.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 165.86 19.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.74 0.781 . . . . 0.0 112.906 169.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t -74.03 164.18 26.95 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.541 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 41.4 tttt 64.42 -50.23 0.3 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 128.669 2.788 . . . . 0.0 114.707 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.6 t 58.32 -93.22 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -158.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -147.9 167.97 23.45 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 158.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 111' ' ' TYR 0.339 7.4 p 40.69 -107.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.021 1.728 . . . . 0.0 109.874 -159.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.415 ' H ' HG12 ' A' ' 110' ' ' VAL . 13.4 m-85 -117.52 17.05 14.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.707 1.603 . . . . 0.0 112.511 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.02 -18.22 62.07 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.992 1.282 . . . . 0.0 115.707 -163.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -141.07 153.29 45.4 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.456 1.628 . . . . 0.0 110.929 167.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.64 -59.37 2.81 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.364 1.465 . . . . 0.0 108.045 169.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 170.92 -37.92 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 129.309 3.044 . . . . 0.0 106.762 -169.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 55.9 70.81 0.6 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.703 1.201 . . . . 0.0 110.256 158.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 t -141.02 153.43 45.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.592 0.757 . . . . 0.0 109.822 -175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 130.71 -174.15 19.9 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.093 1.33 . . . . 0.0 110.628 -174.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.7 p -161.09 163.72 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.442 1.897 . . . . 0.0 106.664 161.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.5 m -68.37 128.32 93.12 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 161.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -67.04 148.14 81.04 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.639 1.559 . . . . 0.0 109.678 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.8 169.8 19.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.521 1.128 . . . . 0.0 110.192 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.05 154.0 51.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.503 1.521 . . . . 0.0 107.128 168.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.94 171.47 18.29 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.103 0.961 . . . . 0.0 109.08 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -152.63 161.94 29.73 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 169.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.19 -140.96 6.18 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.2 t -132.57 158.3 43.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 117.532 0.666 . . . . 0.0 109.738 -167.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -123.08 137.22 54.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 158.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -120.16 113.57 20.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.641 1.576 . . . . 0.0 107.624 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.0 81.58 1.89 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.855 1.262 . . . . 0.0 108.868 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.9 tp -70.53 -41.13 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 167.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.55 115.57 60.12 Favored Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 126.413 1.885 . . . . 0.0 106.486 161.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -59.1 -23.31 68.39 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 CA-C-N 121.021 1.4 . . . . 0.0 111.45 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -68.03 -39.99 82.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.208 1.803 . . . . 0.0 112.895 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.9 tt -146.42 130.77 10.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 119.527 1.058 . . . . 0.0 108.468 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.97 145.66 31.62 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 123.579 0.55 . . . . 0.0 109.525 -160.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.4 m -94.97 151.56 19.07 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.15 152.97 49.89 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 125.053 1.341 . . . . 0.0 109.803 173.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 pp -141.61 154.65 45.54 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.191 1.396 . . . . 0.0 108.824 163.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -145.68 155.46 43.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.678 1.591 . . . . 0.0 108.92 171.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -133.68 149.35 51.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.946 1.698 . . . . 0.0 107.733 166.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -135.12 167.81 20.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.454 1.502 . . . . 0.0 108.857 167.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -83.82 160.56 21.16 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 168.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.61 -26.62 2.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.385 1.074 . . . . 0.0 111.647 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.48 -32.46 0.1 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.711 2.404 . . . . 0.0 115.038 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 62.56 -23.97 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 130.613 3.565 . . . . 0.0 116.382 168.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.1 tt -64.38 122.1 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.698 1.199 . . . . 0.0 112.179 -163.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.48 146.44 16.43 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 106.354 -2.699 . . . . 0.0 106.354 162.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.99 177.53 11.22 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.33 -4.71 1.28 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.299 1.44 . . . . 0.0 113.262 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -144.83 -26.03 0.5 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.536 1.062 . . . . 0.0 112.701 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.2 t -149.75 -150.04 0.33 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.945 1.298 . . . . 0.0 108.189 -171.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.55 162.39 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 159.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 167.41 -23.62 0.12 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.58 -0.567 . . . . 0.0 112.927 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 11.6 m -69.53 98.6 1.15 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.202 1.401 . . . . 0.0 108.406 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -81.81 144.02 51.26 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -160.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -77.74 40.8 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 125.293 3.996 . . . . 0.0 112.108 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -60.44 -30.77 69.86 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -164.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -134.04 173.07 11.98 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.552 1.168 . . . . 0.0 111.474 -159.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -109.49 165.31 12.41 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.314 163.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 18.5 ttt -104.64 148.06 26.96 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 169.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.8 pp -130.64 160.81 33.13 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.334 0.654 . . . . 0.0 111.4 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.39 158.11 44.92 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.589 1.155 . . . . 0.0 108.531 163.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 pp -149.54 156.03 41.29 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.326 1.451 . . . . 0.0 108.712 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.16 175.19 40.29 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 112.271 -0.332 . . . . 0.0 112.271 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.25 145.07 27.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 170.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.8 p -154.18 151.66 29.47 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.275 0.943 . . . . 0.0 110.743 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -106.15 149.83 26.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.342 1.857 . . . . 0.0 108.961 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.12 156.13 46.69 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 127.211 2.204 . . . . 0.0 109.949 171.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -66.93 151.65 47.2 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 159.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -113.99 -111.66 2.97 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -86.26 -33.84 20.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.326 1.05 . . . . 0.0 108.639 160.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -121.86 -172.06 14.16 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.759 1.647 . . . . 0.0 110.463 169.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.59 -26.25 66.83 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.07 -0.665 . . . . 0.0 110.661 170.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -140.38 161.14 38.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.446 2.299 . . . . 0.0 106.082 158.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.377 1.471 . . . . 0.0 111.776 -168.8 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -60.77 167.67 8.18 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.604 2.869 . . . . 0.0 111.738 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.06 17.15 17.97 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -161.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.25 -28.4 53.06 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.431 0.693 . . . . 0.0 112.206 170.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.41 ' H ' ' ND2' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -46.32 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 129.97 3.308 . . . . 0.0 112.047 176.162 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.5 p -154.13 161.59 41.77 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.516 1.926 . . . . 0.0 109.226 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -134.86 149.37 50.31 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.385 1.474 . . . . 0.0 107.462 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -134.85 144.77 47.75 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.79 2.036 . . . . 0.0 108.802 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -150.08 135.16 17.88 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.906 -1.121 . . . . 0.0 108.682 171.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.09 -155.42 11.53 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.717 0.675 . . . . 0.0 112.748 -160.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.77 162.88 33.64 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.843 1.257 . . . . 0.0 111.0 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -139.5 142.22 37.3 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.76 1.624 . . . . 0.0 108.83 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.1 139.32 53.88 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.512 1.925 . . . . 0.0 106.524 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.92 148.27 19.0 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.615 1.102 . . . . 0.0 111.43 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -137.78 129.44 28.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.012 2.125 . . . . 0.0 107.493 -167.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.3 t -142.01 -176.94 4.99 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -50.11 -45.16 52.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.864 2.066 . . . . 0.0 112.182 -159.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.69 -21.52 0.81 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 159.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.614 ' CG ' ' H ' ' A' ' 20' ' ' ASP . 32.5 t60 170.1 -127.98 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 131.146 3.778 . . . . 0.0 104.386 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.614 ' H ' ' CG ' ' A' ' 19' ' ' HIS . 5.2 p-10 -54.78 -31.89 59.41 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.026 1.731 . . . . 0.0 112.364 174.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 36.69 90.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.466 3.106 . . . . 0.0 114.207 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.82 52.78 1.64 Allowed Glycine 0 CA--C 1.537 1.438 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 160.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . 0.309 45.8 p90 -36.38 -98.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 130.355 3.462 . . . . 0.0 115.86 -158.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 tp -65.96 -22.88 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.531 1.059 . . . . 0.0 111.728 -169.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -76.57 -47.77 21.43 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.699 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.2 -0.31 0.69 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -168.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.43 -9.12 4.16 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.177 1.353 . . . . 0.0 112.758 -167.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.48 133.6 6.34 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.553 1.549 . . . . 0.0 109.483 -172.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.44 -32.19 95.78 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.606 2.204 . . . . 0.0 112.428 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.282 1.3 m 54.27 -153.41 0.29 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.672 1.989 . . . . 0.0 111.036 173.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -146.34 -32.67 0.33 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -163.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.412 1.3 pt-20 109.15 121.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 131.381 3.872 . . . . 0.0 112.923 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -154.26 -19.54 0.13 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.286 1.034 . . . . 0.0 113.632 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -161.83 137.56 7.67 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.415 1.462 . . . . 0.0 110.013 -163.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -137.19 -58.13 0.71 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 166.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.41 -169.59 42.6 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.9 170.55 18.54 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.371 1.068 . . . . 0.0 108.741 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.36 -179.14 43.02 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.67 159.09 15.23 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -144.16 156.65 44.42 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.287 0.635 . . . . 0.0 111.113 -162.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.15 171.9 39.83 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 170.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.12 166.3 39.38 Favored Glycine 0 C--N 1.331 0.261 0 CA-C-N 117.778 0.789 . . . . 0.0 111.546 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -148.8 133.37 17.72 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.022 0.929 . . . . 0.0 109.318 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -121.76 154.84 36.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.37 -54.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.835 -172.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.69 152.48 93.51 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.35 1.46 . . . . 0.0 108.289 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -57.3 118.48 5.36 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.004 1.803 . . . . 0.0 109.731 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.6 m-30 62.83 14.76 7.65 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.152 2.181 . . . . 0.0 114.943 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 t -139.91 133.65 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 120.53 1.513 . . . . 0.0 110.596 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.48 -161.43 11.47 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.082 1.325 . . . . 0.0 112.163 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -136.44 155.83 49.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.696 1.198 . . . . 0.0 109.021 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -147.38 149.06 32.02 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.72 1.208 . . . . 0.0 108.223 -169.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 73.3 mtp -151.16 171.9 16.64 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.995 0.918 . . . . 0.0 110.898 -162.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.51 179.02 40.13 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 119.523 -0.598 . . . . 0.0 111.959 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -148.42 149.54 31.91 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.047 1.739 . . . . 0.0 110.29 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -132.49 146.12 51.68 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.418 1.487 . . . . 0.0 110.853 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.17 86.1 2.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.576 2.35 . . . . 0.0 105.927 160.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 40.8 tp -55.7 132.27 48.69 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.45 -41.57 2.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -169.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.08 -24.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 130.278 3.431 . . . . 0.0 117.615 167.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.4 ttt -58.0 121.71 52.64 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.218 1.407 . . . . 0.0 110.216 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.08 58.9 6.34 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.312 2.675 . . . . 0.0 110.126 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.74 109.0 1.57 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -148.2 156.58 42.74 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.96 1.304 . . . . 0.0 107.843 -170.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.27 9.93 85.35 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 120.016 -0.325 . . . . 0.0 112.972 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.5 m -163.82 178.93 7.44 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.679 1.992 . . . . 0.0 107.361 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.1 m -118.77 172.25 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.377 1.471 . . . . 0.0 107.929 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.24 171.02 17.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 168.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -69.62 166.84 18.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.044 2.138 . . . . 0.0 109.828 167.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 172.28 172.51 38.18 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 171.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.81 160.45 42.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.817 1.647 . . . . 0.0 107.497 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 64.98 164.91 0.16 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.061 2.144 . . . . 0.0 113.07 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -177.19 176.15 1.41 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.2 1.8 . . . . 0.0 108.676 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -139.76 155.79 47.12 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 158.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -141.71 142.68 33.31 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.1 172.89 38.34 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.849 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 m -146.15 164.7 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.819 2.047 . . . . 0.0 110.058 173.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -120.62 146.4 46.41 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 163.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.54 116.54 7.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.289 1.436 . . . . 0.0 108.518 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.84 145.67 27.61 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.809 -0.557 . . . . 0.0 110.376 -169.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.48 22.69 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.967 0.907 . . . . 0.0 108.978 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.528 ' HE2' ' CE1' ' A' ' 94' ' ' TYR . 86.7 tttt -142.16 138.31 31.48 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.752 1.221 . . . . 0.0 108.69 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.89 146.55 34.17 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 123.113 0.565 . . . . 0.0 109.505 169.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.402 ' HA3' ' CD1' ' A' ' 94' ' ' TYR . . . 168.5 170.22 32.91 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 118.409 0.549 . . . . 0.0 113.623 -174.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -157.97 157.2 29.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.285 1.034 . . . . 0.0 111.607 -166.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.01 131.12 13.92 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.463 2.775 . . . . 0.0 110.521 172.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 pt -73.68 38.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.511 1.125 . . . . 0.0 112.865 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 64.7 p 63.45 -37.32 0.17 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.622 2.769 . . . . 0.0 113.488 -167.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -69.15 167.04 16.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.768 0.794 . . . . 0.0 108.902 159.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -75.98 16.23 0.45 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.408 2.283 . . . . 0.0 113.983 -173.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.6 tp -102.06 125.46 48.75 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.674 1.19 . . . . 0.0 108.596 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -106.85 111.9 24.62 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.244 1.018 . . . . 0.0 108.531 -170.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.66 143.91 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 121.85 -0.531 . . . . 0.0 110.002 -166.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.528 ' CE1' ' HE2' ' A' ' 82' ' ' LYS . 77.5 m-85 -137.89 158.86 43.48 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.707 0.765 . . . . 0.0 112.869 -166.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.7 m -124.43 147.09 48.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 128.429 2.692 . . . . 0.0 106.179 166.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.28 144.22 31.38 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.059 0.944 . . . . 0.0 108.996 -171.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.1 tt -149.07 147.48 28.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.339 1.056 . . . . 0.0 109.188 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.9 -140.68 7.68 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.19 176.42 28.83 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-O 122.222 0.901 . . . . 0.0 112.789 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -140.0 157.44 45.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.31 1.044 . . . . 0.0 109.087 169.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.5 t -130.26 128.29 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -150.72 110.11 3.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.48 105.06 15.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.26 112.19 21.14 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 170.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -83.51 103.63 13.01 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 p -105.51 16.02 26.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.165 1.786 . . . . 0.0 110.134 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 62.39 -29.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.843 2.457 . . . . 0.0 113.569 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.0 m -158.67 178.88 9.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.934 2.094 . . . . 0.0 108.174 168.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -72.76 83.29 1.18 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.539 0.736 . . . . 0.0 110.092 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.2 p -72.23 -178.72 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.019 1.327 . . . . 0.0 109.826 169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -59.19 25.53 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 129.786 3.234 . . . . 0.0 115.766 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -54.64 160.51 5.06 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 120.63 -1.294 . . . . 0.0 111.215 168.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -124.5 -156.02 0.7 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.934 0.893 . . . . 0.0 110.404 -164.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -72.51 2.17 6.8 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.181 0.993 . . . . 0.0 113.502 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -70.17 172.1 8.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.359 1.064 . . . . 0.0 109.818 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -53.09 142.28 20.6 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.143 0.977 . . . . 0.0 110.697 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.5 t -144.92 43.49 1.34 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 170.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 154.94 -87.95 0.13 Allowed Glycine 0 C--N 1.336 0.578 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -170.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.43 154.68 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.009 1.323 . . . . 0.0 109.3 -172.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 71.3 p -145.62 156.83 52.55 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.713 1.205 . . . . 0.0 110.268 167.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.43 155.76 36.54 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.76 2.307 . . . . 0.0 110.086 166.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.8 124.54 2.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 124.913 1.285 . . . . 0.0 108.288 169.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -133.35 145.86 50.76 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 167.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.89 170.78 21.57 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.923 0.889 . . . . 0.0 110.468 -164.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -126.34 165.2 19.63 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 161.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.16 175.5 43.5 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 118.149 0.974 . . . . 0.0 113.187 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 18.0 m -133.44 140.64 46.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.242 1.417 . . . . 0.0 107.43 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.41 ' CD ' ' HE ' ' A' ' 138' ' ' ARG . 40.4 mt-10 -136.63 148.01 47.21 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.591 1.157 . . . . 0.0 108.092 -169.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -149.97 166.14 30.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.917 0.887 . . . . 0.0 110.385 -168.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.82 143.81 51.11 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 125.159 1.383 . . . . 0.0 109.603 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.56 -26.81 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.012 0.525 . . . . 0.0 110.104 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 91.0 m 139.06 -64.46 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.776 1 C-N-CA 132.894 4.478 . . . . 0.0 106.879 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -67.35 179.81 2.27 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.833 1.689 . . . . 0.0 109.943 159.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -52.81 -3.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 130.542 3.537 . . . . 0.0 117.914 -165.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 68.5 mt -87.61 138.08 19.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.95 161.52 34.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.719 0.808 . . . . 0.0 109.682 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.5 m -135.28 148.91 49.68 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.474 1.509 . . . . 0.0 107.799 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.41 ' HE ' ' CD ' ' A' ' 128' ' ' GLU . 33.5 mtp-105 -135.32 146.13 48.14 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.708 1.203 . . . . 0.0 108.928 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.6 125.66 38.67 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 164.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -140.01 123.58 17.2 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -169.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -120.68 138.03 54.16 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.149 1.78 . . . . 0.0 109.842 -172.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.14 114.97 16.99 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.621 1.968 . . . . 0.0 107.867 -167.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -132.07 162.21 31.36 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.422 1.089 . . . . 0.0 109.346 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.8 m 62.89 -43.96 0.2 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.691 2.397 . . . . 0.0 113.22 -171.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -59.74 116.33 3.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.971 0.909 . . . . 0.0 108.775 168.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -158.45 176.27 12.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.473 1.109 . . . . 0.0 108.504 -167.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 13.2 mt -46.73 -38.28 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 126.249 1.82 . . . . 0.0 109.966 163.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 123.76 22.16 2.28 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.901 1.715 . . . . 0.0 111.992 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -78.67 126.72 31.12 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.79 1.295 . . . . 0.0 113.024 -171.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.85 21.67 1.61 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.339 1.456 . . . . 0.0 110.413 159.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -77.95 -9.36 59.05 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -159.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 29.3 p -148.21 168.6 22.06 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.158 0.983 . . . . 0.0 110.132 -165.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.8 pt -127.75 161.71 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.705 1.202 . . . . 0.0 108.038 169.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 144.58 -161.72 28.0 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 107.855 -2.098 . . . . 0.0 107.855 -167.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 20.1 m -69.75 96.69 1.0 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -108.0 96.58 18.18 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 0.0 109.957 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.35 -25.31 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.407 2.738 . . . . 0.0 111.91 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 33.82 51.45 0.38 Allowed 'General case' 0 CA--C 1.531 0.247 1 C-N-CA 131.792 4.037 . . . . 0.0 113.618 168.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -55.38 -37.94 68.21 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.388 1.475 . . . . 0.0 111.972 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.72 -112.33 3.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -167.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -152.44 141.83 21.6 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.965 0.883 . . . . 0.0 109.391 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.0 tp -118.82 154.33 33.05 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.553 1.941 . . . . 0.0 107.484 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.9 p -153.77 162.1 41.52 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.299 -0.875 . . . . 0.0 111.785 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 7.0 tt -132.52 149.82 52.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.192 2.197 . . . . 0.0 106.767 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.01 162.77 27.8 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 170.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.6 t -139.79 142.75 31.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 8.0 t -151.46 167.92 26.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.711 0.687 . . . . 0.0 110.734 -167.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -115.81 127.71 55.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.016 2.126 . . . . 0.0 106.303 167.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -89.63 137.59 32.2 Favored 'General case' 0 C--N 1.337 0.063 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 170.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -63.14 115.95 4.95 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 173.14 -179.04 44.83 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.404 1.478 . . . . 0.0 111.287 -165.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -149.19 0.51 0.52 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.874 1.27 . . . . 0.0 113.83 -166.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 74.51 -53.54 2.38 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.932 1.253 . . . . 0.0 112.537 -175.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.7 155.59 18.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.532 1.933 . . . . 0.0 110.522 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -111.86 -16.5 13.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.06 1.344 . . . . 0.0 112.829 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 116.48 -1.724 . . . . 0.0 111.294 167.638 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 0.342 . . . . . . . 0 CA--C 1.546 0.811 0 CA-C-O 115.083 -2.389 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.03 173.52 10.2 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 124.717 2.72 . . . . 0.0 111.964 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -57.44 127.59 32.74 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.681 1.192 . . . . 0.0 108.384 169.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -68.9 133.97 48.96 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.726 0.81 . . . . 0.0 109.865 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.99 125.41 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.768 2.427 . . . . 0.0 113.925 -172.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.2 m -121.71 155.32 35.47 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.11 1.364 . . . . 0.0 108.795 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -121.37 129.6 53.14 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.294 1.438 . . . . 0.0 108.01 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -113.13 143.34 44.52 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.993 1.317 . . . . 0.0 107.95 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 t -150.35 158.2 43.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.384 0.993 . . . . 0.0 111.514 159.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.04 -141.59 6.41 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 125.4 1.476 . . . . 0.0 110.041 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.67 155.29 44.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.95 0.375 . . . . 0.0 111.606 -164.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.44 159.81 41.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.144 0.978 . . . . 0.0 111.617 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp -109.75 158.96 17.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.204 1.802 . . . . 0.0 106.411 164.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -129.89 165.35 22.36 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 124.966 1.27 . . . . 0.0 109.933 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -148.3 148.34 30.31 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.4 t -162.88 96.42 0.91 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -159.3 157.96 31.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -121.3 -75.47 0.59 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 101.749 -3.426 . . . . 0.0 101.749 158.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -122.33 -165.75 1.32 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 158.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 27.38 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.644 2.778 . . . . 0.0 115.923 172.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 p -70.68 67.09 0.36 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.403 -0.81 . . . . 0.0 109.848 166.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.01 116.91 1.98 Allowed Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -163.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -45.04 108.8 0.13 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.099 1.76 . . . . 0.0 111.624 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.53 -23.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -159.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -61.23 -18.8 60.18 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.957 0.798 . . . . 0.0 112.871 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.04 -25.97 1.98 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.613 1.165 . . . . 0.0 112.885 171.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.466 ' CG ' ' H ' ' A' ' 28' ' ' GLY 0.252 8.0 t-20 48.22 -172.78 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.951 2.9 . . . . 0.0 113.092 -168.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' H ' ' CG ' ' A' ' 27' ' ' ASN . . . 145.6 81.77 0.05 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -166.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.92 -173.23 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.448 2.765 . . . . 0.0 111.391 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -151.32 155.83 39.54 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.49 1.516 . . . . 0.0 107.653 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -63.26 -19.61 64.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.683 1.193 . . . . 0.0 113.862 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -129.96 109.78 11.15 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 159.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.19 135.98 16.28 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 61.52 -81.17 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -158.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.58 171.23 7.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.015 1.326 . . . . 0.0 110.447 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.2 175.68 36.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.841 2.162 . . . . 0.0 109.127 170.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.03 166.3 32.88 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.026 0.93 . . . . 0.0 110.399 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.37 175.69 44.84 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.482 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.81 157.34 16.78 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.635 1.174 . . . . 0.0 107.883 164.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -151.44 166.2 31.8 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.729 0.776 . . . . 0.0 111.796 175.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.25 171.85 39.9 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.62 166.2 39.18 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -121.06 119.84 33.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 173.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.13 160.34 25.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.414 0.685 . . . . 0.0 109.428 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.08 -27.67 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.364 1.066 . . . . 0.0 111.387 -170.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 135.19 -45.31 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.49 1 C-N-CA 132.24 4.216 . . . . 0.0 111.366 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.97 -87.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.899 1.733 . . . . 0.0 111.178 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -153.72 20.15 0.53 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.565 1.075 . . . . 0.0 113.316 -168.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 t -129.09 142.27 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.14 -162.3 30.38 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 118.756 0.707 . . . . 0.0 113.695 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -126.68 155.3 42.85 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.997 1.319 . . . . 0.0 108.113 166.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -149.16 158.12 43.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.863 1.265 . . . . 0.0 108.455 -169.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.0 mtt -146.1 152.56 39.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.124 1.77 . . . . 0.0 108.731 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -136.73 157.69 23.79 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -136.4 115.78 12.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 103.183 -2.895 . . . . 0.0 103.183 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -123.09 150.53 43.06 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.558 0.743 . . . . 0.0 111.677 -158.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.1 t80 60.33 -177.34 0.1 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.021 1.728 . . . . 0.0 111.666 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -96.8 0.97 50.2 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.353 -0.842 . . . . 0.0 112.542 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 42.83 -93.1 0.01 OUTLIER Glycine 0 CA--C 1.531 1.077 0 C-N-CA 127.49 2.471 . . . . 0.0 114.04 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.01 22.9 3.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.816 1.246 . . . . 0.0 112.64 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 53.6 mtt -55.97 -49.04 95.35 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 116.858 -1.544 . . . . 0.0 113.528 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.78 69.51 7.34 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.404 2.069 . . . . 0.0 111.205 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 65.72 -34.98 0.2 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 128.72 2.808 . . . . 0.0 113.935 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -152.97 -169.35 3.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.115 2.166 . . . . 0.0 108.625 168.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.05 -128.29 2.86 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 170.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 p -71.97 173.33 8.53 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 122.038 0.923 . . . . 0.0 111.892 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.47 -25.75 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -161.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -64.97 -20.61 66.57 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 -162.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.67 177.52 7.82 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.525 1.511 . . . . 0.0 112.083 -164.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -138.17 172.25 23.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.839 2.161 . . . . 0.0 108.199 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 61.21 -56.69 0.1 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.071 2.148 . . . . 0.0 111.727 -162.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.3 t80 63.06 87.26 0.11 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.484 2.313 . . . . 0.0 114.236 159.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.89 152.52 44.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.329 1.052 . . . . 0.0 110.038 166.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.9 168.9 24.25 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.853 0.861 . . . . 0.0 109.737 167.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -147.2 158.98 44.14 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.736 2.014 . . . . 0.0 106.886 162.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.48 76.97 0.08 OUTLIER Glycine 0 C--N 1.335 0.494 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -143.43 163.05 16.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 123.138 0.575 . . . . 0.0 110.33 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -147.29 155.97 42.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.564 1.145 . . . . 0.0 109.808 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 pp -143.73 144.44 31.84 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.238 1.415 . . . . 0.0 107.797 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 t -154.03 153.16 31.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.588 0.709 . . . . 0.0 111.401 -169.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.71 151.67 24.26 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 158.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -135.74 135.46 40.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.303 1.441 . . . . 0.0 108.622 -171.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.3 tp -133.52 168.29 18.9 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 128.023 2.529 . . . . 0.0 107.478 -176.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.53 -176.9 39.71 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -143.8 142.21 20.15 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 168.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -75.42 157.58 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.053 1.835 . . . . 0.0 112.909 -161.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mp 16.37 68.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 131.447 3.899 . . . . 0.0 110.637 162.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.1 m -86.47 54.56 3.2 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.8 t0 60.99 133.84 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 129.714 3.206 . . . . 0.0 111.41 -158.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.7 t70 49.43 -60.39 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 129.193 2.997 . . . . 0.0 115.383 -164.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.35 167.44 16.96 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.383 1.873 . . . . 0.0 112.41 -160.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.97 148.3 25.38 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 tp -90.91 144.04 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 167.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -137.09 134.91 36.98 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.694 1.598 . . . . 0.0 108.519 -164.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.8 m -137.62 147.18 44.78 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -151.67 142.78 23.19 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.881 -0.512 . . . . 0.0 110.687 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 mp -141.59 140.29 33.33 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.518 1.127 . . . . 0.0 108.826 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.96 -150.27 8.22 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 117.757 0.253 . . . . 0.0 113.006 -164.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.83 161.63 24.34 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.653 1.12 . . . . 0.0 112.017 170.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.6 ptm -141.6 149.67 41.03 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.567 1.547 . . . . 0.0 109.973 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.1 127.06 19.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 125.295 1.438 . . . . 0.0 107.664 -167.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -138.47 135.68 35.41 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 117.789 0.268 . . . . 0.0 110.504 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.48 152.15 41.15 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.174 0.99 . . . . 0.0 109.515 172.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.75 165.25 31.98 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 162.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -95.73 116.59 29.1 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.466 0.575 . . . . 0.0 110.106 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 57.1 m 60.25 -36.2 0.08 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.839 2.455 . . . . 0.0 114.0 -165.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt 73.93 165.07 0.29 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 128.659 2.784 . . . . 0.0 111.201 174.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.6 p -68.03 94.13 0.47 Allowed 'General case' 0 C--O 1.241 0.648 0 O-C-N 121.799 -0.563 . . . . 0.0 109.904 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -73.13 71.01 1.13 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.728 1.611 . . . . 0.0 110.391 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.84 170.58 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 158.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -57.98 -36.99 73.4 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.792 -1.193 . . . . 0.0 112.863 -168.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -97.26 2.57 61.26 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.136 -1.369 . . . . 0.0 114.217 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.2 mptt 56.52 141.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 130.135 3.374 . . . . 0.0 115.516 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -66.25 82.14 0.09 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.524 1.13 . . . . 0.0 109.935 167.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -73.28 -16.62 61.38 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -173.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -65.22 15.69 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 -161.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t -77.0 151.33 35.66 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 120.722 -1.236 . . . . 0.0 109.759 175.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 178.83 176.5 46.73 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 121.572 0.54 . . . . 0.0 112.595 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.82 114.74 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 100.461 -3.903 . . . . 0.0 100.461 159.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.95 158.22 52.9 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.538 -158.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.14 167.18 27.5 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.8 2.334 . . . . 0.0 109.925 164.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.25 153.24 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 165.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -143.37 152.34 41.49 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.465 1.506 . . . . 0.0 106.986 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.92 168.64 19.16 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.142 0.577 . . . . 0.0 110.051 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.12 164.46 32.36 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 170.79 -133.21 2.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -173.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.73 162.21 35.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 118.471 1.135 . . . . 0.0 111.615 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -139.93 144.57 37.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.136 1.774 . . . . 0.0 109.048 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -153.17 164.68 37.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.132 0.573 . . . . 0.0 110.925 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.41 143.06 43.76 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 161.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 tp -113.07 -2.93 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.18 0.992 . . . . 0.0 111.084 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.8 m -161.58 136.97 5.66 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 102.806 -3.035 . . . . 0.0 102.806 168.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.72 -23.93 69.25 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.894 1.729 . . . . 0.0 113.905 -161.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.68 -2.07 49.13 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 36.5 pt -127.38 163.39 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.87 0.868 . . . . 0.0 109.79 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.61 169.22 18.05 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.882 0.873 . . . . 0.0 109.127 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.1 m -149.46 138.69 21.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -137.91 145.89 42.65 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.852 1.261 . . . . 0.0 107.63 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.91 140.15 25.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 167.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -136.42 161.09 36.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.95 1.3 . . . . 0.0 110.803 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -136.51 152.35 50.43 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.279 2.232 . . . . 0.0 108.995 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -141.86 148.33 38.62 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.438 2.295 . . . . 0.0 107.35 172.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -138.13 159.9 40.83 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.503 1.521 . . . . 0.0 107.617 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.6 p -80.46 177.83 8.73 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.262 0.554 . . . . 0.0 110.821 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -73.09 4.3 4.52 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 167.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 48.81 68.34 0.72 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.867 2.467 . . . . 0.0 112.745 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 16.9 tt -70.37 71.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.542 1.137 . . . . 0.0 109.717 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.9 -58.3 1.0 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.282 1.896 . . . . 0.0 111.894 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.1 t70 59.66 -95.79 0.06 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 128.055 2.542 . . . . 0.0 111.682 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.55 73.18 3.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.273 1.029 . . . . 0.0 110.743 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.403 ' C ' ' HG1' ' A' ' 152' ' ' THR . 76.6 m80 -70.44 72.12 0.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.621 1.568 . . . . 0.0 110.24 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.403 ' HG1' ' C ' ' A' ' 151' ' ' HIS . 86.3 m -154.27 88.59 1.23 Allowed 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.214 -1.554 . . . . 0.0 109.175 175.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.464 ' CG2' ' H ' ' A' ' 154' ' ' GLY . 20.0 mt 60.94 -169.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 124.768 1.227 . . . . 0.0 108.502 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.464 ' H ' ' CG2' ' A' ' 153' ' ' ILE . . . -71.84 40.06 0.66 Allowed Glycine 0 CA--C 1.534 1.243 0 O-C-N 120.2 -1.562 . . . . 0.0 113.318 176.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.6 t -69.79 158.58 35.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.944 0.872 . . . . 0.0 109.445 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -95.68 112.33 58.72 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.17 167.34 26.46 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.844 2.362 . . . . 0.0 111.329 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -160.48 140.22 11.08 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 159.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -159.61 96.58 1.27 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 127.294 2.238 . . . . 0.0 108.326 -168.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -161.97 -178.34 35.79 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 121.993 0.774 . . . . 0.0 113.205 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 54.5 ttm -144.67 151.67 39.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.143 1.777 . . . . 0.0 107.558 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.9 pp -139.68 162.41 35.17 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.128 0.971 . . . . 0.0 110.04 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.1 m -139.16 155.93 47.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.774 0.829 . . . . 0.0 109.741 165.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 16.1 tp -149.96 119.3 6.85 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.708 2.003 . . . . 0.0 107.4 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -152.89 171.22 31.96 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 121.718 0.621 . . . . 0.0 114.26 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.08 160.38 33.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 126.278 1.831 . . . . 0.0 109.282 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.0 m -152.46 161.99 41.82 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 121.52 -0.738 . . . . 0.0 111.504 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -97.49 152.45 18.98 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.062 1.745 . . . . 0.0 107.365 161.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.83 116.18 27.55 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.21 1.004 . . . . 0.0 110.485 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -57.62 156.52 8.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.522 1.129 . . . . 0.0 113.154 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 114.36 -16.17 19.83 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.325 1.44 . . . . 0.0 114.36 162.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -157.54 171.87 19.57 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.018 1.327 . . . . 0.0 108.483 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 61.73 42.05 99.69 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -135.98 148.28 48.38 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.735 1.614 . . . . 0.0 107.295 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -158.65 174.07 15.62 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.599 1.56 . . . . 0.0 108.373 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 C-N-CA 127.202 2.201 . . . . 0.0 106.39 168.837 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -71.73 157.01 56.44 Favored 'Trans proline' 0 C--N 1.353 0.765 0 CA-C-N 121.248 1.481 . . . . 0.0 110.946 164.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 120.16 9.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.313 1.445 . . . . 0.0 108.372 171.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.83 162.67 2.26 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.563 2.345 . . . . 0.0 114.596 -164.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.42 159.91 40.61 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.641 1.576 . . . . 0.0 107.245 163.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 m -117.7 124.51 48.69 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -104.14 156.42 17.9 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -142.71 156.94 45.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.944 1.698 . . . . 0.0 109.131 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.0 t -150.27 158.64 44.38 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.89 0.768 . . . . 0.0 111.519 162.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.65 -134.34 3.1 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.105 0.86 . . . . 0.0 112.296 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.09 147.74 50.54 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.236 1.014 . . . . 0.0 110.627 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -129.36 139.52 51.68 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.0 mp -115.12 159.5 20.81 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.472 1.909 . . . . 0.0 107.311 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.77 157.52 27.31 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -138.35 149.85 46.0 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.537 1.135 . . . . 0.0 108.358 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.6 p -138.44 126.3 22.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.0 1.32 . . . . 0.0 108.248 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -65.89 148.08 52.35 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.743 2.017 . . . . 0.0 110.17 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -132.93 65.8 1.58 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.26 98.05 3.12 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 158.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -64.44 134.15 53.94 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 169.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 p -70.46 -30.36 67.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.671 0.389 . . . . 0.0 111.701 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.52 66.1 1.46 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 171.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -71.06 48.72 0.12 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.199 1.8 . . . . 0.0 113.446 -174.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.4 mt -55.7 -47.45 79.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 162.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -69.22 103.5 1.95 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 158.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -68.86 23.62 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.381 1.472 . . . . 0.0 113.639 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -155.45 174.8 14.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.989 2.915 . . . . 0.0 106.771 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.89 42.92 1.8 Allowed Glycine 0 CA--C 1.536 1.397 0 CA-C-O 117.106 -1.941 . . . . 0.0 115.976 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -66.08 -9.73 24.52 Favored 'Trans proline' 0 C--N 1.355 0.887 0 CA-C-N 122.485 3.143 . . . . 0.0 113.033 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 m -55.84 80.02 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.145 2.578 . . . . 0.0 109.072 161.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.7 m80 77.86 -17.91 0.54 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 129.241 3.017 . . . . 0.0 113.146 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 46.86 54.21 9.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.991 1.716 . . . . 0.0 112.373 -172.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 71.15 67.45 0.17 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.903 1.681 . . . . 0.0 110.319 163.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -151.7 173.46 14.67 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.423 1.889 . . . . 0.0 109.213 -167.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.3 tp -152.77 -61.05 0.15 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.306 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.2 -167.26 39.74 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 119.584 1.084 . . . . 0.0 113.625 -174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.07 169.22 19.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.154 1.382 . . . . 0.0 109.908 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.41 170.21 38.74 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.072 0.844 . . . . 0.0 112.048 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.46 143.76 26.52 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 171.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -144.97 165.2 28.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.76 152.56 20.33 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 127.309 2.385 . . . . 0.0 109.322 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.89 151.93 19.21 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -148.35 105.72 3.65 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -172.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -122.59 142.14 50.95 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.743 0.701 . . . . 0.0 111.097 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 p -126.66 -16.54 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.812 0.845 . . . . 0.0 112.24 -164.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -159.68 167.92 13.17 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.454 1.902 . . . . 0.0 107.174 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.68 -11.4 27.88 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.672 1.581 . . . . 0.0 114.414 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -87.83 -38.68 15.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.651 1.114 . . . . 0.0 111.65 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.88 147.87 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 122.178 0.99 . . . . 0.0 112.03 -169.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.55 -166.9 18.55 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 127.663 2.554 . . . . 0.0 109.087 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -135.53 163.66 29.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.171 1.388 . . . . 0.0 108.886 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -148.04 152.38 37.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.364 1.066 . . . . 0.0 108.304 164.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 50.4 mtt -149.49 157.11 42.99 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.534 1.134 . . . . 0.0 108.068 -169.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.47 176.52 43.4 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 119.06 0.846 . . . . 0.0 113.08 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -141.72 151.31 42.82 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.572 1.549 . . . . 0.0 109.376 -172.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -129.05 145.78 51.18 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.092 1.357 . . . . 0.0 109.318 170.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -141.18 120.4 12.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 164.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.1 mt 54.83 18.98 2.37 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.657 1.983 . . . . 0.0 114.933 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.08 58.14 1.61 Allowed Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.686 1.13 . . . . 0.0 110.388 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 50.56 37.57 16.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.522 1.929 . . . . 0.0 112.289 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 52.0 ttp -127.36 115.64 21.44 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.219 1.408 . . . . 0.0 108.278 -170.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.85 -26.36 44.66 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.687 2.258 . . . . 0.0 114.222 -164.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -154.94 167.44 30.32 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 164.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -75.19 66.97 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.72 -95.36 0.22 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -168.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.1 t -156.83 172.24 18.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.198 1.799 . . . . 0.0 106.99 169.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.27 17.8 m 39.59 -125.27 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.855 1.662 . . . . 0.0 110.122 -166.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 65.9 -54.52 0.37 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.803 2.441 . . . . 0.0 114.565 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -159.52 -174.74 4.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 173.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 176.31 -24.49 0.06 OUTLIER Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.418 1.961 . . . . 0.0 110.9 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.35 -64.45 0.86 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.866 0.833 . . . . 0.0 109.15 166.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -65.9 162.88 18.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.722 0.809 . . . . 0.0 110.672 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.88 165.52 18.18 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 125.716 1.607 . . . . 0.0 108.531 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.67 134.38 37.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 160.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -157.89 161.12 38.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.54 1.136 . . . . 0.0 108.041 -165.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.8 168.25 41.26 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.146 -0.971 . . . . 0.0 112.146 171.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.7 p -143.87 148.5 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -132.05 130.23 41.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.386 1.874 . . . . 0.0 107.013 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -120.38 150.32 40.95 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 159.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -154.98 132.24 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 120.598 -1.314 . . . . 0.0 109.08 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.12 140.03 31.27 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 164.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -117.72 114.36 23.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.21 136.64 40.09 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.867 0.758 . . . . 0.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.93 -148.53 17.14 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 118.582 -1.121 . . . . 0.0 110.634 -166.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -159.32 157.43 27.24 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 118.508 1.154 . . . . 0.0 112.415 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.33 153.54 69.73 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.323 2.682 . . . . 0.0 111.911 161.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.5 mt -111.36 -34.87 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.832 1.253 . . . . 0.0 108.5 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.2 m -157.56 167.44 30.14 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 168.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.43 -21.41 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.945 1.298 . . . . 0.0 113.107 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -77.75 -34.34 52.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.286 1.835 . . . . 0.0 113.456 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -155.75 155.16 32.6 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 119.977 1.262 . . . . 0.0 114.341 -170.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -134.93 164.02 28.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.024 2.13 . . . . 0.0 109.544 -172.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.39 129.2 73.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.657 1.583 . . . . 0.0 106.899 173.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -137.98 153.36 49.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.085 0.945 . . . . 0.0 111.768 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 51.9 m -96.9 132.41 42.69 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 159.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -99.31 108.93 21.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 167.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tt -98.96 107.53 19.99 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.07 142.01 15.39 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.113 0.863 . . . . 0.0 112.502 -164.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.66 95.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 105.929 -2.868 . . . . 0.0 105.929 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.1 ptp -134.23 157.04 47.29 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.275 0.63 . . . . 0.0 110.304 -171.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.2 p -148.25 150.38 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -117.62 156.17 28.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.602 1.961 . . . . 0.0 107.319 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -143.18 146.0 33.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.378 0.671 . . . . 0.0 109.698 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.48 122.02 11.75 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.115 0.966 . . . . 0.0 109.798 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -71.42 103.96 3.07 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 p -145.31 146.49 31.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.173 0.989 . . . . 0.0 109.076 -166.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -71.79 -21.12 61.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 119.038 -0.506 . . . . 0.0 112.005 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.8 t 55.6 -165.36 0.12 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.429 1.491 . . . . 0.0 112.679 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -66.6 -50.66 62.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.669 1.188 . . . . 0.0 108.605 164.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.269 0.4 OUTLIER 76.64 -39.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.998 2.519 . . . . 0.0 112.503 177.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -67.21 -37.23 83.26 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 158.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -82.78 93.08 1.65 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 159.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -73.31 69.8 1.14 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 110.229 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -149.35 178.46 8.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.223 1.809 . . . . 0.0 108.237 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 58.42 78.11 0.26 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.417 2.287 . . . . 0.0 112.817 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.01 -72.36 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 1 N-CA-C 100.087 -4.042 . . . . 0.0 100.087 158.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.2 t -65.38 159.84 23.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.187 1.795 . . . . 0.0 109.849 158.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -172.77 179.6 44.15 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 127.488 2.471 . . . . 0.0 109.465 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.0 t 62.47 176.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.818 1.247 . . . . 0.0 109.849 -168.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 79.8 p -153.77 174.89 3.37 Favored Pre-proline 0 C--O 1.236 0.393 0 O-C-N 120.696 -1.253 . . . . 0.0 110.109 -168.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.5 158.08 24.6 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.019 1.146 . . . . 0.0 109.708 158.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.2 p -167.24 -178.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.192 1.797 . . . . 0.0 107.752 -172.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -139.01 164.8 28.8 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.596 -1.315 . . . . 0.0 109.694 163.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.77 160.6 40.99 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.199 1.8 . . . . 0.0 108.403 172.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -124.36 145.94 16.04 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.24 -162.37 29.15 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 117.915 0.857 . . . . 0.0 114.615 -169.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.97 158.51 30.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 127.301 2.24 . . . . 0.0 108.38 -169.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -135.56 146.55 48.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.157 1.383 . . . . 0.0 107.568 165.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -150.16 122.88 8.63 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.811 0.844 . . . . 0.0 110.077 -162.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -135.75 82.43 1.95 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.787 2.035 . . . . 0.0 109.201 -172.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.64 -31.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.129 0.972 . . . . 0.0 112.931 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.0 p -136.65 155.08 76.95 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.972 1.309 . . . . 0.0 107.832 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.05 60.76 6.99 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.152 3.234 . . . . 0.0 111.33 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -148.07 -33.54 0.24 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.468 2.307 . . . . 0.0 111.395 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.16 149.58 21.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 127.21 2.204 . . . . 0.0 108.131 -166.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.0 109.12 5.24 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.138 0.881 . . . . 0.0 108.871 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.65 149.03 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.435 1.894 . . . . 0.0 106.99 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.6 157.75 46.04 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.277 0.944 . . . . 0.0 110.592 168.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 37.7 tp -154.44 119.52 5.0 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 125.67 1.588 . . . . 0.0 107.266 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.34 156.45 45.84 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.365 1.066 . . . . 0.0 111.423 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -134.01 152.96 52.06 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.474 1.51 . . . . 0.0 109.801 -173.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -145.15 158.34 43.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.555 1.542 . . . . 0.0 109.915 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -146.2 163.54 35.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.089 1.755 . . . . 0.0 107.372 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 m 43.49 66.17 0.86 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.502 1.521 . . . . 0.0 110.745 -172.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.48 167.24 13.13 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.627 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.62 62.46 3.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.523 1.129 . . . . 0.0 110.068 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.6 tp -151.22 164.01 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.385 1.474 . . . . 0.0 108.402 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.41 -161.47 44.84 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -144.6 177.03 8.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.408 1.483 . . . . 0.0 109.022 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -118.95 12.28 12.77 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.956 1.302 . . . . 0.0 113.033 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.3 -23.79 10.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.073 1.349 . . . . 0.0 111.216 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.2 t -62.95 168.9 3.63 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.753 1.221 . . . . 0.0 111.626 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.58 163.21 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.37 1.468 . . . . 0.0 108.206 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 157.41 -147.33 15.31 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -176.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 9.0 t -69.56 158.54 35.05 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 166.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -68.8 113.0 13.12 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.08 -43.49 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.537 1.491 . . . . 0.0 109.841 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 37.71 47.39 0.82 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.57 2.748 . . . . 0.0 111.795 173.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -89.68 108.09 19.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.427 1.491 . . . . 0.0 108.281 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.35 167.11 44.66 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 171.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -140.96 157.76 44.89 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 pp -140.22 162.37 35.42 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.434 0.694 . . . . 0.0 111.136 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.3 m -135.02 155.85 50.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 160.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 158.64 44.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 169.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -163.6 170.14 38.85 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.25 136.78 41.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.5 p -144.43 166.78 24.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -117.21 154.07 31.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 166.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 -89.76 158.65 17.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.221 0.534 . . . . 0.0 111.56 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -54.49 139.64 36.98 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.92 161.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.05 29.3 0.28 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.151 1.357 . . . . 0.0 111.627 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -69.4 110.75 4.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.14 -33.32 3.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.458 1.98 . . . . 0.0 110.711 -166.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.45 -42.36 10.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.777 1.231 . . . . 0.0 108.54 165.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -123.53 -159.17 0.84 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.759 2.424 . . . . 0.0 107.865 169.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 116.772 -1.585 . . . . 0.0 106.842 172.222 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -69.88 159.69 52.39 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.14 1.894 . . . . 0.0 110.207 172.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -79.49 36.57 0.31 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.952 0.901 . . . . 0.0 111.534 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -75.83 42.67 0.24 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.139 1.776 . . . . 0.0 111.36 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.48 100.3 1.64 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.254 1.421 . . . . 0.0 108.828 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.5 m -130.94 122.13 26.39 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 165.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -102.13 157.99 16.49 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -146.16 159.8 42.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.117 1.367 . . . . 0.0 109.253 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -149.86 161.58 41.99 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 159.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.37 -151.41 20.15 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.06 158.75 42.79 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.307 0.643 . . . . 0.0 110.543 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HE3' ' CZ ' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -136.66 150.38 48.47 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.026 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.79 162.85 32.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.812 1.645 . . . . 0.0 107.957 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.38 157.52 22.34 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 119.198 -0.779 . . . . 0.0 112.105 -170.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -144.11 152.23 40.66 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.906 1.282 . . . . 0.0 110.902 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.9 p 67.88 -132.66 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.669 2.388 . . . . 0.0 112.023 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 62.19 -27.87 0.06 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.063 2.545 . . . . 0.0 116.385 -165.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 50.7 t80 65.84 -42.15 0.36 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.91 2.084 . . . . 0.0 115.111 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.11 171.92 14.19 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.659 2.384 . . . . 0.0 109.006 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -156.42 -176.21 5.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.375 1.87 . . . . 0.0 106.65 159.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.6 p -61.09 -166.92 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 130.992 3.717 . . . . 0.0 112.078 158.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.53 -96.6 0.84 Allowed Glycine 0 C--N 1.339 0.717 0 N-CA-C 105.41 -3.076 . . . . 0.0 105.41 -159.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -162.74 168.62 21.23 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.461 1.104 . . . . 0.0 108.5 158.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.5 mm -134.04 142.41 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 168.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -129.3 -99.02 0.35 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 105.285 -2.116 . . . . 0.0 105.285 161.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -87.79 90.56 8.43 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 162.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 56.88 -169.34 0.1 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.636 1.175 . . . . 0.0 110.043 -163.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.03 174.2 38.46 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 120.923 -1.111 . . . . 0.0 113.011 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.71 -10.14 27.8 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 123.538 2.826 . . . . 0.0 113.691 -175.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -63.9 -11.26 26.32 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.409 1.004 . . . . 0.0 112.897 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 69.24 -69.13 0.17 Allowed 'General case' 0 C--N 1.343 0.316 0 C-N-CA 127.189 2.196 . . . . 0.0 112.066 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.04 76.84 0.13 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.317 1.847 . . . . 0.0 108.983 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.73 17.79 2.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.924 2.49 . . . . 0.0 109.559 177.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 171.21 -54.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 130.203 3.401 . . . . 0.0 107.977 -171.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.79 167.96 27.31 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.109 1.364 . . . . 0.0 110.099 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.11 167.79 28.34 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.568 0.604 . . . . 0.0 112.167 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.3 153.44 29.05 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.641 1.576 . . . . 0.0 110.078 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.79 163.4 32.34 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.298 1.427 . . . . 0.0 111.253 168.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.4 140.34 49.22 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.011 1.724 . . . . 0.0 108.574 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -134.66 158.91 42.85 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -159.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.99 143.39 14.83 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 127.302 2.382 . . . . 0.0 107.801 160.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.38 161.65 26.51 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.931 0.866 . . . . 0.0 112.102 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -149.1 143.97 26.36 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.067 1.347 . . . . 0.0 109.771 -171.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -122.04 123.21 41.08 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 158.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.69 -3.29 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -158.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.56 166.96 14.01 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 173.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.1 107.47 0.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.526 2.151 . . . . 0.0 110.501 -172.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 63.22 26.17 15.09 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.716 2.006 . . . . 0.0 112.6 -176.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -130.82 138.23 54.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.143 0.977 . . . . 0.0 109.632 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.48 -179.57 26.37 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.009 0.814 . . . . 0.0 111.805 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.25 163.27 34.98 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.533 1.533 . . . . 0.0 108.835 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -151.82 159.94 43.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 162.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 77.6 mtm -143.44 156.39 44.64 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -155.4 170.68 33.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.878 -0.201 . . . . 0.0 112.608 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.48 159.18 42.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.483 1.113 . . . . 0.0 110.027 176.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -83.54 167.66 17.16 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.229 1.812 . . . . 0.0 111.797 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -73.01 51.57 0.3 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.569 1.148 . . . . 0.0 110.246 160.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.9 tp -8.95 79.08 0.0 OUTLIER 'General case' 0 C--N 1.342 0.24 0 C-N-CA 130.672 3.589 . . . . 0.0 114.151 -159.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.95 25.07 22.59 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 117.548 -1.695 . . . . 0.0 115.38 171.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.8 mtt-85 89.92 12.4 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.52 2.728 . . . . 0.0 113.017 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 53.9 ttp -46.61 135.16 7.81 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 119.467 1.031 . . . . 0.0 109.885 170.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.02 5.59 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.515 2.81 . . . . 0.0 115.005 -171.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.6 p90 46.86 27.19 0.67 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.776 2.43 . . . . 0.0 115.04 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -144.41 157.52 44.21 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.656 1.983 . . . . 0.0 106.998 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.4 ' C ' ' HG ' ' A' ' 66' ' ' SER . . . -71.43 68.93 0.92 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 172.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.4 ' HG ' ' C ' ' A' ' 65' ' ' GLY . 64.2 m -164.81 79.18 0.35 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.011 1.724 . . . . 0.0 107.881 -176.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t 65.36 47.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 123.146 1.451 . . . . 0.0 108.261 -166.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -53.86 -24.87 17.22 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 128.974 2.91 . . . . 0.0 112.428 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -142.74 158.04 44.04 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 162.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.17 14.86 1.3 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.918 1.723 . . . . 0.0 112.478 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.24 157.93 38.52 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.792 1.637 . . . . 0.0 110.921 -172.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -69.86 -61.52 1.75 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.602 165.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.276 0.0 OUTLIER -146.13 61.05 1.24 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.131 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.19 130.22 41.47 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 158.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -147.84 168.37 22.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.048 0.939 . . . . 0.0 109.001 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.59 57.12 0.19 Allowed Glycine 0 C--N 1.338 0.661 0 CA-C-O 117.618 -1.657 . . . . 0.0 114.03 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.83 155.36 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.983 1.392 . . . . 0.0 110.934 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -133.75 148.26 51.39 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.968 2.107 . . . . 0.0 108.178 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 pp -143.14 152.11 41.44 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.209 1.003 . . . . 0.0 110.961 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 m -155.68 152.07 28.18 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.706 1.202 . . . . 0.0 112.36 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.23 136.08 54.85 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.717 2.407 . . . . 0.0 106.975 159.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -118.56 153.54 34.06 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.977 0.911 . . . . 0.0 110.147 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.14 133.47 52.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 161.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.7 164.98 10.11 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -167.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -161.24 168.87 10.73 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.142 -163.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -62.96 95.46 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 124.154 3.236 . . . . 0.0 110.74 168.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.7 tt -68.01 -44.04 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.077 0.551 . . . . 0.0 110.895 -172.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.0 t -177.16 176.51 1.36 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 129.555 3.142 . . . . 0.0 105.518 175.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 54.09 28.76 9.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.984 1.714 . . . . 0.0 113.721 161.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 60.2 26.1 15.51 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.876 2.47 . . . . 0.0 114.047 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.7 mt -101.85 110.47 22.46 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.071 1.349 . . . . 0.0 109.244 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.72 111.79 21.03 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 166.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.6 137.17 41.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -153.5 166.73 31.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.551 1.167 . . . . 0.0 113.784 -170.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.6 t -129.73 153.45 48.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 158.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.28 155.73 41.68 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.996 -0.44 . . . . 0.0 110.34 -166.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.6 tt -127.8 138.12 52.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.13 -160.1 15.13 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -170.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.99 176.38 47.93 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-O 121.341 0.412 . . . . 0.0 112.299 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -116.33 144.64 43.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.238 1.815 . . . . 0.0 107.699 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.1 t -129.28 94.17 2.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 160.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -129.13 138.73 51.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -143.34 136.46 27.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.767 -0.583 . . . . 0.0 110.867 -174.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.55 161.81 18.35 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 105.933 -1.876 . . . . 0.0 105.933 158.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -81.58 148.6 29.03 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 118.192 -1.403 . . . . 0.0 112.041 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 41.5 p -148.94 93.3 2.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.629 1.571 . . . . 0.0 107.238 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.11 -38.35 51.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.954 0.883 . . . . 0.0 109.249 164.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.0 m -145.98 151.2 37.4 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 159.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -85.48 74.18 10.38 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -173.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.338 29.7 m 51.48 -76.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 128.124 2.57 . . . . 0.0 111.266 -158.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -117.11 -12.02 10.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.318 1.447 . . . . 0.0 112.417 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.77 138.64 17.75 Favored Glycine 0 C--N 1.339 0.701 0 O-C-N 121.105 -0.997 . . . . 0.0 111.298 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -77.68 -20.87 52.97 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 170.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -74.25 108.85 7.29 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -49.32 161.87 0.16 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.237 1.815 . . . . 0.0 114.234 173.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -59.18 131.66 51.68 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.199 159.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t -153.51 94.71 1.83 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.21 1.404 . . . . 0.0 111.245 -170.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -89.79 76.14 1.74 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 p -109.57 100.81 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 p -143.01 127.2 9.57 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.353 0.661 . . . . 0.0 110.05 -166.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -79.28 168.89 19.64 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.931 2.42 . . . . 0.0 110.74 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.4 t -136.33 139.86 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.087 1.355 . . . . 0.0 107.879 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -127.77 118.69 24.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.711 2.004 . . . . 0.0 106.307 160.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.11 166.47 24.56 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.661 -0.649 . . . . 0.0 111.909 -168.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -120.75 158.51 15.65 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 166.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.79 175.23 47.43 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 118.361 1.081 . . . . 0.0 113.412 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.7 m -138.97 135.35 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.463 1.105 . . . . 0.0 108.73 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -105.83 110.74 23.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.534 2.734 . . . . 0.0 105.347 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.91 110.46 22.13 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.16 81.46 1.79 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 47.1 pt -69.36 -3.62 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.154 0.982 . . . . 0.0 112.632 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 45.0 m -154.43 149.71 20.78 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 163.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.54 -7.8 9.62 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.306 2.004 . . . . 0.0 115.855 -171.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -111.49 -12.54 13.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.16 1.384 . . . . 0.0 113.577 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 pp -139.34 147.94 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 121.764 2.075 . . . . 0.0 111.379 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.7 161.1 37.4 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.38 0.672 . . . . 0.0 109.293 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 73.9 m -130.96 135.97 48.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.439 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 6.0 ptp180 -122.19 159.54 27.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 pp -135.02 145.06 47.69 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 125.112 1.508 . . . . 0.0 107.311 159.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.54 162.08 41.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.884 1.274 . . . . 0.0 109.664 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -154.56 154.84 33.73 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.12 0.568 . . . . 0.0 111.118 -165.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -138.22 160.05 40.45 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.301 1.84 . . . . 0.0 107.288 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -137.16 134.84 36.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.953 1.301 . . . . 0.0 108.455 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . 0.251 26.0 m 39.22 47.95 1.49 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.492 2.317 . . . . 0.0 113.216 171.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -52.76 131.38 34.98 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.073 0.949 . . . . 0.0 111.377 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 55.36 4.1 0.09 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.826 2.05 . . . . 0.0 114.779 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 44.5 mt 64.28 -55.97 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.76 2.024 . . . . 0.0 111.166 -164.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 75.83 -48.3 2.3 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.778 1.656 . . . . 0.0 112.001 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -19.35 65.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.116 1.366 . . . . 0.0 112.958 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 52.24 25.77 3.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.246 1.818 . . . . 0.0 113.556 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . 0.309 2.9 m-70 51.06 52.19 15.49 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 127.452 2.301 . . . . 0.0 112.649 -169.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.2 m -69.9 -36.89 75.77 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.475 158.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.488 ' CG2' ' H ' ' A' ' 154' ' ' GLY 0.271 31.2 mm 60.4 -172.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 126.634 1.973 . . . . 0.0 109.907 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.488 ' H ' ' CG2' ' A' ' 153' ' ' ILE . . . 78.84 -52.07 3.88 Favored Glycine 0 CA--C 1.527 0.824 0 O-C-N 120.246 -1.533 . . . . 0.0 110.038 -164.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 33.2 p -132.16 158.47 41.61 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.236 1.414 . . . . 0.0 108.748 166.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 85.6 mtm-85 -130.5 154.2 81.57 Favored Pre-proline 0 C--O 1.232 0.14 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 158.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.96 -18.17 19.05 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.295 1.33 . . . . 0.0 111.141 167.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 31.49 74.39 0.05 OUTLIER 'General case' 0 C--N 1.346 0.451 0 C-N-CA 128.428 2.691 . . . . 0.0 111.643 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -63.61 71.88 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.364 1.866 . . . . 0.0 111.291 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -114.93 119.49 4.66 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.852 1.691 . . . . 0.0 110.999 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -105.65 159.28 16.09 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.042 0.937 . . . . 0.0 110.034 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.73 117.37 17.75 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 164.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.2 m -129.39 160.86 31.77 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.6 pp -144.39 167.08 23.31 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.941 1.296 . . . . 0.0 110.294 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.63 175.24 40.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.814 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.32 148.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 124.592 1.157 . . . . 0.0 108.484 163.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 70.8 m -145.6 118.69 8.84 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -169.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -82.57 123.83 29.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 171.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -90.14 124.95 35.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.82 1.648 . . . . 0.0 106.74 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -59.09 115.79 3.41 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.591 0.756 . . . . 0.0 110.858 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 170.97 163.37 24.89 Favored Glycine 0 CA--C 1.533 1.172 1 C-N-CA 130.876 4.084 . . . . 0.0 105.037 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.65 122.08 4.74 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.242 1.521 . . . . 0.0 111.135 176.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 66.96 30.71 76.41 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 175' ' ' ALA . 2.3 tt0 -96.37 179.01 5.18 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.945 0.498 . . . . 0.0 112.005 -163.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.407 ' H ' ' HG2' ' A' ' 174' ' ' GLU . . . 57.3 -164.75 0.16 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.434 1.894 . . . . 0.0 112.372 -173.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 C-N-CA 127.805 2.442 . . . . 0.0 106.398 176.916 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -130.25 127.06 38.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.298 1.039 . . . . 0.0 108.355 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -82.62 157.95 23.21 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.023 1.329 . . . . 0.0 110.654 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.426 ' CZ ' ' HA3' ' A' ' 42' ' ' GLY . 43.2 p90 -151.68 164.54 36.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.761 2.025 . . . . 0.0 109.7 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -130.98 167.38 19.13 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.176 1.39 . . . . 0.0 108.486 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.82 175.39 40.78 Favored Glycine 0 C--N 1.334 0.435 0 O-C-N 121.474 -0.766 . . . . 0.0 112.087 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.33 147.89 31.81 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.291 1.036 . . . . 0.0 109.267 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.537 ' HE2' ' CE1' ' A' ' 40' ' ' PHE . 40.4 mtmt -132.64 164.83 25.83 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.842 1.257 . . . . 0.0 112.308 -169.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.16 150.09 41.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 128.451 2.7 . . . . 0.0 106.363 159.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.77 163.66 29.07 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 119.366 0.985 . . . . 0.0 114.006 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -143.53 136.85 28.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.002 2.121 . . . . 0.0 109.338 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.7 m . . . . . 0 C--O 1.242 0.669 0 C-N-CA 125.219 1.408 . . . . 0.0 110.791 -176.568 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.742 0.306 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.54 -176.75 44.05 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.79 171.96 13.65 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.366 1.867 . . . . 0.0 108.171 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.61 170.18 38.09 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.906 -1.14 . . . . 0.0 114.695 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.42 137.5 30.43 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.098 1.759 . . . . 0.0 109.059 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.553 ' CD2' ' HA3' ' A' ' 54' ' ' GLY . 46.3 m-85 -139.57 151.8 46.36 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.025 1.33 . . . . 0.0 111.159 -166.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.69 157.91 16.47 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 126.946 2.213 . . . . 0.0 107.884 163.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.426 ' HA3' ' CZ ' ' A' ' 8' ' ' TYR . . . -168.57 166.86 39.9 Favored Glycine 0 N--CA 1.449 -0.438 0 O-C-N 121.344 -1.092 . . . . 0.0 111.054 -174.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -140.34 165.85 26.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.209 0.505 . . . . 0.0 110.837 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -115.18 162.61 16.81 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.815 1.646 . . . . 0.0 107.883 162.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 159.229 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.28 -164.79 19.19 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -139.96 163.04 33.73 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.71 1.604 . . . . 0.0 110.13 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -149.85 127.85 11.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.441 1.896 . . . . 0.0 107.613 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -134.78 125.58 27.21 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.422 1.889 . . . . 0.0 108.211 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.553 ' HA3' ' CD2' ' A' ' 40' ' ' PHE . . . -170.59 -179.22 41.82 Favored Glycine 0 C--N 1.333 0.366 0 O-C-N 121.697 -0.627 . . . . 0.0 113.027 -175.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 125.388 1.475 . . . . 0.0 107.646 -175.105 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.694 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -138.21 141.37 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -122.95 132.66 54.26 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 167.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.61 110.68 10.06 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.151 1.381 . . . . 0.0 107.439 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.9 p -137.17 143.03 42.2 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.31 0.644 . . . . 0.0 111.693 -161.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.01 149.24 25.72 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 160.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.08 156.64 45.95 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.667 0.787 . . . . 0.0 111.759 -171.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.7 tp -133.78 125.38 28.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.959 2.504 . . . . 0.0 105.773 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.82 137.85 9.57 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 106.954 -2.458 . . . . 0.0 106.954 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -138.2 133.92 17.51 Favored Pre-proline 0 C--O 1.237 0.397 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.459 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 92' ' ' ASP . 51.1 Cg_endo -67.1 143.95 67.42 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.434 2.756 . . . . 0.0 110.536 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.468 0.428 0 C-N-CA 123.195 0.598 . . . . 0.0 111.368 168.067 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.238 0.451 0 CA-C-O 121.962 0.887 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -114.18 149.05 36.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.717 2.807 . . . . 0.0 108.826 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -90.68 137.17 22.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 163.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -127.88 144.66 51.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.682 1.193 . . . . 0.0 110.791 -162.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 48.9 m -154.7 148.38 25.39 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.564 1.146 . . . . 0.0 108.462 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -147.76 155.56 41.83 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.666 0.786 . . . . 0.0 110.57 175.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -153.46 158.68 41.72 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.314 1.045 . . . . 0.0 111.003 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.97 -130.92 2.35 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.56 162.5 18.73 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.175 0.893 . . . . 0.0 112.479 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -143.88 149.94 37.68 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.595 1.558 . . . . 0.0 109.783 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.66 150.12 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.504 1.921 . . . . 0.0 107.754 168.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -150.85 143.09 24.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.598 1.159 . . . . 0.0 111.061 -165.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.523 1.129 . . . . 0.0 110.538 167.285 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 119.468 -0.301 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -64.83 163.28 28.6 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.544 1.496 . . . . 0.0 109.306 158.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.1 p -147.54 159.1 8.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 121.702 -0.624 . . . . 0.0 109.741 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -147.57 164.74 32.5 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.063 1.345 . . . . 0.0 109.42 168.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.62 165.77 35.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.705 1.202 . . . . 0.0 108.293 161.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -163.72 170.42 39.04 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 112.049 -0.42 . . . . 0.0 112.049 169.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 158.31 -116.36 0.71 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.1 157.51 28.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 117.94 0.87 . . . . 0.0 111.009 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -128.74 149.96 50.48 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 167.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.21 127.83 18.07 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.352 -0.842 . . . . 0.0 108.965 -158.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.37 136.55 37.7 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.89 -37.01 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.1 0.56 . . . . 0.0 109.656 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 47.3 m -159.83 156.25 23.97 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 103.021 -2.955 . . . . 0.0 103.021 164.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -57.14 -4.35 1.01 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 N-CA-C 118.836 2.591 . . . . 0.0 118.836 -163.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.18 0.26 10.64 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.373 1.869 . . . . 0.0 113.489 173.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.4 tt -134.7 141.96 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.621 1.569 . . . . 0.0 110.595 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.14 170.33 15.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.575 -0.703 . . . . 0.0 109.836 -168.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.3 p -128.12 160.18 32.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.157 0.983 . . . . 0.0 108.655 159.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -140.11 159.24 42.62 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.635 -0.666 . . . . 0.0 110.27 164.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.42 119.85 15.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -138.61 154.68 48.69 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.779 0.8 . . . . 0.0 111.151 -173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.554 ' HH ' ' N ' ' A' ' 160' ' ' GLY . 65.0 t80 -141.83 148.68 39.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.723 2.009 . . . . 0.0 108.484 -162.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -142.4 119.2 11.17 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.142 0 C-N-CA 125.236 1.414 . . . . 0.0 110.134 -167.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.554 ' N ' ' HH ' ' A' ' 141' ' ' TYR . . . . . . . . 0 CA--C 1.528 0.85 0 CA-C-O 121.559 0.533 . . . . 0.0 113.301 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 23.4 ptp -75.95 154.13 36.1 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 169.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -137.29 148.3 46.29 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.424 1.089 . . . . 0.0 108.929 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.3 p -143.1 158.23 43.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.901 0.48 . . . . 0.0 110.136 166.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -145.15 150.36 36.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.49 1.116 . . . . 0.0 109.149 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.17 175.09 40.31 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.66 160.28 3.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 126.735 2.014 . . . . 0.0 109.418 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.37 159.67 41.74 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.042 0.537 . . . . 0.0 109.616 167.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -140.62 140.67 35.1 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.972 1.309 . . . . 0.0 108.138 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.4 mtm105 -89.86 155.29 19.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.267 0.556 . . . . 0.0 110.721 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 67.8 t80 . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 167.148 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 24.0 p30 . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.0 t -157.03 174.33 15.68 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 159.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -133.48 168.11 19.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.474 1.909 . . . . 0.0 109.07 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -139.46 155.9 47.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 109.717 -168.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.3 p -133.45 126.94 32.26 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.504 1.921 . . . . 0.0 107.015 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.56 -159.37 13.03 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 119.038 0.835 . . . . 0.0 113.565 -161.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.9 162.24 36.0 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.182 1.393 . . . . 0.0 109.916 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -141.65 143.56 33.69 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.803 1.641 . . . . 0.0 107.149 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 pp -145.77 145.07 30.68 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.532 0.733 . . . . 0.0 109.462 166.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.65 174.49 29.14 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 124.704 1.145 . . . . 0.0 112.932 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -149.36 167.23 26.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.538 0.735 . . . . 0.0 110.316 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.24 0.569 0 C-N-CA 125.194 1.397 . . . . 0.0 107.992 165.602 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.64 144.73 12.58 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 160.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.05 121.65 2.43 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.94 170.05 39.84 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 121.702 0.612 . . . . 0.0 114.368 -172.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.77 139.93 30.6 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -135.62 165.4 25.63 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.242 1.017 . . . . 0.0 110.758 -167.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.67 162.54 25.84 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.64 165.35 25.86 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -146.18 134.44 21.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.393 1.877 . . . . 0.0 106.284 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.09 118.89 29.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 159.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -160.451 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.417 0.627 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.6 -168.42 26.52 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.943 1.735 . . . . 0.0 110.544 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -148.44 162.54 39.4 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.862 1.265 . . . . 0.0 108.543 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HG2' HH22 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -151.56 157.86 42.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.116 0.966 . . . . 0.0 110.42 171.117 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 64.5 mtt -146.48 152.76 39.53 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 125.799 1.639 . . . . 0.0 107.46 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.02 173.06 44.08 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 119.186 0.903 . . . . 0.0 113.178 170.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 . . . . . 0 N--CA 1.452 -0.348 0 C-N-CA 126.543 1.937 . . . . 0.0 107.954 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.491 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.16 146.03 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 126.458 1.903 . . . . 0.0 107.106 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -130.11 147.75 51.89 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.694 1.598 . . . . 0.0 108.012 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.34 125.79 10.18 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.961 0.904 . . . . 0.0 109.025 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.5 p -141.99 154.07 44.75 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.846 0.355 . . . . 0.0 111.255 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.53 142.77 29.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 164.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -115.41 102.93 10.28 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 mp -92.83 107.44 19.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.09 166.79 39.98 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 117.819 0.281 . . . . 0.0 112.545 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -157.7 157.6 29.9 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.023 0.929 . . . . 0.0 110.341 -171.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.79 125.96 12.15 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.205 2.603 . . . . 0.0 110.443 169.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.1 mm . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.391 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 C--O 1.233 0.188 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -86.94 139.57 30.47 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 20.2 tt -120.09 141.27 41.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -147.83 170.62 17.23 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 123.19 1.471 . . . . 0.0 113.793 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.0 m -137.41 128.05 26.9 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.666 1.986 . . . . 0.0 106.433 163.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -104.85 146.56 28.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.898 0.879 . . . . 0.0 108.734 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 tt -149.83 139.4 21.59 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.772 0.829 . . . . 0.0 109.402 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.16 -128.21 1.6 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.8 174.31 28.47 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-O 122.072 0.818 . . . . 0.0 113.085 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -150.31 162.12 41.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.132 1.373 . . . . 0.0 109.746 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 t -137.09 137.35 46.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -131.73 158.33 41.46 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.379 0.671 . . . . 0.0 110.988 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 . . . . . 0 N--CA 1.452 -0.364 0 C-N-CA 127.113 2.165 . . . . 0.0 106.826 176.729 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.36 161.45 44.75 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.955 1.77 . . . . 0.0 110.042 164.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -148.53 144.29 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -148.2 153.05 38.25 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.632 1.173 . . . . 0.0 108.971 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.9 167.64 29.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.746 1.218 . . . . 0.0 109.477 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -108.73 169.7 14.24 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.67 -173.79 45.94 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 118.747 1.273 . . . . 0.0 113.968 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.0 156.8 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.779 1.231 . . . . 0.0 109.536 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -134.34 151.56 51.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.042 1.337 . . . . 0.0 108.885 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.42 108.66 4.6 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.914 0.886 . . . . 0.0 109.747 -164.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.71 81.36 5.02 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.033 0.833 . . . . 0.0 110.202 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.3 mm -51.2 -39.05 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.489 1.516 . . . . 0.0 110.793 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 51.2 p -135.65 165.66 34.42 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 159.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.58 43.82 0.68 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 122.907 2.405 . . . . 0.0 110.839 164.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -149.25 -45.24 0.14 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.427 2.691 . . . . 0.0 109.531 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.7 tt -137.57 145.16 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 118.973 0.806 . . . . 0.0 110.464 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.66 137.76 30.16 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.93 0.892 . . . . 0.0 109.93 -165.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 53.2 m -93.91 152.93 18.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.37 1.468 . . . . 0.0 109.236 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.403 HH22 ' HG2' ' A' ' 52' ' ' GLU . 37.9 mtp180 -124.02 149.12 46.42 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.215 1.806 . . . . 0.0 107.793 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.98 144.21 41.04 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.476 1.91 . . . . 0.0 106.033 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -144.5 146.94 32.68 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.375 1.47 . . . . 0.0 109.448 -171.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -137.03 121.09 17.76 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 127.079 2.152 . . . . 0.0 107.525 172.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.59 165.88 19.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.994 2.118 . . . . 0.0 108.391 -170.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 122.514 1.149 . . . . 0.0 110.303 -173.871 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 14.6 ttt -72.33 140.39 48.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -138.73 152.03 47.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.28 163.55 32.64 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 123.883 0.739 . . . . 0.0 109.91 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.89 166.77 22.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.494 1.118 . . . . 0.0 108.938 164.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -158.73 172.96 35.66 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.7 t -142.34 145.73 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.21 113.24 4.52 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -159.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.81 132.56 35.16 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 145.3 25.38 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.615 0.643 . . . . 0.0 112.151 -171.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 45.5 t80 . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 124.924 1.29 . . . . 0.0 111.411 171.35 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 p -149.17 162.36 40.14 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.082 0.953 . . . . 0.0 110.822 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -128.25 153.07 47.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.159 1.784 . . . . 0.0 109.113 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -144.92 152.3 40.0 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.288 1.835 . . . . 0.0 108.065 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -150.05 148.34 28.91 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.323 -0.86 . . . . 0.0 111.216 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.64 -104.78 0.2 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 125.687 1.613 . . . . 0.0 109.425 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.37 169.12 25.45 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 118.204 1.002 . . . . 0.0 113.526 -166.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HE3' ' CE1' ' A' ' 40' ' ' PHE . 17.0 ptpt -142.52 166.19 25.34 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.705 1.202 . . . . 0.0 109.212 158.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 tt -131.03 115.98 17.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 163.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.87 146.46 20.55 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -150.8 142.24 23.43 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.526 1.53 . . . . 0.0 111.08 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.1 p . . . . . 0 N--CA 1.454 -0.26 0 C-N-CA 124.34 1.056 . . . . 0.0 109.769 161.749 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.14 96.3 0.19 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 106.991 -2.443 . . . . 0.0 106.991 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.88 129.92 46.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.953 1.301 . . . . 0.0 108.264 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.92 169.5 39.59 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 114.69 0.636 . . . . 0.0 114.69 -169.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.83 154.52 17.21 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.68 1.192 . . . . 0.0 108.951 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.439 ' CE1' ' HE3' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -146.63 155.52 42.52 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.217 1.007 . . . . 0.0 111.799 -171.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.3 158.22 25.85 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 163.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.73 166.2 39.21 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 117.418 0.609 . . . . 0.0 111.743 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -145.05 145.93 31.66 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.418 1.087 . . . . 0.0 110.535 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -87.9 110.9 20.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 162.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 CA--C 1.536 0.415 0 CA-C-N 118.527 0.603 . . . . 0.0 110.244 173.92 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -179.59 -165.72 34.11 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 121.105 -0.997 . . . . 0.0 112.758 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -142.16 160.82 39.46 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.548 1.139 . . . . 0.0 109.311 170.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.61 149.92 35.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.295 1.838 . . . . 0.0 107.954 168.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 53.5 mtt -148.71 153.31 38.04 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.6 1.16 . . . . 0.0 108.193 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.06 173.34 44.12 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-O 119.655 -0.525 . . . . 0.0 111.954 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.0 p90 . . . . . 0 C--O 1.233 0.209 0 C-N-CA 124.024 0.93 . . . . 0.0 109.83 -175.782 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.241 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.3 125.6 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.22 1.408 . . . . 0.0 107.923 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -95.87 144.07 26.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.769 2.428 . . . . 0.0 108.382 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -141.83 125.42 16.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.329 1.052 . . . . 0.0 108.915 169.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.61 123.93 19.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.4 1.08 . . . . 0.0 108.449 -167.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.54 138.47 32.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -99.78 129.22 45.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.323 1.049 . . . . 0.0 108.645 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.08 137.53 52.18 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 158.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.22 -172.45 43.47 Favored Glycine 0 C--O 1.226 -0.363 0 CA-C-O 119.191 -0.783 . . . . 0.0 111.448 -165.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -155.67 157.93 31.65 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.672 1.189 . . . . 0.0 109.253 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -62.2 141.9 89.75 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.882 1.721 . . . . 0.0 109.274 161.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.4 tp . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 123.79 0.836 . . . . 0.0 110.455 171.066 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--O 1.239 0.513 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -140.46 127.01 20.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.399 1.479 . . . . 0.0 109.865 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 pp -99.09 153.98 4.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.751 1.621 . . . . 0.0 109.579 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -150.15 157.6 43.27 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 122.15 0.976 . . . . 0.0 113.415 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.6 m -114.07 121.7 44.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 158.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -105.81 109.22 21.1 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 tt -125.85 128.24 47.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.98 0.809 . . . . 0.0 110.154 -168.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.48 -98.33 0.14 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.04 -162.43 36.23 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.758 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -145.95 159.36 43.35 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.502 1.121 . . . . 0.0 109.872 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.14 151.25 35.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.598 1.159 . . . . 0.0 108.138 168.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -136.04 145.02 45.57 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.809 0.844 . . . . 0.0 111.171 -170.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 . . . . . 0 C--O 1.233 0.231 0 C-N-CA 129.014 2.926 . . . . 0.0 106.809 -177.719 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.71 117.86 5.22 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.992 2.461 . . . . 0.0 108.329 170.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.34 171.15 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.476 0.71 . . . . 0.0 110.227 -172.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -138.55 162.59 34.18 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 165.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.53 163.3 29.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.411 1.884 . . . . 0.0 108.488 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -108.8 151.45 17.08 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 106.969 -2.453 . . . . 0.0 106.969 162.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -174.55 -174.32 41.2 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 117.9 0.85 . . . . 0.0 112.723 -173.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.1 p -146.57 159.52 10.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 124.571 1.149 . . . . 0.0 108.659 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.2 145.08 49.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.049 2.14 . . . . 0.0 107.164 160.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -142.94 106.1 4.56 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.285 1.834 . . . . 0.0 107.534 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.58 81.97 7.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.841 1.256 . . . . 0.0 108.296 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -25.18 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.099 0.56 . . . . 0.0 111.512 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.1 p -137.03 143.65 43.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 158.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.58 -18.57 59.48 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.763 2.308 . . . . 0.0 114.015 -166.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -62.95 -24.26 67.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.73 2.012 . . . . 0.0 112.249 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.27 164.83 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 125.28 1.432 . . . . 0.0 109.806 -167.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.46 150.56 49.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 162.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.4 p -106.92 150.42 26.45 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 158.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -143.79 147.53 34.27 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.097 0.862 . . . . 0.0 110.109 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.49 159.33 42.12 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.206 1.803 . . . . 0.0 107.771 -175.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -163.38 151.99 14.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.457 0.703 . . . . 0.0 111.483 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -145.58 139.84 26.98 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.582 1.153 . . . . 0.0 109.74 160.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -132.46 175.69 9.08 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.058 1.743 . . . . 0.0 108.915 163.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 CA--C 1.536 0.433 0 C-N-CA 124.223 1.009 . . . . 0.0 110.632 169.679 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 19.0 ttm -148.65 118.09 6.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 158.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.01 154.2 31.69 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 165.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.27 155.05 50.88 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 118.887 0.767 . . . . 0.0 109.78 159.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.76 153.52 51.13 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.77 1.628 . . . . 0.0 107.496 168.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.24 175.49 40.31 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 118.696 0.68 . . . . 0.0 112.843 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.4 m -141.33 164.0 20.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.465 1.106 . . . . 0.0 109.946 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 58.8 m -155.93 161.2 40.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.214 -0.928 . . . . 0.0 110.809 166.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -100.76 155.61 17.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.68 1.592 . . . . 0.0 107.233 159.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.1 ptm85 -90.03 158.68 17.22 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 42.5 t80 . . . . . 0 C--O 1.239 0.517 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 158.078 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.8 m -153.06 122.44 6.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -81.62 160.09 23.87 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 170.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -148.27 160.73 42.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.424 1.89 . . . . 0.0 108.022 171.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 t -148.93 161.54 41.68 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.89 -160.49 26.18 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -165.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.59 153.37 40.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.438 ' HE3' ' CZ ' ' A' ' 40' ' ' PHE . 28.0 mtmt -131.0 155.0 47.58 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.903 0.881 . . . . 0.0 109.929 172.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.3 tp -114.19 151.91 32.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.538 2.335 . . . . 0.0 106.074 164.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.91 169.06 29.39 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 118.878 0.763 . . . . 0.0 113.497 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -141.21 136.62 31.92 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.679 1.991 . . . . 0.0 109.068 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.24 0.578 0 C-N-CA 125.109 1.364 . . . . 0.0 110.508 -176.483 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.698 0.285 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.73 159.2 27.88 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 165.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.74 121.87 3.77 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.12 1.768 . . . . 0.0 107.286 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.79 165.56 35.19 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.878 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.33 146.52 24.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.102 1.361 . . . . 0.0 108.129 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.438 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 39.4 m-85 -130.3 154.72 47.34 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.074 0.949 . . . . 0.0 110.322 -171.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.11 137.43 5.81 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.04 166.83 39.73 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -166.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -139.88 168.06 20.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.402 0.601 . . . . 0.0 110.833 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -117.68 151.67 36.77 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.528 1.931 . . . . 0.0 108.049 163.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 164.823 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.465 0.3 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.64 -161.32 13.42 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -177.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -138.59 158.66 43.83 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.126 1.37 . . . . 0.0 109.79 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -139.71 120.3 14.17 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.803 2.441 . . . . 0.0 106.853 169.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -118.9 166.02 13.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.798 1.639 . . . . 0.0 107.854 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.91 173.32 41.5 Favored Glycine 0 N--CA 1.452 -0.281 0 O-C-N 121.792 -0.568 . . . . 0.0 111.982 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 . . . . . 0 N--CA 1.448 -0.546 0 C-N-CA 126.711 2.004 . . . . 0.0 106.535 -177.642 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.501 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 t -138.24 123.51 23.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -95.2 145.03 25.33 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 171.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.0 107.81 4.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.6 p -138.03 144.45 41.05 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.091 0.556 . . . . 0.0 111.717 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.91 152.65 23.38 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 162.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 157.08 47.73 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.399 0.679 . . . . 0.0 112.007 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.3 tp -140.78 136.66 32.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.926 2.49 . . . . 0.0 105.891 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.04 158.75 29.1 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 166.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.91 141.65 18.94 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.907 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 92' ' ' ASP . 49.0 Cg_endo -67.27 145.1 70.98 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.506 2.804 . . . . 0.0 110.385 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 123.053 0.541 . . . . 0.0 111.419 167.209 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.237 0.418 0 CA-C-O 121.895 0.855 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 0.6 OUTLIER -110.73 146.65 35.94 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.862 2.865 . . . . 0.0 108.763 175.458 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.8 mt -90.64 137.76 20.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 163.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -134.35 147.34 50.52 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.364 1.066 . . . . 0.0 111.57 -159.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.9 m -155.07 150.15 26.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.047 1.339 . . . . 0.0 109.41 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -147.44 154.25 40.58 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.34 1.056 . . . . 0.0 110.275 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -152.69 156.55 39.4 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.578 1.151 . . . . 0.0 111.557 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.35 -119.49 0.91 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.27 170.18 26.72 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 118.331 1.066 . . . . 0.0 113.624 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -145.75 126.52 14.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.519 1.528 . . . . 0.0 107.745 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.06 142.26 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.42 146.55 42.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.631 1.572 . . . . 0.0 108.348 -172.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.2 ttp85 . . . . . 0 C--O 1.236 0.366 0 C-N-CA 124.458 1.103 . . . . 0.0 109.961 174.098 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -65.48 159.68 46.59 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 N-CA-C 108.396 -1.425 . . . . 0.0 108.396 158.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.41 157.13 8.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 O-C-N 121.659 -0.651 . . . . 0.0 109.663 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.74 165.06 30.77 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.989 1.316 . . . . 0.0 108.54 165.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.55 162.36 39.92 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 162.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.28 165.86 32.97 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 112.125 -0.39 . . . . 0.0 112.125 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 160.56 -118.65 0.84 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.8 m -138.83 158.45 30.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 117.876 0.838 . . . . 0.0 111.435 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -129.55 141.63 50.93 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 166.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.2 126.26 18.34 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.177 0.991 . . . . 0.0 108.946 -158.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.94 140.44 45.58 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.709 0.686 . . . . 0.0 109.984 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 44.4 mm -117.14 -33.72 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.491 0.716 . . . . 0.0 109.962 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 20.7 m -161.87 157.9 21.02 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 172.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.9 -2.65 0.84 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.749 2.299 . . . . 0.0 116.618 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.23 -10.11 13.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.065 1.746 . . . . 0.0 113.773 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.6 tt -148.28 149.09 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 120.049 1.295 . . . . 0.0 111.833 -171.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.14 169.94 16.77 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.273 1.429 . . . . 0.0 108.333 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.0 p -120.04 160.31 23.06 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.989 1.315 . . . . 0.0 108.369 162.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -141.55 159.38 42.34 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 121.58 -0.7 . . . . 0.0 110.114 165.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.38 120.04 12.52 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.16 155.46 43.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.951 0.881 . . . . 0.0 111.778 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.575 ' HH ' ' N ' ' A' ' 160' ' ' GLY . 76.7 t80 -141.96 152.74 43.77 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.227 1.811 . . . . 0.0 109.829 -159.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -143.75 115.07 7.99 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.096 1.358 . . . . 0.0 108.059 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.2 t80 . . . . . 0 CA--C 1.529 0.169 0 C-N-CA 125.166 1.387 . . . . 0.0 109.98 179.056 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.575 ' N ' ' HH ' ' A' ' 141' ' ' TYR . . . . . . . . 0 CA--C 1.528 0.894 0 CA-C-O 121.158 0.31 . . . . 0.0 113.121 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 23.7 ptp -80.74 155.3 26.79 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 122.336 -0.508 . . . . 0.0 109.747 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.0 tt -139.45 149.41 44.0 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.603 1.161 . . . . 0.0 109.339 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.2 p -136.84 161.72 35.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.633 0.73 . . . . 0.0 111.491 160.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.21 151.45 34.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.125 1.37 . . . . 0.0 109.411 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.41 175.45 40.45 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 114.911 0.725 . . . . 0.0 114.911 -172.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 10.4 m -110.31 152.33 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 127.456 2.302 . . . . 0.0 108.953 172.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.3 t -151.0 113.53 4.65 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.877 0.762 . . . . 0.0 109.145 -172.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -96.26 142.52 28.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.181 1.792 . . . . 0.0 109.305 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -89.67 155.32 19.31 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.546 0.612 . . . . 0.0 111.161 -175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 60.7 t80 . . . . . 0 C--O 1.237 0.429 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 166.31 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.178 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -112.09 154.39 25.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.547 0.739 . . . . 0.0 110.141 -159.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -134.03 156.65 47.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 158.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -135.23 146.92 49.1 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.576 1.55 . . . . 0.0 106.829 -171.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 m -150.01 148.01 28.54 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.186 -0.946 . . . . 0.0 109.307 165.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.45 -142.53 7.69 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.218 0.914 . . . . 0.0 111.93 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.88 159.3 15.02 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.086 1.755 . . . . 0.0 111.829 -168.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -147.99 144.36 27.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.323 1.449 . . . . 0.0 109.903 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -133.59 148.51 51.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.94 1.696 . . . . 0.0 107.658 164.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.67 158.22 23.36 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.022 1.296 . . . . 0.0 109.876 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -154.75 143.24 20.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.369 1.084 . . . . 0.0 110.588 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.234 0.268 0 C-N-CA 124.137 0.975 . . . . 0.0 108.636 160.588 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.16 156.98 21.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 168.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.64 122.02 3.43 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.915 1.286 . . . . 0.0 107.938 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.16 -121.12 0.84 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.32 169.62 16.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.93 0.892 . . . . 0.0 111.58 -167.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -145.74 151.4 37.92 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.903 2.081 . . . . 0.0 107.831 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.94 156.79 27.84 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 160.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.15 166.02 39.18 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 117.748 0.774 . . . . 0.0 111.859 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -123.66 134.64 53.72 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.63 1.972 . . . . 0.0 108.065 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -122.43 118.33 28.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.679 1.992 . . . . 0.0 109.249 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 122.187 0.994 . . . . 0.0 108.608 173.423 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.81 -175.25 40.57 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.861 1.219 . . . . 0.0 111.691 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -140.6 148.19 40.54 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.916 1.286 . . . . 0.0 107.898 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.75 158.76 43.66 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.234 1.413 . . . . 0.0 109.119 -174.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 75.9 mtp -129.1 159.11 37.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.255 1.422 . . . . 0.0 109.809 167.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.47 165.68 16.13 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.2 t80 . . . . . 0 C--O 1.235 0.333 0 C-N-CA 125.505 1.522 . . . . 0.0 107.687 -173.439 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 107.489 -2.245 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.09 165.46 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.044 0.938 . . . . 0.0 109.267 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -128.1 154.27 45.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.275 1.43 . . . . 0.0 107.981 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -141.55 139.4 33.18 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.405 1.082 . . . . 0.0 109.073 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.55 133.46 12.29 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.466 0.706 . . . . 0.0 110.033 -161.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.95 150.7 24.75 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 160.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.484 ' HE3' ' CD2' ' A' ' 94' ' ' TYR . 14.1 tmtt? -131.5 131.33 43.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.765 1.226 . . . . 0.0 109.05 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.2 148.54 26.81 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 159.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 174.1 169.38 36.2 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 119.454 -1.355 . . . . 0.0 114.142 167.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -148.53 133.73 9.31 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.219 -164.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -71.12 135.39 27.12 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.824 3.016 . . . . 0.0 110.467 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.9 tp . . . . . 0 CA--C 1.539 0.547 0 C-N-CA 123.053 0.541 . . . . 0.0 111.421 177.484 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--O 1.233 0.229 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -101.31 125.63 47.97 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.886 1.274 . . . . 0.0 108.491 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.1 mt -90.7 117.38 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -177.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.484 ' CD2' ' HE3' ' A' ' 82' ' ' LYS . 4.4 m-85 -98.45 141.12 31.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.446 1.899 . . . . 0.0 109.788 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.3 m -134.02 115.25 14.1 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 162.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -130.06 148.69 51.94 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 123.774 0.83 . . . . 0.0 110.449 -170.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.37 148.21 27.86 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.974 0.91 . . . . 0.0 110.742 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.07 -121.8 1.05 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.75 167.41 34.7 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 117.861 0.831 . . . . 0.0 113.69 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 36.2 mtm -101.38 150.84 22.6 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.618 1.967 . . . . 0.0 106.975 163.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.3 137.47 50.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -149.71 131.11 14.7 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.293 0 C-N-CA 124.981 1.312 . . . . 0.0 109.45 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.02 144.38 47.2 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.428 2.086 . . . . 0.0 110.863 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.93 164.31 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.13 0.972 . . . . 0.0 110.078 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -147.59 165.54 30.07 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.919 1.688 . . . . 0.0 108.495 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.78 160.41 42.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.32 0.509 . . . . 0.0 110.298 165.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -109.35 159.06 14.22 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 106.131 -2.788 . . . . 0.0 106.131 158.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.79 -173.87 46.09 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 118.539 1.169 . . . . 0.0 112.008 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.21 145.16 31.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -103.05 150.97 23.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.258 1.423 . . . . 0.0 107.544 158.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.39 165.37 28.69 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.533 1.133 . . . . 0.0 109.08 163.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -130.85 88.52 2.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.028 1.731 . . . . 0.0 110.486 -163.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.12 -29.64 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 125.147 1.379 . . . . 0.0 111.118 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.4 t -141.98 146.14 39.19 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 159.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.48 -15.53 49.05 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.501 2.134 . . . . 0.0 114.9 -167.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.97 -41.76 97.02 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.217 0.917 . . . . 0.0 111.004 168.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.0 pt -110.64 163.9 7.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 124.179 0.992 . . . . 0.0 111.188 -164.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.8 158.75 43.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.8 t -141.52 152.78 44.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 158.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -135.33 153.98 51.67 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 123.124 0.569 . . . . 0.0 111.168 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.55 137.32 41.91 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -144.74 154.12 42.4 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.851 1.26 . . . . 0.0 109.803 -164.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -151.02 146.02 25.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.252 1.421 . . . . 0.0 110.735 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -132.13 115.51 15.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.902 2.481 . . . . 0.0 105.965 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.0 t80 . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 168.582 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.706 0 CA-C-O 121.588 0.549 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 26.0 ttt -142.0 156.28 45.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.624 1.97 . . . . 0.0 107.237 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.13 161.78 33.93 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.606 1.162 . . . . 0.0 108.79 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.2 p -147.28 166.4 27.2 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.342 0.591 . . . . 0.0 110.419 166.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.71 165.69 31.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 108.745 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.35 175.14 40.44 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 121.485 -0.388 . . . . 0.0 113.377 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 62.1 t -134.51 146.73 30.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 126.661 1.984 . . . . 0.0 105.709 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.5 m -156.45 174.87 14.79 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 119.934 -1.729 . . . . 0.0 110.433 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -143.72 166.06 25.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 122.926 0.49 . . . . 0.0 111.37 166.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -106.55 158.8 16.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.655 2.382 . . . . 0.0 110.446 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.2 p90 . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 163.722 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.614 0.721 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.9 m -145.2 115.34 7.47 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 119.64 -1.913 . . . . 0.0 108.863 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -114.7 131.53 56.72 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.771 1.628 . . . . 0.0 108.717 -172.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.522 ' CZ ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER -130.78 155.81 46.05 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.193 0.997 . . . . 0.0 111.741 -170.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 m -143.01 144.91 32.48 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.156 2.183 . . . . 0.0 107.633 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.3 -159.49 22.52 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 118.747 0.703 . . . . 0.0 113.522 -169.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.49 157.91 45.28 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.965 1.306 . . . . 0.0 110.629 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.6 163.75 35.63 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.02 0.928 . . . . 0.0 112.794 -175.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mp -141.34 165.78 26.56 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.542 2.337 . . . . 0.0 109.37 171.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.3 171.04 29.54 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.075 0.845 . . . . 0.0 112.249 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -158.57 150.07 20.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.829 0.852 . . . . 0.0 112.101 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 126.264 1.826 . . . . 0.0 108.246 162.841 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.27 165.24 25.5 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 171.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.1 174.66 11.1 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.565 1.946 . . . . 0.0 107.904 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.04 -164.89 31.53 Favored Glycine 0 C--N 1.332 0.338 0 O-C-N 121.848 -0.532 . . . . 0.0 112.675 163.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.29 160.63 14.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -135.74 155.14 50.84 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.653 1.581 . . . . 0.0 107.653 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.26 172.41 40.05 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.522 ' HA3' ' CZ ' ' A' ' 8' ' ' TYR . . . -168.78 166.73 39.87 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 121.553 -0.969 . . . . 0.0 113.099 166.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -137.68 106.09 5.81 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -95.91 132.87 40.75 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.465 0.302 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.356 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 121.767 0.794 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.05 -116.26 0.81 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 167.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -136.4 159.72 40.9 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.942 1.353 . . . . 0.0 111.908 -171.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -144.81 151.86 39.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 128.534 2.733 . . . . 0.0 106.263 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 66.4 mtt -152.65 170.94 19.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.728 1.211 . . . . 0.0 109.458 -162.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.27 179.95 42.14 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.172 0.892 . . . . 0.0 110.921 170.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 4.5 t80 . . . . . 0 C--O 1.235 0.311 0 C-N-CA 123.656 0.782 . . . . 0.0 109.474 178.011 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.745 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.87 131.83 38.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -95.43 132.2 40.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.35 132.53 20.46 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.001 0.92 . . . . 0.0 108.786 175.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.23 142.75 19.64 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.665 -172.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.64 147.14 26.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.966 1.306 . . . . 0.0 108.512 165.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.516 ' HE2' ' CE1' ' A' ' 94' ' ' TYR . 81.2 tttt -143.52 135.17 26.34 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.375 1.47 . . . . 0.0 109.204 -165.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.8 tp -144.28 129.45 18.69 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.729 1.612 . . . . 0.0 107.394 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.73 179.13 19.16 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 117.965 0.348 . . . . 0.0 112.994 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -143.42 138.55 15.58 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.344 1.058 . . . . 0.0 109.298 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.45 117.08 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.798 2.332 . . . . 0.0 109.073 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.7 tt . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 123.023 0.529 . . . . 0.0 110.78 -176.328 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.353 0 CA-C-O 121.5 0.667 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -132.36 136.56 46.91 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.678 1.991 . . . . 0.0 107.917 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.93 110.58 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CE1' ' HE2' ' A' ' 82' ' ' LYS . 10.4 m-85 -111.5 118.43 35.74 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.526 1.931 . . . . 0.0 110.613 -171.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.4 m -96.97 154.6 17.21 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.315 1.846 . . . . 0.0 108.183 171.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.98 165.05 35.86 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.4 tt -138.54 151.13 47.06 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.718 2.007 . . . . 0.0 107.552 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.35 -139.8 8.34 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 119.129 0.877 . . . . 0.0 111.21 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.0 177.9 44.45 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 117.517 0.659 . . . . 0.0 112.448 172.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.2 108.37 19.54 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 125.012 1.325 . . . . 0.0 107.433 168.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.02 122.76 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -88.82 150.7 22.79 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? . . . . . 0 C--O 1.232 0.153 0 C-N-CA 124.307 1.043 . . . . 0.0 109.706 171.593 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -67.04 148.14 81.04 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.639 1.559 . . . . 0.0 109.678 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.8 169.8 19.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.521 1.128 . . . . 0.0 110.192 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.05 154.0 51.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.503 1.521 . . . . 0.0 107.128 168.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.94 171.47 18.29 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.103 0.961 . . . . 0.0 109.08 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -152.63 161.94 29.73 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 169.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.19 -140.96 6.18 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.2 t -132.57 158.3 43.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 117.532 0.666 . . . . 0.0 109.738 -167.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -123.08 137.22 54.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 158.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -120.16 113.57 20.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.641 1.576 . . . . 0.0 107.624 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.0 81.58 1.89 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.855 1.262 . . . . 0.0 108.868 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.9 tp -70.53 -41.13 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 167.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.55 115.57 60.12 Favored Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 126.413 1.885 . . . . 0.0 106.486 161.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -59.1 -23.31 68.39 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 CA-C-N 121.021 1.4 . . . . 0.0 111.45 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -68.03 -39.99 82.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.208 1.803 . . . . 0.0 112.895 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.9 tt -146.42 130.77 10.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 119.527 1.058 . . . . 0.0 108.468 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.97 145.66 31.62 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 123.579 0.55 . . . . 0.0 109.525 -160.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.4 m -94.97 151.56 19.07 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.15 152.97 49.89 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 125.053 1.341 . . . . 0.0 109.803 173.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 pp -141.61 154.65 45.54 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.191 1.396 . . . . 0.0 108.824 163.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -145.68 155.46 43.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.678 1.591 . . . . 0.0 108.92 171.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -133.68 149.35 51.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.946 1.698 . . . . 0.0 107.733 166.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -135.12 167.81 20.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.454 1.502 . . . . 0.0 108.857 167.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 18.0 t80 . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 168.228 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.839 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 18.5 ttt -104.64 148.06 26.96 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 169.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.8 pp -130.64 160.81 33.13 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.334 0.654 . . . . 0.0 111.4 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.39 158.11 44.92 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.589 1.155 . . . . 0.0 108.531 163.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 pp -149.54 156.03 41.29 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.326 1.451 . . . . 0.0 108.712 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.16 175.19 40.29 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 112.271 -0.332 . . . . 0.0 112.271 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.25 145.07 27.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 170.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.8 p -154.18 151.66 29.47 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.275 0.943 . . . . 0.0 110.743 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -106.15 149.83 26.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.342 1.857 . . . . 0.0 108.961 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.12 156.13 46.69 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 127.211 2.204 . . . . 0.0 109.949 171.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 44.6 t80 . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 159.386 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 121.221 0.534 . . . . 0.0 112.047 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.5 p -154.13 161.59 41.77 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.516 1.926 . . . . 0.0 109.226 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -134.86 149.37 50.31 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.385 1.474 . . . . 0.0 107.462 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -134.85 144.77 47.75 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.79 2.036 . . . . 0.0 108.802 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -150.08 135.16 17.88 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.906 -1.121 . . . . 0.0 108.682 171.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.09 -155.42 11.53 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.717 0.675 . . . . 0.0 112.748 -160.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.77 162.88 33.64 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.843 1.257 . . . . 0.0 111.0 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -139.5 142.22 37.3 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.76 1.624 . . . . 0.0 108.83 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.1 139.32 53.88 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.512 1.925 . . . . 0.0 106.524 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.92 148.27 19.0 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.615 1.102 . . . . 0.0 111.43 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -137.78 129.44 28.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.012 2.125 . . . . 0.0 107.493 -167.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.24 0.592 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.105 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 CA--C 1.523 -0.077 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.41 -169.59 42.6 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.9 170.55 18.54 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.371 1.068 . . . . 0.0 108.741 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.36 -179.14 43.02 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.67 159.09 15.23 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -144.16 156.65 44.42 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.287 0.635 . . . . 0.0 111.113 -162.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.15 171.9 39.83 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 170.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.12 166.3 39.38 Favored Glycine 0 C--N 1.331 0.261 0 CA-C-N 117.778 0.789 . . . . 0.0 111.546 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -148.8 133.37 17.72 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.022 0.929 . . . . 0.0 109.318 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -121.76 154.84 36.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.235 0.333 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.835 -172.606 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 t . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.894 0.378 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.48 -161.43 11.47 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.082 1.325 . . . . 0.0 112.163 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -136.44 155.83 49.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.696 1.198 . . . . 0.0 109.021 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -147.38 149.06 32.02 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.72 1.208 . . . . 0.0 108.223 -169.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 73.3 mtp -151.16 171.9 16.64 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.995 0.918 . . . . 0.0 110.898 -162.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.51 179.02 40.13 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 119.523 -0.598 . . . . 0.0 111.959 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 71.9 t80 . . . . . 0 CA--C 1.535 0.396 0 C-N-CA 126.047 1.739 . . . . 0.0 110.29 -175.162 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.375 0 N-CA-C 113.849 0.3 . . . . 0.0 113.849 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 m -146.15 164.7 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.819 2.047 . . . . 0.0 110.058 173.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -120.62 146.4 46.41 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 163.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.54 116.54 7.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.289 1.436 . . . . 0.0 108.518 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.84 145.67 27.61 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.809 -0.557 . . . . 0.0 110.376 -169.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.48 22.69 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.967 0.907 . . . . 0.0 108.978 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.535 ' HE2' ' CE1' ' A' ' 94' ' ' TYR . 86.7 tttt -142.16 138.31 31.48 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.752 1.221 . . . . 0.0 108.69 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.89 146.55 34.17 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 123.113 0.565 . . . . 0.0 109.505 169.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.5 170.22 32.91 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 118.409 0.549 . . . . 0.0 113.623 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -157.97 157.2 29.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.285 1.034 . . . . 0.0 111.607 -166.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.01 131.12 13.92 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.463 2.775 . . . . 0.0 110.521 172.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 pt . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 124.511 1.125 . . . . 0.0 112.865 -178.466 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.6 tp . . . . . 0 C--O 1.234 0.247 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -106.85 111.9 24.62 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.244 1.018 . . . . 0.0 108.531 -170.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.4 HG22 HG12 ' A' ' 127' ' ' VAL . 10.1 pt -109.66 143.91 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 121.85 -0.531 . . . . 0.0 110.002 -166.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.535 ' CE1' ' HE2' ' A' ' 82' ' ' LYS . 77.5 m-85 -137.89 158.86 43.48 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.707 0.765 . . . . 0.0 112.869 -166.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.7 m -124.43 147.09 48.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 128.429 2.692 . . . . 0.0 106.179 166.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.28 144.22 31.38 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.059 0.944 . . . . 0.0 108.996 -171.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.1 tt -149.07 147.48 28.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.339 1.056 . . . . 0.0 109.188 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.9 -140.68 7.68 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.19 176.42 28.83 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-O 122.222 0.901 . . . . 0.0 112.789 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -140.0 157.44 45.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.31 1.044 . . . . 0.0 109.087 169.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.5 t -130.26 128.29 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -150.72 110.11 3.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 71.3 p . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.43 155.76 36.54 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.76 2.307 . . . . 0.0 110.086 166.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.8 124.54 2.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 124.913 1.285 . . . . 0.0 108.288 169.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -133.35 145.86 50.76 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 167.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.89 170.78 21.57 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.923 0.889 . . . . 0.0 110.468 -164.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -126.34 165.2 19.63 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 161.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.16 175.5 43.5 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 118.149 0.974 . . . . 0.0 113.187 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.4 HG12 HG22 ' A' ' 93' ' ' ILE . 18.0 m -133.44 140.64 46.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.242 1.417 . . . . 0.0 107.43 175.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.422 ' CD ' ' HE ' ' A' ' 138' ' ' ARG . 40.4 mt-10 -136.63 148.01 47.21 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.591 1.157 . . . . 0.0 108.092 -169.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -149.97 166.14 30.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.917 0.887 . . . . 0.0 110.385 -168.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.82 143.81 51.11 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 125.159 1.383 . . . . 0.0 109.603 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.56 -26.81 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.012 0.525 . . . . 0.0 110.104 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 91.0 m 139.06 -64.46 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.776 1 C-N-CA 132.894 4.478 . . . . 0.0 106.879 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -67.35 179.81 2.27 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.833 1.689 . . . . 0.0 109.943 159.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -52.81 -3.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 130.542 3.537 . . . . 0.0 117.914 -165.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 68.5 mt -87.61 138.08 19.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.95 161.52 34.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.719 0.808 . . . . 0.0 109.682 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.5 m -135.28 148.91 49.68 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.474 1.509 . . . . 0.0 107.799 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.422 ' HE ' ' CD ' ' A' ' 128' ' ' GLU . 33.5 mtp-105 -135.32 146.13 48.14 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.708 1.203 . . . . 0.0 108.928 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.6 125.66 38.67 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 164.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -140.01 123.58 17.2 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -169.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -120.68 138.03 54.16 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.149 1.78 . . . . 0.0 109.842 -172.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.14 114.97 16.99 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.621 1.968 . . . . 0.0 107.867 -167.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.5 t80 . . . . . 0 CA--C 1.533 0.298 0 C-N-CA 124.422 1.089 . . . . 0.0 109.346 179.228 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -152.44 141.83 21.6 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.965 0.883 . . . . 0.0 109.391 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.0 tp -118.82 154.33 33.05 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.553 1.941 . . . . 0.0 107.484 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.9 p -153.77 162.1 41.52 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.299 -0.875 . . . . 0.0 111.785 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 7.0 tt -132.52 149.82 52.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.192 2.197 . . . . 0.0 106.767 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.01 162.77 27.8 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 170.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.6 t -139.79 142.75 31.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 8.0 t -151.46 167.92 26.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.711 0.687 . . . . 0.0 110.734 -167.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -115.81 127.71 55.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.016 2.126 . . . . 0.0 106.303 167.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -89.63 137.59 32.2 Favored 'General case' 0 C--N 1.337 0.063 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 170.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 . . . . . 0 C--O 1.236 0.381 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -178.103 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.2 m -121.71 155.32 35.47 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.11 1.364 . . . . 0.0 108.795 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -121.37 129.6 53.14 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.294 1.438 . . . . 0.0 108.01 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -113.13 143.34 44.52 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.993 1.317 . . . . 0.0 107.95 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 t -150.35 158.2 43.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.384 0.993 . . . . 0.0 111.514 159.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.04 -141.59 6.41 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 125.4 1.476 . . . . 0.0 110.041 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.67 155.29 44.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.95 0.375 . . . . 0.0 111.606 -164.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.44 159.81 41.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.144 0.978 . . . . 0.0 111.617 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp -109.75 158.96 17.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.204 1.802 . . . . 0.0 106.411 164.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -129.89 165.35 22.36 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 124.966 1.27 . . . . 0.0 109.933 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -148.3 148.34 30.31 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.462 0.169 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.744 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 121.929 0.871 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.2 175.68 36.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.841 2.162 . . . . 0.0 109.127 170.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.03 166.3 32.88 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.026 0.93 . . . . 0.0 110.399 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.37 175.69 44.84 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.482 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.81 157.34 16.78 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.635 1.174 . . . . 0.0 107.883 164.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -151.44 166.2 31.8 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.729 0.776 . . . . 0.0 111.796 175.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.25 171.85 39.9 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.62 166.2 39.18 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -121.06 119.84 33.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 173.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.13 160.34 25.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.414 0.685 . . . . 0.0 109.428 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 124.364 1.066 . . . . 0.0 111.387 -170.578 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.14 -162.3 30.38 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 118.756 0.707 . . . . 0.0 113.695 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -126.68 155.3 42.85 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.997 1.319 . . . . 0.0 108.113 166.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -149.16 158.12 43.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.863 1.265 . . . . 0.0 108.455 -169.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.0 mtt -146.1 152.56 39.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.124 1.77 . . . . 0.0 108.731 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -136.73 157.69 23.79 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 103.183 -2.895 . . . . 0.0 103.183 -177.492 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.227 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -143.43 163.05 16.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 123.138 0.575 . . . . 0.0 110.33 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -147.29 155.97 42.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.564 1.145 . . . . 0.0 109.808 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 pp -143.73 144.44 31.84 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.238 1.415 . . . . 0.0 107.797 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 t -154.03 153.16 31.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.588 0.709 . . . . 0.0 111.401 -169.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.71 151.67 24.26 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 158.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -135.74 135.46 40.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.303 1.441 . . . . 0.0 108.622 -171.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.3 tp -133.52 168.29 18.9 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 128.023 2.529 . . . . 0.0 107.478 -176.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.53 -176.9 39.71 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.431 ' CG ' ' HD2' ' A' ' 86' ' ' PRO . 64.8 t80 -143.8 142.21 20.15 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 168.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 85' ' ' TYR . 63.8 Cg_endo -75.42 157.58 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.053 1.835 . . . . 0.0 112.909 -161.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--N 1.346 0.42 0 C-N-CA 131.447 3.899 . . . . 0.0 110.637 162.775 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 121.526 0.679 . . . . 0.0 112.41 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.97 148.3 25.38 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 tp -90.91 144.04 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 167.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -137.09 134.91 36.98 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.694 1.598 . . . . 0.0 108.519 -164.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.8 m -137.62 147.18 44.78 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -151.67 142.78 23.19 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.881 -0.512 . . . . 0.0 110.687 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 mp -141.59 140.29 33.33 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.518 1.127 . . . . 0.0 108.826 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.96 -150.27 8.22 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 117.757 0.253 . . . . 0.0 113.006 -164.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.83 161.63 24.34 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.653 1.12 . . . . 0.0 112.017 170.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.6 ptm -141.6 149.67 41.03 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.567 1.547 . . . . 0.0 109.973 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.1 127.06 19.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 125.295 1.438 . . . . 0.0 107.664 -167.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -138.47 135.68 35.41 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 117.789 0.268 . . . . 0.0 110.504 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.167 0 C-N-CA 124.174 0.99 . . . . 0.0 109.515 172.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.213 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.538 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.14 167.18 27.5 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.8 2.334 . . . . 0.0 109.925 164.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.25 153.24 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 165.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -143.37 152.34 41.49 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.465 1.506 . . . . 0.0 106.986 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.92 168.64 19.16 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.142 0.577 . . . . 0.0 110.051 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.12 164.46 32.36 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 170.79 -133.21 2.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -173.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.73 162.21 35.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 118.471 1.135 . . . . 0.0 111.615 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -139.93 144.57 37.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.136 1.774 . . . . 0.0 109.048 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -153.17 164.68 37.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.132 0.573 . . . . 0.0 110.925 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.41 143.06 43.76 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 161.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 tp -113.07 -2.93 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.18 0.992 . . . . 0.0 111.084 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.8 m -161.58 136.97 5.66 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 102.806 -3.035 . . . . 0.0 102.806 168.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.72 -23.93 69.25 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.894 1.729 . . . . 0.0 113.905 -161.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.68 -2.07 49.13 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 36.5 pt -127.38 163.39 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.87 0.868 . . . . 0.0 109.79 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.61 169.22 18.05 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.882 0.873 . . . . 0.0 109.127 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.1 m -149.46 138.69 21.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -137.91 145.89 42.65 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.852 1.261 . . . . 0.0 107.63 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.91 140.15 25.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 167.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -136.42 161.09 36.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.95 1.3 . . . . 0.0 110.803 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -136.51 152.35 50.43 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.279 2.232 . . . . 0.0 108.995 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -141.86 148.33 38.62 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.438 2.295 . . . . 0.0 107.35 172.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 C--O 1.237 0.396 0 C-N-CA 125.503 1.521 . . . . 0.0 107.617 172.239 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 CA-C-O 121.993 0.774 . . . . 0.0 113.205 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 54.5 ttm -144.67 151.67 39.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.143 1.777 . . . . 0.0 107.558 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.9 pp -139.68 162.41 35.17 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.128 0.971 . . . . 0.0 110.04 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.1 m -139.16 155.93 47.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.774 0.829 . . . . 0.0 109.741 165.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 16.1 tp -149.96 119.3 6.85 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.708 2.003 . . . . 0.0 107.4 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -152.89 171.22 31.96 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 121.718 0.621 . . . . 0.0 114.26 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.08 160.38 33.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 126.278 1.831 . . . . 0.0 109.282 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.0 m -152.46 161.99 41.82 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 121.52 -0.738 . . . . 0.0 111.504 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -97.49 152.45 18.98 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.062 1.745 . . . . 0.0 107.365 161.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.83 116.18 27.55 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.21 1.004 . . . . 0.0 110.485 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 64.1 t80 . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 124.522 1.129 . . . . 0.0 113.154 -171.829 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.312 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 m -117.7 124.51 48.69 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -104.14 156.42 17.9 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -142.71 156.94 45.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.944 1.698 . . . . 0.0 109.131 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.0 t -150.27 158.64 44.38 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.89 0.768 . . . . 0.0 111.519 162.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.65 -134.34 3.1 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.105 0.86 . . . . 0.0 112.296 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.09 147.74 50.54 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.236 1.014 . . . . 0.0 110.627 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -129.36 139.52 51.68 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.0 mp -115.12 159.5 20.81 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.472 1.909 . . . . 0.0 107.311 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.77 157.52 27.31 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -138.35 149.85 46.0 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.537 1.135 . . . . 0.0 108.358 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.6 p . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 125.0 1.32 . . . . 0.0 108.248 176.755 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.3 tp . . . . . 0 N--CA 1.464 0.258 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.2 -167.26 39.74 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 119.584 1.084 . . . . 0.0 113.625 -174.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.07 169.22 19.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.154 1.382 . . . . 0.0 109.908 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.41 170.21 38.74 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.072 0.844 . . . . 0.0 112.048 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.46 143.76 26.52 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 171.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -144.97 165.2 28.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.76 152.56 20.33 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 127.309 2.385 . . . . 0.0 109.322 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.89 151.93 19.21 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -148.35 105.72 3.65 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -172.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -122.59 142.14 50.95 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.743 0.701 . . . . 0.0 111.097 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 123.812 0.845 . . . . 0.0 112.24 -164.909 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 122.178 0.99 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.55 -166.9 18.55 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 127.663 2.554 . . . . 0.0 109.087 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -135.53 163.66 29.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.171 1.388 . . . . 0.0 108.886 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -148.04 152.38 37.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.364 1.066 . . . . 0.0 108.304 164.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 50.4 mtt -149.49 157.11 42.99 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.534 1.134 . . . . 0.0 108.068 -169.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.47 176.52 43.4 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 119.06 0.846 . . . . 0.0 113.08 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.7 t80 . . . . . 0 C--O 1.236 0.394 0 C-N-CA 125.572 1.549 . . . . 0.0 109.376 -172.393 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.323 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.7 p -143.87 148.5 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -132.05 130.23 41.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.386 1.874 . . . . 0.0 107.013 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -120.38 150.32 40.95 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 159.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -154.98 132.24 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 120.598 -1.314 . . . . 0.0 109.08 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.12 140.03 31.27 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 164.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -117.72 114.36 23.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.21 136.64 40.09 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.867 0.758 . . . . 0.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.93 -148.53 17.14 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 118.582 -1.121 . . . . 0.0 110.634 -166.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.401 ' CG ' ' HD2' ' A' ' 86' ' ' PRO . 1.6 t80 -159.32 157.43 27.24 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 118.508 1.154 . . . . 0.0 112.415 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 92' ' ' ASP . 37.5 Cg_endo -62.33 153.54 69.73 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.323 2.682 . . . . 0.0 111.911 161.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 124.832 1.253 . . . . 0.0 108.5 171.118 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 1.1 m-20 -134.93 164.02 28.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.024 2.13 . . . . 0.0 109.544 -172.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.39 129.2 73.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.657 1.583 . . . . 0.0 106.899 173.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -137.98 153.36 49.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.085 0.945 . . . . 0.0 111.768 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 51.9 m -96.9 132.41 42.69 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 159.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -99.31 108.93 21.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 167.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tt -98.96 107.53 19.99 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.07 142.01 15.39 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.113 0.863 . . . . 0.0 112.502 -164.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.66 95.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 105.929 -2.868 . . . . 0.0 105.929 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.1 ptp -134.23 157.04 47.29 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.275 0.63 . . . . 0.0 110.304 -171.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.2 p -148.25 150.38 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -117.62 156.17 28.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.602 1.961 . . . . 0.0 107.319 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 . . . . . 0 N--CA 1.452 -0.373 0 C-N-CA 123.378 0.671 . . . . 0.0 109.698 175.726 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 C--O 1.236 0.393 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.5 158.08 24.6 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.019 1.146 . . . . 0.0 109.708 158.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.2 p -167.24 -178.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.192 1.797 . . . . 0.0 107.752 -172.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -139.01 164.8 28.8 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.596 -1.315 . . . . 0.0 109.694 163.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.77 160.6 40.99 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.199 1.8 . . . . 0.0 108.403 172.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -124.36 145.94 16.04 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.24 -162.37 29.15 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 117.915 0.857 . . . . 0.0 114.615 -169.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.97 158.51 30.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 127.301 2.24 . . . . 0.0 108.38 -169.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -135.56 146.55 48.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.157 1.383 . . . . 0.0 107.568 165.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -150.16 122.88 8.63 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.811 0.844 . . . . 0.0 110.077 -162.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -135.75 82.43 1.95 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.787 2.035 . . . . 0.0 109.201 -172.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.64 -31.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.129 0.972 . . . . 0.0 112.931 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.0 p -136.65 155.08 76.95 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.972 1.309 . . . . 0.0 107.832 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.05 60.76 6.99 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.152 3.234 . . . . 0.0 111.33 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -148.07 -33.54 0.24 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.468 2.307 . . . . 0.0 111.395 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.16 149.58 21.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 127.21 2.204 . . . . 0.0 108.131 -166.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.0 109.12 5.24 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.138 0.881 . . . . 0.0 108.871 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.65 149.03 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.435 1.894 . . . . 0.0 106.99 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.6 157.75 46.04 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.277 0.944 . . . . 0.0 110.592 168.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 37.7 tp -154.44 119.52 5.0 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 125.67 1.588 . . . . 0.0 107.266 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.34 156.45 45.84 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.365 1.066 . . . . 0.0 111.423 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -134.01 152.96 52.06 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.474 1.51 . . . . 0.0 109.801 -173.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -145.15 158.34 43.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.555 1.542 . . . . 0.0 109.915 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 60.1 t80 . . . . . 0 CA--C 1.534 0.339 0 C-N-CA 126.089 1.755 . . . . 0.0 107.372 -177.693 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.837 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -140.96 157.76 44.89 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 pp -140.22 162.37 35.42 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.434 0.694 . . . . 0.0 111.136 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.3 m -135.02 155.85 50.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 160.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 158.64 44.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 169.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -163.6 170.14 38.85 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.25 136.78 41.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.5 p -144.43 166.78 24.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -117.21 154.07 31.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 166.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 -89.76 158.65 17.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.221 0.534 . . . . 0.0 111.56 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 47.2 t80 . . . . . 0 CA--C 1.537 0.45 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.92 161.509 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.341 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.5 m -130.94 122.13 26.39 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 165.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -102.13 157.99 16.49 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -146.16 159.8 42.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.117 1.367 . . . . 0.0 109.253 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -149.86 161.58 41.99 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 159.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.37 -151.41 20.15 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.06 158.75 42.79 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.307 0.643 . . . . 0.0 110.543 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HE3' ' CZ ' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -136.66 150.38 48.47 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.026 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.79 162.85 32.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.812 1.645 . . . . 0.0 107.957 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.38 157.52 22.34 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 119.198 -0.779 . . . . 0.0 112.105 -170.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -144.11 152.23 40.66 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.906 1.282 . . . . 0.0 110.902 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 127.669 2.388 . . . . 0.0 112.023 173.992 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.11 167.79 28.34 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.568 0.604 . . . . 0.0 112.167 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.3 153.44 29.05 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.641 1.576 . . . . 0.0 110.078 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.79 163.4 32.34 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.298 1.427 . . . . 0.0 111.253 168.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.4 140.34 49.22 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.011 1.724 . . . . 0.0 108.574 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -134.66 158.91 42.85 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -159.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.99 143.39 14.83 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 127.302 2.382 . . . . 0.0 107.801 160.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.38 161.65 26.51 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.931 0.866 . . . . 0.0 112.102 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -149.1 143.97 26.36 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.067 1.347 . . . . 0.0 109.771 -171.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -122.04 123.21 41.08 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 158.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -158.752 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t . . . . . 0 C--O 1.238 0.491 0 CA-C-O 121.994 0.902 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.48 -179.57 26.37 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.009 0.814 . . . . 0.0 111.805 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.25 163.27 34.98 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.533 1.533 . . . . 0.0 108.835 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -151.82 159.94 43.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 162.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 77.6 mtm -143.44 156.39 44.64 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -155.4 170.68 33.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.878 -0.201 . . . . 0.0 112.608 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.496 0 C-N-CA 124.483 1.113 . . . . 0.0 110.027 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.308 0 CA-C-O 117.618 -1.657 . . . . 0.0 114.03 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.83 155.36 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.983 1.392 . . . . 0.0 110.934 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -133.75 148.26 51.39 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.968 2.107 . . . . 0.0 108.178 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 pp -143.14 152.11 41.44 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.209 1.003 . . . . 0.0 110.961 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 m -155.68 152.07 28.18 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.706 1.202 . . . . 0.0 112.36 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.23 136.08 54.85 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.717 2.407 . . . . 0.0 106.975 159.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -118.56 153.54 34.06 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.977 0.911 . . . . 0.0 110.147 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.14 133.47 52.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 161.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.7 164.98 10.11 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -167.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -161.24 168.87 10.73 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.142 -163.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -62.96 95.46 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 124.154 3.236 . . . . 0.0 110.74 168.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.7 tt . . . . . 0 CA--C 1.533 0.308 0 C-N-CA 123.077 0.551 . . . . 0.0 110.895 -172.729 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.7 mt . . . . . 0 C--O 1.233 0.194 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.72 111.79 21.03 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 166.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.6 137.17 41.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -153.5 166.73 31.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.551 1.167 . . . . 0.0 113.784 -170.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.6 t -129.73 153.45 48.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 158.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.28 155.73 41.68 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.996 -0.44 . . . . 0.0 110.34 -166.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.6 tt -127.8 138.12 52.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.13 -160.1 15.13 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -170.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.99 176.38 47.93 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-O 121.341 0.412 . . . . 0.0 112.299 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -116.33 144.64 43.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.238 1.815 . . . . 0.0 107.699 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.1 t -129.28 94.17 2.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 160.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -129.13 138.73 51.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 N--CA 1.451 -0.386 0 O-C-N 121.767 -0.583 . . . . 0.0 110.867 -174.183 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -79.28 168.89 19.64 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.931 2.42 . . . . 0.0 110.74 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.4 t -136.33 139.86 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.087 1.355 . . . . 0.0 107.879 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -127.77 118.69 24.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.711 2.004 . . . . 0.0 106.307 160.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.11 166.47 24.56 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.661 -0.649 . . . . 0.0 111.909 -168.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -120.75 158.51 15.65 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 166.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.79 175.23 47.43 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 118.361 1.081 . . . . 0.0 113.412 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.7 m -138.97 135.35 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.463 1.105 . . . . 0.0 108.73 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -105.83 110.74 23.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.534 2.734 . . . . 0.0 105.347 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.91 110.46 22.13 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.16 81.46 1.79 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 47.1 pt -69.36 -3.62 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.154 0.982 . . . . 0.0 112.632 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 45.0 m -154.43 149.71 20.78 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 163.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.54 -7.8 9.62 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.306 2.004 . . . . 0.0 115.855 -171.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -111.49 -12.54 13.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.16 1.384 . . . . 0.0 113.577 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 pp -139.34 147.94 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 121.764 2.075 . . . . 0.0 111.379 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.7 161.1 37.4 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.38 0.672 . . . . 0.0 109.293 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 73.9 m -130.96 135.97 48.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.451 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 6.0 ptp180 -122.19 159.54 27.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 pp -135.02 145.06 47.69 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 125.112 1.508 . . . . 0.0 107.311 159.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.54 162.08 41.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.884 1.274 . . . . 0.0 109.664 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -154.56 154.84 33.73 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.12 0.568 . . . . 0.0 111.118 -165.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -138.22 160.05 40.45 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.301 1.84 . . . . 0.0 107.288 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 . . . . . 0 CA--C 1.53 0.202 0 C-N-CA 124.953 1.301 . . . . 0.0 108.455 -179.245 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -105.65 159.28 16.09 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.042 0.937 . . . . 0.0 110.034 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.73 117.37 17.75 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 164.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.2 m -129.39 160.86 31.77 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.6 pp -144.39 167.08 23.31 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.941 1.296 . . . . 0.0 110.294 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.63 175.24 40.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.814 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.32 148.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 124.592 1.157 . . . . 0.0 108.484 163.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 70.8 m -145.6 118.69 8.84 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -169.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -82.57 123.83 29.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 171.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -90.14 124.95 35.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.82 1.648 . . . . 0.0 106.74 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 70.1 t80 . . . . . 0 C--O 1.235 0.303 0 C-N-CA 123.591 0.756 . . . . 0.0 110.858 -175.474 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.34 68.1 5.21 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.715 2.943 . . . . 0.0 110.107 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -123.26 29.82 6.55 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.518 1.927 . . . . 0.0 109.667 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -43.91 -51.2 7.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 128.31 2.644 . . . . 0.0 110.165 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -77.59 112.06 13.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 166.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -130.25 127.06 38.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.298 1.039 . . . . 0.0 108.355 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -82.62 157.95 23.21 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.023 1.329 . . . . 0.0 110.654 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.426 ' CZ ' ' HA3' ' A' ' 42' ' ' GLY . 43.2 p90 -151.68 164.54 36.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.761 2.025 . . . . 0.0 109.7 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -130.98 167.38 19.13 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.176 1.39 . . . . 0.0 108.486 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.82 175.39 40.78 Favored Glycine 0 C--N 1.334 0.435 0 O-C-N 121.474 -0.766 . . . . 0.0 112.087 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.33 147.89 31.81 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.291 1.036 . . . . 0.0 109.267 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.537 ' HE2' ' CE1' ' A' ' 40' ' ' PHE . 40.4 mtmt -132.64 164.83 25.83 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.842 1.257 . . . . 0.0 112.308 -169.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.16 150.09 41.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 128.451 2.7 . . . . 0.0 106.363 159.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.77 163.66 29.07 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 119.366 0.985 . . . . 0.0 114.006 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -143.53 136.85 28.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.002 2.121 . . . . 0.0 109.338 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.7 m -142.16 85.02 1.9 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 125.219 1.408 . . . . 0.0 110.791 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 141.26 50.03 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 158.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -169.27 101.98 0.36 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.6 150.49 31.31 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 158.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t70 134.92 -29.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 130.798 3.639 . . . . 0.0 107.864 -158.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 69.2 p -129.35 102.25 6.34 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 162.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.93 -130.15 1.11 Allowed Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.44 0.563 . . . . 0.0 112.291 -170.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -153.2 4.18 0.32 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.621 1.568 . . . . 0.0 114.357 -167.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.308 7.8 pt 58.61 130.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 130.093 3.357 . . . . 0.0 114.096 -164.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.43 170.5 15.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.625 1.17 . . . . 0.0 110.063 168.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -85.46 -112.53 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 166.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -60.04 153.82 20.65 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.928 1.24 . . . . 0.0 108.684 158.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 139.17 99.55 0.45 Allowed Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -170.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.12 65.17 5.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.668 2.912 . . . . 0.0 109.966 174.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.3 m -60.1 146.45 43.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.423 1.489 . . . . 0.0 109.615 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -150.54 141.76 23.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.185 -160.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.406 ' OE1' ' HE2' ' A' ' 73' ' ' LYS . 1.8 tm-20 -85.98 -74.78 0.4 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 166.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -27.87 44.23 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.315 -172.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 69.78 -73.78 0.09 Allowed 'General case' 0 C--N 1.347 0.457 0 C-N-CA 125.984 1.714 . . . . 0.0 110.786 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 pp -159.0 169.49 24.18 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.557 1.143 . . . . 0.0 110.299 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.54 -176.75 44.05 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.79 171.96 13.65 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.366 1.867 . . . . 0.0 108.171 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.61 170.18 38.09 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.906 -1.14 . . . . 0.0 114.695 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.42 137.5 30.43 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.098 1.759 . . . . 0.0 109.059 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.553 ' CD2' ' HA3' ' A' ' 54' ' ' GLY . 46.3 m-85 -139.57 151.8 46.36 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.025 1.33 . . . . 0.0 111.159 -166.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.69 157.91 16.47 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 126.946 2.213 . . . . 0.0 107.884 163.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.426 ' HA3' ' CZ ' ' A' ' 8' ' ' TYR . . . -168.57 166.86 39.9 Favored Glycine 0 N--CA 1.449 -0.438 0 O-C-N 121.344 -1.092 . . . . 0.0 111.054 -174.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -140.34 165.85 26.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.209 0.505 . . . . 0.0 110.837 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -115.18 162.61 16.81 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.815 1.646 . . . . 0.0 107.883 162.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 p -126.59 91.94 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 159.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 57.3 176.73 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 127.54 2.336 . . . . 0.0 112.742 -167.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.9 74.4 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.558 2.172 . . . . 0.0 109.371 160.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -143.96 -72.97 0.27 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.388 1.475 . . . . 0.0 109.127 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.5 m -141.95 166.13 17.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.972 0.909 . . . . 0.0 109.315 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.28 -164.79 19.19 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -139.96 163.04 33.73 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.71 1.604 . . . . 0.0 110.13 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -149.85 127.85 11.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.441 1.896 . . . . 0.0 107.613 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -134.78 125.58 27.21 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.422 1.889 . . . . 0.0 108.211 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.553 ' HA3' ' CD2' ' A' ' 40' ' ' PHE . . . -170.59 -179.22 41.82 Favored Glycine 0 C--N 1.333 0.366 0 O-C-N 121.697 -0.627 . . . . 0.0 113.027 -175.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -119.13 115.76 24.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.388 1.475 . . . . 0.0 107.646 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -98.04 133.31 42.68 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 158.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -161.35 176.63 10.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.242 1.017 . . . . 0.0 110.714 -173.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.5 tp -126.71 101.45 6.63 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.733 1.613 . . . . 0.0 106.908 170.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.37 58.97 1.97 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.753 1.168 . . . . 0.0 112.085 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 58.22 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.905 2.482 . . . . 0.0 110.728 -171.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.7 mtm -138.16 110.76 8.46 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 160.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.63 -12.31 33.09 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.346 2.031 . . . . 0.0 112.83 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.21 -28.01 56.77 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.643 1.577 . . . . 0.0 112.569 165.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 61.45 -15.82 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.558 2.343 . . . . 0.0 115.522 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.28 79.83 0.22 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 166.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 t 70.58 178.02 0.26 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.511 1.924 . . . . 0.0 110.786 -161.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.3 m -143.0 161.95 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 126.13 1.772 . . . . 0.0 109.103 -172.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -67.02 153.96 42.36 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.38 1.085 . . . . 0.0 108.171 167.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.04 -28.79 35.25 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.888 2.075 . . . . 0.0 113.305 -170.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 167.39 178.22 39.46 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.001 1.762 . . . . 0.0 109.689 -168.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 59.41 -8.53 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.763 2.825 . . . . 0.0 116.616 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -57.3 150.03 18.96 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.292 1.837 . . . . 0.0 111.409 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.406 ' HE2' ' OE1' ' A' ' 32' ' ' GLU . 9.0 mptt -76.71 70.51 3.21 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.824 1.25 . . . . 0.0 110.547 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.06 -56.13 4.23 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 126.44 1.896 . . . . 0.0 114.534 -167.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -161.1 165.49 29.55 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 121.664 0.745 . . . . 0.0 111.32 -170.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.57 177.21 46.78 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -138.21 141.37 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -122.95 132.66 54.26 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 167.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.61 110.68 10.06 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.151 1.381 . . . . 0.0 107.439 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.9 p -137.17 143.03 42.2 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.31 0.644 . . . . 0.0 111.693 -161.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.01 149.24 25.72 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 160.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.08 156.64 45.95 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.667 0.787 . . . . 0.0 111.759 -171.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.7 tp -133.78 125.38 28.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.959 2.504 . . . . 0.0 105.773 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.82 137.85 9.57 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 106.954 -2.458 . . . . 0.0 106.954 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -138.2 133.92 17.51 Favored Pre-proline 0 C--O 1.237 0.397 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.459 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 92' ' ' ASP . 51.1 Cg_endo -67.1 143.95 67.42 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.434 2.756 . . . . 0.0 110.536 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.37 -4.34 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.195 0.598 . . . . 0.0 111.368 168.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.8 m -160.57 165.17 31.24 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.593 2.757 . . . . 0.0 104.101 166.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -70.34 50.76 0.12 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.283 1.833 . . . . 0.0 110.48 168.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -151.31 -56.17 0.15 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.858 2.063 . . . . 0.0 109.368 -170.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 pp -143.34 158.06 43.95 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.962 0.887 . . . . 0.0 112.643 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -114.18 149.05 36.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.717 2.807 . . . . 0.0 108.826 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -90.68 137.17 22.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 163.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -127.88 144.66 51.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.682 1.193 . . . . 0.0 110.791 -162.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 48.9 m -154.7 148.38 25.39 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.564 1.146 . . . . 0.0 108.462 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -147.76 155.56 41.83 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.666 0.786 . . . . 0.0 110.57 175.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -153.46 158.68 41.72 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.314 1.045 . . . . 0.0 111.003 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.97 -130.92 2.35 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.56 162.5 18.73 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.175 0.893 . . . . 0.0 112.479 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -143.88 149.94 37.68 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.595 1.558 . . . . 0.0 109.783 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.66 150.12 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.504 1.921 . . . . 0.0 107.754 168.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -150.85 143.09 24.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.598 1.159 . . . . 0.0 111.061 -165.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -143.3 148.34 36.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.523 1.129 . . . . 0.0 110.538 167.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.55 126.84 12.2 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.343 1.457 . . . . 0.0 110.796 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.64 103.46 3.04 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.695 0.798 . . . . 0.0 110.43 -165.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.53 16.12 5.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -159.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -53.79 109.76 0.5 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 162.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.2 t -162.73 -166.23 1.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.522 1.929 . . . . 0.0 107.187 -170.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -68.24 44.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.043 2.537 . . . . 0.0 112.519 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.7 t 50.89 -87.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 128.527 2.731 . . . . 0.0 111.333 -172.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -74.58 -30.22 61.63 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.779 1.231 . . . . 0.0 111.462 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -82.05 74.86 2.42 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.9 pttp -133.86 166.56 22.38 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.542 1.137 . . . . 0.0 112.292 -171.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -72.66 168.96 17.62 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.75 2.42 . . . . 0.0 111.921 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -68.2 119.56 12.96 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 158.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -85.23 -26.4 26.72 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.591 1.156 . . . . 0.0 113.747 -172.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.4 m -149.37 153.83 38.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -170.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -165.19 160.29 33.58 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 166.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.2 p -150.97 139.55 14.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 167.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.2 m -169.96 169.32 4.02 Favored Pre-proline 0 N--CA 1.467 0.375 0 C-N-CA 123.72 0.808 . . . . 0.0 110.513 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -64.83 163.28 28.6 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.544 1.496 . . . . 0.0 109.306 158.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.1 p -147.54 159.1 8.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 121.702 -0.624 . . . . 0.0 109.741 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -147.57 164.74 32.5 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.063 1.345 . . . . 0.0 109.42 168.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.62 165.77 35.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.705 1.202 . . . . 0.0 108.293 161.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -163.72 170.42 39.04 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 112.049 -0.42 . . . . 0.0 112.049 169.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 158.31 -116.36 0.71 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.1 157.51 28.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 117.94 0.87 . . . . 0.0 111.009 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -128.74 149.96 50.48 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 167.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.21 127.83 18.07 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.352 -0.842 . . . . 0.0 108.965 -158.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.37 136.55 37.7 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.89 -37.01 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.1 0.56 . . . . 0.0 109.656 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 47.3 m -159.83 156.25 23.97 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 103.021 -2.955 . . . . 0.0 103.021 164.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -57.14 -4.35 1.01 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 N-CA-C 118.836 2.591 . . . . 0.0 118.836 -163.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.18 0.26 10.64 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.373 1.869 . . . . 0.0 113.489 173.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.4 tt -134.7 141.96 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.621 1.569 . . . . 0.0 110.595 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.14 170.33 15.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.575 -0.703 . . . . 0.0 109.836 -168.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.3 p -128.12 160.18 32.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.157 0.983 . . . . 0.0 108.655 159.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -140.11 159.24 42.62 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.635 -0.666 . . . . 0.0 110.27 164.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.42 119.85 15.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -138.61 154.68 48.69 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.779 0.8 . . . . 0.0 111.151 -173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -141.83 148.68 39.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.723 2.009 . . . . 0.0 108.484 -162.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -142.4 119.2 11.17 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.88 154.13 49.49 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.236 1.414 . . . . 0.0 110.134 -167.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.3 t -150.26 167.27 27.44 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 158.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -77.63 81.04 4.09 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -44.89 141.18 2.27 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.335 1.854 . . . . 0.0 111.047 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mt -84.91 51.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -50.19 110.9 0.97 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 127.273 2.368 . . . . 0.0 113.656 -168.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.9 109.48 1.47 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.991 1.316 . . . . 0.0 109.848 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.27 170.11 23.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.272 -0.893 . . . . 0.0 110.68 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -57.66 126.49 27.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 158.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 26.2 m 50.59 73.14 0.29 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.032 1.333 . . . . 0.0 110.648 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.6 pt -55.88 -2.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 128.949 2.9 . . . . 0.0 116.756 -168.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.33 95.72 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 159.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.03 94.88 3.5 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.593 1.957 . . . . 0.0 108.412 -173.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.1 mtm105 -132.11 159.57 71.59 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 126.69 1.996 . . . . 0.0 107.129 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.67 -16.11 30.17 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.615 1.543 . . . . 0.0 112.466 171.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 47.81 28.27 1.3 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.232 1.813 . . . . 0.0 112.509 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -111.62 127.97 55.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.404 1.082 . . . . 0.0 109.217 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -73.04 179.92 37.91 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.267 1.413 . . . . 0.0 113.301 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 23.4 ptp -75.95 154.13 36.1 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 169.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -137.29 148.3 46.29 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.424 1.089 . . . . 0.0 108.929 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.3 p -143.1 158.23 43.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.901 0.48 . . . . 0.0 110.136 166.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -145.15 150.36 36.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.49 1.116 . . . . 0.0 109.149 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.17 175.09 40.31 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.66 160.28 3.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 126.735 2.014 . . . . 0.0 109.418 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.37 159.67 41.74 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.042 0.537 . . . . 0.0 109.616 167.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -140.62 140.67 35.1 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.972 1.309 . . . . 0.0 108.138 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.4 mtm105 -89.86 155.29 19.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.267 0.556 . . . . 0.0 110.721 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -69.4 115.96 9.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 167.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.49 -164.26 14.14 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.614 1.102 . . . . 0.0 112.266 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 66.19 159.8 0.13 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.244 2.218 . . . . 0.0 113.156 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 59.41 32.72 73.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.338 0.97 . . . . 0.0 112.958 176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -134.06 145.7 49.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.404 1.082 . . . . 0.0 109.063 -164.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -156.29 158.71 37.96 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.694 1.597 . . . . 0.0 108.247 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.503 1.521 . . . . 0.0 111.196 176.39 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -70.76 164.63 34.84 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.039 1.826 . . . . 0.0 110.704 171.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.01 143.26 27.13 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 164.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -130.97 115.55 16.64 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -162.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.39 161.66 41.6 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.128 0.571 . . . . 0.0 111.711 -162.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.0 t -157.03 174.33 15.68 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 159.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -133.48 168.11 19.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.474 1.909 . . . . 0.0 109.07 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -139.46 155.9 47.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 109.717 -168.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.3 p -133.45 126.94 32.26 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.504 1.921 . . . . 0.0 107.015 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.56 -159.37 13.03 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 119.038 0.835 . . . . 0.0 113.565 -161.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.9 162.24 36.0 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.182 1.393 . . . . 0.0 109.916 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -141.65 143.56 33.69 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.803 1.641 . . . . 0.0 107.149 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 pp -145.77 145.07 30.68 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.532 0.733 . . . . 0.0 109.462 166.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.65 174.49 29.14 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 124.704 1.145 . . . . 0.0 112.932 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -149.36 167.23 26.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.538 0.735 . . . . 0.0 110.316 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 t -126.93 150.01 49.54 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.194 1.397 . . . . 0.0 107.992 165.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -72.49 170.46 14.28 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.796 1.238 . . . . 0.0 110.724 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -62.68 151.16 39.05 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 158.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.416 ' HA ' ' CE1' ' A' ' 31' ' ' HIS . 4.4 t-80 39.23 79.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.697 2.399 . . . . 0.0 113.639 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.65 -168.16 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.207 1.003 . . . . 0.0 111.719 163.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 t -56.29 -25.52 48.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.006 1.722 . . . . 0.0 113.2 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.92 -159.84 2.6 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.638 1.59 . . . . 0.0 112.347 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -139.89 166.13 25.46 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.473 -1.016 . . . . 0.0 108.58 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.9 pt -61.75 152.06 6.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 123.097 0.559 . . . . 0.0 110.256 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -78.48 79.48 4.91 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 121.903 -0.498 . . . . 0.0 110.5 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 62.33 -66.4 0.08 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.2 2.6 . . . . 0.0 114.286 161.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.19 -3.21 12.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.251 1.82 . . . . 0.0 111.659 -176.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.31 170.68 35.67 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 119.747 1.158 . . . . 0.0 112.117 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.91 -56.28 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.437 2.758 . . . . 0.0 113.257 -165.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p 56.57 -75.15 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.194 1.798 . . . . 0.0 112.691 -159.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.416 ' CE1' ' HA ' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -76.8 55.77 1.11 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.356 1.462 . . . . 0.0 113.106 -172.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.98 -17.09 33.89 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.947 0.899 . . . . 0.0 112.211 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -173.44 162.13 4.22 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.39 1.876 . . . . 0.0 108.079 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.27 157.22 46.86 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 158.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.98 153.51 46.89 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.034 1.334 . . . . 0.0 109.787 -174.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.64 144.73 12.58 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 160.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.05 121.65 2.43 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.94 170.05 39.84 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 121.702 0.612 . . . . 0.0 114.368 -172.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.77 139.93 30.6 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -135.62 165.4 25.63 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.242 1.017 . . . . 0.0 110.758 -167.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.67 162.54 25.84 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.64 165.35 25.86 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -146.18 134.44 21.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.393 1.877 . . . . 0.0 106.284 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.09 118.89 29.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 159.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.72 -1.42 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -160.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -141.54 167.62 16.46 Favored Pre-proline 0 C--O 1.235 0.327 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.08 133.98 50.2 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 N-CA-C 107.059 -1.939 . . . . 0.0 107.059 158.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 63.32 -9.42 0.12 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 t -136.54 103.99 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 121.84 2.109 . . . . 0.0 111.127 -169.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.6 -168.42 26.52 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.943 1.735 . . . . 0.0 110.544 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -148.44 162.54 39.4 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.862 1.265 . . . . 0.0 108.543 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HG2' HH22 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -151.56 157.86 42.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.116 0.966 . . . . 0.0 110.42 171.117 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 64.5 mtt -146.48 152.76 39.53 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 125.799 1.639 . . . . 0.0 107.46 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.02 173.06 44.08 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 119.186 0.903 . . . . 0.0 113.178 170.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -126.51 116.25 20.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.543 1.937 . . . . 0.0 107.954 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.21 148.66 26.61 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 125.797 1.639 . . . . 0.0 108.907 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -144.97 118.86 9.29 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.41 -35.61 76.19 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 112.15 -167.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.42 150.4 12.07 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.48 118.07 15.99 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 90.0 mtp -60.5 147.82 82.13 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 118.906 -0.569 . . . . 0.0 109.784 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.82 69.47 4.52 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.681 2.921 . . . . 0.0 109.382 171.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -62.13 -28.12 69.42 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.193 0.997 . . . . 0.0 113.564 -162.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? 60.52 -61.32 0.07 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.641 3.176 . . . . 0.0 113.392 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.49 42.34 0.02 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 128.337 2.875 . . . . 0.0 108.034 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.6 m -70.99 167.88 18.23 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.129 0.972 . . . . 0.0 110.867 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.83 170.33 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.926 1.69 . . . . 0.0 107.192 168.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.259 9.5 pt-20 51.47 -24.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 130.691 3.596 . . . . 0.0 117.288 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -68.16 82.25 0.23 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.544 1.538 . . . . 0.0 109.669 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.9 -172.33 13.04 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.007 1.765 . . . . 0.0 110.809 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 59.99 172.47 0.09 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.814 2.046 . . . . 0.0 113.702 -173.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -73.48 131.16 41.48 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.828 1.251 . . . . 0.0 112.131 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -149.94 157.39 43.12 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.412 1.485 . . . . 0.0 110.075 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 41.12 60.22 2.08 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.457 2.303 . . . . 0.0 112.714 172.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -155.14 -179.55 8.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.785 0.834 . . . . 0.0 111.466 -166.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -160.44 -178.31 34.32 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 123.512 0.577 . . . . 0.0 111.851 172.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.16 146.03 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 126.458 1.903 . . . . 0.0 107.106 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -130.11 147.75 51.89 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.694 1.598 . . . . 0.0 108.012 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.34 125.79 10.18 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.961 0.904 . . . . 0.0 109.025 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.5 p -141.99 154.07 44.75 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.846 0.355 . . . . 0.0 111.255 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.53 142.77 29.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 164.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -115.41 102.93 10.28 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 mp -92.83 107.44 19.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.09 166.79 39.98 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 117.819 0.281 . . . . 0.0 112.545 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -157.7 157.6 29.9 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.023 0.929 . . . . 0.0 110.341 -171.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.79 125.96 12.15 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.205 2.603 . . . . 0.0 110.443 169.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.1 mm -62.39 -47.23 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 t -159.12 179.52 8.96 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.377 1.871 . . . . 0.0 106.554 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 25.97 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 130.497 3.519 . . . . 0.0 113.447 163.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -142.04 94.94 2.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.822 1.249 . . . . 0.0 108.974 167.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -163.89 105.89 0.93 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 127.016 2.127 . . . . 0.0 105.423 158.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -86.94 139.57 30.47 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 20.2 tt -120.09 141.27 41.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -147.83 170.62 17.23 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 123.19 1.471 . . . . 0.0 113.793 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.0 m -137.41 128.05 26.9 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.666 1.986 . . . . 0.0 106.433 163.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -104.85 146.56 28.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.898 0.879 . . . . 0.0 108.734 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 tt -149.83 139.4 21.59 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.772 0.829 . . . . 0.0 109.402 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.16 -128.21 1.6 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.8 174.31 28.47 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-O 122.072 0.818 . . . . 0.0 113.085 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -150.31 162.12 41.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.132 1.373 . . . . 0.0 109.746 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 t -137.09 137.35 46.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -131.73 158.33 41.46 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.379 0.671 . . . . 0.0 110.988 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -140.42 104.05 4.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 127.113 2.165 . . . . 0.0 106.826 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.1 107.64 19.13 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 171.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.19 103.44 4.62 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-O 121.264 0.554 . . . . 0.0 110.212 -173.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 t -166.53 171.31 11.91 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.779 2.032 . . . . 0.0 106.719 165.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -77.8 76.49 4.33 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 167.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.8 t -57.53 101.68 0.08 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.836 1.254 . . . . 0.0 111.318 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -161.84 -165.8 1.33 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.219 1.807 . . . . 0.0 108.22 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.6 t 58.99 69.18 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.528 1.531 . . . . 0.0 108.895 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -62.02 5.98 0.08 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.801 2.44 . . . . 0.0 116.244 -163.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.53 -17.32 79.23 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.441 1.019 . . . . 0.0 111.796 163.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.49 165.27 11.65 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.283 1.433 . . . . 0.0 107.203 161.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -144.98 152.91 40.9 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.88 70.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.676 2.79 . . . . 0.0 104.344 -172.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -51.66 -64.27 0.87 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.846 2.058 . . . . 0.0 112.746 -158.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.5 m 65.9 146.65 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.763 2.025 . . . . 0.0 111.672 -167.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.21 -174.38 15.51 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.246 0.927 . . . . 0.0 112.101 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.6 p -88.33 148.72 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.817 1.647 . . . . 0.0 109.637 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.3 t -153.09 152.75 28.58 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.319 1.048 . . . . 0.0 108.999 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.36 161.45 44.75 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.955 1.77 . . . . 0.0 110.042 164.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -148.53 144.29 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -148.2 153.05 38.25 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.632 1.173 . . . . 0.0 108.971 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.9 167.64 29.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.746 1.218 . . . . 0.0 109.477 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -108.73 169.7 14.24 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.67 -173.79 45.94 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 118.747 1.273 . . . . 0.0 113.968 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.0 156.8 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.779 1.231 . . . . 0.0 109.536 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -134.34 151.56 51.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.042 1.337 . . . . 0.0 108.885 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.42 108.66 4.6 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.914 0.886 . . . . 0.0 109.747 -164.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.71 81.36 5.02 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.033 0.833 . . . . 0.0 110.202 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.3 mm -51.2 -39.05 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.489 1.516 . . . . 0.0 110.793 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 51.2 p -135.65 165.66 34.42 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 159.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.58 43.82 0.68 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 122.907 2.405 . . . . 0.0 110.839 164.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -149.25 -45.24 0.14 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.427 2.691 . . . . 0.0 109.531 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.7 tt -137.57 145.16 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 118.973 0.806 . . . . 0.0 110.464 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.66 137.76 30.16 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.93 0.892 . . . . 0.0 109.93 -165.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 53.2 m -93.91 152.93 18.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.37 1.468 . . . . 0.0 109.236 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.403 HH22 ' HG2' ' A' ' 52' ' ' GLU . 37.9 mtp180 -124.02 149.12 46.42 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.215 1.806 . . . . 0.0 107.793 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.98 144.21 41.04 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.476 1.91 . . . . 0.0 106.033 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -144.5 146.94 32.68 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.375 1.47 . . . . 0.0 109.448 -171.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -137.03 121.09 17.76 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 127.079 2.152 . . . . 0.0 107.525 172.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.59 165.88 19.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.994 2.118 . . . . 0.0 108.391 -170.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -83.39 164.26 20.06 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 122.514 1.149 . . . . 0.0 110.303 -173.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.0 m -151.31 96.37 2.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 102.005 -3.331 . . . . 0.0 102.005 166.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 53.71 -176.14 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.558 1.543 . . . . 0.0 111.457 -158.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -157.22 144.72 18.81 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.857 1.263 . . . . 0.0 107.965 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.401 ' CG2' ' H ' ' A' ' 152' ' ' THR . 32.6 mt 45.48 68.09 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.377 2.271 . . . . 0.0 110.628 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.0 -82.18 1.62 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 166.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 150' ' ' ALA . 6.8 p-10 -38.89 -89.39 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 131.193 3.797 . . . . 0.0 115.367 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.412 ' H ' ' CG ' ' A' ' 149' ' ' ASP . . . -73.63 70.15 1.32 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.488 1.515 . . . . 0.0 108.526 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -54.97 121.72 9.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.641 0.776 . . . . 0.0 112.43 -161.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.401 ' H ' ' CG2' ' A' ' 147' ' ' ILE . 71.0 p 66.16 -1.15 1.23 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.719 2.408 . . . . 0.0 115.043 -175.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 75.6 mt -103.45 -34.59 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.216 1.406 . . . . 0.0 109.313 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -163.23 175.15 39.56 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 118.93 0.786 . . . . 0.0 112.229 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 11.7 t -132.37 102.15 5.63 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.444 1.898 . . . . 0.0 106.16 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 15.3 mtp-105 -130.63 96.32 23.99 Favored Pre-proline 0 CA--C 1.533 0.318 0 O-C-N 121.468 -0.77 . . . . 0.0 109.998 -170.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -78.84 178.28 7.72 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.269 1.979 . . . . 0.0 108.576 158.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.62 -55.42 20.35 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 159.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -145.55 152.16 39.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -69.47 -168.14 5.95 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 170.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 14.6 ttt -72.33 140.39 48.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -138.73 152.03 47.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.28 163.55 32.64 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 123.883 0.739 . . . . 0.0 109.91 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.89 166.77 22.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.494 1.118 . . . . 0.0 108.938 164.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -158.73 172.96 35.66 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.7 t -142.34 145.73 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.21 113.24 4.52 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -159.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.81 132.56 35.16 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 145.3 25.38 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.615 0.643 . . . . 0.0 112.151 -171.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -76.98 149.78 35.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.924 1.29 . . . . 0.0 111.411 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.72 166.08 36.58 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 106.953 -2.459 . . . . 0.0 106.953 159.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.51 35.46 2.04 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.221 1.008 . . . . 0.0 109.111 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 78.48 -62.81 3.77 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -164.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 176' ' ' ALA . 16.6 pt-20 -72.47 170.82 13.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.538 0.735 . . . . 0.0 110.519 160.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -86.98 -3.36 59.08 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.69 1.196 . . . . 0.0 113.193 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.461 ' H ' ' HG3' ' A' ' 174' ' ' GLU . . . . . . . . 0 C--O 1.25 1.084 0 C-N-CA 126.295 1.838 . . . . 0.0 109.481 -159.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -69.72 170.77 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.239 1.96 . . . . 0.0 110.506 167.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 -159.03 0.94 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.681 1.193 . . . . 0.0 108.053 171.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -48.92 178.15 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.648 1.579 . . . . 0.0 112.926 161.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -81.57 -60.51 2.23 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.827 -1.17 . . . . 0.0 109.943 170.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 p -149.17 162.36 40.14 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.082 0.953 . . . . 0.0 110.822 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -128.25 153.07 47.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.159 1.784 . . . . 0.0 109.113 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -144.92 152.3 40.0 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.288 1.835 . . . . 0.0 108.065 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -150.05 148.34 28.91 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.323 -0.86 . . . . 0.0 111.216 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.64 -104.78 0.2 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 125.687 1.613 . . . . 0.0 109.425 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.37 169.12 25.45 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 118.204 1.002 . . . . 0.0 113.526 -166.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HE3' ' CE1' ' A' ' 40' ' ' PHE . 17.0 ptpt -142.52 166.19 25.34 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.705 1.202 . . . . 0.0 109.212 158.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 tt -131.03 115.98 17.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 163.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.87 146.46 20.55 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -150.8 142.24 23.43 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.526 1.53 . . . . 0.0 111.08 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.1 p -154.2 172.73 17.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.34 1.056 . . . . 0.0 109.769 161.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 171.77 2.18 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 158.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -110.2 -53.15 2.71 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.798 1.239 . . . . 0.0 110.872 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -130.07 -54.8 1.12 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.654 0.782 . . . . 0.0 109.942 172.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 165.6 -49.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 129.873 3.269 . . . . 0.0 107.138 -176.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -143.73 30.95 1.31 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.28 1.832 . . . . 0.0 108.468 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.35 -144.23 48.24 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.095 -1.628 . . . . 0.0 109.176 -168.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -78.19 50.59 0.92 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.602 -0.94 . . . . 0.0 109.922 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 mm 47.21 46.35 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.28 1.832 . . . . 0.0 109.598 -167.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -62.05 94.41 0.05 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 128.158 2.583 . . . . 0.0 110.663 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -126.65 146.77 50.06 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.755 1.622 . . . . 0.0 107.404 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.2 -38.89 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.656 2.382 . . . . 0.0 113.668 -167.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.81 82.87 0.32 Allowed Glycine 0 CA--C 1.531 1.092 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 162.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -69.54 173.2 11.12 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.444 2.763 . . . . 0.0 111.697 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 32' ' ' GLU . 11.8 t -146.12 176.31 9.83 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -71.95 -12.81 61.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.124 1.37 . . . . 0.0 113.26 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.42 ' H ' HG23 ' A' ' 30' ' ' THR . 2.0 tm-20 51.72 -164.63 0.06 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.574 1.15 . . . . 0.0 109.501 -159.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 72.71 156.34 0.17 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.677 1.991 . . . . 0.0 114.714 163.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -135.85 142.85 44.83 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 170.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.1 169.56 17.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.37 0.268 . . . . 0.0 110.35 170.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.14 96.3 0.19 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 106.991 -2.443 . . . . 0.0 106.991 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.88 129.92 46.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.953 1.301 . . . . 0.0 108.264 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.92 169.5 39.59 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 114.69 0.636 . . . . 0.0 114.69 -169.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.83 154.52 17.21 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.68 1.192 . . . . 0.0 108.951 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.439 ' CE1' ' HE3' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -146.63 155.52 42.52 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.217 1.007 . . . . 0.0 111.799 -171.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.3 158.22 25.85 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 163.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.73 166.2 39.21 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 117.418 0.609 . . . . 0.0 111.743 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -145.05 145.93 31.66 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.418 1.087 . . . . 0.0 110.535 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -87.9 110.9 20.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 162.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -75.59 -23.21 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 118.527 0.603 . . . . 0.0 110.244 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.36 166.44 15.15 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 126.938 2.095 . . . . 0.0 106.687 169.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.22 6.4 0.66 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.817 2.345 . . . . 0.0 114.433 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -137.83 1.01 2.26 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.614 1.566 . . . . 0.0 113.513 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 t -143.85 149.58 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 119.549 1.068 . . . . 0.0 109.057 -174.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -179.59 -165.72 34.11 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 121.105 -0.997 . . . . 0.0 112.758 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -142.16 160.82 39.46 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.548 1.139 . . . . 0.0 109.311 170.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.61 149.92 35.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.295 1.838 . . . . 0.0 107.954 168.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 53.5 mtt -148.71 153.31 38.04 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.6 1.16 . . . . 0.0 108.193 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.06 173.34 44.12 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-O 119.655 -0.525 . . . . 0.0 111.954 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -135.06 136.4 42.02 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.024 0.93 . . . . 0.0 109.83 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.67 166.67 25.15 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.756 1.222 . . . . 0.0 112.241 -166.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -155.38 173.81 16.13 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.203 1.001 . . . . 0.0 110.102 162.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 tp -59.26 -29.69 67.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.723 1.609 . . . . 0.0 111.701 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.87 176.91 50.15 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.875 1.226 . . . . 0.0 111.839 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 68' ' ' GLU . 21.2 ttp180 -160.03 176.11 12.21 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.103 1.761 . . . . 0.0 106.961 169.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 tmm? 25.11 77.65 0.24 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 129.034 2.933 . . . . 0.0 113.163 169.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.52 65.33 8.07 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.837 3.025 . . . . 0.0 111.501 -172.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 52.67 -161.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.662 1.985 . . . . 0.0 111.336 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.0 mttp 75.61 -52.43 0.64 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.167 2.187 . . . . 0.0 110.114 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.22 120.52 22.32 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 160.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -71.59 -10.1 59.26 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.4 t -140.98 156.5 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.379 1.872 . . . . 0.0 106.079 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 60' ' ' ARG . 3.4 tp10 -122.7 132.26 54.17 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 171.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -80.02 73.72 6.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.836 1.255 . . . . 0.0 109.69 -174.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.4 91.63 1.74 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -171.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.46 -62.41 1.89 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.279 1.432 . . . . 0.0 112.09 -173.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -61.98 155.49 23.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.549 0.74 . . . . 0.0 109.617 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.89 174.79 12.7 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.288 0.635 . . . . 0.0 110.402 -169.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.18 155.72 4.64 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.561 161.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -170.61 168.31 7.63 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 124.321 1.048 . . . . 0.0 109.896 -170.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.8 171.79 27.46 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.3 125.6 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.22 1.408 . . . . 0.0 107.923 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -95.87 144.07 26.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.769 2.428 . . . . 0.0 108.382 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -141.83 125.42 16.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.329 1.052 . . . . 0.0 108.915 169.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.61 123.93 19.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.4 1.08 . . . . 0.0 108.449 -167.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.54 138.47 32.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -99.78 129.22 45.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.323 1.049 . . . . 0.0 108.645 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.08 137.53 52.18 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 158.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.22 -172.45 43.47 Favored Glycine 0 C--O 1.226 -0.363 0 CA-C-O 119.191 -0.783 . . . . 0.0 111.448 -165.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -155.67 157.93 31.65 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.672 1.189 . . . . 0.0 109.253 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -62.2 141.9 89.75 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.882 1.721 . . . . 0.0 109.274 161.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.4 tp -107.73 -4.68 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.79 0.836 . . . . 0.0 110.455 171.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.8 m -149.92 -87.53 0.08 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 159.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -152.52 -44.02 0.1 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.173 1.789 . . . . 0.0 106.83 159.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.14 -20.41 53.45 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.915 2.486 . . . . 0.0 112.645 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.67 138.88 51.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.878 1.671 . . . . 0.0 108.483 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -140.46 127.01 20.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.399 1.479 . . . . 0.0 109.865 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 pp -99.09 153.98 4.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.751 1.621 . . . . 0.0 109.579 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -150.15 157.6 43.27 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 122.15 0.976 . . . . 0.0 113.415 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.6 m -114.07 121.7 44.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 158.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -105.81 109.22 21.1 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 tt -125.85 128.24 47.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.98 0.809 . . . . 0.0 110.154 -168.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.48 -98.33 0.14 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.04 -162.43 36.23 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.758 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -145.95 159.36 43.35 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.502 1.121 . . . . 0.0 109.872 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.14 151.25 35.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.598 1.159 . . . . 0.0 108.138 168.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -136.04 145.02 45.57 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.809 0.844 . . . . 0.0 111.171 -170.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -119.35 111.19 17.85 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 129.014 2.926 . . . . 0.0 106.809 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.34 107.4 17.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 165.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -91.86 119.22 31.45 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.2 m 69.67 -39.92 0.44 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.912 2.085 . . . . 0.0 113.454 168.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -73.51 175.3 7.16 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.052 1.341 . . . . 0.0 111.381 170.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.5 m -152.51 -75.22 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 159.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 41.51 62.35 1.56 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.336 1.855 . . . . 0.0 113.45 165.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 m -135.67 154.5 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -71.0 -27.7 63.89 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.058 0.943 . . . . 0.0 112.151 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.82 76.09 1.02 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -162.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -138.99 -65.45 0.49 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.494 1.518 . . . . 0.0 106.986 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.27 178.5 8.7 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 128.741 2.816 . . . . 0.0 104.414 159.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -148.58 150.5 33.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.51 29.97 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.463 2.305 . . . . 0.0 112.315 169.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.05 153.58 46.83 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 162.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.78 -161.02 25.81 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 p -129.64 145.53 35.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 126.361 1.864 . . . . 0.0 107.025 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.3 t -140.85 96.98 7.27 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.71 117.86 5.22 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.992 2.461 . . . . 0.0 108.329 170.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.34 171.15 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.476 0.71 . . . . 0.0 110.227 -172.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -138.55 162.59 34.18 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 165.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.53 163.3 29.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.411 1.884 . . . . 0.0 108.488 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -108.8 151.45 17.08 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 106.969 -2.453 . . . . 0.0 106.969 162.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -174.55 -174.32 41.2 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 117.9 0.85 . . . . 0.0 112.723 -173.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.1 p -146.57 159.52 10.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 124.571 1.149 . . . . 0.0 108.659 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.2 145.08 49.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.049 2.14 . . . . 0.0 107.164 160.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -142.94 106.1 4.56 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.285 1.834 . . . . 0.0 107.534 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.58 81.97 7.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.841 1.256 . . . . 0.0 108.296 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -25.18 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.099 0.56 . . . . 0.0 111.512 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.1 p -137.03 143.65 43.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 158.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.58 -18.57 59.48 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.763 2.308 . . . . 0.0 114.015 -166.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -62.95 -24.26 67.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.73 2.012 . . . . 0.0 112.249 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.27 164.83 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 125.28 1.432 . . . . 0.0 109.806 -167.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.46 150.56 49.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 162.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.4 p -106.92 150.42 26.45 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 158.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -143.79 147.53 34.27 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.097 0.862 . . . . 0.0 110.109 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.49 159.33 42.12 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.206 1.803 . . . . 0.0 107.771 -175.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -163.38 151.99 14.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.457 0.703 . . . . 0.0 111.483 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -145.58 139.84 26.98 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.582 1.153 . . . . 0.0 109.74 160.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -132.46 175.69 9.08 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.058 1.743 . . . . 0.0 108.915 163.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -93.03 164.28 13.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.223 1.009 . . . . 0.0 110.632 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.5 m -131.5 118.74 20.59 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.067 1.747 . . . . 0.0 106.812 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -62.05 138.37 58.37 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t30 37.07 59.65 1.08 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.966 2.106 . . . . 0.0 112.224 -172.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.0 tp -63.17 90.26 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.501 1.12 . . . . 0.0 108.689 165.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 146.05 -172.94 26.54 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.247 1.403 . . . . 0.0 110.439 -171.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -148.26 171.87 15.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.193 1.797 . . . . 0.0 107.303 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 47.73 36.13 5.36 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.543 1.937 . . . . 0.0 112.353 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 48.82 13.46 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 129.315 3.046 . . . . 0.0 115.73 -170.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.271 1.2 p 41.51 -89.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.535 2.334 . . . . 0.0 111.777 -161.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.5 tp -139.26 49.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 122.506 1.146 . . . . 0.0 108.588 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.02 -57.18 4.34 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -172.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 13.8 t -79.59 158.69 27.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 111.08 166.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.0 mtt85 -130.95 159.48 71.21 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 129.249 3.02 . . . . 0.0 108.01 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -64.72 -179.19 0.88 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.744 1.63 . . . . 0.0 109.961 159.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -134.91 121.22 20.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 160.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.02 -3.05 11.61 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.016 1.726 . . . . 0.0 109.905 163.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 38.21 -115.63 0.42 Allowed Glycine 0 C--N 1.342 0.903 0 C-N-CA 126.748 2.118 . . . . 0.0 111.146 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 19.0 ttm -148.65 118.09 6.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 158.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.01 154.2 31.69 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 165.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.27 155.05 50.88 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 118.887 0.767 . . . . 0.0 109.78 159.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.76 153.52 51.13 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.77 1.628 . . . . 0.0 107.496 168.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.24 175.49 40.31 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 118.696 0.68 . . . . 0.0 112.843 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.4 m -141.33 164.0 20.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.465 1.106 . . . . 0.0 109.946 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 58.8 m -155.93 161.2 40.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.214 -0.928 . . . . 0.0 110.809 166.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -100.76 155.61 17.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.68 1.592 . . . . 0.0 107.233 159.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.1 ptm85 -90.03 158.68 17.22 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -73.55 116.0 13.6 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 158.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 151.86 150.7 5.42 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 123.909 0.766 . . . . 0.0 111.299 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 67.04 -63.35 0.28 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 128.635 2.774 . . . . 0.0 111.832 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -75.62 42.78 1.54 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.41 1.481 . . . . 0.0 111.838 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -80.53 61.05 4.12 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.306 1.842 . . . . 0.0 109.365 -174.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 57.64 -168.67 0.12 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.516 1.926 . . . . 0.0 112.004 -166.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 C-N-CA 127.79 2.436 . . . . 0.0 106.391 174.786 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.93 170.6 19.79 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.206 1.937 . . . . 0.0 110.614 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -141.18 77.18 1.58 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 170.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.92 -7.7 18.15 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.693 1.597 . . . . 0.0 115.06 -161.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.07 145.95 46.51 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 163.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.8 m -153.06 122.44 6.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -81.62 160.09 23.87 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 170.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -148.27 160.73 42.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.424 1.89 . . . . 0.0 108.022 171.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 t -148.93 161.54 41.68 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.89 -160.49 26.18 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -165.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.59 153.37 40.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.438 ' HE3' ' CZ ' ' A' ' 40' ' ' PHE . 28.0 mtmt -131.0 155.0 47.58 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.903 0.881 . . . . 0.0 109.929 172.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.3 tp -114.19 151.91 32.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.538 2.335 . . . . 0.0 106.074 164.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.91 169.06 29.39 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 118.878 0.763 . . . . 0.0 113.497 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -141.21 136.62 31.92 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.679 1.991 . . . . 0.0 109.068 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -143.2 80.91 1.69 Allowed 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.109 1.364 . . . . 0.0 110.508 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.29 146.08 50.83 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 158.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -169.48 107.43 0.4 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -128.61 153.96 46.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 158.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 153.41 -49.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.48 2.712 . . . . 0.0 108.088 -159.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.7 m -135.38 96.79 3.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.07 -109.95 0.27 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.872 -0.404 . . . . 0.0 113.079 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -157.09 2.15 0.13 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.315 1.446 . . . . 0.0 114.548 -166.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.298 9.4 pt 57.22 140.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 131.268 3.827 . . . . 0.0 115.038 -167.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.04 172.66 12.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.049 1.339 . . . . 0.0 109.663 167.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -88.32 -111.82 0.06 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -60.37 153.64 22.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.822 1.192 . . . . 0.0 108.383 158.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.27 98.01 0.27 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -170.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.15 63.18 5.18 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.931 3.087 . . . . 0.0 110.093 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.3 m -62.28 147.21 48.83 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.946 1.698 . . . . 0.0 109.93 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -151.78 148.72 28.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.823 -161.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.65 -82.57 0.2 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 164.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -28.34 59.57 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.008 -171.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 71.26 -62.43 0.45 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 126.309 1.844 . . . . 0.0 110.135 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 pp -146.63 174.24 11.62 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.941 1.296 . . . . 0.0 110.736 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.73 159.2 27.88 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 165.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.74 121.87 3.77 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.12 1.768 . . . . 0.0 107.286 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.79 165.56 35.19 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.878 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.33 146.52 24.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.102 1.361 . . . . 0.0 108.129 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.438 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 39.4 m-85 -130.3 154.72 47.34 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.074 0.949 . . . . 0.0 110.322 -171.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.11 137.43 5.81 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.04 166.83 39.73 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -166.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -139.88 168.06 20.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.402 0.601 . . . . 0.0 110.833 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -117.68 151.67 36.77 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.528 1.931 . . . . 0.0 108.049 163.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 p -116.74 90.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 164.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 58.21 176.96 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 127.207 2.203 . . . . 0.0 112.56 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.63 75.05 0.82 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.529 2.152 . . . . 0.0 109.231 162.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -147.73 -75.82 0.18 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.298 1.439 . . . . 0.0 109.438 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.63 166.46 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.911 0.884 . . . . 0.0 109.242 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.64 -161.32 13.42 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -177.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -138.59 158.66 43.83 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.126 1.37 . . . . 0.0 109.79 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -139.71 120.3 14.17 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.803 2.441 . . . . 0.0 106.853 169.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -118.9 166.02 13.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.798 1.639 . . . . 0.0 107.854 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.91 173.32 41.5 Favored Glycine 0 N--CA 1.452 -0.281 0 O-C-N 121.792 -0.568 . . . . 0.0 111.982 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -134.67 115.85 14.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.711 2.004 . . . . 0.0 106.535 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.27 139.5 30.68 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.609 1.563 . . . . 0.0 107.73 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -158.47 136.66 10.75 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.993 0.425 . . . . 0.0 111.25 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.5 tp -140.92 113.73 8.31 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.492 1.517 . . . . 0.0 108.11 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.42 39.22 1.89 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.292 0.949 . . . . 0.0 113.158 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? 56.46 -72.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.552 2.341 . . . . 0.0 110.716 -159.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.5 mtm -122.48 97.01 45.29 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 173.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.5 -11.53 28.98 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.468 2.112 . . . . 0.0 112.789 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -53.03 -26.49 15.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.497 1.919 . . . . 0.0 112.799 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 77.8 tttt 63.18 -7.82 0.15 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.434 2.294 . . . . 0.0 114.984 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.0 77.61 0.22 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 165.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 t 69.2 173.76 0.29 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.447 2.299 . . . . 0.0 111.58 -164.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.5 m -149.74 172.45 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 128.042 2.537 . . . . 0.0 107.245 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -89.04 151.51 22.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.476 1.131 . . . . 0.0 108.556 164.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.32 -53.13 31.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.693 2.397 . . . . 0.0 112.262 171.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 171.54 -146.44 9.48 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 119.953 1.251 . . . . 0.0 111.828 -171.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 63.02 -29.77 0.09 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 130.405 3.482 . . . . 0.0 115.335 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.96 170.6 2.05 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.693 1.597 . . . . 0.0 111.717 169.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -93.98 130.77 39.97 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.558 0.743 . . . . 0.0 110.011 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.55 -52.81 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -160.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -162.5 169.75 19.82 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.498 0.59 . . . . 0.0 111.688 -167.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.03 175.63 42.19 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 t -138.24 123.51 23.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -95.2 145.03 25.33 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 171.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.0 107.81 4.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.6 p -138.03 144.45 41.05 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.091 0.556 . . . . 0.0 111.717 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.91 152.65 23.38 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 162.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 157.08 47.73 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.399 0.679 . . . . 0.0 112.007 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.3 tp -140.78 136.66 32.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.926 2.49 . . . . 0.0 105.891 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.04 158.75 29.1 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 166.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.91 141.65 18.94 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.907 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 92' ' ' ASP . 49.0 Cg_endo -67.27 145.1 70.98 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.506 2.804 . . . . 0.0 110.385 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -112.57 -4.92 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.053 0.541 . . . . 0.0 111.419 167.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 53.6 m -162.05 165.05 27.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.908 2.883 . . . . 0.0 103.947 167.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -70.16 51.2 0.12 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.276 1.83 . . . . 0.0 110.501 167.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -150.0 -54.13 0.16 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.946 2.098 . . . . 0.0 109.519 -170.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -144.69 156.0 43.86 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.895 0.855 . . . . 0.0 112.546 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 0.6 OUTLIER -110.73 146.65 35.94 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.862 2.865 . . . . 0.0 108.763 175.458 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.8 mt -90.64 137.76 20.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 163.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -134.35 147.34 50.52 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.364 1.066 . . . . 0.0 111.57 -159.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.9 m -155.07 150.15 26.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.047 1.339 . . . . 0.0 109.41 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -147.44 154.25 40.58 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.34 1.056 . . . . 0.0 110.275 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -152.69 156.55 39.4 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.578 1.151 . . . . 0.0 111.557 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.35 -119.49 0.91 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.27 170.18 26.72 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 118.331 1.066 . . . . 0.0 113.624 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -145.75 126.52 14.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.519 1.528 . . . . 0.0 107.745 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.06 142.26 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.42 146.55 42.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.631 1.572 . . . . 0.0 108.348 -172.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.2 ttp85 -141.24 148.74 40.36 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.458 1.103 . . . . 0.0 109.961 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.09 137.37 36.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.966 2.106 . . . . 0.0 108.369 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -75.83 103.05 5.73 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -85.29 24.94 1.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -162.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -74.52 62.68 1.03 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.91 1.684 . . . . 0.0 111.763 -174.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.4 t -80.7 -160.98 0.35 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.215 1.406 . . . . 0.0 108.275 159.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -129.79 160.99 31.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.721 1.209 . . . . 0.0 109.813 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 51.75 -151.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.008 1.323 . . . . 0.0 109.456 -174.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -77.2 -3.92 42.08 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.981 -1.074 . . . . 0.0 112.39 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.04 60.8 4.65 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 124.196 0.903 . . . . 0.0 111.449 -168.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -114.46 164.75 13.54 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 122.024 0.916 . . . . 0.0 112.1 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -76.31 171.72 14.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.779 2.431 . . . . 0.0 111.982 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -66.3 115.27 6.07 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 159.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -80.96 -31.31 34.93 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.302 1.441 . . . . 0.0 113.724 -174.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.9 m -145.72 156.65 43.76 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -167.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -153.11 157.7 27.49 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 165.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.66 30.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.071 1.348 . . . . 0.0 109.613 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 m -66.92 157.35 84.67 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.668 1.587 . . . . 0.0 112.796 -169.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -65.48 159.68 46.59 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 N-CA-C 108.396 -1.425 . . . . 0.0 108.396 158.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.41 157.13 8.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 O-C-N 121.659 -0.651 . . . . 0.0 109.663 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.74 165.06 30.77 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.989 1.316 . . . . 0.0 108.54 165.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.55 162.36 39.92 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 162.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.28 165.86 32.97 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 112.125 -0.39 . . . . 0.0 112.125 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 160.56 -118.65 0.84 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.8 m -138.83 158.45 30.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 117.876 0.838 . . . . 0.0 111.435 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -129.55 141.63 50.93 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 166.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.2 126.26 18.34 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.177 0.991 . . . . 0.0 108.946 -158.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.94 140.44 45.58 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.709 0.686 . . . . 0.0 109.984 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 44.4 mm -117.14 -33.72 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.491 0.716 . . . . 0.0 109.962 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 20.7 m -161.87 157.9 21.02 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 172.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.9 -2.65 0.84 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.749 2.299 . . . . 0.0 116.618 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.23 -10.11 13.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.065 1.746 . . . . 0.0 113.773 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.6 tt -148.28 149.09 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 120.049 1.295 . . . . 0.0 111.833 -171.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.14 169.94 16.77 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.273 1.429 . . . . 0.0 108.333 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.0 p -120.04 160.31 23.06 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.989 1.315 . . . . 0.0 108.369 162.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -141.55 159.38 42.34 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 121.58 -0.7 . . . . 0.0 110.114 165.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.38 120.04 12.52 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.16 155.46 43.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.951 0.881 . . . . 0.0 111.778 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.96 152.74 43.77 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.227 1.811 . . . . 0.0 109.829 -159.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -143.75 115.07 7.99 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.096 1.358 . . . . 0.0 108.059 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -107.38 154.22 21.63 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.166 1.387 . . . . 0.0 109.98 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.6 t -145.73 165.0 30.06 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 159.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -79.32 69.93 5.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.682 0.793 . . . . 0.0 110.083 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -52.16 111.87 0.7 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.856 1.662 . . . . 0.0 111.001 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.1 mt -82.57 42.84 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 125.382 1.473 . . . . 0.0 108.878 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -19.19 97.41 0.01 OUTLIER Glycine 0 C--N 1.339 0.732 0 C-N-CA 130.22 3.771 . . . . 0.0 116.271 -173.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.59 105.84 0.49 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.879 1.272 . . . . 0.0 109.597 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -164.21 173.8 11.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.636 1.174 . . . . 0.0 110.316 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -57.33 128.13 35.49 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 158.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.1 m 50.63 70.15 0.55 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.586 1.554 . . . . 0.0 111.626 174.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 37.6 pt -55.94 1.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 128.407 2.683 . . . . 0.0 116.601 -171.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.32 -49.56 65.1 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 120.318 -1.489 . . . . 0.0 109.588 161.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.3 m -74.97 95.68 3.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 127.052 2.141 . . . . 0.0 109.4 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -131.72 159.46 71.84 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 126.108 1.763 . . . . 0.0 107.899 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -66.11 -18.41 56.44 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.77 1.647 . . . . 0.0 111.426 165.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.8 t0 50.01 40.58 21.59 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.53 2.332 . . . . 0.0 112.893 166.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -137.49 143.07 41.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.104 1.362 . . . . 0.0 109.272 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -80.59 -178.39 52.06 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.988 1.756 . . . . 0.0 113.121 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 23.7 ptp -80.74 155.3 26.79 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 122.336 -0.508 . . . . 0.0 109.747 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.0 tt -139.45 149.41 44.0 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.603 1.161 . . . . 0.0 109.339 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.2 p -136.84 161.72 35.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.633 0.73 . . . . 0.0 111.491 160.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.21 151.45 34.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.125 1.37 . . . . 0.0 109.411 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.41 175.45 40.45 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 114.911 0.725 . . . . 0.0 114.911 -172.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 10.4 m -110.31 152.33 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 127.456 2.302 . . . . 0.0 108.953 172.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.3 t -151.0 113.53 4.65 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.877 0.762 . . . . 0.0 109.145 -172.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -96.26 142.52 28.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.181 1.792 . . . . 0.0 109.305 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -89.67 155.32 19.31 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.546 0.612 . . . . 0.0 111.161 -175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -70.36 115.22 9.29 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 166.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.07 176.99 42.7 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.794 1.188 . . . . 0.0 110.556 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 63.65 168.34 0.15 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.456 1.502 . . . . 0.0 110.232 -165.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 54.36 47.32 69.31 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -170.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -147.75 151.95 36.92 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.328 1.451 . . . . 0.0 107.508 -168.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -160.05 -173.63 4.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.225 1.81 . . . . 0.0 107.552 -177.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.934 1.694 . . . . 0.0 106.695 171.45 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.71 105.02 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.513 2.142 . . . . 0.0 108.894 169.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt 55.86 81.11 0.13 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.875 1.67 . . . . 0.0 110.169 -166.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.57 157.43 2.94 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.466 171.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.67 146.17 55.14 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 160.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -112.09 154.39 25.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.547 0.739 . . . . 0.0 110.141 -159.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -134.03 156.65 47.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 158.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -135.23 146.92 49.1 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.576 1.55 . . . . 0.0 106.829 -171.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 m -150.01 148.01 28.54 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.186 -0.946 . . . . 0.0 109.307 165.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.45 -142.53 7.69 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.218 0.914 . . . . 0.0 111.93 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.88 159.3 15.02 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.086 1.755 . . . . 0.0 111.829 -168.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -147.99 144.36 27.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.323 1.449 . . . . 0.0 109.903 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -133.59 148.51 51.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.94 1.696 . . . . 0.0 107.658 164.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.67 158.22 23.36 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.022 1.296 . . . . 0.0 109.876 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -154.75 143.24 20.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.369 1.084 . . . . 0.0 110.588 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -148.22 140.92 24.57 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.137 0.975 . . . . 0.0 108.636 160.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -71.87 69.93 0.71 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 160.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -67.15 -30.09 69.98 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.497 0.719 . . . . 0.0 112.234 -170.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -107.65 147.37 30.78 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 158.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -124.29 154.97 39.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 158.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 69.6 p 50.36 -105.67 0.2 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.583 1.153 . . . . 0.0 109.38 -158.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.01 -178.62 20.59 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 127.306 2.384 . . . . 0.0 109.095 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -54.77 128.58 33.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.786 1.234 . . . . 0.0 111.241 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt 47.71 55.4 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.028 1.731 . . . . 0.0 109.664 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.308 0.0 OUTLIER 56.31 12.67 1.06 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.916 2.886 . . . . 0.0 115.051 -174.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 73.35 -63.48 0.43 Allowed 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 128.268 2.627 . . . . 0.0 110.815 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 73.7 -21.09 0.27 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.904 2.482 . . . . 0.0 111.512 -167.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.61 175.64 54.27 Favored Glycine 0 CA--C 1.538 1.473 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 158.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.74 150.9 50.99 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.321 2.014 . . . . 0.0 111.21 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -69.95 89.24 0.59 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.22 1.01 . . . . 0.0 109.08 172.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -131.23 -2.05 3.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.914 1.286 . . . . 0.0 112.399 -177.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -75.72 45.81 0.34 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.115 2.166 . . . . 0.0 112.538 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -60.66 162.43 6.57 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.886 1.674 . . . . 0.0 111.034 162.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -129.01 160.08 33.89 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 161.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 pp -147.1 166.37 27.1 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.165 0.986 . . . . 0.0 109.779 -174.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.16 156.98 21.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 168.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.64 122.02 3.43 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.915 1.286 . . . . 0.0 107.938 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.16 -121.12 0.84 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.32 169.62 16.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.93 0.892 . . . . 0.0 111.58 -167.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -145.74 151.4 37.92 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.903 2.081 . . . . 0.0 107.831 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.94 156.79 27.84 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 160.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.15 166.02 39.18 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 117.748 0.774 . . . . 0.0 111.859 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -123.66 134.64 53.72 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.63 1.972 . . . . 0.0 108.065 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -122.43 118.33 28.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.679 1.992 . . . . 0.0 109.249 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.25 79.77 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 122.187 0.994 . . . . 0.0 108.608 173.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.496 ' HB3' ' HD2' ' A' ' 47' ' ' PRO 0.322 5.0 m120 63.89 -163.71 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 125.282 1.433 . . . . 0.0 109.857 167.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 46' ' ' ASN . 47.9 Cg_endo -80.29 60.3 7.79 Favored 'Trans proline' 0 C--N 1.357 1.011 0 CA-C-N 124.393 2.605 . . . . 0.0 111.071 -169.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -143.17 -77.19 0.24 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.905 0.882 . . . . 0.0 111.139 -176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.0 p -150.54 165.72 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.911 0.884 . . . . 0.0 109.08 -160.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.81 -175.25 40.57 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.861 1.219 . . . . 0.0 111.691 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -140.6 148.19 40.54 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.916 1.286 . . . . 0.0 107.898 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.75 158.76 43.66 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.234 1.413 . . . . 0.0 109.119 -174.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 75.9 mtp -129.1 159.11 37.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.255 1.422 . . . . 0.0 109.809 167.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.47 165.68 16.13 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -149.82 150.04 31.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.505 1.522 . . . . 0.0 107.687 -173.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -126.24 142.6 51.46 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.363 1.065 . . . . 0.0 109.469 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -67.74 -72.05 0.19 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.898 0.879 . . . . 0.0 110.986 -175.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mp 46.33 -147.46 0.15 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.041 0.936 . . . . 0.0 109.082 -161.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.56 -48.95 2.98 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.432 1.015 . . . . 0.0 115.11 166.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.94 65.98 3.49 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.549 1.175 . . . . 0.0 110.337 -176.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.7 mtp -61.92 164.42 10.37 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.652 1.181 . . . . 0.0 109.154 161.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.8 -37.71 53.73 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.052 1.835 . . . . 0.0 112.66 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 61.41 -57.8 0.1 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.525 2.73 . . . . 0.0 114.755 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt 55.25 30.7 15.14 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.534 1.534 . . . . 0.0 113.123 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.93 -129.48 1.65 Allowed Glycine 0 C--N 1.336 0.549 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.6 p -64.5 -177.47 0.31 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 159.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.5 m -60.58 158.31 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 158.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.38 149.13 30.36 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 57.37 -44.5 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 128.768 2.827 . . . . 0.0 113.668 -160.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 169.92 167.29 30.2 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 127.272 2.367 . . . . 0.0 108.635 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.24 60.74 1.11 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.82 0.848 . . . . 0.0 109.439 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.498 ' CE2' ' HE3' ' A' ' 107' ' ' LYS . 8.2 m-85 -81.09 62.21 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.483 1.135 . . . . 0.0 113.376 -160.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -70.24 91.93 0.75 Allowed 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 158.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.58 151.31 24.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 122.662 0.385 . . . . 0.0 109.986 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -78.79 119.85 22.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.4 101.73 0.22 Allowed Glycine 0 C--N 1.333 0.379 0 N-CA-C 107.489 -2.245 . . . . 0.0 107.489 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.09 165.46 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.044 0.938 . . . . 0.0 109.267 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -128.1 154.27 45.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.275 1.43 . . . . 0.0 107.981 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -141.55 139.4 33.18 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.405 1.082 . . . . 0.0 109.073 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.55 133.46 12.29 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.466 0.706 . . . . 0.0 110.033 -161.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.95 150.7 24.75 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 160.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.484 ' HE3' ' CD2' ' A' ' 94' ' ' TYR . 14.1 tmtt? -131.5 131.33 43.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.765 1.226 . . . . 0.0 109.05 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.2 148.54 26.81 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 159.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 174.1 169.38 36.2 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 119.454 -1.355 . . . . 0.0 114.142 167.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -148.53 133.73 9.31 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.219 -164.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -71.12 135.39 27.12 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.824 3.016 . . . . 0.0 110.467 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.18 -30.47 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 123.053 0.541 . . . . 0.0 111.421 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.6 m -163.5 -48.3 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.518 2.327 . . . . 0.0 106.145 160.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -149.41 -179.11 6.81 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.482 2.313 . . . . 0.0 105.956 167.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.3 t0 65.85 -65.32 0.18 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.556 2.342 . . . . 0.0 113.216 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 mp -101.36 106.17 17.3 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -166.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -101.31 125.63 47.97 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.886 1.274 . . . . 0.0 108.491 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.1 mt -90.7 117.38 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -177.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.484 ' CD2' ' HE3' ' A' ' 82' ' ' LYS . 4.4 m-85 -98.45 141.12 31.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.446 1.899 . . . . 0.0 109.788 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.3 m -134.02 115.25 14.1 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 162.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -130.06 148.69 51.94 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 123.774 0.83 . . . . 0.0 110.449 -170.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.37 148.21 27.86 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.974 0.91 . . . . 0.0 110.742 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.07 -121.8 1.05 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.75 167.41 34.7 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 117.861 0.831 . . . . 0.0 113.69 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 36.2 mtm -101.38 150.84 22.6 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.618 1.967 . . . . 0.0 106.975 163.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.3 137.47 50.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -149.71 131.11 14.7 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.83 111.05 7.87 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.981 1.312 . . . . 0.0 109.45 171.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -122.23 124.47 43.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 158.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.56 115.02 10.25 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.605 1.162 . . . . 0.0 108.135 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 82.5 p -75.61 63.19 1.52 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.38 2.272 . . . . 0.0 109.38 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.498 ' HE3' ' CE2' ' A' ' 72' ' ' TYR . 1.8 pttm -69.12 47.57 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.962 2.905 . . . . 0.0 113.318 -174.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.8 m -160.84 162.85 32.34 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 120.238 -1.539 . . . . 0.0 109.258 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.43 77.1 2.49 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.66 167.73 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.005 1.322 . . . . 0.0 109.636 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -67.49 25.27 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.578 2.351 . . . . 0.0 114.314 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.25 -59.88 2.75 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.25 1.405 . . . . 0.0 110.762 -172.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.7 tptt 60.75 -11.94 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.363 2.665 . . . . 0.0 116.115 173.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -59.33 97.68 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.114 1.325 . . . . 0.0 108.294 163.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -64.72 -17.43 64.12 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.777 0.831 . . . . 0.0 113.158 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -129.52 131.09 46.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 159.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.78 158.53 41.05 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 163.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.84 -99.96 0.73 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 106.749 -2.54 . . . . 0.0 106.749 -163.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.6 144.28 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.645 1.578 . . . . 0.0 109.442 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.8 m -138.03 128.47 15.45 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.855 1.262 . . . . 0.0 108.838 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.02 144.38 47.2 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.428 2.086 . . . . 0.0 110.863 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.93 164.31 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.13 0.972 . . . . 0.0 110.078 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -147.59 165.54 30.07 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.919 1.688 . . . . 0.0 108.495 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.78 160.41 42.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.32 0.509 . . . . 0.0 110.298 165.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -109.35 159.06 14.22 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 106.131 -2.788 . . . . 0.0 106.131 158.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.79 -173.87 46.09 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 118.539 1.169 . . . . 0.0 112.008 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.21 145.16 31.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -103.05 150.97 23.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.258 1.423 . . . . 0.0 107.544 158.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.39 165.37 28.69 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.533 1.133 . . . . 0.0 109.08 163.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -130.85 88.52 2.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.028 1.731 . . . . 0.0 110.486 -163.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.12 -29.64 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 125.147 1.379 . . . . 0.0 111.118 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.4 t -141.98 146.14 39.19 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 159.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.48 -15.53 49.05 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.501 2.134 . . . . 0.0 114.9 -167.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.97 -41.76 97.02 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.217 0.917 . . . . 0.0 111.004 168.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.0 pt -110.64 163.9 7.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 124.179 0.992 . . . . 0.0 111.188 -164.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.8 158.75 43.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.8 t -141.52 152.78 44.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 158.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -135.33 153.98 51.67 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 123.124 0.569 . . . . 0.0 111.168 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.55 137.32 41.91 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -144.74 154.12 42.4 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.851 1.26 . . . . 0.0 109.803 -164.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -151.02 146.02 25.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.252 1.421 . . . . 0.0 110.735 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -132.13 115.51 15.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.902 2.481 . . . . 0.0 105.965 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -84.12 164.22 19.33 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 168.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . 0.281 4.9 t 57.64 -171.18 0.1 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.745 2.418 . . . . 0.0 111.94 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.0 t30 55.51 -161.27 0.17 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.76 1.224 . . . . 0.0 109.784 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 62.87 45.7 5.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.41 1.484 . . . . 0.0 114.163 158.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.5 tt -140.1 157.26 25.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 119.154 0.888 . . . . 0.0 110.885 169.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.27 -17.02 0.46 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.619 1.581 . . . . 0.0 113.649 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -150.39 147.53 27.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.022 1.911 . . . . 0.0 110.313 171.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -169.89 87.84 0.15 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 130.871 3.668 . . . . 0.0 106.054 174.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -74.83 79.2 2.1 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.44 -0.788 . . . . 0.0 110.325 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.2 m 67.79 -29.53 0.16 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.363 2.665 . . . . 0.0 114.354 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.7 pt -128.01 174.81 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.199 1.799 . . . . 0.0 109.129 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.26 -152.71 21.39 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -167.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.3 m -69.58 158.38 35.37 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.61 1.164 . . . . 0.0 109.368 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.5 mtp-105 -68.62 158.77 84.48 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.754 1.221 . . . . 0.0 109.107 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.06 34.5 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.868 3.712 . . . . 0.0 112.6 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -155.97 99.11 1.95 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 129.468 3.107 . . . . 0.0 103.485 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -121.45 -130.76 0.28 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.171 0.988 . . . . 0.0 110.494 -158.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 179.42 176.33 46.98 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-N 119.153 0.888 . . . . 0.0 112.443 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 26.0 ttt -142.0 156.28 45.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.624 1.97 . . . . 0.0 107.237 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.13 161.78 33.93 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.606 1.162 . . . . 0.0 108.79 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.2 p -147.28 166.4 27.2 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.342 0.591 . . . . 0.0 110.419 166.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.71 165.69 31.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 108.745 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.35 175.14 40.44 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 121.485 -0.388 . . . . 0.0 113.377 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 62.1 t -134.51 146.73 30.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 126.661 1.984 . . . . 0.0 105.709 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.5 m -156.45 174.87 14.79 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 119.934 -1.729 . . . . 0.0 110.433 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -143.72 166.06 25.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 122.926 0.49 . . . . 0.0 111.37 166.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -106.55 158.8 16.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.655 2.382 . . . . 0.0 110.446 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -53.93 155.05 3.61 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 163.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 85.12 17.07 63.58 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.341 -0.699 . . . . 0.0 112.511 -167.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -53.86 122.01 9.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.529 1.132 . . . . 0.0 109.217 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 89.84 3.64 73.55 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.001 1.286 . . . . 0.0 113.543 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.68 -159.77 0.31 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.959 1.704 . . . . 0.0 110.886 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 62.33 -56.75 0.14 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.467 2.707 . . . . 0.0 113.915 -168.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 C-N-CA 127.513 2.325 . . . . 0.0 112.046 -172.89 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.6 150.73 83.77 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.212 1.942 . . . . 0.0 110.465 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.43 178.14 8.67 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.169 0.988 . . . . 0.0 108.369 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.87 -163.08 0.2 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -158.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.71 -177.38 1.24 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.298 1.439 . . . . 0.0 110.481 170.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.9 m -145.2 115.34 7.47 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 119.64 -1.913 . . . . 0.0 108.863 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -114.7 131.53 56.72 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.771 1.628 . . . . 0.0 108.717 -172.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.522 ' CZ ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER -130.78 155.81 46.05 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.193 0.997 . . . . 0.0 111.741 -170.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 m -143.01 144.91 32.48 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.156 2.183 . . . . 0.0 107.633 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.3 -159.49 22.52 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 118.747 0.703 . . . . 0.0 113.522 -169.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.49 157.91 45.28 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.965 1.306 . . . . 0.0 110.629 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.6 163.75 35.63 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.02 0.928 . . . . 0.0 112.794 -175.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mp -141.34 165.78 26.56 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.542 2.337 . . . . 0.0 109.37 171.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.3 171.04 29.54 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.075 0.845 . . . . 0.0 112.249 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -158.57 150.07 20.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.829 0.852 . . . . 0.0 112.101 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 t -151.47 146.12 25.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.264 1.826 . . . . 0.0 108.246 162.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -89.54 -21.64 22.8 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.928 0.491 . . . . 0.0 111.932 167.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 54.0 6.81 0.1 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.245 2.218 . . . . 0.0 116.196 -170.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -158.86 179.6 8.93 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.886 3.274 . . . . 0.0 106.496 163.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -138.26 156.15 47.94 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.242 -0.911 . . . . 0.0 111.152 160.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.263 12.8 t 44.19 -158.71 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.119 1.767 . . . . 0.0 111.855 -172.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.29 154.92 46.72 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.091 -1.006 . . . . 0.0 111.427 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -137.0 94.02 2.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 164.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.332 0.3 OUTLIER 44.32 -141.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 126.773 2.029 . . . . 0.0 110.255 -176.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.41 ' ND2' ' H ' ' A' ' 26' ' ' ASN . 18.5 t30 48.49 -106.17 0.17 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.602 1.961 . . . . 0.0 110.246 -176.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.41 ' H ' ' ND2' ' A' ' 25' ' ' ASN . 1.7 p-10 -135.34 11.66 3.52 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.017 2.127 . . . . 0.0 110.302 172.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 t30 135.54 153.68 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.588 1 C-N-CA 133.022 4.529 . . . . 0.0 105.33 -158.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.51 -157.38 28.44 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.968 1.271 . . . . 0.0 112.328 -168.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -63.34 -11.93 28.04 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.97 1.78 . . . . 0.0 111.592 167.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.53 16.65 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 130.421 3.488 . . . . 0.0 114.994 160.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -80.69 -20.2 43.45 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.4 -1.438 . . . . 0.0 109.286 158.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -122.66 176.5 5.91 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.908 1.683 . . . . 0.0 109.236 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -159.38 179.65 8.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.439 2.296 . . . . 0.0 106.535 175.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -128.97 142.4 50.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.09 163.81 20.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.753 1.221 . . . . 0.0 108.559 163.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.27 165.24 25.5 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 171.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.1 174.66 11.1 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.565 1.946 . . . . 0.0 107.904 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.04 -164.89 31.53 Favored Glycine 0 C--N 1.332 0.338 0 O-C-N 121.848 -0.532 . . . . 0.0 112.675 163.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.29 160.63 14.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -135.74 155.14 50.84 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.653 1.581 . . . . 0.0 107.653 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.26 172.41 40.05 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.522 ' HA3' ' CZ ' ' A' ' 8' ' ' TYR . . . -168.78 166.73 39.87 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 121.553 -0.969 . . . . 0.0 113.099 166.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -137.68 106.09 5.81 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -95.91 132.87 40.75 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.2 m -67.28 -27.47 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.35 145.31 14.91 Favored Pre-proline 0 C--O 1.233 0.185 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 158.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.88 99.73 0.28 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.282 2.655 . . . . 0.0 109.145 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.6 t80 158.48 -51.67 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 129.64 3.176 . . . . 0.0 107.569 -159.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -150.79 151.29 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.767 0.794 . . . . 0.0 111.86 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.05 -116.26 0.81 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 167.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -136.4 159.72 40.9 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.942 1.353 . . . . 0.0 111.908 -171.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -144.81 151.86 39.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 128.534 2.733 . . . . 0.0 106.263 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 66.4 mtt -152.65 170.94 19.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.728 1.211 . . . . 0.0 109.458 -162.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.27 179.95 42.14 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.172 0.892 . . . . 0.0 110.921 170.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -139.23 146.59 40.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.656 0.782 . . . . 0.0 109.474 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -127.72 112.58 14.97 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.493 1.517 . . . . 0.0 107.655 -171.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -158.07 179.44 9.17 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.707 1.603 . . . . 0.0 107.349 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -73.18 46.08 0.17 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.547 1.939 . . . . 0.0 112.636 -176.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.75 -140.48 30.13 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.135 1.35 . . . . 0.0 111.422 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.09 79.39 1.23 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.6 tpp -45.08 125.43 5.44 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.117 1.367 . . . . 0.0 108.573 165.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.7 -24.69 61.98 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.136 1.891 . . . . 0.0 112.921 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.6 t80 71.02 8.95 6.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.192 2.197 . . . . 0.0 116.85 158.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -98.54 -84.66 0.39 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.061 1.755 . . . . 0.0 112.059 -172.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.58 103.33 0.6 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 124.704 1.145 . . . . 0.0 111.662 -169.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.7 m 52.62 31.77 10.7 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.039 0.936 . . . . 0.0 111.835 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.2 19.8 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 126.015 1.726 . . . . 0.0 111.968 -174.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 50.43 36.66 13.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.208 2.203 . . . . 0.0 113.989 167.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -144.31 177.13 8.84 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.461 1.904 . . . . 0.0 107.739 169.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.47 -100.59 0.14 Allowed Glycine 0 C--N 1.339 0.706 0 CA-C-O 118.918 -0.935 . . . . 0.0 111.267 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.74 69.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.811 0.805 . . . . 0.0 111.538 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -63.28 118.79 8.49 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -147.47 80.5 1.51 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.67 156.33 41.11 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 122.813 0.445 . . . . 0.0 111.789 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -146.71 -178.97 6.46 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.699 2.4 . . . . 0.0 107.59 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.58 170.17 35.13 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 165.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.87 131.83 38.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -95.43 132.2 40.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.35 132.53 20.46 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.001 0.92 . . . . 0.0 108.786 175.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.23 142.75 19.64 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.665 -172.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.64 147.14 26.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.966 1.306 . . . . 0.0 108.512 165.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.516 ' HE2' ' CE1' ' A' ' 94' ' ' TYR . 81.2 tttt -143.52 135.17 26.34 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.375 1.47 . . . . 0.0 109.204 -165.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.8 tp -144.28 129.45 18.69 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.729 1.612 . . . . 0.0 107.394 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.73 179.13 19.16 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 117.965 0.348 . . . . 0.0 112.994 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -143.42 138.55 15.58 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.344 1.058 . . . . 0.0 109.298 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.45 117.08 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.798 2.332 . . . . 0.0 109.073 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.7 tt -90.86 -10.55 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.023 0.529 . . . . 0.0 110.78 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 48.3 m -151.05 -78.79 0.12 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 158.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -152.54 -59.76 0.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.771 0.828 . . . . 0.0 109.369 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -78.29 1.47 21.61 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.202 1.801 . . . . 0.0 113.012 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.43 147.39 45.34 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.145 1.378 . . . . 0.0 110.213 171.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -132.36 136.56 46.91 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.678 1.991 . . . . 0.0 107.917 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.93 110.58 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CE1' ' HE2' ' A' ' 82' ' ' LYS . 10.4 m-85 -111.5 118.43 35.74 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.526 1.931 . . . . 0.0 110.613 -171.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.4 m -96.97 154.6 17.21 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.315 1.846 . . . . 0.0 108.183 171.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.98 165.05 35.86 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.4 tt -138.54 151.13 47.06 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.718 2.007 . . . . 0.0 107.552 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.35 -139.8 8.34 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 119.129 0.877 . . . . 0.0 111.21 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.0 177.9 44.45 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 117.517 0.659 . . . . 0.0 112.448 172.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.2 108.37 19.54 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 125.012 1.325 . . . . 0.0 107.433 168.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.02 122.76 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -88.82 150.7 22.79 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -143.28 109.48 5.32 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.307 1.043 . . . . 0.0 109.706 171.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.51 170.61 11.75 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 161.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 165.86 19.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.74 0.781 . . . . 0.0 112.906 169.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t -74.03 164.18 26.95 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.541 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 41.4 tttt 64.42 -50.23 0.3 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 128.669 2.788 . . . . 0.0 114.707 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.6 t 58.32 -93.22 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -158.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -147.9 167.97 23.45 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 158.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.42 HG13 ' H ' ' A' ' 111' ' ' TYR 0.339 7.4 p 40.69 -107.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.021 1.728 . . . . 0.0 109.874 -159.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.42 ' H ' HG13 ' A' ' 110' ' ' VAL . 13.4 m-85 -117.52 17.05 14.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.707 1.603 . . . . 0.0 112.511 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.02 -18.22 62.07 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.992 1.282 . . . . 0.0 115.707 -163.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -141.07 153.29 45.4 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.456 1.628 . . . . 0.0 110.929 167.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.64 -59.37 2.81 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.364 1.465 . . . . 0.0 108.045 169.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 170.92 -37.92 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 129.309 3.044 . . . . 0.0 106.762 -169.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 55.9 70.81 0.6 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.703 1.201 . . . . 0.0 110.256 158.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 t -141.02 153.43 45.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.592 0.757 . . . . 0.0 109.822 -175.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 130.71 -174.15 19.9 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.093 1.33 . . . . 0.0 110.628 -174.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.7 p -161.09 163.72 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.442 1.897 . . . . 0.0 106.664 161.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.5 m -68.37 128.32 93.12 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 161.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -67.04 148.14 81.04 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.639 1.559 . . . . 0.0 109.678 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.8 169.8 19.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.521 1.128 . . . . 0.0 110.192 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.05 154.0 51.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.503 1.521 . . . . 0.0 107.128 168.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.94 171.47 18.29 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.103 0.961 . . . . 0.0 109.08 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -152.63 161.94 29.73 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 169.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.19 -140.96 6.18 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.2 t -132.57 158.3 43.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 117.532 0.666 . . . . 0.0 109.738 -167.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -123.08 137.22 54.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 158.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -120.16 113.57 20.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.641 1.576 . . . . 0.0 107.624 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.0 81.58 1.89 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.855 1.262 . . . . 0.0 108.868 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.9 tp -70.53 -41.13 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 167.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.55 115.57 60.12 Favored Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 126.413 1.885 . . . . 0.0 106.486 161.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -59.1 -23.31 68.39 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 CA-C-N 121.021 1.4 . . . . 0.0 111.45 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -68.03 -39.99 82.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.208 1.803 . . . . 0.0 112.895 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.9 tt -146.42 130.77 10.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 119.527 1.058 . . . . 0.0 108.468 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.97 145.66 31.62 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 123.579 0.55 . . . . 0.0 109.525 -160.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.4 m -94.97 151.56 19.07 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.15 152.97 49.89 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 125.053 1.341 . . . . 0.0 109.803 173.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 pp -141.61 154.65 45.54 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.191 1.396 . . . . 0.0 108.824 163.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -145.68 155.46 43.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.678 1.591 . . . . 0.0 108.92 171.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -133.68 149.35 51.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.946 1.698 . . . . 0.0 107.733 166.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -135.12 167.81 20.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.454 1.502 . . . . 0.0 108.857 167.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -83.82 160.56 21.16 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 168.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.61 -26.62 2.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.385 1.074 . . . . 0.0 111.647 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.48 -32.46 0.1 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.711 2.404 . . . . 0.0 115.038 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 62.56 -23.97 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 130.613 3.565 . . . . 0.0 116.382 168.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.1 tt -64.38 122.1 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.698 1.199 . . . . 0.0 112.179 -163.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.48 146.44 16.43 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 106.354 -2.699 . . . . 0.0 106.354 162.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.99 177.53 11.22 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.33 -4.71 1.28 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.299 1.44 . . . . 0.0 113.262 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -144.83 -26.03 0.5 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.536 1.062 . . . . 0.0 112.701 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.2 t -149.75 -150.04 0.33 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.945 1.298 . . . . 0.0 108.189 -171.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.55 162.39 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 159.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 167.41 -23.62 0.12 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.58 -0.567 . . . . 0.0 112.927 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 11.6 m -69.53 98.6 1.15 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.202 1.401 . . . . 0.0 108.406 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -81.81 144.02 51.26 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -160.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -77.74 40.8 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 125.293 3.996 . . . . 0.0 112.108 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -60.44 -30.77 69.86 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -164.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -134.04 173.07 11.98 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.552 1.168 . . . . 0.0 111.474 -159.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -109.49 165.31 12.41 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.314 163.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 18.5 ttt -104.64 148.06 26.96 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 169.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.8 pp -130.64 160.81 33.13 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.334 0.654 . . . . 0.0 111.4 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.39 158.11 44.92 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.589 1.155 . . . . 0.0 108.531 163.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 pp -149.54 156.03 41.29 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.326 1.451 . . . . 0.0 108.712 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.16 175.19 40.29 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 112.271 -0.332 . . . . 0.0 112.271 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.25 145.07 27.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 170.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.8 p -154.18 151.66 29.47 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.275 0.943 . . . . 0.0 110.743 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -106.15 149.83 26.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.342 1.857 . . . . 0.0 108.961 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.12 156.13 46.69 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 127.211 2.204 . . . . 0.0 109.949 171.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -66.93 151.65 47.2 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 159.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -113.99 -111.66 2.97 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -86.26 -33.84 20.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.326 1.05 . . . . 0.0 108.639 160.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -121.86 -172.06 14.16 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.759 1.647 . . . . 0.0 110.463 169.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.59 -26.25 66.83 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.07 -0.665 . . . . 0.0 110.661 170.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -140.38 161.14 38.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.446 2.299 . . . . 0.0 106.082 158.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.377 1.471 . . . . 0.0 111.776 -168.8 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -60.77 167.67 8.18 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.604 2.869 . . . . 0.0 111.738 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.06 17.15 17.97 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -161.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.25 -28.4 53.06 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.431 0.693 . . . . 0.0 112.206 170.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.491 ' ND2' ' H ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -46.32 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 129.97 3.308 . . . . 0.0 112.047 176.162 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.5 p -154.13 161.59 41.77 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.516 1.926 . . . . 0.0 109.226 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -134.86 149.37 50.31 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.385 1.474 . . . . 0.0 107.462 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -134.85 144.77 47.75 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.79 2.036 . . . . 0.0 108.802 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -150.08 135.16 17.88 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.906 -1.121 . . . . 0.0 108.682 171.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.09 -155.42 11.53 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.717 0.675 . . . . 0.0 112.748 -160.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.77 162.88 33.64 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.843 1.257 . . . . 0.0 111.0 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -139.5 142.22 37.3 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.76 1.624 . . . . 0.0 108.83 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.1 139.32 53.88 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.512 1.925 . . . . 0.0 106.524 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.92 148.27 19.0 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.615 1.102 . . . . 0.0 111.43 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -137.78 129.44 28.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.012 2.125 . . . . 0.0 107.493 -167.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.3 t -142.01 -176.94 4.99 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -50.11 -45.16 52.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.864 2.066 . . . . 0.0 112.182 -159.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.69 -21.52 0.81 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 159.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.584 ' CG ' ' H ' ' A' ' 20' ' ' ASP . 32.5 t60 170.1 -127.98 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 131.146 3.778 . . . . 0.0 104.386 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.584 ' H ' ' CG ' ' A' ' 19' ' ' HIS . 5.2 p-10 -54.78 -31.89 59.41 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.026 1.731 . . . . 0.0 112.364 174.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 36.69 90.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.466 3.106 . . . . 0.0 114.207 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.82 52.78 1.64 Allowed Glycine 0 CA--C 1.537 1.438 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 160.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . 0.309 45.8 p90 -36.38 -98.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 130.355 3.462 . . . . 0.0 115.86 -158.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 tp -65.96 -22.88 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.531 1.059 . . . . 0.0 111.728 -169.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -76.57 -47.77 21.43 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.699 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.2 -0.31 0.69 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -168.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.43 -9.12 4.16 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.177 1.353 . . . . 0.0 112.758 -167.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.48 133.6 6.34 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.553 1.549 . . . . 0.0 109.483 -172.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.44 -32.19 95.78 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.606 2.204 . . . . 0.0 112.428 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.282 1.3 m 54.27 -153.41 0.29 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.672 1.989 . . . . 0.0 111.036 173.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -146.34 -32.67 0.33 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -163.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.412 1.3 pt-20 109.15 121.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 131.381 3.872 . . . . 0.0 112.923 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -154.26 -19.54 0.13 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.286 1.034 . . . . 0.0 113.632 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -161.83 137.56 7.67 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.415 1.462 . . . . 0.0 110.013 -163.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -137.19 -58.13 0.71 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 166.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.41 -169.59 42.6 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.9 170.55 18.54 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.371 1.068 . . . . 0.0 108.741 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.36 -179.14 43.02 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.67 159.09 15.23 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -144.16 156.65 44.42 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.287 0.635 . . . . 0.0 111.113 -162.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.15 171.9 39.83 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 170.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.12 166.3 39.38 Favored Glycine 0 C--N 1.331 0.261 0 CA-C-N 117.778 0.789 . . . . 0.0 111.546 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -148.8 133.37 17.72 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.022 0.929 . . . . 0.0 109.318 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -121.76 154.84 36.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.37 -54.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.835 -172.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.69 152.48 93.51 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.35 1.46 . . . . 0.0 108.289 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -57.3 118.48 5.36 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.004 1.803 . . . . 0.0 109.731 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.6 m-30 62.83 14.76 7.65 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.152 2.181 . . . . 0.0 114.943 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 t -139.91 133.65 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 120.53 1.513 . . . . 0.0 110.596 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.48 -161.43 11.47 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.082 1.325 . . . . 0.0 112.163 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -136.44 155.83 49.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.696 1.198 . . . . 0.0 109.021 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -147.38 149.06 32.02 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.72 1.208 . . . . 0.0 108.223 -169.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 73.3 mtp -151.16 171.9 16.64 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.995 0.918 . . . . 0.0 110.898 -162.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.51 179.02 40.13 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 119.523 -0.598 . . . . 0.0 111.959 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -148.42 149.54 31.91 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.047 1.739 . . . . 0.0 110.29 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -132.49 146.12 51.68 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.418 1.487 . . . . 0.0 110.853 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.17 86.1 2.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.576 2.35 . . . . 0.0 105.927 160.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 40.8 tp -55.7 132.27 48.69 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.45 -41.57 2.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -169.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.08 -24.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 130.278 3.431 . . . . 0.0 117.615 167.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.4 ttt -58.0 121.71 52.64 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.218 1.407 . . . . 0.0 110.216 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.08 58.9 6.34 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.312 2.675 . . . . 0.0 110.126 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.74 109.0 1.57 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -148.2 156.58 42.74 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.96 1.304 . . . . 0.0 107.843 -170.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.27 9.93 85.35 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 120.016 -0.325 . . . . 0.0 112.972 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.5 m -163.82 178.93 7.44 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.679 1.992 . . . . 0.0 107.361 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.1 m -118.77 172.25 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.377 1.471 . . . . 0.0 107.929 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.24 171.02 17.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 168.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -69.62 166.84 18.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.044 2.138 . . . . 0.0 109.828 167.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 172.28 172.51 38.18 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 171.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.81 160.45 42.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.817 1.647 . . . . 0.0 107.497 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 64.98 164.91 0.16 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.061 2.144 . . . . 0.0 113.07 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -177.19 176.15 1.41 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.2 1.8 . . . . 0.0 108.676 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 58' ' ' LEU . . . -139.76 155.79 47.12 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 158.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -141.71 142.68 33.31 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.1 172.89 38.34 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.849 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 m -146.15 164.7 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.819 2.047 . . . . 0.0 110.058 173.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -120.62 146.4 46.41 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 163.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.54 116.54 7.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.289 1.436 . . . . 0.0 108.518 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.84 145.67 27.61 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.809 -0.557 . . . . 0.0 110.376 -169.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.48 22.69 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.967 0.907 . . . . 0.0 108.978 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.535 ' HE2' ' CE1' ' A' ' 94' ' ' TYR . 86.7 tttt -142.16 138.31 31.48 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.752 1.221 . . . . 0.0 108.69 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.89 146.55 34.17 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 123.113 0.565 . . . . 0.0 109.505 169.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.5 170.22 32.91 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 118.409 0.549 . . . . 0.0 113.623 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -157.97 157.2 29.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.285 1.034 . . . . 0.0 111.607 -166.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.01 131.12 13.92 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.463 2.775 . . . . 0.0 110.521 172.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 pt -73.68 38.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.511 1.125 . . . . 0.0 112.865 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 64.7 p 63.45 -37.32 0.17 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.622 2.769 . . . . 0.0 113.488 -167.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -69.15 167.04 16.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.768 0.794 . . . . 0.0 108.902 159.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -75.98 16.23 0.45 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.408 2.283 . . . . 0.0 113.983 -173.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.6 tp -102.06 125.46 48.75 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.674 1.19 . . . . 0.0 108.596 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -106.85 111.9 24.62 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.244 1.018 . . . . 0.0 108.531 -170.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.4 HG22 HG12 ' A' ' 127' ' ' VAL . 10.1 pt -109.66 143.91 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 121.85 -0.531 . . . . 0.0 110.002 -166.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.535 ' CE1' ' HE2' ' A' ' 82' ' ' LYS . 77.5 m-85 -137.89 158.86 43.48 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.707 0.765 . . . . 0.0 112.869 -166.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.7 m -124.43 147.09 48.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 128.429 2.692 . . . . 0.0 106.179 166.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.28 144.22 31.38 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.059 0.944 . . . . 0.0 108.996 -171.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.1 tt -149.07 147.48 28.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.339 1.056 . . . . 0.0 109.188 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.9 -140.68 7.68 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.19 176.42 28.83 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-O 122.222 0.901 . . . . 0.0 112.789 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -140.0 157.44 45.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.31 1.044 . . . . 0.0 109.087 169.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.5 t -130.26 128.29 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -150.72 110.11 3.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.48 105.06 15.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.26 112.19 21.14 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 170.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -83.51 103.63 13.01 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 p -105.51 16.02 26.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.165 1.786 . . . . 0.0 110.134 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 62.39 -29.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.843 2.457 . . . . 0.0 113.569 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.0 m -158.67 178.88 9.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.934 2.094 . . . . 0.0 108.174 168.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -72.76 83.29 1.18 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.539 0.736 . . . . 0.0 110.092 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 111' ' ' TYR . 4.2 p -72.23 -178.72 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.019 1.327 . . . . 0.0 109.826 169.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.464 ' H ' HG22 ' A' ' 110' ' ' VAL . 14.6 t80 -59.19 25.53 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 129.786 3.234 . . . . 0.0 115.766 176.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -54.64 160.51 5.06 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 120.63 -1.294 . . . . 0.0 111.215 168.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -124.5 -156.02 0.7 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.934 0.893 . . . . 0.0 110.404 -164.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -72.51 2.17 6.8 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.181 0.993 . . . . 0.0 113.502 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -70.17 172.1 8.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.359 1.064 . . . . 0.0 109.818 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' OD2' ' OG ' ' A' ' 120' ' ' SER . 2.6 m-20 -53.09 142.28 20.6 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.143 0.977 . . . . 0.0 110.697 173.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.5 t -144.92 43.49 1.34 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 170.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 154.94 -87.95 0.13 Allowed Glycine 0 C--N 1.336 0.578 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -170.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.43 154.68 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.009 1.323 . . . . 0.0 109.3 -172.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.409 ' OG ' ' OD2' ' A' ' 116' ' ' ASP . 71.3 p -145.62 156.83 52.55 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.713 1.205 . . . . 0.0 110.268 167.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.43 155.76 36.54 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.76 2.307 . . . . 0.0 110.086 166.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.8 124.54 2.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 124.913 1.285 . . . . 0.0 108.288 169.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -133.35 145.86 50.76 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 167.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.89 170.78 21.57 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.923 0.889 . . . . 0.0 110.468 -164.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -126.34 165.2 19.63 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 161.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.16 175.5 43.5 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 118.149 0.974 . . . . 0.0 113.187 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.4 HG12 HG22 ' A' ' 93' ' ' ILE . 18.0 m -133.44 140.64 46.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.242 1.417 . . . . 0.0 107.43 175.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.422 ' CD ' ' HE ' ' A' ' 138' ' ' ARG . 40.4 mt-10 -136.63 148.01 47.21 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.591 1.157 . . . . 0.0 108.092 -169.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -149.97 166.14 30.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.917 0.887 . . . . 0.0 110.385 -168.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.82 143.81 51.11 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 125.159 1.383 . . . . 0.0 109.603 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.56 -26.81 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.012 0.525 . . . . 0.0 110.104 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 91.0 m 139.06 -64.46 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.776 1 C-N-CA 132.894 4.478 . . . . 0.0 106.879 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -67.35 179.81 2.27 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.833 1.689 . . . . 0.0 109.943 159.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -52.81 -3.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 130.542 3.537 . . . . 0.0 117.914 -165.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 68.5 mt -87.61 138.08 19.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.95 161.52 34.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.719 0.808 . . . . 0.0 109.682 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.5 m -135.28 148.91 49.68 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.474 1.509 . . . . 0.0 107.799 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.422 ' HE ' ' CD ' ' A' ' 128' ' ' GLU . 33.5 mtp-105 -135.32 146.13 48.14 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.708 1.203 . . . . 0.0 108.928 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.6 125.66 38.67 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 164.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -140.01 123.58 17.2 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -169.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -120.68 138.03 54.16 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.149 1.78 . . . . 0.0 109.842 -172.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.14 114.97 16.99 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.621 1.968 . . . . 0.0 107.867 -167.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -132.07 162.21 31.36 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.422 1.089 . . . . 0.0 109.346 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.8 m 62.89 -43.96 0.2 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.691 2.397 . . . . 0.0 113.22 -171.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -59.74 116.33 3.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.971 0.909 . . . . 0.0 108.775 168.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -158.45 176.27 12.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.473 1.109 . . . . 0.0 108.504 -167.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 147' ' ' ILE . 13.2 mt -46.73 -38.28 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 126.249 1.82 . . . . 0.0 109.966 163.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 123.76 22.16 2.28 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.901 1.715 . . . . 0.0 111.992 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -78.67 126.72 31.12 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.79 1.295 . . . . 0.0 113.024 -171.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.85 21.67 1.61 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.339 1.456 . . . . 0.0 110.413 159.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -77.95 -9.36 59.05 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -159.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 29.3 p -148.21 168.6 22.06 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.158 0.983 . . . . 0.0 110.132 -165.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.8 pt -127.75 161.71 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.705 1.202 . . . . 0.0 108.038 169.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 144.58 -161.72 28.0 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 107.855 -2.098 . . . . 0.0 107.855 -167.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 20.1 m -69.75 96.69 1.0 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -108.0 96.58 18.18 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 0.0 109.957 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.35 -25.31 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.407 2.738 . . . . 0.0 111.91 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 33.82 51.45 0.38 Allowed 'General case' 0 CA--C 1.531 0.247 1 C-N-CA 131.792 4.037 . . . . 0.0 113.618 168.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -55.38 -37.94 68.21 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.388 1.475 . . . . 0.0 111.972 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.72 -112.33 3.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -167.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -152.44 141.83 21.6 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.965 0.883 . . . . 0.0 109.391 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.0 tp -118.82 154.33 33.05 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.553 1.941 . . . . 0.0 107.484 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.9 p -153.77 162.1 41.52 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.299 -0.875 . . . . 0.0 111.785 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 7.0 tt -132.52 149.82 52.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.192 2.197 . . . . 0.0 106.767 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.01 162.77 27.8 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 170.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.6 t -139.79 142.75 31.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 8.0 t -151.46 167.92 26.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.711 0.687 . . . . 0.0 110.734 -167.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -115.81 127.71 55.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.016 2.126 . . . . 0.0 106.303 167.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -89.63 137.59 32.2 Favored 'General case' 0 C--N 1.337 0.063 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 170.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -63.14 115.95 4.95 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 173.14 -179.04 44.83 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.404 1.478 . . . . 0.0 111.287 -165.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -149.19 0.51 0.52 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.874 1.27 . . . . 0.0 113.83 -166.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 74.51 -53.54 2.38 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.932 1.253 . . . . 0.0 112.537 -175.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.7 155.59 18.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.532 1.933 . . . . 0.0 110.522 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -111.86 -16.5 13.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.06 1.344 . . . . 0.0 112.829 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 116.48 -1.724 . . . . 0.0 111.294 167.638 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 0.342 . . . . . . . 0 CA--C 1.546 0.811 0 CA-C-O 115.083 -2.389 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.03 173.52 10.2 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 124.717 2.72 . . . . 0.0 111.964 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -57.44 127.59 32.74 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.681 1.192 . . . . 0.0 108.384 169.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -68.9 133.97 48.96 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.726 0.81 . . . . 0.0 109.865 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.99 125.41 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.768 2.427 . . . . 0.0 113.925 -172.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.2 m -121.71 155.32 35.47 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.11 1.364 . . . . 0.0 108.795 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -121.37 129.6 53.14 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.294 1.438 . . . . 0.0 108.01 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -113.13 143.34 44.52 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.993 1.317 . . . . 0.0 107.95 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 t -150.35 158.2 43.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.384 0.993 . . . . 0.0 111.514 159.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.04 -141.59 6.41 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 125.4 1.476 . . . . 0.0 110.041 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.67 155.29 44.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.95 0.375 . . . . 0.0 111.606 -164.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.44 159.81 41.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.144 0.978 . . . . 0.0 111.617 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp -109.75 158.96 17.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.204 1.802 . . . . 0.0 106.411 164.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -129.89 165.35 22.36 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 124.966 1.27 . . . . 0.0 109.933 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -148.3 148.34 30.31 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.4 t -162.88 96.42 0.91 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -159.3 157.96 31.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -121.3 -75.47 0.59 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 101.749 -3.426 . . . . 0.0 101.749 158.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -122.33 -165.75 1.32 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 158.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 27.38 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.644 2.778 . . . . 0.0 115.923 172.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 p -70.68 67.09 0.36 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.403 -0.81 . . . . 0.0 109.848 166.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.01 116.91 1.98 Allowed Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -163.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -45.04 108.8 0.13 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.099 1.76 . . . . 0.0 111.624 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.53 -23.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -159.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -61.23 -18.8 60.18 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.957 0.798 . . . . 0.0 112.871 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.04 -25.97 1.98 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.613 1.165 . . . . 0.0 112.885 171.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.434 ' CG ' ' H ' ' A' ' 28' ' ' GLY 0.252 8.0 t-20 48.22 -172.78 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.951 2.9 . . . . 0.0 113.092 -168.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.434 ' H ' ' CG ' ' A' ' 27' ' ' ASN . . . 145.6 81.77 0.05 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -166.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.92 -173.23 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.448 2.765 . . . . 0.0 111.391 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -151.32 155.83 39.54 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.49 1.516 . . . . 0.0 107.653 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -63.26 -19.61 64.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.683 1.193 . . . . 0.0 113.862 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -129.96 109.78 11.15 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 159.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.19 135.98 16.28 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 61.52 -81.17 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -158.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.58 171.23 7.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.015 1.326 . . . . 0.0 110.447 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.2 175.68 36.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.841 2.162 . . . . 0.0 109.127 170.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.03 166.3 32.88 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.026 0.93 . . . . 0.0 110.399 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.37 175.69 44.84 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.482 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.81 157.34 16.78 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.635 1.174 . . . . 0.0 107.883 164.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -151.44 166.2 31.8 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.729 0.776 . . . . 0.0 111.796 175.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.25 171.85 39.9 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.62 166.2 39.18 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -121.06 119.84 33.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 173.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.13 160.34 25.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.414 0.685 . . . . 0.0 109.428 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.08 -27.67 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.364 1.066 . . . . 0.0 111.387 -170.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 135.19 -45.31 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.49 1 C-N-CA 132.24 4.216 . . . . 0.0 111.366 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.97 -87.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.899 1.733 . . . . 0.0 111.178 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -153.72 20.15 0.53 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.565 1.075 . . . . 0.0 113.316 -168.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 t -129.09 142.27 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.14 -162.3 30.38 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 118.756 0.707 . . . . 0.0 113.695 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -126.68 155.3 42.85 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.997 1.319 . . . . 0.0 108.113 166.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -149.16 158.12 43.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.863 1.265 . . . . 0.0 108.455 -169.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.0 mtt -146.1 152.56 39.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.124 1.77 . . . . 0.0 108.731 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -136.73 157.69 23.79 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -136.4 115.78 12.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 103.183 -2.895 . . . . 0.0 103.183 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -123.09 150.53 43.06 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.558 0.743 . . . . 0.0 111.677 -158.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.1 t80 60.33 -177.34 0.1 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.021 1.728 . . . . 0.0 111.666 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -96.8 0.97 50.2 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.353 -0.842 . . . . 0.0 112.542 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 42.83 -93.1 0.01 OUTLIER Glycine 0 CA--C 1.531 1.077 0 C-N-CA 127.49 2.471 . . . . 0.0 114.04 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.01 22.9 3.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.816 1.246 . . . . 0.0 112.64 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 53.6 mtt -55.97 -49.04 95.35 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 116.858 -1.544 . . . . 0.0 113.528 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.78 69.51 7.34 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.404 2.069 . . . . 0.0 111.205 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 65.72 -34.98 0.2 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 128.72 2.808 . . . . 0.0 113.935 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -152.97 -169.35 3.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.115 2.166 . . . . 0.0 108.625 168.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.05 -128.29 2.86 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 170.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 p -71.97 173.33 8.53 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 122.038 0.923 . . . . 0.0 111.892 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.47 -25.75 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -161.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 7.6 pm0 -64.97 -20.61 66.57 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 -162.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.67 177.52 7.82 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.525 1.511 . . . . 0.0 112.083 -164.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -138.17 172.25 23.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.839 2.161 . . . . 0.0 108.199 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 61.21 -56.69 0.1 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.071 2.148 . . . . 0.0 111.727 -162.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.3 t80 63.06 87.26 0.11 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.484 2.313 . . . . 0.0 114.236 159.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.89 152.52 44.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.329 1.052 . . . . 0.0 110.038 166.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.9 168.9 24.25 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.853 0.861 . . . . 0.0 109.737 167.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -147.2 158.98 44.14 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.736 2.014 . . . . 0.0 106.886 162.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.48 76.97 0.08 OUTLIER Glycine 0 C--N 1.335 0.494 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -143.43 163.05 16.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 123.138 0.575 . . . . 0.0 110.33 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -147.29 155.97 42.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.564 1.145 . . . . 0.0 109.808 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 pp -143.73 144.44 31.84 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.238 1.415 . . . . 0.0 107.797 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 t -154.03 153.16 31.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.588 0.709 . . . . 0.0 111.401 -169.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.71 151.67 24.26 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 158.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -135.74 135.46 40.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.303 1.441 . . . . 0.0 108.622 -171.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.3 tp -133.52 168.29 18.9 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 128.023 2.529 . . . . 0.0 107.478 -176.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.53 -176.9 39.71 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.431 ' CG ' ' HD2' ' A' ' 86' ' ' PRO . 64.8 t80 -143.8 142.21 20.15 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 168.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 85' ' ' TYR . 63.8 Cg_endo -75.42 157.58 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.053 1.835 . . . . 0.0 112.909 -161.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mp 16.37 68.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 131.447 3.899 . . . . 0.0 110.637 162.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.1 m -86.47 54.56 3.2 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.8 t0 60.99 133.84 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 129.714 3.206 . . . . 0.0 111.41 -158.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.7 t70 49.43 -60.39 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 129.193 2.997 . . . . 0.0 115.383 -164.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.35 167.44 16.96 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.383 1.873 . . . . 0.0 112.41 -160.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.97 148.3 25.38 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 tp -90.91 144.04 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 167.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -137.09 134.91 36.98 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.694 1.598 . . . . 0.0 108.519 -164.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.8 m -137.62 147.18 44.78 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -151.67 142.78 23.19 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.881 -0.512 . . . . 0.0 110.687 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 mp -141.59 140.29 33.33 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.518 1.127 . . . . 0.0 108.826 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.96 -150.27 8.22 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 117.757 0.253 . . . . 0.0 113.006 -164.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.83 161.63 24.34 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.653 1.12 . . . . 0.0 112.017 170.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.6 ptm -141.6 149.67 41.03 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.567 1.547 . . . . 0.0 109.973 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.1 127.06 19.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 125.295 1.438 . . . . 0.0 107.664 -167.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -138.47 135.68 35.41 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 117.789 0.268 . . . . 0.0 110.504 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.48 152.15 41.15 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.174 0.99 . . . . 0.0 109.515 172.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.75 165.25 31.98 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 162.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -95.73 116.59 29.1 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.466 0.575 . . . . 0.0 110.106 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 57.1 m 60.25 -36.2 0.08 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.839 2.455 . . . . 0.0 114.0 -165.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt 73.93 165.07 0.29 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 128.659 2.784 . . . . 0.0 111.201 174.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.6 p -68.03 94.13 0.47 Allowed 'General case' 0 C--O 1.241 0.648 0 O-C-N 121.799 -0.563 . . . . 0.0 109.904 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -73.13 71.01 1.13 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.728 1.611 . . . . 0.0 110.391 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.84 170.58 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 158.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -57.98 -36.99 73.4 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.792 -1.193 . . . . 0.0 112.863 -168.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -97.26 2.57 61.26 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.136 -1.369 . . . . 0.0 114.217 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.2 mptt 56.52 141.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 130.135 3.374 . . . . 0.0 115.516 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -66.25 82.14 0.09 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.524 1.13 . . . . 0.0 109.935 167.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -73.28 -16.62 61.38 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -173.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -65.22 15.69 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 -161.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t -77.0 151.33 35.66 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 120.722 -1.236 . . . . 0.0 109.759 175.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 178.83 176.5 46.73 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 121.572 0.54 . . . . 0.0 112.595 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.82 114.74 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 100.461 -3.903 . . . . 0.0 100.461 159.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.95 158.22 52.9 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.538 -158.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.14 167.18 27.5 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.8 2.334 . . . . 0.0 109.925 164.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.25 153.24 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 165.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -143.37 152.34 41.49 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.465 1.506 . . . . 0.0 106.986 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.92 168.64 19.16 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.142 0.577 . . . . 0.0 110.051 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.12 164.46 32.36 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 170.79 -133.21 2.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -173.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.73 162.21 35.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 118.471 1.135 . . . . 0.0 111.615 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -139.93 144.57 37.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.136 1.774 . . . . 0.0 109.048 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -153.17 164.68 37.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.132 0.573 . . . . 0.0 110.925 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.41 143.06 43.76 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 161.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 tp -113.07 -2.93 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.18 0.992 . . . . 0.0 111.084 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.8 m -161.58 136.97 5.66 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 102.806 -3.035 . . . . 0.0 102.806 168.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.72 -23.93 69.25 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.894 1.729 . . . . 0.0 113.905 -161.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.68 -2.07 49.13 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 36.5 pt -127.38 163.39 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.87 0.868 . . . . 0.0 109.79 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.61 169.22 18.05 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.882 0.873 . . . . 0.0 109.127 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.1 m -149.46 138.69 21.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -137.91 145.89 42.65 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.852 1.261 . . . . 0.0 107.63 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.91 140.15 25.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 167.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -136.42 161.09 36.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.95 1.3 . . . . 0.0 110.803 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -136.51 152.35 50.43 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.279 2.232 . . . . 0.0 108.995 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -141.86 148.33 38.62 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.438 2.295 . . . . 0.0 107.35 172.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -138.13 159.9 40.83 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.503 1.521 . . . . 0.0 107.617 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.6 p -80.46 177.83 8.73 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.262 0.554 . . . . 0.0 110.821 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -73.09 4.3 4.52 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 167.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 48.81 68.34 0.72 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.867 2.467 . . . . 0.0 112.745 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 16.9 tt -70.37 71.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.542 1.137 . . . . 0.0 109.717 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.9 -58.3 1.0 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.282 1.896 . . . . 0.0 111.894 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.1 t70 59.66 -95.79 0.06 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 128.055 2.542 . . . . 0.0 111.682 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.55 73.18 3.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.273 1.029 . . . . 0.0 110.743 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -70.44 72.12 0.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.621 1.568 . . . . 0.0 110.24 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 86.3 m -154.27 88.59 1.23 Allowed 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.214 -1.554 . . . . 0.0 109.175 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.71 HG22 ' H ' ' A' ' 154' ' ' GLY . 20.0 mt 60.94 -169.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 124.768 1.227 . . . . 0.0 108.502 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.71 ' H ' HG22 ' A' ' 153' ' ' ILE . . . -71.84 40.06 0.66 Allowed Glycine 0 CA--C 1.534 1.243 0 O-C-N 120.2 -1.562 . . . . 0.0 113.318 176.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.6 t -69.79 158.58 35.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.944 0.872 . . . . 0.0 109.445 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -95.68 112.33 58.72 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.17 167.34 26.46 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.844 2.362 . . . . 0.0 111.329 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -160.48 140.22 11.08 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 159.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -159.61 96.58 1.27 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 127.294 2.238 . . . . 0.0 108.326 -168.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -161.97 -178.34 35.79 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 121.993 0.774 . . . . 0.0 113.205 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 54.5 ttm -144.67 151.67 39.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.143 1.777 . . . . 0.0 107.558 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.9 pp -139.68 162.41 35.17 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.128 0.971 . . . . 0.0 110.04 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.1 m -139.16 155.93 47.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.774 0.829 . . . . 0.0 109.741 165.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 16.1 tp -149.96 119.3 6.85 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.708 2.003 . . . . 0.0 107.4 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -152.89 171.22 31.96 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 121.718 0.621 . . . . 0.0 114.26 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.08 160.38 33.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 126.278 1.831 . . . . 0.0 109.282 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.0 m -152.46 161.99 41.82 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 121.52 -0.738 . . . . 0.0 111.504 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -97.49 152.45 18.98 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.062 1.745 . . . . 0.0 107.365 161.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.83 116.18 27.55 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.21 1.004 . . . . 0.0 110.485 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -57.62 156.52 8.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.522 1.129 . . . . 0.0 113.154 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 114.36 -16.17 19.83 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.325 1.44 . . . . 0.0 114.36 162.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -157.54 171.87 19.57 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.018 1.327 . . . . 0.0 108.483 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 61.73 42.05 99.69 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -135.98 148.28 48.38 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.735 1.614 . . . . 0.0 107.295 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -158.65 174.07 15.62 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.599 1.56 . . . . 0.0 108.373 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 C-N-CA 127.202 2.201 . . . . 0.0 106.39 168.837 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -71.73 157.01 56.44 Favored 'Trans proline' 0 C--N 1.353 0.765 0 CA-C-N 121.248 1.481 . . . . 0.0 110.946 164.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 120.16 9.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.313 1.445 . . . . 0.0 108.372 171.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.83 162.67 2.26 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.563 2.345 . . . . 0.0 114.596 -164.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.42 159.91 40.61 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.641 1.576 . . . . 0.0 107.245 163.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 m -117.7 124.51 48.69 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -104.14 156.42 17.9 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -142.71 156.94 45.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.944 1.698 . . . . 0.0 109.131 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.0 t -150.27 158.64 44.38 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.89 0.768 . . . . 0.0 111.519 162.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.65 -134.34 3.1 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.105 0.86 . . . . 0.0 112.296 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.09 147.74 50.54 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.236 1.014 . . . . 0.0 110.627 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -129.36 139.52 51.68 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.0 mp -115.12 159.5 20.81 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.472 1.909 . . . . 0.0 107.311 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.77 157.52 27.31 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -138.35 149.85 46.0 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.537 1.135 . . . . 0.0 108.358 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.6 p -138.44 126.3 22.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.0 1.32 . . . . 0.0 108.248 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -65.89 148.08 52.35 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.743 2.017 . . . . 0.0 110.17 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -132.93 65.8 1.58 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.407 ' CE1' HG21 ' A' ' 155' ' ' THR . 0.4 OUTLIER -74.26 98.05 3.12 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 158.135 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -64.44 134.15 53.94 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 169.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 p -70.46 -30.36 67.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.671 0.389 . . . . 0.0 111.701 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.52 66.1 1.46 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 171.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -71.06 48.72 0.12 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.199 1.8 . . . . 0.0 113.446 -174.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.4 mt -55.7 -47.45 79.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 162.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -69.22 103.5 1.95 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 158.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -68.86 23.62 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.381 1.472 . . . . 0.0 113.639 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -155.45 174.8 14.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.989 2.915 . . . . 0.0 106.771 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.89 42.92 1.8 Allowed Glycine 0 CA--C 1.536 1.397 0 CA-C-O 117.106 -1.941 . . . . 0.0 115.976 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -66.08 -9.73 24.52 Favored 'Trans proline' 0 C--N 1.355 0.887 0 CA-C-N 122.485 3.143 . . . . 0.0 113.033 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 m -55.84 80.02 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.145 2.578 . . . . 0.0 109.072 161.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.7 m80 77.86 -17.91 0.54 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 129.241 3.017 . . . . 0.0 113.146 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 46.86 54.21 9.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.991 1.716 . . . . 0.0 112.373 -172.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 71.15 67.45 0.17 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.903 1.681 . . . . 0.0 110.319 163.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -151.7 173.46 14.67 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.423 1.889 . . . . 0.0 109.213 -167.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.3 tp -152.77 -61.05 0.15 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.306 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.2 -167.26 39.74 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 119.584 1.084 . . . . 0.0 113.625 -174.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.07 169.22 19.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.154 1.382 . . . . 0.0 109.908 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.41 170.21 38.74 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.072 0.844 . . . . 0.0 112.048 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.46 143.76 26.52 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 171.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -144.97 165.2 28.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.76 152.56 20.33 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 127.309 2.385 . . . . 0.0 109.322 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.89 151.93 19.21 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -148.35 105.72 3.65 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -172.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -122.59 142.14 50.95 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.743 0.701 . . . . 0.0 111.097 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 p -126.66 -16.54 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.812 0.845 . . . . 0.0 112.24 -164.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -159.68 167.92 13.17 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.454 1.902 . . . . 0.0 107.174 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.68 -11.4 27.88 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.672 1.581 . . . . 0.0 114.414 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -87.83 -38.68 15.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.651 1.114 . . . . 0.0 111.65 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.88 147.87 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 122.178 0.99 . . . . 0.0 112.03 -169.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.55 -166.9 18.55 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 127.663 2.554 . . . . 0.0 109.087 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -135.53 163.66 29.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.171 1.388 . . . . 0.0 108.886 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -148.04 152.38 37.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.364 1.066 . . . . 0.0 108.304 164.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 50.4 mtt -149.49 157.11 42.99 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.534 1.134 . . . . 0.0 108.068 -169.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.47 176.52 43.4 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 119.06 0.846 . . . . 0.0 113.08 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -141.72 151.31 42.82 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.572 1.549 . . . . 0.0 109.376 -172.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -129.05 145.78 51.18 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.092 1.357 . . . . 0.0 109.318 170.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -141.18 120.4 12.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 164.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.1 mt 54.83 18.98 2.37 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.657 1.983 . . . . 0.0 114.933 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.08 58.14 1.61 Allowed Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.686 1.13 . . . . 0.0 110.388 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 50.56 37.57 16.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.522 1.929 . . . . 0.0 112.289 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 52.0 ttp -127.36 115.64 21.44 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.219 1.408 . . . . 0.0 108.278 -170.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.85 -26.36 44.66 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.687 2.258 . . . . 0.0 114.222 -164.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -154.94 167.44 30.32 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 164.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -75.19 66.97 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.72 -95.36 0.22 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -168.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.1 t -156.83 172.24 18.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.198 1.799 . . . . 0.0 106.99 169.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.27 17.8 m 39.59 -125.27 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.855 1.662 . . . . 0.0 110.122 -166.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 65.9 -54.52 0.37 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.803 2.441 . . . . 0.0 114.565 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -159.52 -174.74 4.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 173.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 176.31 -24.49 0.06 OUTLIER Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.418 1.961 . . . . 0.0 110.9 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.35 -64.45 0.86 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.866 0.833 . . . . 0.0 109.15 166.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -65.9 162.88 18.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.722 0.809 . . . . 0.0 110.672 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.88 165.52 18.18 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 125.716 1.607 . . . . 0.0 108.531 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.67 134.38 37.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 160.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -157.89 161.12 38.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.54 1.136 . . . . 0.0 108.041 -165.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.8 168.25 41.26 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.146 -0.971 . . . . 0.0 112.146 171.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.7 p -143.87 148.5 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -132.05 130.23 41.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.386 1.874 . . . . 0.0 107.013 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -120.38 150.32 40.95 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 159.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -154.98 132.24 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 120.598 -1.314 . . . . 0.0 109.08 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.12 140.03 31.27 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 164.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -117.72 114.36 23.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.21 136.64 40.09 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.867 0.758 . . . . 0.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.93 -148.53 17.14 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 118.582 -1.121 . . . . 0.0 110.634 -166.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.401 ' CG ' ' HD2' ' A' ' 86' ' ' PRO . 1.6 t80 -159.32 157.43 27.24 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 118.508 1.154 . . . . 0.0 112.415 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 92' ' ' ASP . 37.5 Cg_endo -62.33 153.54 69.73 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.323 2.682 . . . . 0.0 111.911 161.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.5 mt -111.36 -34.87 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.832 1.253 . . . . 0.0 108.5 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.2 m -157.56 167.44 30.14 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 168.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.43 -21.41 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.945 1.298 . . . . 0.0 113.107 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -77.75 -34.34 52.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.286 1.835 . . . . 0.0 113.456 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -155.75 155.16 32.6 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 119.977 1.262 . . . . 0.0 114.341 -170.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 1.1 m-20 -134.93 164.02 28.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.024 2.13 . . . . 0.0 109.544 -172.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.39 129.2 73.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.657 1.583 . . . . 0.0 106.899 173.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -137.98 153.36 49.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.085 0.945 . . . . 0.0 111.768 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 51.9 m -96.9 132.41 42.69 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 159.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -99.31 108.93 21.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 167.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tt -98.96 107.53 19.99 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.07 142.01 15.39 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.113 0.863 . . . . 0.0 112.502 -164.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.66 95.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 105.929 -2.868 . . . . 0.0 105.929 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.1 ptp -134.23 157.04 47.29 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.275 0.63 . . . . 0.0 110.304 -171.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.2 p -148.25 150.38 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -117.62 156.17 28.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.602 1.961 . . . . 0.0 107.319 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -143.18 146.0 33.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.378 0.671 . . . . 0.0 109.698 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.48 122.02 11.75 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.115 0.966 . . . . 0.0 109.798 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -71.42 103.96 3.07 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 p -145.31 146.49 31.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.173 0.989 . . . . 0.0 109.076 -166.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -71.79 -21.12 61.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 119.038 -0.506 . . . . 0.0 112.005 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.8 t 55.6 -165.36 0.12 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.429 1.491 . . . . 0.0 112.679 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -66.6 -50.66 62.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.669 1.188 . . . . 0.0 108.605 164.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.269 0.4 OUTLIER 76.64 -39.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.998 2.519 . . . . 0.0 112.503 177.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -67.21 -37.23 83.26 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 158.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -82.78 93.08 1.65 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 159.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -73.31 69.8 1.14 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 110.229 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -149.35 178.46 8.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.223 1.809 . . . . 0.0 108.237 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 58.42 78.11 0.26 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.417 2.287 . . . . 0.0 112.817 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.01 -72.36 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 1 N-CA-C 100.087 -4.042 . . . . 0.0 100.087 158.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.2 t -65.38 159.84 23.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.187 1.795 . . . . 0.0 109.849 158.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -172.77 179.6 44.15 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 127.488 2.471 . . . . 0.0 109.465 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 120' ' ' SER . 52.0 t 62.47 176.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.818 1.247 . . . . 0.0 109.849 -168.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.489 ' H ' HG12 ' A' ' 119' ' ' VAL . 79.8 p -153.77 174.89 3.37 Favored Pre-proline 0 C--O 1.236 0.393 0 O-C-N 120.696 -1.253 . . . . 0.0 110.109 -168.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.5 158.08 24.6 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.019 1.146 . . . . 0.0 109.708 158.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.2 p -167.24 -178.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.192 1.797 . . . . 0.0 107.752 -172.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -139.01 164.8 28.8 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.596 -1.315 . . . . 0.0 109.694 163.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.77 160.6 40.99 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.199 1.8 . . . . 0.0 108.403 172.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -124.36 145.94 16.04 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.24 -162.37 29.15 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 117.915 0.857 . . . . 0.0 114.615 -169.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.97 158.51 30.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 127.301 2.24 . . . . 0.0 108.38 -169.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -135.56 146.55 48.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.157 1.383 . . . . 0.0 107.568 165.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -150.16 122.88 8.63 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.811 0.844 . . . . 0.0 110.077 -162.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -135.75 82.43 1.95 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.787 2.035 . . . . 0.0 109.201 -172.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.64 -31.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.129 0.972 . . . . 0.0 112.931 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.0 p -136.65 155.08 76.95 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.972 1.309 . . . . 0.0 107.832 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.05 60.76 6.99 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.152 3.234 . . . . 0.0 111.33 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -148.07 -33.54 0.24 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.468 2.307 . . . . 0.0 111.395 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.16 149.58 21.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 127.21 2.204 . . . . 0.0 108.131 -166.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.0 109.12 5.24 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.138 0.881 . . . . 0.0 108.871 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.65 149.03 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.435 1.894 . . . . 0.0 106.99 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.6 157.75 46.04 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.277 0.944 . . . . 0.0 110.592 168.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 37.7 tp -154.44 119.52 5.0 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 125.67 1.588 . . . . 0.0 107.266 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.34 156.45 45.84 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.365 1.066 . . . . 0.0 111.423 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -134.01 152.96 52.06 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.474 1.51 . . . . 0.0 109.801 -173.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -145.15 158.34 43.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.555 1.542 . . . . 0.0 109.915 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -146.2 163.54 35.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.089 1.755 . . . . 0.0 107.372 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 m 43.49 66.17 0.86 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.502 1.521 . . . . 0.0 110.745 -172.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.48 167.24 13.13 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.627 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.62 62.46 3.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.523 1.129 . . . . 0.0 110.068 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.6 tp -151.22 164.01 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.385 1.474 . . . . 0.0 108.402 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.41 -161.47 44.84 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -144.6 177.03 8.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.408 1.483 . . . . 0.0 109.022 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -118.95 12.28 12.77 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.956 1.302 . . . . 0.0 113.033 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.3 -23.79 10.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.073 1.349 . . . . 0.0 111.216 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.2 t -62.95 168.9 3.63 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.753 1.221 . . . . 0.0 111.626 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.58 163.21 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.37 1.468 . . . . 0.0 108.206 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 157.41 -147.33 15.31 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -176.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' THR . . . . . 0.407 HG21 ' CE1' ' A' ' 19' ' ' HIS . 9.0 t -69.56 158.54 35.05 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 166.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -68.8 113.0 13.12 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.08 -43.49 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.537 1.491 . . . . 0.0 109.841 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 37.71 47.39 0.82 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.57 2.748 . . . . 0.0 111.795 173.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -89.68 108.09 19.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.427 1.491 . . . . 0.0 108.281 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.35 167.11 44.66 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 171.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -140.96 157.76 44.89 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 pp -140.22 162.37 35.42 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.434 0.694 . . . . 0.0 111.136 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.3 m -135.02 155.85 50.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 160.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 158.64 44.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 169.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -163.6 170.14 38.85 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.25 136.78 41.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.5 p -144.43 166.78 24.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -117.21 154.07 31.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 166.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 -89.76 158.65 17.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.221 0.534 . . . . 0.0 111.56 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -54.49 139.64 36.98 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.92 161.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.05 29.3 0.28 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.151 1.357 . . . . 0.0 111.627 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -69.4 110.75 4.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.14 -33.32 3.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.458 1.98 . . . . 0.0 110.711 -166.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.45 -42.36 10.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.777 1.231 . . . . 0.0 108.54 165.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -123.53 -159.17 0.84 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.759 2.424 . . . . 0.0 107.865 169.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 116.772 -1.585 . . . . 0.0 106.842 172.222 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -69.88 159.69 52.39 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.14 1.894 . . . . 0.0 110.207 172.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -79.49 36.57 0.31 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.952 0.901 . . . . 0.0 111.534 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -75.83 42.67 0.24 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.139 1.776 . . . . 0.0 111.36 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.48 100.3 1.64 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.254 1.421 . . . . 0.0 108.828 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.5 m -130.94 122.13 26.39 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 165.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -102.13 157.99 16.49 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -146.16 159.8 42.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.117 1.367 . . . . 0.0 109.253 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -149.86 161.58 41.99 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 159.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.37 -151.41 20.15 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.06 158.75 42.79 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.307 0.643 . . . . 0.0 110.543 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HE3' ' CZ ' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -136.66 150.38 48.47 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.026 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.79 162.85 32.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.812 1.645 . . . . 0.0 107.957 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.38 157.52 22.34 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 119.198 -0.779 . . . . 0.0 112.105 -170.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -144.11 152.23 40.66 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.906 1.282 . . . . 0.0 110.902 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.9 p 67.88 -132.66 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.669 2.388 . . . . 0.0 112.023 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 62.19 -27.87 0.06 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.063 2.545 . . . . 0.0 116.385 -165.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 50.7 t80 65.84 -42.15 0.36 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.91 2.084 . . . . 0.0 115.111 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.11 171.92 14.19 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.659 2.384 . . . . 0.0 109.006 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -156.42 -176.21 5.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.375 1.87 . . . . 0.0 106.65 159.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.6 p -61.09 -166.92 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 130.992 3.717 . . . . 0.0 112.078 158.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.53 -96.6 0.84 Allowed Glycine 0 C--N 1.339 0.717 0 N-CA-C 105.41 -3.076 . . . . 0.0 105.41 -159.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -162.74 168.62 21.23 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.461 1.104 . . . . 0.0 108.5 158.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.5 mm -134.04 142.41 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 168.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -129.3 -99.02 0.35 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 105.285 -2.116 . . . . 0.0 105.285 161.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -87.79 90.56 8.43 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 162.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 56.88 -169.34 0.1 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.636 1.175 . . . . 0.0 110.043 -163.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.03 174.2 38.46 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 120.923 -1.111 . . . . 0.0 113.011 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.71 -10.14 27.8 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 123.538 2.826 . . . . 0.0 113.691 -175.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -63.9 -11.26 26.32 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.409 1.004 . . . . 0.0 112.897 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 69.24 -69.13 0.17 Allowed 'General case' 0 C--N 1.343 0.316 0 C-N-CA 127.189 2.196 . . . . 0.0 112.066 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.04 76.84 0.13 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.317 1.847 . . . . 0.0 108.983 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.73 17.79 2.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.924 2.49 . . . . 0.0 109.559 177.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 171.21 -54.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 130.203 3.401 . . . . 0.0 107.977 -171.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.79 167.96 27.31 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.109 1.364 . . . . 0.0 110.099 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.11 167.79 28.34 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.568 0.604 . . . . 0.0 112.167 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.3 153.44 29.05 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.641 1.576 . . . . 0.0 110.078 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.79 163.4 32.34 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.298 1.427 . . . . 0.0 111.253 168.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.4 140.34 49.22 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.011 1.724 . . . . 0.0 108.574 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -134.66 158.91 42.85 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -159.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.99 143.39 14.83 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 127.302 2.382 . . . . 0.0 107.801 160.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.38 161.65 26.51 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.931 0.866 . . . . 0.0 112.102 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -149.1 143.97 26.36 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.067 1.347 . . . . 0.0 109.771 -171.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -122.04 123.21 41.08 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 158.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.69 -3.29 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -158.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.56 166.96 14.01 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 173.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.1 107.47 0.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.526 2.151 . . . . 0.0 110.501 -172.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 63.22 26.17 15.09 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.716 2.006 . . . . 0.0 112.6 -176.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -130.82 138.23 54.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.143 0.977 . . . . 0.0 109.632 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.48 -179.57 26.37 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.009 0.814 . . . . 0.0 111.805 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.25 163.27 34.98 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.533 1.533 . . . . 0.0 108.835 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -151.82 159.94 43.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 162.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 77.6 mtm -143.44 156.39 44.64 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -155.4 170.68 33.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.878 -0.201 . . . . 0.0 112.608 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.48 159.18 42.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.483 1.113 . . . . 0.0 110.027 176.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -83.54 167.66 17.16 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.229 1.812 . . . . 0.0 111.797 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -73.01 51.57 0.3 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.569 1.148 . . . . 0.0 110.246 160.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.9 tp -8.95 79.08 0.0 OUTLIER 'General case' 0 C--N 1.342 0.24 0 C-N-CA 130.672 3.589 . . . . 0.0 114.151 -159.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.95 25.07 22.59 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 117.548 -1.695 . . . . 0.0 115.38 171.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.8 mtt-85 89.92 12.4 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.52 2.728 . . . . 0.0 113.017 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 53.9 ttp -46.61 135.16 7.81 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 119.467 1.031 . . . . 0.0 109.885 170.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.02 5.59 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.515 2.81 . . . . 0.0 115.005 -171.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.6 p90 46.86 27.19 0.67 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.776 2.43 . . . . 0.0 115.04 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -144.41 157.52 44.21 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.656 1.983 . . . . 0.0 106.998 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -71.43 68.93 0.92 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 172.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.2 m -164.81 79.18 0.35 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.011 1.724 . . . . 0.0 107.881 -176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t 65.36 47.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 123.146 1.451 . . . . 0.0 108.261 -166.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -53.86 -24.87 17.22 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 128.974 2.91 . . . . 0.0 112.428 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -142.74 158.04 44.04 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 162.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.17 14.86 1.3 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.918 1.723 . . . . 0.0 112.478 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.24 157.93 38.52 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.792 1.637 . . . . 0.0 110.921 -172.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -69.86 -61.52 1.75 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.602 165.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.276 0.0 OUTLIER -146.13 61.05 1.24 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.131 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.19 130.22 41.47 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 158.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -147.84 168.37 22.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.048 0.939 . . . . 0.0 109.001 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.59 57.12 0.19 Allowed Glycine 0 C--N 1.338 0.661 0 CA-C-O 117.618 -1.657 . . . . 0.0 114.03 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.83 155.36 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.983 1.392 . . . . 0.0 110.934 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -133.75 148.26 51.39 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.968 2.107 . . . . 0.0 108.178 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 pp -143.14 152.11 41.44 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.209 1.003 . . . . 0.0 110.961 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 m -155.68 152.07 28.18 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.706 1.202 . . . . 0.0 112.36 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.23 136.08 54.85 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.717 2.407 . . . . 0.0 106.975 159.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -118.56 153.54 34.06 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.977 0.911 . . . . 0.0 110.147 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.14 133.47 52.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 161.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.7 164.98 10.11 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -167.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -161.24 168.87 10.73 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.142 -163.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -62.96 95.46 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 124.154 3.236 . . . . 0.0 110.74 168.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.7 tt -68.01 -44.04 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.077 0.551 . . . . 0.0 110.895 -172.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.0 t -177.16 176.51 1.36 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 129.555 3.142 . . . . 0.0 105.518 175.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 54.09 28.76 9.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.984 1.714 . . . . 0.0 113.721 161.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 60.2 26.1 15.51 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.876 2.47 . . . . 0.0 114.047 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.7 mt -101.85 110.47 22.46 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.071 1.349 . . . . 0.0 109.244 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.72 111.79 21.03 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 166.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.6 137.17 41.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -153.5 166.73 31.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.551 1.167 . . . . 0.0 113.784 -170.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.6 t -129.73 153.45 48.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 158.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.28 155.73 41.68 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.996 -0.44 . . . . 0.0 110.34 -166.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.6 tt -127.8 138.12 52.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.13 -160.1 15.13 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -170.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.99 176.38 47.93 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-O 121.341 0.412 . . . . 0.0 112.299 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -116.33 144.64 43.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.238 1.815 . . . . 0.0 107.699 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.1 t -129.28 94.17 2.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 160.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -129.13 138.73 51.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -143.34 136.46 27.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.767 -0.583 . . . . 0.0 110.867 -174.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.55 161.81 18.35 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 105.933 -1.876 . . . . 0.0 105.933 158.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -81.58 148.6 29.03 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 118.192 -1.403 . . . . 0.0 112.041 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 41.5 p -148.94 93.3 2.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.629 1.571 . . . . 0.0 107.238 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.11 -38.35 51.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.954 0.883 . . . . 0.0 109.249 164.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.0 m -145.98 151.2 37.4 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 159.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -85.48 74.18 10.38 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -173.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.338 29.7 m 51.48 -76.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 128.124 2.57 . . . . 0.0 111.266 -158.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -117.11 -12.02 10.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.318 1.447 . . . . 0.0 112.417 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.77 138.64 17.75 Favored Glycine 0 C--N 1.339 0.701 0 O-C-N 121.105 -0.997 . . . . 0.0 111.298 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -77.68 -20.87 52.97 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 170.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -74.25 108.85 7.29 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -49.32 161.87 0.16 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.237 1.815 . . . . 0.0 114.234 173.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -59.18 131.66 51.68 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.199 159.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t -153.51 94.71 1.83 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.21 1.404 . . . . 0.0 111.245 -170.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -89.79 76.14 1.74 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 p -109.57 100.81 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 p -143.01 127.2 9.57 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.353 0.661 . . . . 0.0 110.05 -166.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -79.28 168.89 19.64 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.931 2.42 . . . . 0.0 110.74 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.4 t -136.33 139.86 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.087 1.355 . . . . 0.0 107.879 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -127.77 118.69 24.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.711 2.004 . . . . 0.0 106.307 160.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.11 166.47 24.56 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.661 -0.649 . . . . 0.0 111.909 -168.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -120.75 158.51 15.65 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 166.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.79 175.23 47.43 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 118.361 1.081 . . . . 0.0 113.412 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.7 m -138.97 135.35 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.463 1.105 . . . . 0.0 108.73 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -105.83 110.74 23.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.534 2.734 . . . . 0.0 105.347 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.91 110.46 22.13 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.16 81.46 1.79 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 47.1 pt -69.36 -3.62 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.154 0.982 . . . . 0.0 112.632 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 45.0 m -154.43 149.71 20.78 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 163.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.54 -7.8 9.62 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.306 2.004 . . . . 0.0 115.855 -171.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -111.49 -12.54 13.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.16 1.384 . . . . 0.0 113.577 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 pp -139.34 147.94 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 121.764 2.075 . . . . 0.0 111.379 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.7 161.1 37.4 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.38 0.672 . . . . 0.0 109.293 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 73.9 m -130.96 135.97 48.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.451 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 6.0 ptp180 -122.19 159.54 27.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 pp -135.02 145.06 47.69 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 125.112 1.508 . . . . 0.0 107.311 159.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.54 162.08 41.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.884 1.274 . . . . 0.0 109.664 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -154.56 154.84 33.73 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.12 0.568 . . . . 0.0 111.118 -165.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -138.22 160.05 40.45 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.301 1.84 . . . . 0.0 107.288 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -137.16 134.84 36.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.953 1.301 . . . . 0.0 108.455 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 147' ' ' ILE 0.251 26.0 m 39.22 47.95 1.49 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.492 2.317 . . . . 0.0 113.216 171.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -52.76 131.38 34.98 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.073 0.949 . . . . 0.0 111.377 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 55.36 4.1 0.09 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.826 2.05 . . . . 0.0 114.779 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.422 ' HA ' HG22 ' A' ' 144' ' ' THR . 44.5 mt 64.28 -55.97 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.76 2.024 . . . . 0.0 111.166 -164.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 75.83 -48.3 2.3 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.778 1.656 . . . . 0.0 112.001 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -19.35 65.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.116 1.366 . . . . 0.0 112.958 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 52.24 25.77 3.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.246 1.818 . . . . 0.0 113.556 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . 0.309 2.9 m-70 51.06 52.19 15.49 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 127.452 2.301 . . . . 0.0 112.649 -169.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.2 m -69.9 -36.89 75.77 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.475 158.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.772 HG22 ' H ' ' A' ' 154' ' ' GLY 0.271 31.2 mm 60.4 -172.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 126.634 1.973 . . . . 0.0 109.907 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.772 ' H ' HG22 ' A' ' 153' ' ' ILE . . . 78.84 -52.07 3.88 Favored Glycine 0 CA--C 1.527 0.824 0 O-C-N 120.246 -1.533 . . . . 0.0 110.038 -164.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 33.2 p -132.16 158.47 41.61 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.236 1.414 . . . . 0.0 108.748 166.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 85.6 mtm-85 -130.5 154.2 81.57 Favored Pre-proline 0 C--O 1.232 0.14 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 158.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.96 -18.17 19.05 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.295 1.33 . . . . 0.0 111.141 167.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 31.49 74.39 0.05 OUTLIER 'General case' 0 C--N 1.346 0.451 0 C-N-CA 128.428 2.691 . . . . 0.0 111.643 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -63.61 71.88 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.364 1.866 . . . . 0.0 111.291 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -114.93 119.49 4.66 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.852 1.691 . . . . 0.0 110.999 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -105.65 159.28 16.09 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.042 0.937 . . . . 0.0 110.034 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.73 117.37 17.75 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 164.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.2 m -129.39 160.86 31.77 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.6 pp -144.39 167.08 23.31 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.941 1.296 . . . . 0.0 110.294 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.63 175.24 40.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.814 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.32 148.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 124.592 1.157 . . . . 0.0 108.484 163.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 70.8 m -145.6 118.69 8.84 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -169.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -82.57 123.83 29.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 171.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -90.14 124.95 35.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.82 1.648 . . . . 0.0 106.74 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -59.09 115.79 3.41 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.591 0.756 . . . . 0.0 110.858 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 170.97 163.37 24.89 Favored Glycine 0 CA--C 1.533 1.172 1 C-N-CA 130.876 4.084 . . . . 0.0 105.037 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -156.65 122.08 4.74 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.242 1.521 . . . . 0.0 111.135 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 66.96 30.71 76.41 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -96.37 179.01 5.18 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.945 0.498 . . . . 0.0 112.005 -163.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 57.3 -164.75 0.16 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.434 1.894 . . . . 0.0 112.372 -173.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 C-N-CA 127.805 2.442 . . . . 0.0 106.398 176.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -130.25 127.06 38.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.298 1.039 . . . . 0.0 108.355 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -82.62 157.95 23.21 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.023 1.329 . . . . 0.0 110.654 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.426 ' CZ ' ' HA3' ' A' ' 42' ' ' GLY . 43.2 p90 -151.68 164.54 36.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.761 2.025 . . . . 0.0 109.7 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -130.98 167.38 19.13 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.176 1.39 . . . . 0.0 108.486 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.82 175.39 40.78 Favored Glycine 0 C--N 1.334 0.435 0 O-C-N 121.474 -0.766 . . . . 0.0 112.087 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.33 147.89 31.81 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.291 1.036 . . . . 0.0 109.267 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.537 ' HE2' ' CE1' ' A' ' 40' ' ' PHE . 40.4 mtmt -132.64 164.83 25.83 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.842 1.257 . . . . 0.0 112.308 -169.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.16 150.09 41.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 128.451 2.7 . . . . 0.0 106.363 159.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.77 163.66 29.07 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 119.366 0.985 . . . . 0.0 114.006 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -143.53 136.85 28.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.002 2.121 . . . . 0.0 109.338 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.7 m . . . . . 0 C--O 1.242 0.669 0 C-N-CA 125.219 1.408 . . . . 0.0 110.791 -176.568 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.742 0.306 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.54 -176.75 44.05 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.79 171.96 13.65 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.366 1.867 . . . . 0.0 108.171 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.61 170.18 38.09 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.906 -1.14 . . . . 0.0 114.695 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.42 137.5 30.43 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.098 1.759 . . . . 0.0 109.059 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.553 ' CD2' ' HA3' ' A' ' 54' ' ' GLY . 46.3 m-85 -139.57 151.8 46.36 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.025 1.33 . . . . 0.0 111.159 -166.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.69 157.91 16.47 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 126.946 2.213 . . . . 0.0 107.884 163.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.426 ' HA3' ' CZ ' ' A' ' 8' ' ' TYR . . . -168.57 166.86 39.9 Favored Glycine 0 N--CA 1.449 -0.438 0 O-C-N 121.344 -1.092 . . . . 0.0 111.054 -174.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -140.34 165.85 26.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.209 0.505 . . . . 0.0 110.837 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -115.18 162.61 16.81 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.815 1.646 . . . . 0.0 107.883 162.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 159.229 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.5 m . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.28 -164.79 19.19 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -139.96 163.04 33.73 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.71 1.604 . . . . 0.0 110.13 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -149.85 127.85 11.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.441 1.896 . . . . 0.0 107.613 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -134.78 125.58 27.21 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.422 1.889 . . . . 0.0 108.211 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.553 ' HA3' ' CD2' ' A' ' 40' ' ' PHE . . . -170.59 -179.22 41.82 Favored Glycine 0 C--N 1.333 0.366 0 O-C-N 121.697 -0.627 . . . . 0.0 113.027 -175.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 125.388 1.475 . . . . 0.0 107.646 -175.105 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.694 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -138.21 141.37 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -122.95 132.66 54.26 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 167.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.61 110.68 10.06 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.151 1.381 . . . . 0.0 107.439 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.9 p -137.17 143.03 42.2 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.31 0.644 . . . . 0.0 111.693 -161.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.01 149.24 25.72 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 160.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.08 156.64 45.95 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.667 0.787 . . . . 0.0 111.759 -171.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.7 tp -133.78 125.38 28.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.959 2.504 . . . . 0.0 105.773 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.82 137.85 9.57 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 106.954 -2.458 . . . . 0.0 106.954 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -138.2 133.92 17.51 Favored Pre-proline 0 C--O 1.237 0.397 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.459 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 92' ' ' ASP . 51.1 Cg_endo -67.1 143.95 67.42 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.434 2.756 . . . . 0.0 110.536 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.468 0.428 0 C-N-CA 123.195 0.598 . . . . 0.0 111.368 168.067 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.238 0.451 0 CA-C-O 121.962 0.887 . . . . 0.0 112.643 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -114.18 149.05 36.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.717 2.807 . . . . 0.0 108.826 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -90.68 137.17 22.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 163.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -127.88 144.66 51.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.682 1.193 . . . . 0.0 110.791 -162.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 48.9 m -154.7 148.38 25.39 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.564 1.146 . . . . 0.0 108.462 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -147.76 155.56 41.83 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.666 0.786 . . . . 0.0 110.57 175.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -153.46 158.68 41.72 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.314 1.045 . . . . 0.0 111.003 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.97 -130.92 2.35 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.56 162.5 18.73 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.175 0.893 . . . . 0.0 112.479 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -143.88 149.94 37.68 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.595 1.558 . . . . 0.0 109.783 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.66 150.12 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.504 1.921 . . . . 0.0 107.754 168.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -150.85 143.09 24.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.598 1.159 . . . . 0.0 111.061 -165.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 124.523 1.129 . . . . 0.0 110.538 167.285 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 119.468 -0.301 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -64.83 163.28 28.6 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.544 1.496 . . . . 0.0 109.306 158.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.1 p -147.54 159.1 8.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 121.702 -0.624 . . . . 0.0 109.741 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -147.57 164.74 32.5 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.063 1.345 . . . . 0.0 109.42 168.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.62 165.77 35.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.705 1.202 . . . . 0.0 108.293 161.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -163.72 170.42 39.04 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 112.049 -0.42 . . . . 0.0 112.049 169.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 158.31 -116.36 0.71 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.1 157.51 28.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 117.94 0.87 . . . . 0.0 111.009 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -128.74 149.96 50.48 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 167.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.21 127.83 18.07 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.352 -0.842 . . . . 0.0 108.965 -158.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.37 136.55 37.7 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.89 -37.01 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.1 0.56 . . . . 0.0 109.656 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 47.3 m -159.83 156.25 23.97 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 103.021 -2.955 . . . . 0.0 103.021 164.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -57.14 -4.35 1.01 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 N-CA-C 118.836 2.591 . . . . 0.0 118.836 -163.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.18 0.26 10.64 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.373 1.869 . . . . 0.0 113.489 173.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.4 tt -134.7 141.96 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.621 1.569 . . . . 0.0 110.595 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.14 170.33 15.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.575 -0.703 . . . . 0.0 109.836 -168.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.3 p -128.12 160.18 32.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.157 0.983 . . . . 0.0 108.655 159.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -140.11 159.24 42.62 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.635 -0.666 . . . . 0.0 110.27 164.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.42 119.85 15.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -138.61 154.68 48.69 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.779 0.8 . . . . 0.0 111.151 -173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.554 ' HH ' ' N ' ' A' ' 160' ' ' GLY . 65.0 t80 -141.83 148.68 39.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.723 2.009 . . . . 0.0 108.484 -162.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -142.4 119.2 11.17 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.142 0 C-N-CA 125.236 1.414 . . . . 0.0 110.134 -167.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.554 ' N ' ' HH ' ' A' ' 141' ' ' TYR . . . . . . . . 0 CA--C 1.528 0.85 0 CA-C-O 121.559 0.533 . . . . 0.0 113.301 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 23.4 ptp -75.95 154.13 36.1 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 169.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -137.29 148.3 46.29 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.424 1.089 . . . . 0.0 108.929 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.3 p -143.1 158.23 43.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.901 0.48 . . . . 0.0 110.136 166.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -145.15 150.36 36.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.49 1.116 . . . . 0.0 109.149 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.17 175.09 40.31 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.66 160.28 3.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 126.735 2.014 . . . . 0.0 109.418 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.37 159.67 41.74 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.042 0.537 . . . . 0.0 109.616 167.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -140.62 140.67 35.1 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.972 1.309 . . . . 0.0 108.138 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.4 mtm105 -89.86 155.29 19.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.267 0.556 . . . . 0.0 110.721 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 67.8 t80 . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 167.148 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.0 t -157.03 174.33 15.68 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 159.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -133.48 168.11 19.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.474 1.909 . . . . 0.0 109.07 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -139.46 155.9 47.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 109.717 -168.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.3 p -133.45 126.94 32.26 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.504 1.921 . . . . 0.0 107.015 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.56 -159.37 13.03 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 119.038 0.835 . . . . 0.0 113.565 -161.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.9 162.24 36.0 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.182 1.393 . . . . 0.0 109.916 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -141.65 143.56 33.69 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.803 1.641 . . . . 0.0 107.149 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 pp -145.77 145.07 30.68 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.532 0.733 . . . . 0.0 109.462 166.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.65 174.49 29.14 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 124.704 1.145 . . . . 0.0 112.932 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -149.36 167.23 26.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.538 0.735 . . . . 0.0 110.316 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 C--O 1.24 0.569 0 C-N-CA 125.194 1.397 . . . . 0.0 107.992 165.602 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.64 144.73 12.58 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 160.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.05 121.65 2.43 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.94 170.05 39.84 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 121.702 0.612 . . . . 0.0 114.368 -172.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.77 139.93 30.6 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -135.62 165.4 25.63 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.242 1.017 . . . . 0.0 110.758 -167.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.67 162.54 25.84 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.64 165.35 25.86 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -146.18 134.44 21.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.393 1.877 . . . . 0.0 106.284 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.09 118.89 29.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 159.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -160.451 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.47 0.549 0 CA-C-O 121.417 0.627 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.6 -168.42 26.52 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.943 1.735 . . . . 0.0 110.544 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -148.44 162.54 39.4 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.862 1.265 . . . . 0.0 108.543 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HG2' HH22 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -151.56 157.86 42.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.116 0.966 . . . . 0.0 110.42 171.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 64.5 mtt -146.48 152.76 39.53 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 125.799 1.639 . . . . 0.0 107.46 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.02 173.06 44.08 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 119.186 0.903 . . . . 0.0 113.178 170.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 . . . . . 0 N--CA 1.452 -0.348 0 C-N-CA 126.543 1.937 . . . . 0.0 107.954 179.994 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.491 0 N-CA-C 111.851 -0.5 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.16 146.03 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 126.458 1.903 . . . . 0.0 107.106 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -130.11 147.75 51.89 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.694 1.598 . . . . 0.0 108.012 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.34 125.79 10.18 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.961 0.904 . . . . 0.0 109.025 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.5 p -141.99 154.07 44.75 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.846 0.355 . . . . 0.0 111.255 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.53 142.77 29.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 164.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -115.41 102.93 10.28 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 mp -92.83 107.44 19.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.09 166.79 39.98 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 117.819 0.281 . . . . 0.0 112.545 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -157.7 157.6 29.9 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.023 0.929 . . . . 0.0 110.341 -171.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.79 125.96 12.15 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.205 2.603 . . . . 0.0 110.443 169.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.1 mm . . . . . 0 N--CA 1.465 0.316 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.391 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 C--O 1.233 0.188 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -86.94 139.57 30.47 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 20.2 tt -120.09 141.27 41.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -147.83 170.62 17.23 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 123.19 1.471 . . . . 0.0 113.793 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.0 m -137.41 128.05 26.9 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.666 1.986 . . . . 0.0 106.433 163.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -104.85 146.56 28.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.898 0.879 . . . . 0.0 108.734 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 tt -149.83 139.4 21.59 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.772 0.829 . . . . 0.0 109.402 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.16 -128.21 1.6 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.8 174.31 28.47 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-O 122.072 0.818 . . . . 0.0 113.085 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -150.31 162.12 41.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.132 1.373 . . . . 0.0 109.746 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 t -137.09 137.35 46.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -131.73 158.33 41.46 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.379 0.671 . . . . 0.0 110.988 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 . . . . . 0 N--CA 1.452 -0.364 0 C-N-CA 127.113 2.165 . . . . 0.0 106.826 176.729 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.36 161.45 44.75 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.955 1.77 . . . . 0.0 110.042 164.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -148.53 144.29 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -148.2 153.05 38.25 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.632 1.173 . . . . 0.0 108.971 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.9 167.64 29.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.746 1.218 . . . . 0.0 109.477 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -108.73 169.7 14.24 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.67 -173.79 45.94 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 118.747 1.273 . . . . 0.0 113.968 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.0 156.8 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.779 1.231 . . . . 0.0 109.536 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -134.34 151.56 51.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.042 1.337 . . . . 0.0 108.885 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.42 108.66 4.6 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.914 0.886 . . . . 0.0 109.747 -164.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.71 81.36 5.02 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.033 0.833 . . . . 0.0 110.202 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.3 mm -51.2 -39.05 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.489 1.516 . . . . 0.0 110.793 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 51.2 p -135.65 165.66 34.42 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 159.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.58 43.82 0.68 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 122.907 2.405 . . . . 0.0 110.839 164.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -149.25 -45.24 0.14 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.427 2.691 . . . . 0.0 109.531 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.7 tt -137.57 145.16 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 118.973 0.806 . . . . 0.0 110.464 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.66 137.76 30.16 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.93 0.892 . . . . 0.0 109.93 -165.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 53.2 m -93.91 152.93 18.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.37 1.468 . . . . 0.0 109.236 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.403 HH22 ' HG2' ' A' ' 52' ' ' GLU . 37.9 mtp180 -124.02 149.12 46.42 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.215 1.806 . . . . 0.0 107.793 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.98 144.21 41.04 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.476 1.91 . . . . 0.0 106.033 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -144.5 146.94 32.68 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.375 1.47 . . . . 0.0 109.448 -171.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -137.03 121.09 17.76 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 127.079 2.152 . . . . 0.0 107.525 172.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.59 165.88 19.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.994 2.118 . . . . 0.0 108.391 -170.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 . . . . . 0 C--O 1.235 0.336 0 CA-C-O 122.514 1.149 . . . . 0.0 110.303 -173.871 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 14.6 ttt -72.33 140.39 48.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -138.73 152.03 47.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.28 163.55 32.64 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 123.883 0.739 . . . . 0.0 109.91 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.89 166.77 22.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.494 1.118 . . . . 0.0 108.938 164.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -158.73 172.96 35.66 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.7 t -142.34 145.73 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.21 113.24 4.52 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -159.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.81 132.56 35.16 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 145.3 25.38 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.615 0.643 . . . . 0.0 112.151 -171.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 45.5 t80 . . . . . 0 CA--C 1.536 0.431 0 C-N-CA 124.924 1.29 . . . . 0.0 111.411 171.35 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 118.099 -0.953 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 p -149.17 162.36 40.14 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.082 0.953 . . . . 0.0 110.822 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -128.25 153.07 47.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.159 1.784 . . . . 0.0 109.113 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -144.92 152.3 40.0 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.288 1.835 . . . . 0.0 108.065 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -150.05 148.34 28.91 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.323 -0.86 . . . . 0.0 111.216 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.64 -104.78 0.2 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 125.687 1.613 . . . . 0.0 109.425 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.37 169.12 25.45 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 118.204 1.002 . . . . 0.0 113.526 -166.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HE3' ' CE1' ' A' ' 40' ' ' PHE . 17.0 ptpt -142.52 166.19 25.34 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.705 1.202 . . . . 0.0 109.212 158.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 tt -131.03 115.98 17.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 163.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.87 146.46 20.55 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -150.8 142.24 23.43 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.526 1.53 . . . . 0.0 111.08 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.1 p . . . . . 0 N--CA 1.454 -0.26 0 C-N-CA 124.34 1.056 . . . . 0.0 109.769 161.749 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.14 96.3 0.19 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 106.991 -2.443 . . . . 0.0 106.991 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.88 129.92 46.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.953 1.301 . . . . 0.0 108.264 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.92 169.5 39.59 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 114.69 0.636 . . . . 0.0 114.69 -169.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.83 154.52 17.21 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.68 1.192 . . . . 0.0 108.951 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.439 ' CE1' ' HE3' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -146.63 155.52 42.52 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.217 1.007 . . . . 0.0 111.799 -171.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.3 158.22 25.85 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 163.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.73 166.2 39.21 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 117.418 0.609 . . . . 0.0 111.743 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -145.05 145.93 31.66 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.418 1.087 . . . . 0.0 110.535 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -87.9 110.9 20.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 162.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 CA--C 1.536 0.415 0 CA-C-N 118.527 0.603 . . . . 0.0 110.244 173.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -179.59 -165.72 34.11 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 121.105 -0.997 . . . . 0.0 112.758 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -142.16 160.82 39.46 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.548 1.139 . . . . 0.0 109.311 170.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.61 149.92 35.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.295 1.838 . . . . 0.0 107.954 168.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 53.5 mtt -148.71 153.31 38.04 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.6 1.16 . . . . 0.0 108.193 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.06 173.34 44.12 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-O 119.655 -0.525 . . . . 0.0 111.954 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.0 p90 . . . . . 0 C--O 1.233 0.209 0 C-N-CA 124.024 0.93 . . . . 0.0 109.83 -175.782 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.241 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.3 125.6 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.22 1.408 . . . . 0.0 107.923 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -95.87 144.07 26.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.769 2.428 . . . . 0.0 108.382 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -141.83 125.42 16.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.329 1.052 . . . . 0.0 108.915 169.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.61 123.93 19.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.4 1.08 . . . . 0.0 108.449 -167.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.54 138.47 32.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -99.78 129.22 45.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.323 1.049 . . . . 0.0 108.645 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.08 137.53 52.18 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 158.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.22 -172.45 43.47 Favored Glycine 0 C--O 1.226 -0.363 0 CA-C-O 119.191 -0.783 . . . . 0.0 111.448 -165.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -155.67 157.93 31.65 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.672 1.189 . . . . 0.0 109.253 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -62.2 141.9 89.75 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.882 1.721 . . . . 0.0 109.274 161.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.4 tp . . . . . 0 CA--C 1.541 0.598 0 C-N-CA 123.79 0.836 . . . . 0.0 110.455 171.066 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 mp . . . . . 0 C--O 1.239 0.513 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -140.46 127.01 20.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.399 1.479 . . . . 0.0 109.865 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 pp -99.09 153.98 4.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.751 1.621 . . . . 0.0 109.579 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -150.15 157.6 43.27 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 122.15 0.976 . . . . 0.0 113.415 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.6 m -114.07 121.7 44.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 158.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -105.81 109.22 21.1 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 tt -125.85 128.24 47.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.98 0.809 . . . . 0.0 110.154 -168.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.48 -98.33 0.14 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.04 -162.43 36.23 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.758 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -145.95 159.36 43.35 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.502 1.121 . . . . 0.0 109.872 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.14 151.25 35.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.598 1.159 . . . . 0.0 108.138 168.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -136.04 145.02 45.57 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.809 0.844 . . . . 0.0 111.171 -170.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 . . . . . 0 C--O 1.233 0.231 0 C-N-CA 129.014 2.926 . . . . 0.0 106.809 -177.719 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.71 117.86 5.22 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.992 2.461 . . . . 0.0 108.329 170.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.34 171.15 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.476 0.71 . . . . 0.0 110.227 -172.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -138.55 162.59 34.18 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 165.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.53 163.3 29.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.411 1.884 . . . . 0.0 108.488 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -108.8 151.45 17.08 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 106.969 -2.453 . . . . 0.0 106.969 162.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -174.55 -174.32 41.2 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 117.9 0.85 . . . . 0.0 112.723 -173.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.1 p -146.57 159.52 10.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 124.571 1.149 . . . . 0.0 108.659 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.2 145.08 49.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.049 2.14 . . . . 0.0 107.164 160.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -142.94 106.1 4.56 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.285 1.834 . . . . 0.0 107.534 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.58 81.97 7.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.841 1.256 . . . . 0.0 108.296 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -25.18 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.099 0.56 . . . . 0.0 111.512 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.1 p -137.03 143.65 43.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 158.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.58 -18.57 59.48 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.763 2.308 . . . . 0.0 114.015 -166.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -62.95 -24.26 67.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.73 2.012 . . . . 0.0 112.249 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.27 164.83 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 125.28 1.432 . . . . 0.0 109.806 -167.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.46 150.56 49.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 162.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.4 p -106.92 150.42 26.45 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 158.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -143.79 147.53 34.27 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.097 0.862 . . . . 0.0 110.109 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.49 159.33 42.12 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.206 1.803 . . . . 0.0 107.771 -175.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -163.38 151.99 14.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.457 0.703 . . . . 0.0 111.483 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -145.58 139.84 26.98 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.582 1.153 . . . . 0.0 109.74 160.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -132.46 175.69 9.08 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.058 1.743 . . . . 0.0 108.915 163.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 CA--C 1.536 0.433 0 C-N-CA 124.223 1.009 . . . . 0.0 110.632 169.679 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 111.146 -0.781 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 19.0 ttm -148.65 118.09 6.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 158.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.01 154.2 31.69 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 165.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.27 155.05 50.88 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 118.887 0.767 . . . . 0.0 109.78 159.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.76 153.52 51.13 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.77 1.628 . . . . 0.0 107.496 168.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.24 175.49 40.31 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 118.696 0.68 . . . . 0.0 112.843 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.4 m -141.33 164.0 20.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.465 1.106 . . . . 0.0 109.946 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 58.8 m -155.93 161.2 40.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.214 -0.928 . . . . 0.0 110.809 166.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -100.76 155.61 17.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.68 1.592 . . . . 0.0 107.233 159.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.1 ptm85 -90.03 158.68 17.22 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 42.5 t80 . . . . . 0 C--O 1.239 0.517 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 158.078 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.8 m -153.06 122.44 6.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -81.62 160.09 23.87 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 170.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -148.27 160.73 42.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.424 1.89 . . . . 0.0 108.022 171.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 t -148.93 161.54 41.68 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.89 -160.49 26.18 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -165.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.59 153.37 40.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.438 ' HE3' ' CZ ' ' A' ' 40' ' ' PHE . 28.0 mtmt -131.0 155.0 47.58 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.903 0.881 . . . . 0.0 109.929 172.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.3 tp -114.19 151.91 32.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.538 2.335 . . . . 0.0 106.074 164.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.91 169.06 29.39 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 118.878 0.763 . . . . 0.0 113.497 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -141.21 136.62 31.92 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.679 1.991 . . . . 0.0 109.068 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.24 0.578 0 C-N-CA 125.109 1.364 . . . . 0.0 110.508 -176.483 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.698 0.285 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.73 159.2 27.88 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 165.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.74 121.87 3.77 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.12 1.768 . . . . 0.0 107.286 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.79 165.56 35.19 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.878 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.33 146.52 24.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.102 1.361 . . . . 0.0 108.129 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.438 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 39.4 m-85 -130.3 154.72 47.34 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.074 0.949 . . . . 0.0 110.322 -171.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.11 137.43 5.81 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.04 166.83 39.73 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -166.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -139.88 168.06 20.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.402 0.601 . . . . 0.0 110.833 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -117.68 151.67 36.77 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.528 1.931 . . . . 0.0 108.049 163.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 164.823 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.465 0.3 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.64 -161.32 13.42 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -177.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -138.59 158.66 43.83 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.126 1.37 . . . . 0.0 109.79 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -139.71 120.3 14.17 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.803 2.441 . . . . 0.0 106.853 169.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -118.9 166.02 13.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.798 1.639 . . . . 0.0 107.854 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.91 173.32 41.5 Favored Glycine 0 N--CA 1.452 -0.281 0 O-C-N 121.792 -0.568 . . . . 0.0 111.982 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 . . . . . 0 N--CA 1.448 -0.546 0 C-N-CA 126.711 2.004 . . . . 0.0 106.535 -177.642 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.501 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 t -138.24 123.51 23.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -95.2 145.03 25.33 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 171.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.0 107.81 4.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.6 p -138.03 144.45 41.05 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.091 0.556 . . . . 0.0 111.717 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.91 152.65 23.38 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 162.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 157.08 47.73 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.399 0.679 . . . . 0.0 112.007 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.3 tp -140.78 136.66 32.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.926 2.49 . . . . 0.0 105.891 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.04 158.75 29.1 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 166.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.91 141.65 18.94 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.907 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 92' ' ' ASP . 49.0 Cg_endo -67.27 145.1 70.98 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.506 2.804 . . . . 0.0 110.385 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.468 0.442 0 C-N-CA 123.053 0.541 . . . . 0.0 111.419 167.209 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.237 0.418 0 CA-C-O 121.895 0.855 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 0.6 OUTLIER -110.73 146.65 35.94 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.862 2.865 . . . . 0.0 108.763 175.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.8 mt -90.64 137.76 20.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 163.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -134.35 147.34 50.52 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.364 1.066 . . . . 0.0 111.57 -159.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.9 m -155.07 150.15 26.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.047 1.339 . . . . 0.0 109.41 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -147.44 154.25 40.58 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.34 1.056 . . . . 0.0 110.275 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -152.69 156.55 39.4 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.578 1.151 . . . . 0.0 111.557 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.35 -119.49 0.91 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.27 170.18 26.72 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 118.331 1.066 . . . . 0.0 113.624 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -145.75 126.52 14.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.519 1.528 . . . . 0.0 107.745 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.06 142.26 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.42 146.55 42.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.631 1.572 . . . . 0.0 108.348 -172.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.2 ttp85 . . . . . 0 C--O 1.236 0.366 0 C-N-CA 124.458 1.103 . . . . 0.0 109.961 174.098 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -65.48 159.68 46.59 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 N-CA-C 108.396 -1.425 . . . . 0.0 108.396 158.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.41 157.13 8.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 O-C-N 121.659 -0.651 . . . . 0.0 109.663 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.74 165.06 30.77 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.989 1.316 . . . . 0.0 108.54 165.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.55 162.36 39.92 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 162.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.28 165.86 32.97 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 112.125 -0.39 . . . . 0.0 112.125 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 160.56 -118.65 0.84 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.8 m -138.83 158.45 30.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 117.876 0.838 . . . . 0.0 111.435 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -129.55 141.63 50.93 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 166.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.2 126.26 18.34 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.177 0.991 . . . . 0.0 108.946 -158.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.94 140.44 45.58 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.709 0.686 . . . . 0.0 109.984 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 44.4 mm -117.14 -33.72 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.491 0.716 . . . . 0.0 109.962 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 20.7 m -161.87 157.9 21.02 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 172.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.9 -2.65 0.84 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.749 2.299 . . . . 0.0 116.618 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.23 -10.11 13.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.065 1.746 . . . . 0.0 113.773 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.6 tt -148.28 149.09 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 120.049 1.295 . . . . 0.0 111.833 -171.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.14 169.94 16.77 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.273 1.429 . . . . 0.0 108.333 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.0 p -120.04 160.31 23.06 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.989 1.315 . . . . 0.0 108.369 162.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -141.55 159.38 42.34 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 121.58 -0.7 . . . . 0.0 110.114 165.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.38 120.04 12.52 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.16 155.46 43.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.951 0.881 . . . . 0.0 111.778 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.575 ' HH ' ' N ' ' A' ' 160' ' ' GLY . 76.7 t80 -141.96 152.74 43.77 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.227 1.811 . . . . 0.0 109.829 -159.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -143.75 115.07 7.99 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.096 1.358 . . . . 0.0 108.059 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.2 t80 . . . . . 0 CA--C 1.529 0.169 0 C-N-CA 125.166 1.387 . . . . 0.0 109.98 179.056 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.575 ' N ' ' HH ' ' A' ' 141' ' ' TYR . . . . . . . . 0 CA--C 1.528 0.894 0 CA-C-O 121.158 0.31 . . . . 0.0 113.121 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 23.7 ptp -80.74 155.3 26.79 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 122.336 -0.508 . . . . 0.0 109.747 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.0 tt -139.45 149.41 44.0 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.603 1.161 . . . . 0.0 109.339 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.2 p -136.84 161.72 35.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.633 0.73 . . . . 0.0 111.491 160.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.21 151.45 34.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.125 1.37 . . . . 0.0 109.411 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.41 175.45 40.45 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 114.911 0.725 . . . . 0.0 114.911 -172.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 10.4 m -110.31 152.33 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 127.456 2.302 . . . . 0.0 108.953 172.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.3 t -151.0 113.53 4.65 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.877 0.762 . . . . 0.0 109.145 -172.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -96.26 142.52 28.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.181 1.792 . . . . 0.0 109.305 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -89.67 155.32 19.31 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.546 0.612 . . . . 0.0 111.161 -175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 60.7 t80 . . . . . 0 C--O 1.237 0.429 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 166.31 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.178 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -112.09 154.39 25.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.547 0.739 . . . . 0.0 110.141 -159.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -134.03 156.65 47.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 158.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -135.23 146.92 49.1 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.576 1.55 . . . . 0.0 106.829 -171.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 m -150.01 148.01 28.54 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.186 -0.946 . . . . 0.0 109.307 165.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.45 -142.53 7.69 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.218 0.914 . . . . 0.0 111.93 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.88 159.3 15.02 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.086 1.755 . . . . 0.0 111.829 -168.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -147.99 144.36 27.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.323 1.449 . . . . 0.0 109.903 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -133.59 148.51 51.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.94 1.696 . . . . 0.0 107.658 164.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.67 158.22 23.36 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.022 1.296 . . . . 0.0 109.876 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -154.75 143.24 20.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.369 1.084 . . . . 0.0 110.588 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.234 0.268 0 C-N-CA 124.137 0.975 . . . . 0.0 108.636 160.588 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.16 156.98 21.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 168.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.64 122.02 3.43 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.915 1.286 . . . . 0.0 107.938 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.16 -121.12 0.84 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.32 169.62 16.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.93 0.892 . . . . 0.0 111.58 -167.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -145.74 151.4 37.92 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.903 2.081 . . . . 0.0 107.831 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.94 156.79 27.84 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 160.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.15 166.02 39.18 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 117.748 0.774 . . . . 0.0 111.859 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -123.66 134.64 53.72 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.63 1.972 . . . . 0.0 108.065 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -122.43 118.33 28.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.679 1.992 . . . . 0.0 109.249 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 122.187 0.994 . . . . 0.0 108.608 173.423 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.81 -175.25 40.57 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.861 1.219 . . . . 0.0 111.691 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -140.6 148.19 40.54 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.916 1.286 . . . . 0.0 107.898 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.75 158.76 43.66 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.234 1.413 . . . . 0.0 109.119 -174.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 75.9 mtp -129.1 159.11 37.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.255 1.422 . . . . 0.0 109.809 167.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.47 165.68 16.13 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.2 t80 . . . . . 0 C--O 1.235 0.333 0 C-N-CA 125.505 1.522 . . . . 0.0 107.687 -173.439 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 107.489 -2.245 . . . . 0.0 107.489 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.09 165.46 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.044 0.938 . . . . 0.0 109.267 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -128.1 154.27 45.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.275 1.43 . . . . 0.0 107.981 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -141.55 139.4 33.18 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.405 1.082 . . . . 0.0 109.073 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.55 133.46 12.29 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.466 0.706 . . . . 0.0 110.033 -161.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.95 150.7 24.75 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 160.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.484 ' HE3' ' CD2' ' A' ' 94' ' ' TYR . 14.1 tmtt? -131.5 131.33 43.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.765 1.226 . . . . 0.0 109.05 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.2 148.54 26.81 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 159.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 174.1 169.38 36.2 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 119.454 -1.355 . . . . 0.0 114.142 167.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -148.53 133.73 9.31 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.219 -164.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -71.12 135.39 27.12 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.824 3.016 . . . . 0.0 110.467 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.9 tp . . . . . 0 CA--C 1.539 0.547 0 C-N-CA 123.053 0.541 . . . . 0.0 111.421 177.484 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--O 1.233 0.229 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -101.31 125.63 47.97 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.886 1.274 . . . . 0.0 108.491 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.1 mt -90.7 117.38 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -177.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.484 ' CD2' ' HE3' ' A' ' 82' ' ' LYS . 4.4 m-85 -98.45 141.12 31.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.446 1.899 . . . . 0.0 109.788 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.3 m -134.02 115.25 14.1 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 162.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -130.06 148.69 51.94 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 123.774 0.83 . . . . 0.0 110.449 -170.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.37 148.21 27.86 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.974 0.91 . . . . 0.0 110.742 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.07 -121.8 1.05 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.75 167.41 34.7 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 117.861 0.831 . . . . 0.0 113.69 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 36.2 mtm -101.38 150.84 22.6 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.618 1.967 . . . . 0.0 106.975 163.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.3 137.47 50.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -149.71 131.11 14.7 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.293 0 C-N-CA 124.981 1.312 . . . . 0.0 109.45 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.02 144.38 47.2 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.428 2.086 . . . . 0.0 110.863 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.93 164.31 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.13 0.972 . . . . 0.0 110.078 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -147.59 165.54 30.07 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.919 1.688 . . . . 0.0 108.495 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.78 160.41 42.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.32 0.509 . . . . 0.0 110.298 165.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -109.35 159.06 14.22 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 106.131 -2.788 . . . . 0.0 106.131 158.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.79 -173.87 46.09 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 118.539 1.169 . . . . 0.0 112.008 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.21 145.16 31.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -103.05 150.97 23.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.258 1.423 . . . . 0.0 107.544 158.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.39 165.37 28.69 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.533 1.133 . . . . 0.0 109.08 163.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -130.85 88.52 2.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.028 1.731 . . . . 0.0 110.486 -163.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.12 -29.64 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 125.147 1.379 . . . . 0.0 111.118 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.4 t -141.98 146.14 39.19 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 159.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.48 -15.53 49.05 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.501 2.134 . . . . 0.0 114.9 -167.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.97 -41.76 97.02 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.217 0.917 . . . . 0.0 111.004 168.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.0 pt -110.64 163.9 7.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 124.179 0.992 . . . . 0.0 111.188 -164.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.8 158.75 43.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.8 t -141.52 152.78 44.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 158.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -135.33 153.98 51.67 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 123.124 0.569 . . . . 0.0 111.168 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.55 137.32 41.91 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -144.74 154.12 42.4 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.851 1.26 . . . . 0.0 109.803 -164.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -151.02 146.02 25.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.252 1.421 . . . . 0.0 110.735 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -132.13 115.51 15.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.902 2.481 . . . . 0.0 105.965 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.0 t80 . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 168.582 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.706 0 CA-C-O 121.588 0.549 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 26.0 ttt -142.0 156.28 45.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.624 1.97 . . . . 0.0 107.237 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.13 161.78 33.93 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.606 1.162 . . . . 0.0 108.79 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.2 p -147.28 166.4 27.2 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.342 0.591 . . . . 0.0 110.419 166.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.71 165.69 31.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 108.745 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.35 175.14 40.44 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 121.485 -0.388 . . . . 0.0 113.377 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 62.1 t -134.51 146.73 30.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 126.661 1.984 . . . . 0.0 105.709 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.5 m -156.45 174.87 14.79 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 119.934 -1.729 . . . . 0.0 110.433 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -143.72 166.06 25.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 122.926 0.49 . . . . 0.0 111.37 166.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -106.55 158.8 16.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.655 2.382 . . . . 0.0 110.446 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.2 p90 . . . . . 0 CA--C 1.538 0.488 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 163.722 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.541 0.613 0 CA-C-O 121.614 0.721 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.9 m -145.2 115.34 7.47 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 119.64 -1.913 . . . . 0.0 108.863 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -114.7 131.53 56.72 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.771 1.628 . . . . 0.0 108.717 -172.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.522 ' CZ ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER -130.78 155.81 46.05 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.193 0.997 . . . . 0.0 111.741 -170.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 m -143.01 144.91 32.48 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.156 2.183 . . . . 0.0 107.633 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.3 -159.49 22.52 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 118.747 0.703 . . . . 0.0 113.522 -169.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.49 157.91 45.28 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.965 1.306 . . . . 0.0 110.629 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.6 163.75 35.63 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.02 0.928 . . . . 0.0 112.794 -175.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mp -141.34 165.78 26.56 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.542 2.337 . . . . 0.0 109.37 171.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.3 171.04 29.54 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.075 0.845 . . . . 0.0 112.249 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -158.57 150.07 20.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.829 0.852 . . . . 0.0 112.101 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 126.264 1.826 . . . . 0.0 108.246 162.841 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.27 165.24 25.5 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 171.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.1 174.66 11.1 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.565 1.946 . . . . 0.0 107.904 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.04 -164.89 31.53 Favored Glycine 0 C--N 1.332 0.338 0 O-C-N 121.848 -0.532 . . . . 0.0 112.675 163.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.29 160.63 14.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -135.74 155.14 50.84 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.653 1.581 . . . . 0.0 107.653 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.26 172.41 40.05 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.522 ' HA3' ' CZ ' ' A' ' 8' ' ' TYR . . . -168.78 166.73 39.87 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 121.553 -0.969 . . . . 0.0 113.099 166.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -137.68 106.09 5.81 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -95.91 132.87 40.75 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.465 0.302 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.356 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 121.767 0.794 . . . . 0.0 111.86 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.05 -116.26 0.81 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 167.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -136.4 159.72 40.9 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.942 1.353 . . . . 0.0 111.908 -171.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -144.81 151.86 39.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 128.534 2.733 . . . . 0.0 106.263 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 66.4 mtt -152.65 170.94 19.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.728 1.211 . . . . 0.0 109.458 -162.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.27 179.95 42.14 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.172 0.892 . . . . 0.0 110.921 170.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 4.5 t80 . . . . . 0 C--O 1.235 0.311 0 C-N-CA 123.656 0.782 . . . . 0.0 109.474 178.011 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.745 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.87 131.83 38.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -95.43 132.2 40.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.35 132.53 20.46 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.001 0.92 . . . . 0.0 108.786 175.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.23 142.75 19.64 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.665 -172.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.64 147.14 26.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.966 1.306 . . . . 0.0 108.512 165.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.516 ' HE2' ' CE1' ' A' ' 94' ' ' TYR . 81.2 tttt -143.52 135.17 26.34 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.375 1.47 . . . . 0.0 109.204 -165.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.8 tp -144.28 129.45 18.69 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.729 1.612 . . . . 0.0 107.394 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.73 179.13 19.16 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 117.965 0.348 . . . . 0.0 112.994 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -143.42 138.55 15.58 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.344 1.058 . . . . 0.0 109.298 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.45 117.08 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.798 2.332 . . . . 0.0 109.073 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.7 tt . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 123.023 0.529 . . . . 0.0 110.78 -176.328 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.353 0 CA-C-O 121.5 0.667 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -132.36 136.56 46.91 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.678 1.991 . . . . 0.0 107.917 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.93 110.58 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CE1' ' HE2' ' A' ' 82' ' ' LYS . 10.4 m-85 -111.5 118.43 35.74 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.526 1.931 . . . . 0.0 110.613 -171.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.4 m -96.97 154.6 17.21 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.315 1.846 . . . . 0.0 108.183 171.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.98 165.05 35.86 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.4 tt -138.54 151.13 47.06 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.718 2.007 . . . . 0.0 107.552 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.35 -139.8 8.34 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 119.129 0.877 . . . . 0.0 111.21 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.0 177.9 44.45 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 117.517 0.659 . . . . 0.0 112.448 172.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.2 108.37 19.54 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 125.012 1.325 . . . . 0.0 107.433 168.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.02 122.76 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -88.82 150.7 22.79 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? . . . . . 0 C--O 1.232 0.153 0 C-N-CA 124.307 1.043 . . . . 0.0 109.706 171.593 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -67.04 148.14 81.04 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.639 1.559 . . . . 0.0 109.678 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.8 169.8 19.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.521 1.128 . . . . 0.0 110.192 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.05 154.0 51.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.503 1.521 . . . . 0.0 107.128 168.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.94 171.47 18.29 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.103 0.961 . . . . 0.0 109.08 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -152.63 161.94 29.73 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 169.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.19 -140.96 6.18 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.2 t -132.57 158.3 43.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 117.532 0.666 . . . . 0.0 109.738 -167.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -123.08 137.22 54.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 158.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -120.16 113.57 20.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.641 1.576 . . . . 0.0 107.624 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.0 81.58 1.89 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.855 1.262 . . . . 0.0 108.868 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.9 tp -70.53 -41.13 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 167.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.55 115.57 60.12 Favored Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 126.413 1.885 . . . . 0.0 106.486 161.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -59.1 -23.31 68.39 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 CA-C-N 121.021 1.4 . . . . 0.0 111.45 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -68.03 -39.99 82.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.208 1.803 . . . . 0.0 112.895 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.9 tt -146.42 130.77 10.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 119.527 1.058 . . . . 0.0 108.468 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.97 145.66 31.62 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 123.579 0.55 . . . . 0.0 109.525 -160.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.4 m -94.97 151.56 19.07 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.15 152.97 49.89 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 125.053 1.341 . . . . 0.0 109.803 173.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 pp -141.61 154.65 45.54 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.191 1.396 . . . . 0.0 108.824 163.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -145.68 155.46 43.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.678 1.591 . . . . 0.0 108.92 171.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -133.68 149.35 51.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.946 1.698 . . . . 0.0 107.733 166.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -135.12 167.81 20.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.454 1.502 . . . . 0.0 108.857 167.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 18.0 t80 . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 168.228 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.839 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 18.5 ttt -104.64 148.06 26.96 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 169.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.8 pp -130.64 160.81 33.13 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.334 0.654 . . . . 0.0 111.4 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.39 158.11 44.92 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.589 1.155 . . . . 0.0 108.531 163.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 pp -149.54 156.03 41.29 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.326 1.451 . . . . 0.0 108.712 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.16 175.19 40.29 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 112.271 -0.332 . . . . 0.0 112.271 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.25 145.07 27.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 170.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.8 p -154.18 151.66 29.47 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.275 0.943 . . . . 0.0 110.743 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -106.15 149.83 26.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.342 1.857 . . . . 0.0 108.961 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.12 156.13 46.69 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 127.211 2.204 . . . . 0.0 109.949 171.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 44.6 t80 . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 159.386 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 121.221 0.534 . . . . 0.0 112.047 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.5 p -154.13 161.59 41.77 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.516 1.926 . . . . 0.0 109.226 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -134.86 149.37 50.31 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.385 1.474 . . . . 0.0 107.462 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -134.85 144.77 47.75 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.79 2.036 . . . . 0.0 108.802 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -150.08 135.16 17.88 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.906 -1.121 . . . . 0.0 108.682 171.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.09 -155.42 11.53 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.717 0.675 . . . . 0.0 112.748 -160.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.77 162.88 33.64 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.843 1.257 . . . . 0.0 111.0 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -139.5 142.22 37.3 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.76 1.624 . . . . 0.0 108.83 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.1 139.32 53.88 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.512 1.925 . . . . 0.0 106.524 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.92 148.27 19.0 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.615 1.102 . . . . 0.0 111.43 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -137.78 129.44 28.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.012 2.125 . . . . 0.0 107.493 -167.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.3 t . . . . . 0 C--O 1.24 0.592 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.105 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 CA--C 1.523 -0.077 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.41 -169.59 42.6 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.9 170.55 18.54 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.371 1.068 . . . . 0.0 108.741 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.36 -179.14 43.02 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.67 159.09 15.23 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -144.16 156.65 44.42 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.287 0.635 . . . . 0.0 111.113 -162.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.15 171.9 39.83 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 170.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.12 166.3 39.38 Favored Glycine 0 C--N 1.331 0.261 0 CA-C-N 117.778 0.789 . . . . 0.0 111.546 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -148.8 133.37 17.72 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.022 0.929 . . . . 0.0 109.318 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -121.76 154.84 36.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.235 0.333 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.835 -172.606 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 t . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.894 0.378 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.48 -161.43 11.47 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.082 1.325 . . . . 0.0 112.163 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -136.44 155.83 49.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.696 1.198 . . . . 0.0 109.021 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -147.38 149.06 32.02 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.72 1.208 . . . . 0.0 108.223 -169.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 73.3 mtp -151.16 171.9 16.64 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.995 0.918 . . . . 0.0 110.898 -162.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.51 179.02 40.13 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 119.523 -0.598 . . . . 0.0 111.959 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 71.9 t80 . . . . . 0 CA--C 1.535 0.396 0 C-N-CA 126.047 1.739 . . . . 0.0 110.29 -175.162 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.375 0 N-CA-C 113.849 0.3 . . . . 0.0 113.849 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 m -146.15 164.7 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.819 2.047 . . . . 0.0 110.058 173.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -120.62 146.4 46.41 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 163.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.54 116.54 7.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.289 1.436 . . . . 0.0 108.518 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.84 145.67 27.61 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.809 -0.557 . . . . 0.0 110.376 -169.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.48 22.69 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.967 0.907 . . . . 0.0 108.978 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.535 ' HE2' ' CE1' ' A' ' 94' ' ' TYR . 86.7 tttt -142.16 138.31 31.48 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.752 1.221 . . . . 0.0 108.69 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.89 146.55 34.17 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 123.113 0.565 . . . . 0.0 109.505 169.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.5 170.22 32.91 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 118.409 0.549 . . . . 0.0 113.623 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -157.97 157.2 29.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.285 1.034 . . . . 0.0 111.607 -166.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.01 131.12 13.92 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.463 2.775 . . . . 0.0 110.521 172.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 pt . . . . . 0 CA--C 1.543 0.685 0 C-N-CA 124.511 1.125 . . . . 0.0 112.865 -178.466 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.6 tp . . . . . 0 C--O 1.234 0.247 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -106.85 111.9 24.62 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.244 1.018 . . . . 0.0 108.531 -170.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.4 HG22 HG12 ' A' ' 127' ' ' VAL . 10.1 pt -109.66 143.91 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 121.85 -0.531 . . . . 0.0 110.002 -166.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.535 ' CE1' ' HE2' ' A' ' 82' ' ' LYS . 77.5 m-85 -137.89 158.86 43.48 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.707 0.765 . . . . 0.0 112.869 -166.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.7 m -124.43 147.09 48.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 128.429 2.692 . . . . 0.0 106.179 166.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.28 144.22 31.38 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.059 0.944 . . . . 0.0 108.996 -171.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.1 tt -149.07 147.48 28.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.339 1.056 . . . . 0.0 109.188 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.9 -140.68 7.68 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.19 176.42 28.83 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-O 122.222 0.901 . . . . 0.0 112.789 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -140.0 157.44 45.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.31 1.044 . . . . 0.0 109.087 169.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.5 t -130.26 128.29 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -150.72 110.11 3.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 71.3 p . . . . . 0 CA--C 1.539 0.535 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.43 155.76 36.54 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.76 2.307 . . . . 0.0 110.086 166.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.8 124.54 2.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 124.913 1.285 . . . . 0.0 108.288 169.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -133.35 145.86 50.76 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 167.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.89 170.78 21.57 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.923 0.889 . . . . 0.0 110.468 -164.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -126.34 165.2 19.63 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 161.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.16 175.5 43.5 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 118.149 0.974 . . . . 0.0 113.187 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.4 HG12 HG22 ' A' ' 93' ' ' ILE . 18.0 m -133.44 140.64 46.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.242 1.417 . . . . 0.0 107.43 175.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.422 ' CD ' ' HE ' ' A' ' 138' ' ' ARG . 40.4 mt-10 -136.63 148.01 47.21 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.591 1.157 . . . . 0.0 108.092 -169.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -149.97 166.14 30.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.917 0.887 . . . . 0.0 110.385 -168.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.82 143.81 51.11 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 125.159 1.383 . . . . 0.0 109.603 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.56 -26.81 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.012 0.525 . . . . 0.0 110.104 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 91.0 m 139.06 -64.46 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.776 1 C-N-CA 132.894 4.478 . . . . 0.0 106.879 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -67.35 179.81 2.27 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.833 1.689 . . . . 0.0 109.943 159.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -52.81 -3.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 130.542 3.537 . . . . 0.0 117.914 -165.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 68.5 mt -87.61 138.08 19.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.95 161.52 34.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.719 0.808 . . . . 0.0 109.682 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.5 m -135.28 148.91 49.68 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.474 1.509 . . . . 0.0 107.799 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.422 ' HE ' ' CD ' ' A' ' 128' ' ' GLU . 33.5 mtp-105 -135.32 146.13 48.14 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.708 1.203 . . . . 0.0 108.928 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.6 125.66 38.67 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 164.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -140.01 123.58 17.2 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -169.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -120.68 138.03 54.16 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.149 1.78 . . . . 0.0 109.842 -172.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.14 114.97 16.99 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.621 1.968 . . . . 0.0 107.867 -167.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.5 t80 . . . . . 0 CA--C 1.533 0.298 0 C-N-CA 124.422 1.089 . . . . 0.0 109.346 179.228 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -152.44 141.83 21.6 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.965 0.883 . . . . 0.0 109.391 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.0 tp -118.82 154.33 33.05 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.553 1.941 . . . . 0.0 107.484 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.9 p -153.77 162.1 41.52 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.299 -0.875 . . . . 0.0 111.785 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 7.0 tt -132.52 149.82 52.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.192 2.197 . . . . 0.0 106.767 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.01 162.77 27.8 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 170.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.6 t -139.79 142.75 31.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 8.0 t -151.46 167.92 26.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.711 0.687 . . . . 0.0 110.734 -167.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -115.81 127.71 55.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.016 2.126 . . . . 0.0 106.303 167.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -89.63 137.59 32.2 Favored 'General case' 0 C--N 1.337 0.063 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 170.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 . . . . . 0 C--O 1.236 0.381 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -178.103 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.2 m -121.71 155.32 35.47 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.11 1.364 . . . . 0.0 108.795 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -121.37 129.6 53.14 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.294 1.438 . . . . 0.0 108.01 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -113.13 143.34 44.52 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.993 1.317 . . . . 0.0 107.95 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 t -150.35 158.2 43.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.384 0.993 . . . . 0.0 111.514 159.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.04 -141.59 6.41 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 125.4 1.476 . . . . 0.0 110.041 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.67 155.29 44.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.95 0.375 . . . . 0.0 111.606 -164.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.44 159.81 41.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.144 0.978 . . . . 0.0 111.617 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp -109.75 158.96 17.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.204 1.802 . . . . 0.0 106.411 164.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -129.89 165.35 22.36 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 124.966 1.27 . . . . 0.0 109.933 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -148.3 148.34 30.31 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 N--CA 1.462 0.169 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.744 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 121.929 0.871 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.2 175.68 36.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.841 2.162 . . . . 0.0 109.127 170.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.03 166.3 32.88 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.026 0.93 . . . . 0.0 110.399 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.37 175.69 44.84 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.482 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.81 157.34 16.78 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.635 1.174 . . . . 0.0 107.883 164.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -151.44 166.2 31.8 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.729 0.776 . . . . 0.0 111.796 175.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.25 171.85 39.9 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.62 166.2 39.18 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -121.06 119.84 33.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 173.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.13 160.34 25.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.414 0.685 . . . . 0.0 109.428 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 CA--C 1.538 0.518 0 C-N-CA 124.364 1.066 . . . . 0.0 111.387 -170.578 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 t . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.14 -162.3 30.38 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 118.756 0.707 . . . . 0.0 113.695 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -126.68 155.3 42.85 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.997 1.319 . . . . 0.0 108.113 166.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -149.16 158.12 43.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.863 1.265 . . . . 0.0 108.455 -169.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.0 mtt -146.1 152.56 39.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.124 1.77 . . . . 0.0 108.731 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -136.73 157.69 23.79 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 103.183 -2.895 . . . . 0.0 103.183 -177.492 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.227 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -143.43 163.05 16.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 123.138 0.575 . . . . 0.0 110.33 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -147.29 155.97 42.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.564 1.145 . . . . 0.0 109.808 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 pp -143.73 144.44 31.84 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.238 1.415 . . . . 0.0 107.797 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 t -154.03 153.16 31.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.588 0.709 . . . . 0.0 111.401 -169.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.71 151.67 24.26 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 158.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -135.74 135.46 40.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.303 1.441 . . . . 0.0 108.622 -171.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.3 tp -133.52 168.29 18.9 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 128.023 2.529 . . . . 0.0 107.478 -176.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.53 -176.9 39.71 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.431 ' CG ' ' HD2' ' A' ' 86' ' ' PRO . 64.8 t80 -143.8 142.21 20.15 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 168.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 85' ' ' TYR . 63.8 Cg_endo -75.42 157.58 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.053 1.835 . . . . 0.0 112.909 -161.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--N 1.346 0.42 0 C-N-CA 131.447 3.899 . . . . 0.0 110.637 162.775 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 121.526 0.679 . . . . 0.0 112.41 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.97 148.3 25.38 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 tp -90.91 144.04 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 167.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -137.09 134.91 36.98 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.694 1.598 . . . . 0.0 108.519 -164.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.8 m -137.62 147.18 44.78 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -151.67 142.78 23.19 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.881 -0.512 . . . . 0.0 110.687 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 mp -141.59 140.29 33.33 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.518 1.127 . . . . 0.0 108.826 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.96 -150.27 8.22 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 117.757 0.253 . . . . 0.0 113.006 -164.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.83 161.63 24.34 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.653 1.12 . . . . 0.0 112.017 170.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.6 ptm -141.6 149.67 41.03 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.567 1.547 . . . . 0.0 109.973 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.1 127.06 19.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 125.295 1.438 . . . . 0.0 107.664 -167.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -138.47 135.68 35.41 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 117.789 0.268 . . . . 0.0 110.504 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.167 0 C-N-CA 124.174 0.99 . . . . 0.0 109.515 172.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.213 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.538 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.14 167.18 27.5 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.8 2.334 . . . . 0.0 109.925 164.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.25 153.24 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 165.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -143.37 152.34 41.49 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.465 1.506 . . . . 0.0 106.986 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.92 168.64 19.16 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.142 0.577 . . . . 0.0 110.051 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.12 164.46 32.36 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 170.79 -133.21 2.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -173.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.73 162.21 35.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 118.471 1.135 . . . . 0.0 111.615 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -139.93 144.57 37.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.136 1.774 . . . . 0.0 109.048 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -153.17 164.68 37.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.132 0.573 . . . . 0.0 110.925 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.41 143.06 43.76 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 161.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 tp -113.07 -2.93 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.18 0.992 . . . . 0.0 111.084 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.8 m -161.58 136.97 5.66 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 102.806 -3.035 . . . . 0.0 102.806 168.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.72 -23.93 69.25 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.894 1.729 . . . . 0.0 113.905 -161.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.68 -2.07 49.13 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 36.5 pt -127.38 163.39 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.87 0.868 . . . . 0.0 109.79 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.61 169.22 18.05 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.882 0.873 . . . . 0.0 109.127 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.1 m -149.46 138.69 21.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -137.91 145.89 42.65 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.852 1.261 . . . . 0.0 107.63 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.91 140.15 25.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 167.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -136.42 161.09 36.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.95 1.3 . . . . 0.0 110.803 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -136.51 152.35 50.43 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.279 2.232 . . . . 0.0 108.995 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -141.86 148.33 38.62 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.438 2.295 . . . . 0.0 107.35 172.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 . . . . . 0 C--O 1.237 0.396 0 C-N-CA 125.503 1.521 . . . . 0.0 107.617 172.239 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 CA-C-O 121.993 0.774 . . . . 0.0 113.205 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 54.5 ttm -144.67 151.67 39.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.143 1.777 . . . . 0.0 107.558 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.9 pp -139.68 162.41 35.17 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.128 0.971 . . . . 0.0 110.04 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.1 m -139.16 155.93 47.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.774 0.829 . . . . 0.0 109.741 165.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 16.1 tp -149.96 119.3 6.85 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.708 2.003 . . . . 0.0 107.4 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -152.89 171.22 31.96 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 121.718 0.621 . . . . 0.0 114.26 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.08 160.38 33.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 126.278 1.831 . . . . 0.0 109.282 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.0 m -152.46 161.99 41.82 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 121.52 -0.738 . . . . 0.0 111.504 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -97.49 152.45 18.98 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.062 1.745 . . . . 0.0 107.365 161.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.83 116.18 27.55 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.21 1.004 . . . . 0.0 110.485 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 64.1 t80 . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 124.522 1.129 . . . . 0.0 113.154 -171.829 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.312 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 m -117.7 124.51 48.69 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -104.14 156.42 17.9 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -142.71 156.94 45.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.944 1.698 . . . . 0.0 109.131 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.0 t -150.27 158.64 44.38 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.89 0.768 . . . . 0.0 111.519 162.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.65 -134.34 3.1 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.105 0.86 . . . . 0.0 112.296 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.09 147.74 50.54 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.236 1.014 . . . . 0.0 110.627 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -129.36 139.52 51.68 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.0 mp -115.12 159.5 20.81 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.472 1.909 . . . . 0.0 107.311 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.77 157.52 27.31 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -138.35 149.85 46.0 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.537 1.135 . . . . 0.0 108.358 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.6 p . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 125.0 1.32 . . . . 0.0 108.248 176.755 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.3 tp . . . . . 0 N--CA 1.464 0.258 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.2 -167.26 39.74 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 119.584 1.084 . . . . 0.0 113.625 -174.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.07 169.22 19.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.154 1.382 . . . . 0.0 109.908 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.41 170.21 38.74 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.072 0.844 . . . . 0.0 112.048 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.46 143.76 26.52 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 171.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -144.97 165.2 28.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.76 152.56 20.33 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 127.309 2.385 . . . . 0.0 109.322 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.89 151.93 19.21 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -148.35 105.72 3.65 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -172.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -122.59 142.14 50.95 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.743 0.701 . . . . 0.0 111.097 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 CA--C 1.538 0.499 0 C-N-CA 123.812 0.845 . . . . 0.0 112.24 -164.909 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 122.178 0.99 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.55 -166.9 18.55 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 127.663 2.554 . . . . 0.0 109.087 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -135.53 163.66 29.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.171 1.388 . . . . 0.0 108.886 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -148.04 152.38 37.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.364 1.066 . . . . 0.0 108.304 164.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 50.4 mtt -149.49 157.11 42.99 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.534 1.134 . . . . 0.0 108.068 -169.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.47 176.52 43.4 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 119.06 0.846 . . . . 0.0 113.08 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.7 t80 . . . . . 0 C--O 1.236 0.394 0 C-N-CA 125.572 1.549 . . . . 0.0 109.376 -172.393 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.323 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.7 p -143.87 148.5 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -132.05 130.23 41.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.386 1.874 . . . . 0.0 107.013 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -120.38 150.32 40.95 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 159.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -154.98 132.24 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 120.598 -1.314 . . . . 0.0 109.08 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.12 140.03 31.27 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 164.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -117.72 114.36 23.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.21 136.64 40.09 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.867 0.758 . . . . 0.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.93 -148.53 17.14 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 118.582 -1.121 . . . . 0.0 110.634 -166.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.401 ' CG ' ' HD2' ' A' ' 86' ' ' PRO . 1.6 t80 -159.32 157.43 27.24 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 118.508 1.154 . . . . 0.0 112.415 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 92' ' ' ASP . 37.5 Cg_endo -62.33 153.54 69.73 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.323 2.682 . . . . 0.0 111.911 161.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 124.832 1.253 . . . . 0.0 108.5 171.118 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 1.1 m-20 -134.93 164.02 28.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.024 2.13 . . . . 0.0 109.544 -172.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.39 129.2 73.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.657 1.583 . . . . 0.0 106.899 173.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -137.98 153.36 49.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.085 0.945 . . . . 0.0 111.768 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 51.9 m -96.9 132.41 42.69 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 159.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -99.31 108.93 21.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 167.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tt -98.96 107.53 19.99 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.07 142.01 15.39 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.113 0.863 . . . . 0.0 112.502 -164.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.66 95.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 105.929 -2.868 . . . . 0.0 105.929 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.1 ptp -134.23 157.04 47.29 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.275 0.63 . . . . 0.0 110.304 -171.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.2 p -148.25 150.38 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -117.62 156.17 28.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.602 1.961 . . . . 0.0 107.319 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 . . . . . 0 N--CA 1.452 -0.373 0 C-N-CA 123.378 0.671 . . . . 0.0 109.698 175.726 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 79.8 p . . . . . 0 C--O 1.236 0.393 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.5 158.08 24.6 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.019 1.146 . . . . 0.0 109.708 158.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.2 p -167.24 -178.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.192 1.797 . . . . 0.0 107.752 -172.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -139.01 164.8 28.8 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.596 -1.315 . . . . 0.0 109.694 163.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.77 160.6 40.99 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.199 1.8 . . . . 0.0 108.403 172.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -124.36 145.94 16.04 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.24 -162.37 29.15 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 117.915 0.857 . . . . 0.0 114.615 -169.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.97 158.51 30.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 127.301 2.24 . . . . 0.0 108.38 -169.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -135.56 146.55 48.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.157 1.383 . . . . 0.0 107.568 165.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -150.16 122.88 8.63 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.811 0.844 . . . . 0.0 110.077 -162.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -135.75 82.43 1.95 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.787 2.035 . . . . 0.0 109.201 -172.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.64 -31.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.129 0.972 . . . . 0.0 112.931 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.0 p -136.65 155.08 76.95 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.972 1.309 . . . . 0.0 107.832 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.05 60.76 6.99 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.152 3.234 . . . . 0.0 111.33 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -148.07 -33.54 0.24 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.468 2.307 . . . . 0.0 111.395 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.16 149.58 21.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 127.21 2.204 . . . . 0.0 108.131 -166.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.0 109.12 5.24 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.138 0.881 . . . . 0.0 108.871 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.65 149.03 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.435 1.894 . . . . 0.0 106.99 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.6 157.75 46.04 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.277 0.944 . . . . 0.0 110.592 168.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 37.7 tp -154.44 119.52 5.0 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 125.67 1.588 . . . . 0.0 107.266 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.34 156.45 45.84 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.365 1.066 . . . . 0.0 111.423 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -134.01 152.96 52.06 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.474 1.51 . . . . 0.0 109.801 -173.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -145.15 158.34 43.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.555 1.542 . . . . 0.0 109.915 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 60.1 t80 . . . . . 0 CA--C 1.534 0.339 0 C-N-CA 126.089 1.755 . . . . 0.0 107.372 -177.693 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.837 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -140.96 157.76 44.89 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 pp -140.22 162.37 35.42 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.434 0.694 . . . . 0.0 111.136 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.3 m -135.02 155.85 50.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 160.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 158.64 44.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 169.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -163.6 170.14 38.85 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.25 136.78 41.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.5 p -144.43 166.78 24.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -117.21 154.07 31.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 166.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 -89.76 158.65 17.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.221 0.534 . . . . 0.0 111.56 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 47.2 t80 . . . . . 0 CA--C 1.537 0.45 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.92 161.509 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.341 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.5 m -130.94 122.13 26.39 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 165.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -102.13 157.99 16.49 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -146.16 159.8 42.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.117 1.367 . . . . 0.0 109.253 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -149.86 161.58 41.99 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 159.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.37 -151.41 20.15 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.06 158.75 42.79 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.307 0.643 . . . . 0.0 110.543 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HE3' ' CZ ' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -136.66 150.38 48.47 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.026 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.79 162.85 32.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.812 1.645 . . . . 0.0 107.957 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.38 157.52 22.34 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 119.198 -0.779 . . . . 0.0 112.105 -170.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -144.11 152.23 40.66 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.906 1.282 . . . . 0.0 110.902 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 127.669 2.388 . . . . 0.0 112.023 173.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.089 0 CA-C-O 119.245 -0.407 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.11 167.79 28.34 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.568 0.604 . . . . 0.0 112.167 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.3 153.44 29.05 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.641 1.576 . . . . 0.0 110.078 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.79 163.4 32.34 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.298 1.427 . . . . 0.0 111.253 168.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.4 140.34 49.22 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.011 1.724 . . . . 0.0 108.574 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -134.66 158.91 42.85 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -159.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.99 143.39 14.83 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 127.302 2.382 . . . . 0.0 107.801 160.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.38 161.65 26.51 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.931 0.866 . . . . 0.0 112.102 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -149.1 143.97 26.36 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.067 1.347 . . . . 0.0 109.771 -171.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -122.04 123.21 41.08 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 158.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -158.752 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t . . . . . 0 C--O 1.238 0.491 0 CA-C-O 121.994 0.902 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.48 -179.57 26.37 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.009 0.814 . . . . 0.0 111.805 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.25 163.27 34.98 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.533 1.533 . . . . 0.0 108.835 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -151.82 159.94 43.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 162.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 77.6 mtm -143.44 156.39 44.64 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -155.4 170.68 33.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.878 -0.201 . . . . 0.0 112.608 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.496 0 C-N-CA 124.483 1.113 . . . . 0.0 110.027 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.308 0 CA-C-O 117.618 -1.657 . . . . 0.0 114.03 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.83 155.36 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.983 1.392 . . . . 0.0 110.934 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -133.75 148.26 51.39 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.968 2.107 . . . . 0.0 108.178 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 pp -143.14 152.11 41.44 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.209 1.003 . . . . 0.0 110.961 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 m -155.68 152.07 28.18 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.706 1.202 . . . . 0.0 112.36 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.23 136.08 54.85 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.717 2.407 . . . . 0.0 106.975 159.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -118.56 153.54 34.06 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.977 0.911 . . . . 0.0 110.147 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.14 133.47 52.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 161.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.7 164.98 10.11 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -167.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -161.24 168.87 10.73 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.142 -163.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -62.96 95.46 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 124.154 3.236 . . . . 0.0 110.74 168.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.7 tt . . . . . 0 CA--C 1.533 0.308 0 C-N-CA 123.077 0.551 . . . . 0.0 110.895 -172.729 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.7 mt . . . . . 0 C--O 1.233 0.194 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.72 111.79 21.03 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 166.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.6 137.17 41.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -153.5 166.73 31.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.551 1.167 . . . . 0.0 113.784 -170.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.6 t -129.73 153.45 48.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 158.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.28 155.73 41.68 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.996 -0.44 . . . . 0.0 110.34 -166.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.6 tt -127.8 138.12 52.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.13 -160.1 15.13 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -170.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.99 176.38 47.93 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-O 121.341 0.412 . . . . 0.0 112.299 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -116.33 144.64 43.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.238 1.815 . . . . 0.0 107.699 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.1 t -129.28 94.17 2.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 160.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -129.13 138.73 51.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 N--CA 1.451 -0.386 0 O-C-N 121.767 -0.583 . . . . 0.0 110.867 -174.183 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 CA--C 1.536 0.426 0 CA-C-O 118.969 -0.539 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -79.28 168.89 19.64 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.931 2.42 . . . . 0.0 110.74 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.4 t -136.33 139.86 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.087 1.355 . . . . 0.0 107.879 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -127.77 118.69 24.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.711 2.004 . . . . 0.0 106.307 160.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.11 166.47 24.56 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.661 -0.649 . . . . 0.0 111.909 -168.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -120.75 158.51 15.65 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 166.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.79 175.23 47.43 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 118.361 1.081 . . . . 0.0 113.412 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.7 m -138.97 135.35 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.463 1.105 . . . . 0.0 108.73 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -105.83 110.74 23.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.534 2.734 . . . . 0.0 105.347 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.91 110.46 22.13 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.16 81.46 1.79 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 47.1 pt -69.36 -3.62 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.154 0.982 . . . . 0.0 112.632 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 45.0 m -154.43 149.71 20.78 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 163.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.54 -7.8 9.62 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.306 2.004 . . . . 0.0 115.855 -171.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -111.49 -12.54 13.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.16 1.384 . . . . 0.0 113.577 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 pp -139.34 147.94 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 121.764 2.075 . . . . 0.0 111.379 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.7 161.1 37.4 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.38 0.672 . . . . 0.0 109.293 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 73.9 m -130.96 135.97 48.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.451 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 6.0 ptp180 -122.19 159.54 27.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 pp -135.02 145.06 47.69 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 125.112 1.508 . . . . 0.0 107.311 159.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.54 162.08 41.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.884 1.274 . . . . 0.0 109.664 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -154.56 154.84 33.73 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.12 0.568 . . . . 0.0 111.118 -165.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -138.22 160.05 40.45 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.301 1.84 . . . . 0.0 107.288 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 . . . . . 0 CA--C 1.53 0.202 0 C-N-CA 124.953 1.301 . . . . 0.0 108.455 -179.245 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -105.65 159.28 16.09 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.042 0.937 . . . . 0.0 110.034 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.73 117.37 17.75 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 164.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.2 m -129.39 160.86 31.77 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.6 pp -144.39 167.08 23.31 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.941 1.296 . . . . 0.0 110.294 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.63 175.24 40.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.814 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.32 148.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 124.592 1.157 . . . . 0.0 108.484 163.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 70.8 m -145.6 118.69 8.84 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -169.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -82.57 123.83 29.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 171.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -90.14 124.95 35.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.82 1.648 . . . . 0.0 106.74 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 70.1 t80 . . . . . 0 C--O 1.235 0.303 0 C-N-CA 123.591 0.756 . . . . 0.0 110.858 -175.474 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.665 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.34 68.1 5.21 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.715 2.943 . . . . 0.0 110.107 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -123.26 29.82 6.55 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.518 1.927 . . . . 0.0 109.667 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -43.91 -51.2 7.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 128.31 2.644 . . . . 0.0 110.165 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -77.59 112.06 13.99 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 166.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.3 m -130.25 127.06 38.8 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.298 1.039 . . . . 0.0 108.355 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -82.62 157.95 23.21 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.023 1.329 . . . . 0.0 110.654 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.426 ' CZ ' ' HA3' ' A' ' 42' ' ' GLY . 43.2 p90 -151.68 164.54 36.71 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.761 2.025 . . . . 0.0 109.7 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.4 t -130.98 167.38 19.13 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.176 1.39 . . . . 0.0 108.486 170.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.82 175.39 40.78 Favored Glycine 0 C--N 1.334 0.435 0 O-C-N 121.474 -0.766 . . . . 0.0 112.087 174.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.33 147.89 31.81 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.291 1.036 . . . . 0.0 109.267 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.537 ' HE2' ' CE1' ' A' ' 40' ' ' PHE . 40.4 mtmt -132.64 164.83 25.83 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.842 1.257 . . . . 0.0 112.308 -169.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 19.9 tp -120.16 150.09 41.19 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 128.451 2.7 . . . . 0.0 106.363 159.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.77 163.66 29.07 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 119.366 0.985 . . . . 0.0 114.006 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -143.53 136.85 28.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.002 2.121 . . . . 0.0 109.338 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.7 m -142.16 85.02 1.9 Allowed 'General case' 0 C--O 1.242 0.669 0 C-N-CA 125.219 1.408 . . . . 0.0 110.791 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 141.26 50.03 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 158.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 31.7 t80 -169.27 101.98 0.36 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.6 150.49 31.31 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 158.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.3 t70 134.92 -29.51 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 130.798 3.639 . . . . 0.0 107.864 -158.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 69.2 p -129.35 102.25 6.34 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 162.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.93 -130.15 1.11 Allowed Glycine 0 CA--C 1.527 0.836 0 CA-C-N 118.44 0.563 . . . . 0.0 112.291 -170.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -153.2 4.18 0.32 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.621 1.568 . . . . 0.0 114.357 -167.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.308 7.8 pt 58.61 130.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 130.093 3.357 . . . . 0.0 114.096 -164.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.43 170.5 15.9 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.625 1.17 . . . . 0.0 110.063 168.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -85.46 -112.53 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 166.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -60.04 153.82 20.65 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.928 1.24 . . . . 0.0 108.684 158.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 139.17 99.55 0.45 Allowed Glycine 0 CA--C 1.529 0.943 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -170.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.12 65.17 5.22 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.668 2.912 . . . . 0.0 109.966 174.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.3 m -60.1 146.45 43.02 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.423 1.489 . . . . 0.0 109.615 176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -150.54 141.76 23.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.185 -160.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.406 ' OE1' ' HE2' ' A' ' 73' ' ' LYS . 1.8 tm-20 -85.98 -74.78 0.4 Allowed 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 166.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.85 -27.87 44.23 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.315 -172.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 69.78 -73.78 0.09 Allowed 'General case' 0 C--N 1.347 0.457 0 C-N-CA 125.984 1.714 . . . . 0.0 110.786 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 pp -159.0 169.49 24.18 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.557 1.143 . . . . 0.0 110.299 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.54 -176.75 44.05 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.79 171.96 13.65 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 126.366 1.867 . . . . 0.0 108.171 172.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.61 170.18 38.09 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.906 -1.14 . . . . 0.0 114.695 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -142.42 137.5 30.43 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 126.098 1.759 . . . . 0.0 109.059 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.553 ' CD2' ' HA3' ' A' ' 54' ' ' GLY . 46.3 m-85 -139.57 151.8 46.36 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.025 1.33 . . . . 0.0 111.159 -166.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.69 157.91 16.47 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 126.946 2.213 . . . . 0.0 107.884 163.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.426 ' HA3' ' CZ ' ' A' ' 8' ' ' TYR . . . -168.57 166.86 39.9 Favored Glycine 0 N--CA 1.449 -0.438 0 O-C-N 121.344 -1.092 . . . . 0.0 111.054 -174.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -140.34 165.85 26.29 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 117.209 0.505 . . . . 0.0 110.837 165.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.0 mm100 -115.18 162.61 16.81 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.815 1.646 . . . . 0.0 107.883 162.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.2 p -126.59 91.94 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 159.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 57.3 176.73 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 127.54 2.336 . . . . 0.0 112.742 -167.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.9 74.4 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.558 2.172 . . . . 0.0 109.371 160.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -143.96 -72.97 0.27 Allowed 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.388 1.475 . . . . 0.0 109.127 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.5 m -141.95 166.13 17.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.972 0.909 . . . . 0.0 109.315 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.28 -164.79 19.19 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -139.96 163.04 33.73 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 125.71 1.604 . . . . 0.0 110.13 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -149.85 127.85 11.9 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.441 1.896 . . . . 0.0 107.613 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -134.78 125.58 27.21 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 126.422 1.889 . . . . 0.0 108.211 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.553 ' HA3' ' CD2' ' A' ' 40' ' ' PHE . . . -170.59 -179.22 41.82 Favored Glycine 0 C--N 1.333 0.366 0 O-C-N 121.697 -0.627 . . . . 0.0 113.027 -175.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -119.13 115.76 24.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.388 1.475 . . . . 0.0 107.646 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -98.04 133.31 42.68 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 158.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -161.35 176.63 10.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.242 1.017 . . . . 0.0 110.714 -173.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 55.5 tp -126.71 101.45 6.63 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.733 1.613 . . . . 0.0 106.908 170.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.37 58.97 1.97 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.753 1.168 . . . . 0.0 112.085 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.2 mtp180 58.22 -78.35 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 127.905 2.482 . . . . 0.0 110.728 -171.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 66.7 mtm -138.16 110.76 8.46 Favored Pre-proline 0 N--CA 1.453 -0.318 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 160.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.63 -12.31 33.09 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.346 2.031 . . . . 0.0 112.83 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -56.21 -28.01 56.77 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.643 1.577 . . . . 0.0 112.569 165.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 61.45 -15.82 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.558 2.343 . . . . 0.0 115.522 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.28 79.83 0.22 Allowed Glycine 0 CA--C 1.527 0.838 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 166.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.5 t 70.58 178.02 0.26 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.511 1.924 . . . . 0.0 110.786 -161.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.3 m -143.0 161.95 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 126.13 1.772 . . . . 0.0 109.103 -172.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -67.02 153.96 42.36 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.38 1.085 . . . . 0.0 108.171 167.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.04 -28.79 35.25 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 126.888 2.075 . . . . 0.0 113.305 -170.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 167.39 178.22 39.46 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 126.001 1.762 . . . . 0.0 109.689 -168.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 59.41 -8.53 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 128.763 2.825 . . . . 0.0 116.616 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -57.3 150.03 18.96 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.292 1.837 . . . . 0.0 111.409 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.406 ' HE2' ' OE1' ' A' ' 32' ' ' GLU . 9.0 mptt -76.71 70.51 3.21 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.824 1.25 . . . . 0.0 110.547 -176.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -44.06 -56.13 4.23 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 126.44 1.896 . . . . 0.0 114.534 -167.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -161.1 165.49 29.55 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 121.664 0.745 . . . . 0.0 111.32 -170.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.57 177.21 46.78 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 171.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -138.21 141.37 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -122.95 132.66 54.26 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 106.125 -1.805 . . . . 0.0 106.125 167.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.61 110.68 10.06 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.151 1.381 . . . . 0.0 107.439 -174.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.9 p -137.17 143.03 42.2 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.31 0.644 . . . . 0.0 111.693 -161.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.01 149.24 25.72 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 160.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.08 156.64 45.95 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.667 0.787 . . . . 0.0 111.759 -171.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.7 tp -133.78 125.38 28.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.959 2.504 . . . . 0.0 105.773 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.82 137.85 9.57 Favored Glycine 0 C--N 1.332 0.339 0 N-CA-C 106.954 -2.458 . . . . 0.0 106.954 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -138.2 133.92 17.51 Favored Pre-proline 0 C--O 1.237 0.397 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.459 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 92' ' ' ASP . 51.1 Cg_endo -67.1 143.95 67.42 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.434 2.756 . . . . 0.0 110.536 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.37 -4.34 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 123.195 0.598 . . . . 0.0 111.368 168.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.8 m -160.57 165.17 31.24 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.593 2.757 . . . . 0.0 104.101 166.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -70.34 50.76 0.12 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.283 1.833 . . . . 0.0 110.48 168.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -151.31 -56.17 0.15 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.858 2.063 . . . . 0.0 109.368 -170.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.7 pp -143.34 158.06 43.95 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.962 0.887 . . . . 0.0 112.643 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -114.18 149.05 36.29 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 128.717 2.807 . . . . 0.0 108.826 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.5 mt -90.68 137.17 22.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 163.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -127.88 144.66 51.09 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.682 1.193 . . . . 0.0 110.791 -162.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 48.9 m -154.7 148.38 25.39 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.564 1.146 . . . . 0.0 108.462 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 16.4 ptt180 -147.76 155.56 41.83 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.666 0.786 . . . . 0.0 110.57 175.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -153.46 158.68 41.72 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 124.314 1.045 . . . . 0.0 111.003 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 162.97 -130.92 2.35 Favored Glycine 0 CA--C 1.522 0.492 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -124.56 162.5 18.73 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 124.175 0.893 . . . . 0.0 112.479 -175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.6 tmm? -143.88 149.94 37.68 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.595 1.558 . . . . 0.0 109.783 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.1 p -136.66 150.12 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.504 1.921 . . . . 0.0 107.754 168.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -150.85 143.09 24.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.598 1.159 . . . . 0.0 111.061 -165.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 50.5 ttp85 -143.3 148.34 36.17 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.523 1.129 . . . . 0.0 110.538 167.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.55 126.84 12.2 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.343 1.457 . . . . 0.0 110.796 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.64 103.46 3.04 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.695 0.798 . . . . 0.0 110.43 -165.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.53 16.12 5.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -159.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? -53.79 109.76 0.5 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 162.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.2 t -162.73 -166.23 1.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.522 1.929 . . . . 0.0 107.187 -170.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -68.24 44.66 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.043 2.537 . . . . 0.0 112.519 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.7 t 50.89 -87.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 128.527 2.731 . . . . 0.0 111.333 -172.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -74.58 -30.22 61.63 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.779 1.231 . . . . 0.0 111.462 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -82.05 74.86 2.42 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 108.916 -1.673 . . . . 0.0 108.916 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.9 pttp -133.86 166.56 22.38 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.542 1.137 . . . . 0.0 112.292 -171.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -72.66 168.96 17.62 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.75 2.42 . . . . 0.0 111.921 171.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -68.2 119.56 12.96 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 158.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -85.23 -26.4 26.72 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.591 1.156 . . . . 0.0 113.747 -172.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.4 m -149.37 153.83 38.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 -170.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -165.19 160.29 33.58 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 166.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.2 p -150.97 139.55 14.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 167.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 17.2 m -169.96 169.32 4.02 Favored Pre-proline 0 N--CA 1.467 0.375 0 C-N-CA 123.72 0.808 . . . . 0.0 110.513 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -64.83 163.28 28.6 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 121.544 1.496 . . . . 0.0 109.306 158.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.1 p -147.54 159.1 8.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 121.702 -0.624 . . . . 0.0 109.741 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -147.57 164.74 32.5 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.063 1.345 . . . . 0.0 109.42 168.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -155.62 165.77 35.56 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.705 1.202 . . . . 0.0 108.293 161.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -163.72 170.42 39.04 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 112.049 -0.42 . . . . 0.0 112.049 169.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 158.31 -116.36 0.71 Allowed Glycine 0 CA--C 1.522 0.519 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 -174.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.1 157.51 28.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 117.94 0.87 . . . . 0.0 111.009 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -128.74 149.96 50.48 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 167.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.21 127.83 18.07 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.352 -0.842 . . . . 0.0 108.965 -158.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.37 136.55 37.7 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 48.2 mm -112.89 -37.01 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.1 0.56 . . . . 0.0 109.656 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 47.3 m -159.83 156.25 23.97 Favored Pre-proline 0 CA--C 1.55 0.976 0 N-CA-C 103.021 -2.955 . . . . 0.0 103.021 164.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -57.14 -4.35 1.01 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 N-CA-C 118.836 2.591 . . . . 0.0 118.836 -163.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.18 0.26 10.64 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.373 1.869 . . . . 0.0 113.489 173.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 19.4 tt -134.7 141.96 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.621 1.569 . . . . 0.0 110.595 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.14 170.33 15.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.575 -0.703 . . . . 0.0 109.836 -168.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.3 p -128.12 160.18 32.82 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.157 0.983 . . . . 0.0 108.655 159.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.9 ptt-85 -140.11 159.24 42.62 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.635 -0.666 . . . . 0.0 110.27 164.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.42 119.85 15.89 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -138.61 154.68 48.69 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.779 0.8 . . . . 0.0 111.151 -173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -141.83 148.68 39.23 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.723 2.009 . . . . 0.0 108.484 -162.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -142.4 119.2 11.17 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.88 154.13 49.49 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.236 1.414 . . . . 0.0 110.134 -167.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.3 t -150.26 167.27 27.44 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 158.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -77.63 81.04 4.09 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 170.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -44.89 141.18 2.27 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.335 1.854 . . . . 0.0 111.047 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 12.0 mt -84.91 51.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -50.19 110.9 0.97 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 127.273 2.368 . . . . 0.0 113.656 -168.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -62.9 109.48 1.47 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.991 1.316 . . . . 0.0 109.848 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -157.27 170.11 23.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.272 -0.893 . . . . 0.0 110.68 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -57.66 126.49 27.6 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 158.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 26.2 m 50.59 73.14 0.29 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.032 1.333 . . . . 0.0 110.648 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 45.6 pt -55.88 -2.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 128.949 2.9 . . . . 0.0 116.756 -168.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -58.43 -42.33 95.72 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 159.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.03 94.88 3.5 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.593 1.957 . . . . 0.0 108.412 -173.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.1 mtm105 -132.11 159.57 71.59 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 126.69 1.996 . . . . 0.0 107.129 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.67 -16.11 30.17 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.615 1.543 . . . . 0.0 112.466 171.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 47.81 28.27 1.3 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.232 1.813 . . . . 0.0 112.509 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -111.62 127.97 55.91 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.404 1.082 . . . . 0.0 109.217 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -73.04 179.92 37.91 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.267 1.413 . . . . 0.0 113.301 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 23.4 ptp -75.95 154.13 36.1 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 169.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.5 tt -137.29 148.3 46.29 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.424 1.089 . . . . 0.0 108.929 -178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.3 p -143.1 158.23 43.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.901 0.48 . . . . 0.0 110.136 166.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -145.15 150.36 36.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.49 1.116 . . . . 0.0 109.149 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.17 175.09 40.31 Favored Glycine 0 C--N 1.333 0.375 0 N-CA-C 113.977 0.351 . . . . 0.0 113.977 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.7 m -98.66 160.28 3.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 126.735 2.014 . . . . 0.0 109.418 172.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.37 159.67 41.74 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.042 0.537 . . . . 0.0 109.616 167.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -140.62 140.67 35.1 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.972 1.309 . . . . 0.0 108.138 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 34.4 mtm105 -89.86 155.29 19.25 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.267 0.556 . . . . 0.0 110.721 -175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -69.4 115.96 9.27 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 167.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.49 -164.26 14.14 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 124.614 1.102 . . . . 0.0 112.266 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 66.19 159.8 0.13 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.244 2.218 . . . . 0.0 113.156 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 59.41 32.72 73.46 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.338 0.97 . . . . 0.0 112.958 176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -134.06 145.7 49.64 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.404 1.082 . . . . 0.0 109.063 -164.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -156.29 158.71 37.96 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.694 1.597 . . . . 0.0 108.247 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.503 1.521 . . . . 0.0 111.196 176.39 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.46 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -70.76 164.63 34.84 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.039 1.826 . . . . 0.0 110.704 171.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.01 143.26 27.13 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 164.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -130.97 115.55 16.64 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -162.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -154.39 161.66 41.6 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.128 0.571 . . . . 0.0 111.711 -162.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.0 t -157.03 174.33 15.68 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 159.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -133.48 168.11 19.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.474 1.909 . . . . 0.0 109.07 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -139.46 155.9 47.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.422 1.089 . . . . 0.0 109.717 -168.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.3 p -133.45 126.94 32.26 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 126.504 1.921 . . . . 0.0 107.015 175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.56 -159.37 13.03 Favored Glycine 0 CA--C 1.524 0.597 0 CA-C-N 119.038 0.835 . . . . 0.0 113.565 -161.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -142.9 162.24 36.0 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 125.182 1.393 . . . . 0.0 109.916 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -141.65 143.56 33.69 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.803 1.641 . . . . 0.0 107.149 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 pp -145.77 145.07 30.68 Favored 'General case' 0 N--CA 1.462 0.139 0 C-N-CA 123.532 0.733 . . . . 0.0 109.462 166.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.65 174.49 29.14 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 124.704 1.145 . . . . 0.0 112.932 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -149.36 167.23 26.71 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.538 0.735 . . . . 0.0 110.316 170.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 t -126.93 150.01 49.54 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.194 1.397 . . . . 0.0 107.992 165.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -72.49 170.46 14.28 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.796 1.238 . . . . 0.0 110.724 -174.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -62.68 151.16 39.05 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 158.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.416 ' HA ' ' CE1' ' A' ' 31' ' ' HIS . 4.4 t-80 39.23 79.19 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.697 2.399 . . . . 0.0 113.639 173.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.65 -168.16 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.207 1.003 . . . . 0.0 111.719 163.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 t -56.29 -25.52 48.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.006 1.722 . . . . 0.0 113.2 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.92 -159.84 2.6 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.638 1.59 . . . . 0.0 112.347 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -139.89 166.13 25.46 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.473 -1.016 . . . . 0.0 108.58 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.9 pt -61.75 152.06 6.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 123.097 0.559 . . . . 0.0 110.256 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -78.48 79.48 4.91 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 121.903 -0.498 . . . . 0.0 110.5 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 62.33 -66.4 0.08 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.2 2.6 . . . . 0.0 114.286 161.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.19 -3.21 12.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.251 1.82 . . . . 0.0 111.659 -176.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -159.31 170.68 35.67 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-N 119.747 1.158 . . . . 0.0 112.117 174.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.91 -56.28 0.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.437 2.758 . . . . 0.0 113.257 -165.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.4 p 56.57 -75.15 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.194 1.798 . . . . 0.0 112.691 -159.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.416 ' CE1' ' HA ' ' A' ' 19' ' ' HIS . 0.6 OUTLIER -76.8 55.77 1.11 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.356 1.462 . . . . 0.0 113.106 -172.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.98 -17.09 33.89 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.947 0.899 . . . . 0.0 112.211 172.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -173.44 162.13 4.22 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.39 1.876 . . . . 0.0 108.079 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.27 157.22 46.86 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 158.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.98 153.51 46.89 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.034 1.334 . . . . 0.0 109.787 -174.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.64 144.73 12.58 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 160.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.05 121.65 2.43 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 175.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.94 170.05 39.84 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-O 121.702 0.612 . . . . 0.0 114.368 -172.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.77 139.93 30.6 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -135.62 165.4 25.63 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.242 1.017 . . . . 0.0 110.758 -167.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.67 162.54 25.84 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 163.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.64 165.35 25.86 Favored Glycine 0 CA--C 1.518 0.258 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 -176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -146.18 134.44 21.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.393 1.877 . . . . 0.0 106.284 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.09 118.89 29.81 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 159.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -145.72 -1.42 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -160.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -141.54 167.62 16.46 Favored Pre-proline 0 C--O 1.235 0.327 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -61.08 133.98 50.2 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 N-CA-C 107.059 -1.939 . . . . 0.0 107.059 158.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 63.32 -9.42 0.12 Allowed 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.2 t -136.54 103.99 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 121.84 2.109 . . . . 0.0 111.127 -169.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -102.6 -168.42 26.52 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.943 1.735 . . . . 0.0 110.544 168.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -148.44 162.54 39.4 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.862 1.265 . . . . 0.0 108.543 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HG2' HH22 ' A' ' 138' ' ' ARG . 0.0 OUTLIER -151.56 157.86 42.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.116 0.966 . . . . 0.0 110.42 171.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 64.5 mtt -146.48 152.76 39.53 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 125.799 1.639 . . . . 0.0 107.46 -175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.02 173.06 44.08 Favored Glycine 0 C--N 1.332 0.357 0 CA-C-N 119.186 0.903 . . . . 0.0 113.178 170.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -126.51 116.25 20.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.543 1.937 . . . . 0.0 107.954 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -84.21 148.66 26.61 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 125.797 1.639 . . . . 0.0 108.907 176.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -144.97 118.86 9.29 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.41 -35.61 76.19 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 112.15 -167.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.42 150.4 12.07 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -73.48 118.07 15.99 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 90.0 mtp -60.5 147.82 82.13 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-O 118.906 -0.569 . . . . 0.0 109.784 175.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.82 69.47 4.52 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.681 2.921 . . . . 0.0 109.382 171.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -62.13 -28.12 69.42 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.193 0.997 . . . . 0.0 113.564 -162.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? 60.52 -61.32 0.07 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.641 3.176 . . . . 0.0 113.392 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.49 42.34 0.02 OUTLIER Glycine 0 CA--C 1.527 0.818 0 C-N-CA 128.337 2.875 . . . . 0.0 108.034 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.6 m -70.99 167.88 18.23 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.129 0.972 . . . . 0.0 110.867 -176.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.6 m -130.83 170.33 19.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.926 1.69 . . . . 0.0 107.192 168.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.259 9.5 pt-20 51.47 -24.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 130.691 3.596 . . . . 0.0 117.288 -174.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -68.16 82.25 0.23 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.544 1.538 . . . . 0.0 109.669 170.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -131.9 -172.33 13.04 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.007 1.765 . . . . 0.0 110.809 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 59.99 172.47 0.09 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.814 2.046 . . . . 0.0 113.702 -173.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -73.48 131.16 41.48 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.828 1.251 . . . . 0.0 112.131 -169.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -149.94 157.39 43.12 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.412 1.485 . . . . 0.0 110.075 172.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 41.12 60.22 2.08 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.457 2.303 . . . . 0.0 112.714 172.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -155.14 -179.55 8.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.785 0.834 . . . . 0.0 111.466 -166.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -160.44 -178.31 34.32 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 123.512 0.577 . . . . 0.0 111.851 172.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -140.16 146.03 25.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 126.458 1.903 . . . . 0.0 107.106 175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -130.11 147.75 51.89 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 125.694 1.598 . . . . 0.0 108.012 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.34 125.79 10.18 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.961 0.904 . . . . 0.0 109.025 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 63.5 p -141.99 154.07 44.75 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-O 120.846 0.355 . . . . 0.0 111.255 -177.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.53 142.77 29.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 164.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -115.41 102.93 10.28 Favored 'General case' 0 N--CA 1.458 -0.065 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 mp -92.83 107.44 19.22 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 -178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.09 166.79 39.98 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 117.819 0.281 . . . . 0.0 112.545 -171.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -157.7 157.6 29.9 Favored Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 124.023 0.929 . . . . 0.0 110.341 -171.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -70.79 125.96 12.15 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.205 2.603 . . . . 0.0 110.443 169.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.1 mm -62.39 -47.23 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 168.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.8 t -159.12 179.52 8.96 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.377 1.871 . . . . 0.0 106.554 173.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 25.97 -87.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 130.497 3.519 . . . . 0.0 113.447 163.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -142.04 94.94 2.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.822 1.249 . . . . 0.0 108.974 167.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -163.89 105.89 0.93 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 127.016 2.127 . . . . 0.0 105.423 158.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -86.94 139.57 30.47 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 172.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 20.2 tt -120.09 141.27 41.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 169.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -147.83 170.62 17.23 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 123.19 1.471 . . . . 0.0 113.793 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.0 m -137.41 128.05 26.9 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.666 1.986 . . . . 0.0 106.433 163.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -104.85 146.56 28.82 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.898 0.879 . . . . 0.0 108.734 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.4 tt -149.83 139.4 21.59 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.772 0.829 . . . . 0.0 109.402 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 170.16 -128.21 1.6 Allowed Glycine 0 C--N 1.333 0.39 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -148.8 174.31 28.47 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-O 122.072 0.818 . . . . 0.0 113.085 -173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -150.31 162.12 41.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 125.132 1.373 . . . . 0.0 109.746 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.2 t -137.09 137.35 46.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 171.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -131.73 158.33 41.46 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 123.379 0.671 . . . . 0.0 110.988 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -140.42 104.05 4.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 127.113 2.165 . . . . 0.0 106.826 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -101.1 107.64 19.13 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 171.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.19 103.44 4.62 Favored 'General case' 0 C--O 1.23 0.061 0 CA-C-O 121.264 0.554 . . . . 0.0 110.212 -173.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.7 t -166.53 171.31 11.91 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.779 2.032 . . . . 0.0 106.719 165.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -77.8 76.49 4.33 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 167.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.8 t -57.53 101.68 0.08 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.836 1.254 . . . . 0.0 111.318 -168.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -161.84 -165.8 1.33 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.219 1.807 . . . . 0.0 108.22 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.6 t 58.99 69.18 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.528 1.531 . . . . 0.0 108.895 -176.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -62.02 5.98 0.08 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.801 2.44 . . . . 0.0 116.244 -163.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -77.53 -17.32 79.23 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.441 1.019 . . . . 0.0 111.796 163.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.49 165.27 11.65 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.283 1.433 . . . . 0.0 107.203 161.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -144.98 152.91 40.9 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.88 70.44 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 128.676 2.79 . . . . 0.0 104.344 -172.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -51.66 -64.27 0.87 Allowed 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 126.846 2.058 . . . . 0.0 112.746 -158.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 85.5 m 65.9 146.65 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.763 2.025 . . . . 0.0 111.672 -167.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 114.21 -174.38 15.51 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.246 0.927 . . . . 0.0 112.101 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.6 p -88.33 148.72 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.817 1.647 . . . . 0.0 109.637 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.3 t -153.09 152.75 28.58 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.319 1.048 . . . . 0.0 108.999 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.36 161.45 44.75 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.955 1.77 . . . . 0.0 110.042 164.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.0 p -148.53 144.29 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -148.2 153.05 38.25 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.632 1.173 . . . . 0.0 108.971 171.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.9 167.64 29.87 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.746 1.218 . . . . 0.0 109.477 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -108.73 169.7 14.24 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 173.67 -173.79 45.94 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 118.747 1.273 . . . . 0.0 113.968 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.0 156.8 35.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.779 1.231 . . . . 0.0 109.536 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -134.34 151.56 51.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.042 1.337 . . . . 0.0 108.885 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.42 108.66 4.6 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.914 0.886 . . . . 0.0 109.747 -164.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -78.71 81.36 5.02 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.033 0.833 . . . . 0.0 110.202 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.3 mm -51.2 -39.05 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 125.489 1.516 . . . . 0.0 110.793 -178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 51.2 p -135.65 165.66 34.42 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 159.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.58 43.82 0.68 Allowed 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 122.907 2.405 . . . . 0.0 110.839 164.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -149.25 -45.24 0.14 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 128.427 2.691 . . . . 0.0 109.531 -178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 14.7 tt -137.57 145.16 29.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 118.973 0.806 . . . . 0.0 110.464 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.66 137.76 30.16 Favored 'General case' 0 C--N 1.343 0.291 0 C-N-CA 123.93 0.892 . . . . 0.0 109.93 -165.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 53.2 m -93.91 152.93 18.51 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.37 1.468 . . . . 0.0 109.236 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.403 HH22 ' HG2' ' A' ' 52' ' ' GLU . 37.9 mtp180 -124.02 149.12 46.42 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.215 1.806 . . . . 0.0 107.793 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.98 144.21 41.04 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.476 1.91 . . . . 0.0 106.033 171.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -144.5 146.94 32.68 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.375 1.47 . . . . 0.0 109.448 -171.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -137.03 121.09 17.76 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 127.079 2.152 . . . . 0.0 107.525 172.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.59 165.88 19.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.994 2.118 . . . . 0.0 108.391 -170.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -83.39 164.26 20.06 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 122.514 1.149 . . . . 0.0 110.303 -173.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 44.0 m -151.31 96.37 2.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 102.005 -3.331 . . . . 0.0 102.005 166.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 53.71 -176.14 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.558 1.543 . . . . 0.0 111.457 -158.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -157.22 144.72 18.81 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.857 1.263 . . . . 0.0 107.965 169.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.401 ' CG2' ' H ' ' A' ' 152' ' ' THR . 32.6 mt 45.48 68.09 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 127.377 2.271 . . . . 0.0 110.628 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.0 -82.18 1.62 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 166.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 150' ' ' ALA . 6.8 p-10 -38.89 -89.39 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 131.193 3.797 . . . . 0.0 115.367 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.412 ' H ' ' CG ' ' A' ' 149' ' ' ASP . . . -73.63 70.15 1.32 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.488 1.515 . . . . 0.0 108.526 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -54.97 121.72 9.32 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.641 0.776 . . . . 0.0 112.43 -161.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.401 ' H ' ' CG2' ' A' ' 147' ' ' ILE . 71.0 p 66.16 -1.15 1.23 Allowed 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 127.719 2.408 . . . . 0.0 115.043 -175.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 75.6 mt -103.45 -34.59 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.216 1.406 . . . . 0.0 109.313 177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -163.23 175.15 39.56 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 118.93 0.786 . . . . 0.0 112.229 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 11.7 t -132.37 102.15 5.63 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.444 1.898 . . . . 0.0 106.16 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 15.3 mtp-105 -130.63 96.32 23.99 Favored Pre-proline 0 CA--C 1.533 0.318 0 O-C-N 121.468 -0.77 . . . . 0.0 109.998 -170.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -78.84 178.28 7.72 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.269 1.979 . . . . 0.0 108.576 158.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -64.62 -55.42 20.35 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 159.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -145.55 152.16 39.28 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -69.47 -168.14 5.95 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 170.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 14.6 ttt -72.33 140.39 48.47 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 166.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -138.73 152.03 47.63 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 171.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.28 163.55 32.64 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 123.883 0.739 . . . . 0.0 109.91 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.89 166.77 22.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.494 1.118 . . . . 0.0 108.938 164.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -158.73 172.96 35.66 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 48.7 t -142.34 145.73 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.21 113.24 4.52 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -159.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -82.81 132.56 35.16 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 145.3 25.38 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.615 0.643 . . . . 0.0 112.151 -171.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -76.98 149.78 35.92 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.924 1.29 . . . . 0.0 111.411 171.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.72 166.08 36.58 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 106.953 -2.459 . . . . 0.0 106.953 159.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.51 35.46 2.04 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.221 1.008 . . . . 0.0 109.111 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 78.48 -62.81 3.77 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 -164.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 176' ' ' ALA . 16.6 pt-20 -72.47 170.82 13.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.538 0.735 . . . . 0.0 110.519 160.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -86.98 -3.36 59.08 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.69 1.196 . . . . 0.0 113.193 177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.461 ' H ' ' HG3' ' A' ' 174' ' ' GLU . . . . . . . . 0 C--O 1.25 1.084 0 C-N-CA 126.295 1.838 . . . . 0.0 109.481 -159.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -69.72 170.77 15.75 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.239 1.96 . . . . 0.0 110.506 167.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.17 -159.03 0.94 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.681 1.193 . . . . 0.0 108.053 171.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -48.92 178.15 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.648 1.579 . . . . 0.0 112.926 161.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.57 -60.51 2.23 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.827 -1.17 . . . . 0.0 109.943 170.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.2 p -149.17 162.36 40.14 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.082 0.953 . . . . 0.0 110.822 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -128.25 153.07 47.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.159 1.784 . . . . 0.0 109.113 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -144.92 152.3 40.0 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.288 1.835 . . . . 0.0 108.065 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -150.05 148.34 28.91 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 121.323 -0.86 . . . . 0.0 111.216 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.64 -104.78 0.2 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 125.687 1.613 . . . . 0.0 109.425 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -157.37 169.12 25.45 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 118.204 1.002 . . . . 0.0 113.526 -166.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' HE3' ' CE1' ' A' ' 40' ' ' PHE . 17.0 ptpt -142.52 166.19 25.34 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.705 1.202 . . . . 0.0 109.212 158.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.5 tt -131.03 115.98 17.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 163.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.87 146.46 20.55 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 107.931 -2.068 . . . . 0.0 107.931 167.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -150.8 142.24 23.43 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.526 1.53 . . . . 0.0 111.08 -170.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.1 p -154.2 172.73 17.14 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.34 1.056 . . . . 0.0 109.769 161.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.19 171.77 2.18 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 158.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -110.2 -53.15 2.71 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.798 1.239 . . . . 0.0 110.872 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -130.07 -54.8 1.12 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.654 0.782 . . . . 0.0 109.942 172.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 165.6 -49.78 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 129.873 3.269 . . . . 0.0 107.138 -176.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.2 m -143.73 30.95 1.31 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.28 1.832 . . . . 0.0 108.468 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.35 -144.23 48.24 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.095 -1.628 . . . . 0.0 109.176 -168.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -78.19 50.59 0.92 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.602 -0.94 . . . . 0.0 109.922 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.4 mm 47.21 46.35 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 126.28 1.832 . . . . 0.0 109.598 -167.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -62.05 94.41 0.05 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 128.158 2.583 . . . . 0.0 110.663 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -126.65 146.77 50.06 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 125.755 1.622 . . . . 0.0 107.404 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.2 -38.89 0.09 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.656 2.382 . . . . 0.0 113.668 -167.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -107.81 82.87 0.32 Allowed Glycine 0 CA--C 1.531 1.092 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 162.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -69.54 173.2 11.12 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 123.444 2.763 . . . . 0.0 111.697 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.42 HG23 ' H ' ' A' ' 32' ' ' GLU . 11.8 t -146.12 176.31 9.83 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 167.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -71.95 -12.81 61.42 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.124 1.37 . . . . 0.0 113.26 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.42 ' H ' HG23 ' A' ' 30' ' ' THR . 2.0 tm-20 51.72 -164.63 0.06 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.574 1.15 . . . . 0.0 109.501 -159.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 72.71 156.34 0.17 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.677 1.991 . . . . 0.0 114.714 163.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -135.85 142.85 44.83 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 170.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.1 169.56 17.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.37 0.268 . . . . 0.0 110.35 170.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.14 96.3 0.19 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 106.991 -2.443 . . . . 0.0 106.991 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.88 129.92 46.01 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.953 1.301 . . . . 0.0 108.264 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -164.92 169.5 39.59 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 114.69 0.636 . . . . 0.0 114.69 -169.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.83 154.52 17.21 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.68 1.192 . . . . 0.0 108.951 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.439 ' CE1' ' HE3' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -146.63 155.52 42.52 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.217 1.007 . . . . 0.0 111.799 -171.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.3 158.22 25.85 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 163.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.73 166.2 39.21 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 117.418 0.609 . . . . 0.0 111.743 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -145.05 145.93 31.66 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.418 1.087 . . . . 0.0 110.535 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -87.9 110.9 20.89 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 162.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.4 p -75.59 -23.21 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 118.527 0.603 . . . . 0.0 110.244 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.36 166.44 15.15 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 126.938 2.095 . . . . 0.0 106.687 169.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.22 6.4 0.66 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.817 2.345 . . . . 0.0 114.433 -175.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -137.83 1.01 2.26 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.614 1.566 . . . . 0.0 113.513 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.6 t -143.85 149.58 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 119.549 1.068 . . . . 0.0 109.057 -174.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -179.59 -165.72 34.11 Favored Glycine 0 C--N 1.336 0.576 0 O-C-N 121.105 -0.997 . . . . 0.0 112.758 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -142.16 160.82 39.46 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 124.548 1.139 . . . . 0.0 109.311 170.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -145.61 149.92 35.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 126.295 1.838 . . . . 0.0 107.954 168.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 53.5 mtt -148.71 153.31 38.04 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.6 1.16 . . . . 0.0 108.193 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.06 173.34 44.12 Favored Glycine 0 C--N 1.333 0.375 0 CA-C-O 119.655 -0.525 . . . . 0.0 111.954 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -135.06 136.4 42.02 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.024 0.93 . . . . 0.0 109.83 -175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.67 166.67 25.15 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.756 1.222 . . . . 0.0 112.241 -166.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -155.38 173.81 16.13 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.203 1.001 . . . . 0.0 110.102 162.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 50.7 tp -59.26 -29.69 67.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.723 1.609 . . . . 0.0 111.701 166.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.87 176.91 50.15 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.875 1.226 . . . . 0.0 111.839 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 68' ' ' GLU . 21.2 ttp180 -160.03 176.11 12.21 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.103 1.761 . . . . 0.0 106.961 169.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.8 tmm? 25.11 77.65 0.24 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 129.034 2.933 . . . . 0.0 113.163 169.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.52 65.33 8.07 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.837 3.025 . . . . 0.0 111.501 -172.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 52.67 -161.69 0.1 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.662 1.985 . . . . 0.0 111.336 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.0 mttp 75.61 -52.43 0.64 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 127.167 2.187 . . . . 0.0 110.114 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.22 120.52 22.32 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 108.344 -1.902 . . . . 0.0 108.344 160.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.8 m -71.59 -10.1 59.26 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.4 t -140.98 156.5 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.379 1.872 . . . . 0.0 106.079 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 60' ' ' ARG . 3.4 tp10 -122.7 132.26 54.17 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 171.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -80.02 73.72 6.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.836 1.255 . . . . 0.0 109.69 -174.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.4 91.63 1.74 Allowed Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -171.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.46 -62.41 1.89 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.279 1.432 . . . . 0.0 112.09 -173.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -61.98 155.49 23.62 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.549 0.74 . . . . 0.0 109.617 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.89 174.79 12.7 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.288 0.635 . . . . 0.0 110.402 -169.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.18 155.72 4.64 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.561 161.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -170.61 168.31 7.63 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 124.321 1.048 . . . . 0.0 109.896 -170.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.8 171.79 27.46 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 112.032 -0.427 . . . . 0.0 112.032 171.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.3 125.6 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.22 1.408 . . . . 0.0 107.923 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -95.87 144.07 26.53 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 127.769 2.428 . . . . 0.0 108.382 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -141.83 125.42 16.81 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.329 1.052 . . . . 0.0 108.915 169.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.61 123.93 19.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.4 1.08 . . . . 0.0 108.449 -167.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.54 138.47 32.74 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 171.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.3 mttm -99.78 129.22 45.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.323 1.049 . . . . 0.0 108.645 -178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.0 pp -128.08 137.53 52.18 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 158.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.22 -172.45 43.47 Favored Glycine 0 C--O 1.226 -0.363 0 CA-C-O 119.191 -0.783 . . . . 0.0 111.448 -165.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -155.67 157.93 31.65 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 124.672 1.189 . . . . 0.0 109.253 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -62.2 141.9 89.75 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.882 1.721 . . . . 0.0 109.274 161.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.4 tp -107.73 -4.68 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.79 0.836 . . . . 0.0 110.455 171.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 99.8 m -149.92 -87.53 0.08 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 104.604 -2.369 . . . . 0.0 104.604 159.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -152.52 -44.02 0.1 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.173 1.789 . . . . 0.0 106.83 159.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.14 -20.41 53.45 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.915 2.486 . . . . 0.0 112.645 174.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.67 138.88 51.43 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.878 1.671 . . . . 0.0 108.483 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -140.46 127.01 20.18 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.399 1.479 . . . . 0.0 109.865 177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 pp -99.09 153.98 4.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 125.751 1.621 . . . . 0.0 109.579 -172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -150.15 157.6 43.27 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 122.15 0.976 . . . . 0.0 113.415 -169.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 88.6 m -114.07 121.7 44.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 158.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -105.81 109.22 21.1 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 tt -125.85 128.24 47.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.98 0.809 . . . . 0.0 110.154 -168.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 168.48 -98.33 0.14 Allowed Glycine 0 C--N 1.333 0.406 0 N-CA-C 108.688 -1.765 . . . . 0.0 108.688 176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.04 -162.43 36.23 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.758 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -145.95 159.36 43.35 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.502 1.121 . . . . 0.0 109.872 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.14 151.25 35.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.598 1.159 . . . . 0.0 108.138 168.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -136.04 145.02 45.57 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.809 0.844 . . . . 0.0 111.171 -170.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -119.35 111.19 17.85 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 129.014 2.926 . . . . 0.0 106.809 -177.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.34 107.4 17.97 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 104.193 -2.521 . . . . 0.0 104.193 165.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -91.86 119.22 31.45 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -174.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 50.2 m 69.67 -39.92 0.44 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.912 2.085 . . . . 0.0 113.454 168.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -73.51 175.3 7.16 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.052 1.341 . . . . 0.0 111.381 170.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.5 m -152.51 -75.22 0.13 Allowed 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 159.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 41.51 62.35 1.56 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.336 1.855 . . . . 0.0 113.45 165.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 m -135.67 154.5 34.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -71.0 -27.7 63.89 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.058 0.943 . . . . 0.0 112.151 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.82 76.09 1.02 Allowed Glycine 0 C--N 1.339 0.745 0 N-CA-C 107.721 -2.152 . . . . 0.0 107.721 -162.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -138.99 -65.45 0.49 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.494 1.518 . . . . 0.0 106.986 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.27 178.5 8.7 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 128.741 2.816 . . . . 0.0 104.414 159.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -148.58 150.5 33.43 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -70.51 29.97 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.463 2.305 . . . . 0.0 112.315 169.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.05 153.58 46.83 Favored 'General case' 0 C--N 1.341 0.226 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 162.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.78 -161.02 25.81 Favored Glycine 0 C--N 1.338 0.649 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 p -129.64 145.53 35.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 126.361 1.864 . . . . 0.0 107.025 173.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 8.3 t -140.85 96.98 7.27 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.71 117.86 5.22 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.992 2.461 . . . . 0.0 108.329 170.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.6 m -146.34 171.15 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 123.476 0.71 . . . . 0.0 110.227 -172.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -138.55 162.59 34.18 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 165.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.53 163.3 29.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.411 1.884 . . . . 0.0 108.488 174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -108.8 151.45 17.08 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 106.969 -2.453 . . . . 0.0 106.969 162.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -174.55 -174.32 41.2 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 117.9 0.85 . . . . 0.0 112.723 -173.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 10.1 p -146.57 159.52 10.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 124.571 1.149 . . . . 0.0 108.659 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.2 145.08 49.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.049 2.14 . . . . 0.0 107.164 160.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -142.94 106.1 4.56 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.285 1.834 . . . . 0.0 107.534 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -87.58 81.97 7.58 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.841 1.256 . . . . 0.0 108.296 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.43 -25.18 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.099 0.56 . . . . 0.0 111.512 177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.1 p -137.03 143.65 43.07 Favored Pre-proline 0 CA--C 1.538 0.502 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 158.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.58 -18.57 59.48 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 122.763 2.308 . . . . 0.0 114.015 -166.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -62.95 -24.26 67.79 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.73 2.012 . . . . 0.0 112.249 176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.27 164.83 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 125.28 1.432 . . . . 0.0 109.806 -167.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.46 150.56 49.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 162.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 61.4 p -106.92 150.42 26.45 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 158.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -143.79 147.53 34.27 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.097 0.862 . . . . 0.0 110.109 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.49 159.33 42.12 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.206 1.803 . . . . 0.0 107.771 -175.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -163.38 151.99 14.01 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.457 0.703 . . . . 0.0 111.483 -167.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -145.58 139.84 26.98 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.582 1.153 . . . . 0.0 109.74 160.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -132.46 175.69 9.08 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 126.058 1.743 . . . . 0.0 108.915 163.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -93.03 164.28 13.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.223 1.009 . . . . 0.0 110.632 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 37.5 m -131.5 118.74 20.59 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.067 1.747 . . . . 0.0 106.812 177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -62.05 138.37 58.37 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 2.1 t30 37.07 59.65 1.08 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.966 2.106 . . . . 0.0 112.224 -172.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.0 tp -63.17 90.26 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.501 1.12 . . . . 0.0 108.689 165.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 146.05 -172.94 26.54 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.247 1.403 . . . . 0.0 110.439 -171.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -148.26 171.87 15.27 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.193 1.797 . . . . 0.0 107.303 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 47.73 36.13 5.36 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.543 1.937 . . . . 0.0 112.353 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 48.82 13.46 0.06 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 129.315 3.046 . . . . 0.0 115.73 -170.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . 0.271 1.2 p 41.51 -89.79 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.535 2.334 . . . . 0.0 111.777 -161.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 8.5 tp -139.26 49.36 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 122.506 1.146 . . . . 0.0 108.588 175.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 79.02 -57.18 4.34 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -172.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 13.8 t -79.59 158.69 27.06 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 111.08 166.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 18.0 mtt85 -130.95 159.48 71.21 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 129.249 3.02 . . . . 0.0 108.01 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -64.72 -179.19 0.88 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.744 1.63 . . . . 0.0 109.961 159.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -134.91 121.22 20.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.649 -1.612 . . . . 0.0 106.649 160.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.02 -3.05 11.61 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 126.016 1.726 . . . . 0.0 109.905 163.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 38.21 -115.63 0.42 Allowed Glycine 0 C--N 1.342 0.903 0 C-N-CA 126.748 2.118 . . . . 0.0 111.146 -174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 19.0 ttm -148.65 118.09 6.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 158.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.01 154.2 31.69 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 165.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.27 155.05 50.88 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 118.887 0.767 . . . . 0.0 109.78 159.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.76 153.52 51.13 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 125.77 1.628 . . . . 0.0 107.496 168.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.24 175.49 40.31 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 118.696 0.68 . . . . 0.0 112.843 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 18.4 m -141.33 164.0 20.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.465 1.106 . . . . 0.0 109.946 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 58.8 m -155.93 161.2 40.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 121.214 -0.928 . . . . 0.0 110.809 166.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -100.76 155.61 17.82 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.68 1.592 . . . . 0.0 107.233 159.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.1 ptm85 -90.03 158.68 17.22 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -73.55 116.0 13.6 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 158.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 151.86 150.7 5.42 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 123.909 0.766 . . . . 0.0 111.299 177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 67.04 -63.35 0.28 Allowed 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 128.635 2.774 . . . . 0.0 111.832 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -75.62 42.78 1.54 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.41 1.481 . . . . 0.0 111.838 173.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -80.53 61.05 4.12 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.306 1.842 . . . . 0.0 109.365 -174.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 57.64 -168.67 0.12 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.516 1.926 . . . . 0.0 112.004 -166.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 C-N-CA 127.79 2.436 . . . . 0.0 106.391 174.786 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.93 170.6 19.79 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.206 1.937 . . . . 0.0 110.614 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -141.18 77.18 1.58 Allowed 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 170.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.92 -7.7 18.15 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.693 1.597 . . . . 0.0 115.06 -161.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.07 145.95 46.51 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 163.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.8 m -153.06 122.44 6.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 173.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -81.62 160.09 23.87 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 170.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -148.27 160.73 42.67 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 126.424 1.89 . . . . 0.0 108.022 171.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.6 t -148.93 161.54 41.68 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 172.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.89 -160.49 26.18 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -165.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -145.59 153.37 40.99 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.438 ' HE3' ' CZ ' ' A' ' 40' ' ' PHE . 28.0 mtmt -131.0 155.0 47.58 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.903 0.881 . . . . 0.0 109.929 172.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.3 tp -114.19 151.91 32.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.538 2.335 . . . . 0.0 106.074 164.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.91 169.06 29.39 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 118.878 0.763 . . . . 0.0 113.497 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -141.21 136.62 31.92 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 126.679 1.991 . . . . 0.0 109.068 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.1 m -143.2 80.91 1.69 Allowed 'General case' 0 C--O 1.24 0.578 0 C-N-CA 125.109 1.364 . . . . 0.0 110.508 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.29 146.08 50.83 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 158.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -169.48 107.43 0.4 Allowed 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -128.61 153.96 46.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.022 -2.585 . . . . 0.0 104.022 158.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 153.41 -49.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 128.48 2.712 . . . . 0.0 108.088 -159.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 91.7 m -135.38 96.79 3.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.07 -109.95 0.27 Allowed Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.872 -0.404 . . . . 0.0 113.079 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -157.09 2.15 0.13 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.315 1.446 . . . . 0.0 114.548 -166.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.298 9.4 pt 57.22 140.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 131.268 3.827 . . . . 0.0 115.038 -167.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.04 172.66 12.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.049 1.339 . . . . 0.0 109.663 167.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -88.32 -111.82 0.06 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 164.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -60.37 153.64 22.31 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.822 1.192 . . . . 0.0 108.383 158.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 143.27 98.01 0.27 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -170.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.15 63.18 5.18 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.931 3.087 . . . . 0.0 110.093 174.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.3 m -62.28 147.21 48.83 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.946 1.698 . . . . 0.0 109.93 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -151.78 148.72 28.21 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.823 -161.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.65 -82.57 0.2 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 164.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -28.34 59.57 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.008 -171.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 71.26 -62.43 0.45 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 126.309 1.844 . . . . 0.0 110.135 -173.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 pp -146.63 174.24 11.62 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.941 1.296 . . . . 0.0 110.736 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.73 159.2 27.88 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 165.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.74 121.87 3.77 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.12 1.768 . . . . 0.0 107.286 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.79 165.56 35.19 Favored Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.878 -174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.33 146.52 24.31 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.102 1.361 . . . . 0.0 108.129 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.438 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 39.4 m-85 -130.3 154.72 47.34 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.074 0.949 . . . . 0.0 110.322 -171.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.11 137.43 5.81 Favored Glycine 0 CA--C 1.52 0.386 0 N-CA-C 107.823 -2.111 . . . . 0.0 107.823 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.04 166.83 39.73 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -166.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -139.88 168.06 20.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 117.402 0.601 . . . . 0.0 110.833 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -117.68 151.67 36.77 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 126.528 1.931 . . . . 0.0 108.049 163.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 1.8 p -116.74 90.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 164.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 19.1 m-20 58.21 176.96 0.04 OUTLIER Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 127.207 2.203 . . . . 0.0 112.56 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.63 75.05 0.82 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.529 2.152 . . . . 0.0 109.231 162.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -147.73 -75.82 0.18 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.298 1.439 . . . . 0.0 109.438 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.63 166.46 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 123.911 0.884 . . . . 0.0 109.242 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -164.64 -161.32 13.42 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -177.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -138.59 158.66 43.83 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.126 1.37 . . . . 0.0 109.79 172.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -139.71 120.3 14.17 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 127.803 2.441 . . . . 0.0 106.853 169.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -118.9 166.02 13.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.798 1.639 . . . . 0.0 107.854 169.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.91 173.32 41.5 Favored Glycine 0 N--CA 1.452 -0.281 0 O-C-N 121.792 -0.568 . . . . 0.0 111.982 173.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -134.67 115.85 14.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.711 2.004 . . . . 0.0 106.535 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.27 139.5 30.68 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.609 1.563 . . . . 0.0 107.73 172.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -158.47 136.66 10.75 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.993 0.425 . . . . 0.0 111.25 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 58.5 tp -140.92 113.73 8.31 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.492 1.517 . . . . 0.0 108.11 173.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -78.42 39.22 1.89 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.292 0.949 . . . . 0.0 113.158 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? 56.46 -72.41 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 127.552 2.341 . . . . 0.0 110.716 -159.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 60.5 mtm -122.48 97.01 45.29 Favored Pre-proline 0 N--CA 1.448 -0.545 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 173.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -64.5 -11.53 28.98 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.468 2.112 . . . . 0.0 112.789 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -53.03 -26.49 15.83 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.497 1.919 . . . . 0.0 112.799 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 77.8 tttt 63.18 -7.82 0.15 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.434 2.294 . . . . 0.0 114.984 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -68.0 77.61 0.22 Allowed Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 165.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 4.4 t 69.2 173.76 0.29 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.447 2.299 . . . . 0.0 111.58 -164.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.5 m -149.74 172.45 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 128.042 2.537 . . . . 0.0 107.245 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -89.04 151.51 22.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 122.476 1.131 . . . . 0.0 108.556 164.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -50.32 -53.13 31.04 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.693 2.397 . . . . 0.0 112.262 171.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 171.54 -146.44 9.48 Favored Glycine 0 CA--C 1.533 1.169 0 CA-C-N 119.953 1.251 . . . . 0.0 111.828 -171.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 63.02 -29.77 0.09 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 130.405 3.482 . . . . 0.0 115.335 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.96 170.6 2.05 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.693 1.597 . . . . 0.0 111.717 169.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -93.98 130.77 39.97 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.558 0.743 . . . . 0.0 110.011 175.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.55 -52.81 2.91 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -160.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -162.5 169.75 19.82 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.498 0.59 . . . . 0.0 111.688 -167.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.03 175.63 42.19 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 t -138.24 123.51 23.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -95.2 145.03 25.33 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 171.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.0 107.81 4.32 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.6 p -138.03 144.45 41.05 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.091 0.556 . . . . 0.0 111.717 -174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.91 152.65 23.38 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 162.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.79 157.08 47.73 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.399 0.679 . . . . 0.0 112.007 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.3 tp -140.78 136.66 32.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.926 2.49 . . . . 0.0 105.891 175.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.04 158.75 29.1 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 166.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.91 141.65 18.94 Favored Pre-proline 0 C--O 1.238 0.452 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.907 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 92' ' ' ASP . 49.0 Cg_endo -67.27 145.1 70.98 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.506 2.804 . . . . 0.0 110.385 177.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.1 pp -112.57 -4.92 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.053 0.541 . . . . 0.0 111.419 167.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 53.6 m -162.05 165.05 27.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.908 2.883 . . . . 0.0 103.947 167.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -70.16 51.2 0.12 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.276 1.83 . . . . 0.0 110.501 167.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -150.0 -54.13 0.16 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.946 2.098 . . . . 0.0 109.519 -170.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.9 pp -144.69 156.0 43.86 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.895 0.855 . . . . 0.0 112.546 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 0.6 OUTLIER -110.73 146.65 35.94 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.862 2.865 . . . . 0.0 108.763 175.458 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.8 mt -90.64 137.76 20.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 163.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -134.35 147.34 50.52 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.364 1.066 . . . . 0.0 111.57 -159.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.9 m -155.07 150.15 26.92 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.047 1.339 . . . . 0.0 109.41 169.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -147.44 154.25 40.58 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.34 1.056 . . . . 0.0 110.275 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -152.69 156.55 39.4 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.578 1.151 . . . . 0.0 111.557 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 157.35 -119.49 0.91 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.27 170.18 26.72 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 118.331 1.066 . . . . 0.0 113.624 -177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -145.75 126.52 14.36 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.519 1.528 . . . . 0.0 107.745 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.2 p -109.06 142.26 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 172.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.42 146.55 42.3 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.631 1.572 . . . . 0.0 108.348 -172.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 49.2 ttp85 -141.24 148.74 40.36 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.458 1.103 . . . . 0.0 109.961 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.09 137.37 36.14 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 126.966 2.106 . . . . 0.0 108.369 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -75.83 103.05 5.73 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.0 t -85.29 24.94 1.06 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -162.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -74.52 62.68 1.03 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.91 1.684 . . . . 0.0 111.763 -174.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.4 t -80.7 -160.98 0.35 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.215 1.406 . . . . 0.0 108.275 159.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -129.79 160.99 31.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.721 1.209 . . . . 0.0 109.813 172.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER 51.75 -151.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 125.008 1.323 . . . . 0.0 109.456 -174.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -77.2 -3.92 42.08 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 120.981 -1.074 . . . . 0.0 112.39 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -81.04 60.8 4.65 Favored Glycine 0 C--N 1.34 0.776 0 C-N-CA 124.196 0.903 . . . . 0.0 111.449 -168.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.2 pttp -114.46 164.75 13.54 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 122.024 0.916 . . . . 0.0 112.1 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -76.31 171.72 14.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 127.779 2.431 . . . . 0.0 111.982 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -66.3 115.27 6.07 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 159.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -80.96 -31.31 34.93 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.302 1.441 . . . . 0.0 113.724 -174.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.9 m -145.72 156.65 43.76 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -167.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -153.11 157.7 27.49 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 165.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.3 p -151.66 30.34 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 125.071 1.348 . . . . 0.0 109.613 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 14.5 m -66.92 157.35 84.67 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 125.668 1.587 . . . . 0.0 112.796 -169.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -65.48 159.68 46.59 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 N-CA-C 108.396 -1.425 . . . . 0.0 108.396 158.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.41 157.13 8.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 O-C-N 121.659 -0.651 . . . . 0.0 109.663 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -146.74 165.06 30.77 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.989 1.316 . . . . 0.0 108.54 165.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -156.55 162.36 39.92 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 162.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.28 165.86 32.97 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 112.125 -0.39 . . . . 0.0 112.125 170.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 160.56 -118.65 0.84 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.8 m -138.83 158.45 30.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 117.876 0.838 . . . . 0.0 111.435 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -129.55 141.63 50.93 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 166.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.2 126.26 18.34 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.177 0.991 . . . . 0.0 108.946 -158.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -73.94 140.44 45.58 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.709 0.686 . . . . 0.0 109.984 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 44.4 mm -117.14 -33.72 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 123.491 0.716 . . . . 0.0 109.962 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 20.7 m -161.87 157.9 21.02 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 172.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.9 -2.65 0.84 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.749 2.299 . . . . 0.0 116.618 -175.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -113.23 -10.11 13.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.065 1.746 . . . . 0.0 113.773 174.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 18.6 tt -148.28 149.09 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 120.049 1.295 . . . . 0.0 111.833 -171.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.14 169.94 16.77 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.273 1.429 . . . . 0.0 108.333 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 11.0 p -120.04 160.31 23.06 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 124.989 1.315 . . . . 0.0 108.369 162.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 18.1 ptt-85 -141.55 159.38 42.34 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 121.58 -0.7 . . . . 0.0 110.114 165.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.38 120.04 12.52 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.16 155.46 43.93 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.951 0.881 . . . . 0.0 111.778 -178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.96 152.74 43.77 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.227 1.811 . . . . 0.0 109.829 -159.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -143.75 115.07 7.99 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.096 1.358 . . . . 0.0 108.059 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -107.38 154.22 21.63 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.166 1.387 . . . . 0.0 109.98 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 14.6 t -145.73 165.0 30.06 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 159.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -79.32 69.93 5.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.682 0.793 . . . . 0.0 110.083 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -52.16 111.87 0.7 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.856 1.662 . . . . 0.0 111.001 177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.1 mt -82.57 42.84 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 125.382 1.473 . . . . 0.0 108.878 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -19.19 97.41 0.01 OUTLIER Glycine 0 C--N 1.339 0.732 0 C-N-CA 130.22 3.771 . . . . 0.0 116.271 -173.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -60.59 105.84 0.49 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.879 1.272 . . . . 0.0 109.597 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -164.21 173.8 11.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.636 1.174 . . . . 0.0 110.316 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -57.33 128.13 35.49 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 158.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.1 m 50.63 70.15 0.55 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.586 1.554 . . . . 0.0 111.626 174.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 37.6 pt -55.94 1.56 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 128.407 2.683 . . . . 0.0 116.601 -171.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -64.32 -49.56 65.1 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 120.318 -1.489 . . . . 0.0 109.588 161.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.3 m -74.97 95.68 3.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 127.052 2.141 . . . . 0.0 109.4 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -131.72 159.46 71.84 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 126.108 1.763 . . . . 0.0 107.899 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -66.11 -18.41 56.44 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 121.77 1.647 . . . . 0.0 111.426 165.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.8 t0 50.01 40.58 21.59 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.53 2.332 . . . . 0.0 112.893 166.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -137.49 143.07 41.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.104 1.362 . . . . 0.0 109.272 -169.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -80.59 -178.39 52.06 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.988 1.756 . . . . 0.0 113.121 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 23.7 ptp -80.74 155.3 26.79 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 122.336 -0.508 . . . . 0.0 109.747 171.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 6.0 tt -139.45 149.41 44.0 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.603 1.161 . . . . 0.0 109.339 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 5.2 p -136.84 161.72 35.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.633 0.73 . . . . 0.0 111.491 160.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -149.21 151.45 34.3 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.125 1.37 . . . . 0.0 109.411 174.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.41 175.45 40.45 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 114.911 0.725 . . . . 0.0 114.911 -172.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 10.4 m -110.31 152.33 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 127.456 2.302 . . . . 0.0 108.953 172.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.3 t -151.0 113.53 4.65 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.877 0.762 . . . . 0.0 109.145 -172.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -96.26 142.52 28.31 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.181 1.792 . . . . 0.0 109.305 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 37.2 mtm105 -89.67 155.32 19.31 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.546 0.612 . . . . 0.0 111.161 -175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -70.36 115.22 9.29 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 166.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.07 176.99 42.7 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 124.794 1.188 . . . . 0.0 110.556 174.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 63.65 168.34 0.15 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.456 1.502 . . . . 0.0 110.232 -165.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 54.36 47.32 69.31 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -170.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -147.75 151.95 36.92 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.328 1.451 . . . . 0.0 107.508 -168.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -160.05 -173.63 4.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.225 1.81 . . . . 0.0 107.552 -177.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.934 1.694 . . . . 0.0 106.695 171.45 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.71 105.02 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.513 2.142 . . . . 0.0 108.894 169.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt 55.86 81.11 0.13 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.875 1.67 . . . . 0.0 110.169 -166.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -54.57 157.43 2.94 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.466 171.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.67 146.17 55.14 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 160.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -112.09 154.39 25.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.547 0.739 . . . . 0.0 110.141 -159.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -134.03 156.65 47.84 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 158.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -135.23 146.92 49.1 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.576 1.55 . . . . 0.0 106.829 -171.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 m -150.01 148.01 28.54 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 121.186 -0.946 . . . . 0.0 109.307 165.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.45 -142.53 7.69 Favored Glycine 0 C--N 1.34 0.789 0 C-N-CA 124.218 0.914 . . . . 0.0 111.93 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.88 159.3 15.02 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.086 1.755 . . . . 0.0 111.829 -168.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -147.99 144.36 27.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.323 1.449 . . . . 0.0 109.903 -176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 tt -133.59 148.51 51.59 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.94 1.696 . . . . 0.0 107.658 164.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.67 158.22 23.36 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.022 1.296 . . . . 0.0 109.876 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -154.75 143.24 20.57 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.369 1.084 . . . . 0.0 110.588 -176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -148.22 140.92 24.57 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.137 0.975 . . . . 0.0 108.636 160.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -71.87 69.93 0.71 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 160.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -67.15 -30.09 69.98 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.497 0.719 . . . . 0.0 112.234 -170.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -107.65 147.37 30.78 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 158.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -124.29 154.97 39.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 158.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 69.6 p 50.36 -105.67 0.2 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.583 1.153 . . . . 0.0 109.38 -158.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.01 -178.62 20.59 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 127.306 2.384 . . . . 0.0 109.095 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -54.77 128.58 33.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.786 1.234 . . . . 0.0 111.241 -173.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.6 mt 47.71 55.4 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.028 1.731 . . . . 0.0 109.664 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.308 0.0 OUTLIER 56.31 12.67 1.06 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 128.916 2.886 . . . . 0.0 115.051 -174.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 73.35 -63.48 0.43 Allowed 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 128.268 2.627 . . . . 0.0 110.815 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 73.7 -21.09 0.27 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.904 2.482 . . . . 0.0 111.512 -167.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.61 175.64 54.27 Favored Glycine 0 CA--C 1.538 1.473 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 158.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.74 150.9 50.99 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.321 2.014 . . . . 0.0 111.21 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.7 t -69.95 89.24 0.59 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 122.22 1.01 . . . . 0.0 109.08 172.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -131.23 -2.05 3.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.914 1.286 . . . . 0.0 112.399 -177.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -75.72 45.81 0.34 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.115 2.166 . . . . 0.0 112.538 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -60.66 162.43 6.57 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.886 1.674 . . . . 0.0 111.034 162.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -129.01 160.08 33.89 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 161.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 pp -147.1 166.37 27.1 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.165 0.986 . . . . 0.0 109.779 -174.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.16 156.98 21.04 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 107.938 -2.065 . . . . 0.0 107.938 168.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.64 122.02 3.43 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.915 1.286 . . . . 0.0 107.938 -176.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.16 -121.12 0.84 Allowed Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -134.32 169.62 16.95 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.93 0.892 . . . . 0.0 111.58 -167.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -145.74 151.4 37.92 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.903 2.081 . . . . 0.0 107.831 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.94 156.79 27.84 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 160.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.15 166.02 39.18 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 117.748 0.774 . . . . 0.0 111.859 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -123.66 134.64 53.72 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 126.63 1.972 . . . . 0.0 108.065 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -122.43 118.33 28.1 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.679 1.992 . . . . 0.0 109.249 177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -78.25 79.77 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 122.187 0.994 . . . . 0.0 108.608 173.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.496 ' HB3' ' HD2' ' A' ' 47' ' ' PRO 0.322 5.0 m120 63.89 -163.71 0.01 OUTLIER Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 125.282 1.433 . . . . 0.0 109.857 167.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 46' ' ' ASN . 47.9 Cg_endo -80.29 60.3 7.79 Favored 'Trans proline' 0 C--N 1.357 1.011 0 CA-C-N 124.393 2.605 . . . . 0.0 111.071 -169.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -143.17 -77.19 0.24 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.905 0.882 . . . . 0.0 111.139 -176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.0 p -150.54 165.72 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 123.911 0.884 . . . . 0.0 109.08 -160.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.81 -175.25 40.57 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 124.861 1.219 . . . . 0.0 111.691 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -140.6 148.19 40.54 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.916 1.286 . . . . 0.0 107.898 172.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -144.75 158.76 43.66 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.234 1.413 . . . . 0.0 109.119 -174.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 75.9 mtp -129.1 159.11 37.03 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.255 1.422 . . . . 0.0 109.809 167.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.47 165.68 16.13 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -149.82 150.04 31.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.505 1.522 . . . . 0.0 107.687 -173.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -126.24 142.6 51.46 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.363 1.065 . . . . 0.0 109.469 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -67.74 -72.05 0.19 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.898 0.879 . . . . 0.0 110.986 -175.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.0 mp 46.33 -147.46 0.15 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.041 0.936 . . . . 0.0 109.082 -161.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.56 -48.95 2.98 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.432 1.015 . . . . 0.0 115.11 166.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.94 65.98 3.49 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 118.549 1.175 . . . . 0.0 110.337 -176.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.7 mtp -61.92 164.42 10.37 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.652 1.181 . . . . 0.0 109.154 161.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.8 -37.71 53.73 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.052 1.835 . . . . 0.0 112.66 -176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 61.41 -57.8 0.1 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.525 2.73 . . . . 0.0 114.755 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt 55.25 30.7 15.14 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.534 1.534 . . . . 0.0 113.123 175.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 173.93 -129.48 1.65 Allowed Glycine 0 C--N 1.336 0.549 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 87.6 p -64.5 -177.47 0.31 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 159.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.5 m -60.58 158.31 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 158.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -149.38 149.13 30.36 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 57.37 -44.5 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 128.768 2.827 . . . . 0.0 113.668 -160.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 169.92 167.29 30.2 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 127.272 2.367 . . . . 0.0 108.635 169.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.24 60.74 1.11 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.82 0.848 . . . . 0.0 109.439 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.498 ' CE2' ' HE3' ' A' ' 107' ' ' LYS . 8.2 m-85 -81.09 62.21 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 122.483 1.135 . . . . 0.0 113.376 -160.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -70.24 91.93 0.75 Allowed 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 158.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.58 151.31 24.86 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 122.662 0.385 . . . . 0.0 109.986 174.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -78.79 119.85 22.59 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.4 101.73 0.22 Allowed Glycine 0 C--N 1.333 0.379 0 N-CA-C 107.489 -2.245 . . . . 0.0 107.489 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.09 165.46 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 124.044 0.938 . . . . 0.0 109.267 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -128.1 154.27 45.9 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.275 1.43 . . . . 0.0 107.981 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -141.55 139.4 33.18 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.405 1.082 . . . . 0.0 109.073 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.55 133.46 12.29 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 123.466 0.706 . . . . 0.0 110.033 -161.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.95 150.7 24.75 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 160.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.484 ' HE3' ' CD2' ' A' ' 94' ' ' TYR . 14.1 tmtt? -131.5 131.33 43.35 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 124.765 1.226 . . . . 0.0 109.05 -174.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.4 tp -105.2 148.54 26.81 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 159.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 174.1 169.38 36.2 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 119.454 -1.355 . . . . 0.0 114.142 167.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -148.53 133.73 9.31 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.219 -164.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -71.12 135.39 27.12 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.824 3.016 . . . . 0.0 110.467 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.18 -30.47 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 123.053 0.541 . . . . 0.0 111.421 177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 38.6 m -163.5 -48.3 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.518 2.327 . . . . 0.0 106.145 160.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -149.41 -179.11 6.81 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.482 2.313 . . . . 0.0 105.956 167.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.3 t0 65.85 -65.32 0.18 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.556 2.342 . . . . 0.0 113.216 174.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 mp -101.36 106.17 17.3 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -166.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -101.31 125.63 47.97 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.886 1.274 . . . . 0.0 108.491 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.1 mt -90.7 117.38 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -177.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.484 ' CD2' ' HE3' ' A' ' 82' ' ' LYS . 4.4 m-85 -98.45 141.12 31.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.446 1.899 . . . . 0.0 109.788 -174.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.3 m -134.02 115.25 14.1 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 162.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -130.06 148.69 51.94 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 123.774 0.83 . . . . 0.0 110.449 -170.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.5 pp -151.37 148.21 27.86 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.974 0.91 . . . . 0.0 110.742 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 163.07 -121.8 1.05 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.75 167.41 34.7 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 117.861 0.831 . . . . 0.0 113.69 -175.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 36.2 mtm -101.38 150.84 22.6 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.618 1.967 . . . . 0.0 106.975 163.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.9 m -135.3 137.47 50.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -149.71 131.11 14.7 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.83 111.05 7.87 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.981 1.312 . . . . 0.0 109.45 171.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -122.23 124.47 43.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 158.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.56 115.02 10.25 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.605 1.162 . . . . 0.0 108.135 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 82.5 p -75.61 63.19 1.52 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.38 2.272 . . . . 0.0 109.38 -176.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.498 ' HE3' ' CE2' ' A' ' 72' ' ' TYR . 1.8 pttm -69.12 47.57 0.07 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.962 2.905 . . . . 0.0 113.318 -174.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.8 m -160.84 162.85 32.34 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 120.238 -1.539 . . . . 0.0 109.258 172.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.43 77.1 2.49 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 174.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.66 167.73 25.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.005 1.322 . . . . 0.0 109.636 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -67.49 25.27 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.578 2.351 . . . . 0.0 114.314 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.25 -59.88 2.75 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.25 1.405 . . . . 0.0 110.762 -172.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 49.7 tptt 60.75 -11.94 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 128.363 2.665 . . . . 0.0 116.115 173.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -59.33 97.68 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 120.114 1.325 . . . . 0.0 108.294 163.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.0 m170 -64.72 -17.43 64.12 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.777 0.831 . . . . 0.0 113.158 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -129.52 131.09 46.53 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 159.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.78 158.53 41.05 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 163.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.84 -99.96 0.73 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 106.749 -2.54 . . . . 0.0 106.749 -163.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.6 144.28 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.645 1.578 . . . . 0.0 109.442 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.8 m -138.03 128.47 15.45 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.855 1.262 . . . . 0.0 108.838 169.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.02 144.38 47.2 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.428 2.086 . . . . 0.0 110.863 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.93 164.31 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 124.13 0.972 . . . . 0.0 110.078 175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -147.59 165.54 30.07 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.919 1.688 . . . . 0.0 108.495 173.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -153.78 160.41 42.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.32 0.509 . . . . 0.0 110.298 165.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -109.35 159.06 14.22 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 106.131 -2.788 . . . . 0.0 106.131 158.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 178.79 -173.87 46.09 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 118.539 1.169 . . . . 0.0 112.008 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.21 145.16 31.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -103.05 150.97 23.06 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.258 1.423 . . . . 0.0 107.544 158.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -145.39 165.37 28.69 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.533 1.133 . . . . 0.0 109.08 163.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -130.85 88.52 2.62 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.028 1.731 . . . . 0.0 110.486 -163.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.12 -29.64 22.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 125.147 1.379 . . . . 0.0 111.118 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.4 t -141.98 146.14 39.19 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 159.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -63.48 -15.53 49.05 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.501 2.134 . . . . 0.0 114.9 -167.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.97 -41.76 97.02 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.217 0.917 . . . . 0.0 111.004 168.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 10.0 pt -110.64 163.9 7.11 Favored 'Isoleucine or valine' 0 C--N 1.341 0.227 0 C-N-CA 124.179 0.992 . . . . 0.0 111.188 -164.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.8 158.75 43.72 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.8 t -141.52 152.78 44.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 158.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -135.33 153.98 51.67 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 123.124 0.569 . . . . 0.0 111.168 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.55 137.32 41.91 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -144.74 154.12 42.4 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.851 1.26 . . . . 0.0 109.803 -164.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -151.02 146.02 25.92 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.252 1.421 . . . . 0.0 110.735 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -132.13 115.51 15.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 127.902 2.481 . . . . 0.0 105.965 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -84.12 164.22 19.33 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 168.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . 0.281 4.9 t 57.64 -171.18 0.1 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.745 2.418 . . . . 0.0 111.94 -175.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.0 t30 55.51 -161.27 0.17 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.76 1.224 . . . . 0.0 109.784 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 62.87 45.7 5.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.41 1.484 . . . . 0.0 114.163 158.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.5 tt -140.1 157.26 25.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 119.154 0.888 . . . . 0.0 110.885 169.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -140.27 -17.02 0.46 Allowed Glycine 0 CA--C 1.529 0.953 0 C-N-CA 125.619 1.581 . . . . 0.0 113.649 174.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -150.39 147.53 27.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 120.022 1.911 . . . . 0.0 110.313 171.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -169.89 87.84 0.15 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 130.871 3.668 . . . . 0.0 106.054 174.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -74.83 79.2 2.1 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.44 -0.788 . . . . 0.0 110.325 -174.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.2 m 67.79 -29.53 0.16 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 128.363 2.665 . . . . 0.0 114.354 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.7 pt -128.01 174.81 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 126.199 1.799 . . . . 0.0 109.129 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.26 -152.71 21.39 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -167.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 24.3 m -69.58 158.38 35.37 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.61 1.164 . . . . 0.0 109.368 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 17.5 mtp-105 -68.62 158.77 84.48 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 124.754 1.221 . . . . 0.0 109.107 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.06 34.5 0.26 Allowed 'Trans proline' 0 CA--C 1.548 1.204 0 C-N-CA 124.868 3.712 . . . . 0.0 112.6 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -155.97 99.11 1.95 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 129.468 3.107 . . . . 0.0 103.485 -173.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -121.45 -130.76 0.28 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.171 0.988 . . . . 0.0 110.494 -158.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 179.42 176.33 46.98 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-N 119.153 0.888 . . . . 0.0 112.443 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 26.0 ttt -142.0 156.28 45.44 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.624 1.97 . . . . 0.0 107.237 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.7 mp -134.13 161.78 33.93 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 124.606 1.162 . . . . 0.0 108.79 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.2 p -147.28 166.4 27.2 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-O 121.342 0.591 . . . . 0.0 110.419 166.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.7 pp -149.71 165.69 31.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 108.745 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.35 175.14 40.44 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 121.485 -0.388 . . . . 0.0 113.377 178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 62.1 t -134.51 146.73 30.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 126.661 1.984 . . . . 0.0 105.709 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 74.5 m -156.45 174.87 14.79 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 119.934 -1.729 . . . . 0.0 110.433 177.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -143.72 166.06 25.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 122.926 0.49 . . . . 0.0 111.37 166.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 15.7 mtt180 -106.55 158.8 16.66 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 127.655 2.382 . . . . 0.0 110.446 -173.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -53.93 155.05 3.61 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 163.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 85.12 17.07 63.58 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.341 -0.699 . . . . 0.0 112.511 -167.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -53.86 122.01 9.14 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.529 1.132 . . . . 0.0 109.217 169.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 89.84 3.64 73.55 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.001 1.286 . . . . 0.0 113.543 -176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 60.68 -159.77 0.31 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.959 1.704 . . . . 0.0 110.886 -171.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 62.33 -56.75 0.14 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 128.467 2.707 . . . . 0.0 113.915 -168.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 C-N-CA 127.513 2.325 . . . . 0.0 112.046 -172.89 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.6 150.73 83.77 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.212 1.942 . . . . 0.0 110.465 175.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.43 178.14 8.67 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.169 0.988 . . . . 0.0 108.369 176.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.87 -163.08 0.2 Allowed 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -158.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.71 -177.38 1.24 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.298 1.439 . . . . 0.0 110.481 170.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 97.9 m -145.2 115.34 7.47 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 119.64 -1.913 . . . . 0.0 108.863 174.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.8 p90 -114.7 131.53 56.72 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.771 1.628 . . . . 0.0 108.717 -172.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.522 ' CZ ' ' HA3' ' A' ' 42' ' ' GLY . 0.3 OUTLIER -130.78 155.81 46.05 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.193 0.997 . . . . 0.0 111.741 -170.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.5 m -143.01 144.91 32.48 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.156 2.183 . . . . 0.0 107.633 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.3 -159.49 22.52 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-N 118.747 0.703 . . . . 0.0 113.522 -169.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.49 157.91 45.28 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.965 1.306 . . . . 0.0 110.629 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.6 163.75 35.63 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.02 0.928 . . . . 0.0 112.794 -175.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.6 mp -141.34 165.78 26.56 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.542 2.337 . . . . 0.0 109.37 171.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.3 171.04 29.54 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.075 0.845 . . . . 0.0 112.249 170.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -158.57 150.07 20.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.829 0.852 . . . . 0.0 112.101 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.1 t -151.47 146.12 25.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.264 1.826 . . . . 0.0 108.246 162.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -89.54 -21.64 22.8 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.928 0.491 . . . . 0.0 111.932 167.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 54.0 6.81 0.1 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.245 2.218 . . . . 0.0 116.196 -170.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -158.86 179.6 8.93 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 129.886 3.274 . . . . 0.0 106.496 163.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -138.26 156.15 47.94 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.242 -0.911 . . . . 0.0 111.152 160.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.263 12.8 t 44.19 -158.71 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.119 1.767 . . . . 0.0 111.855 -172.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.29 154.92 46.72 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 121.091 -1.006 . . . . 0.0 111.427 177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -137.0 94.02 2.91 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.463 -1.681 . . . . 0.0 106.463 164.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . 0.332 0.3 OUTLIER 44.32 -141.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 126.773 2.029 . . . . 0.0 110.255 -176.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.41 ' ND2' ' H ' ' A' ' 26' ' ' ASN . 18.5 t30 48.49 -106.17 0.17 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.602 1.961 . . . . 0.0 110.246 -176.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.41 ' H ' ' ND2' ' A' ' 25' ' ' ASN . 1.7 p-10 -135.34 11.66 3.52 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.017 2.127 . . . . 0.0 110.302 172.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.8 t30 135.54 153.68 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.588 1 C-N-CA 133.022 4.529 . . . . 0.0 105.33 -158.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.51 -157.38 28.44 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 124.968 1.271 . . . . 0.0 112.328 -168.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -63.34 -11.93 28.04 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 121.97 1.78 . . . . 0.0 111.592 167.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.53 16.65 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 130.421 3.488 . . . . 0.0 114.994 160.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 66.3 m80 -80.69 -20.2 43.45 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.4 -1.438 . . . . 0.0 109.286 158.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -122.66 176.5 5.91 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.908 1.683 . . . . 0.0 109.236 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -159.38 179.65 8.77 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 127.439 2.296 . . . . 0.0 106.535 175.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -128.97 142.4 50.94 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 167.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.09 163.81 20.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.753 1.221 . . . . 0.0 108.559 163.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -138.27 165.24 25.5 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 171.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.1 174.66 11.1 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.565 1.946 . . . . 0.0 107.904 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 154.04 -164.89 31.53 Favored Glycine 0 C--N 1.332 0.338 0 O-C-N 121.848 -0.532 . . . . 0.0 112.675 163.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.29 160.63 14.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -135.74 155.14 50.84 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.653 1.581 . . . . 0.0 107.653 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.26 172.41 40.05 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.522 ' HA3' ' CZ ' ' A' ' 8' ' ' TYR . . . -168.78 166.73 39.87 Favored Glycine 0 N--CA 1.45 -0.386 0 O-C-N 121.553 -0.969 . . . . 0.0 113.099 166.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -137.68 106.09 5.81 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 169.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -95.91 132.87 40.75 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.2 m -67.28 -27.47 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.35 145.31 14.91 Favored Pre-proline 0 C--O 1.233 0.185 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 158.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.88 99.73 0.28 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.282 2.655 . . . . 0.0 109.145 -175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.6 t80 158.48 -51.67 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 129.64 3.176 . . . . 0.0 107.569 -159.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.1 p -150.79 151.29 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.767 0.794 . . . . 0.0 111.86 -173.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.05 -116.26 0.81 Allowed Glycine 0 C--N 1.335 0.512 0 N-CA-C 109.206 -1.557 . . . . 0.0 109.206 167.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -136.4 159.72 40.9 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 122.942 1.353 . . . . 0.0 111.908 -171.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -144.81 151.86 39.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 128.534 2.733 . . . . 0.0 106.263 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 66.4 mtt -152.65 170.94 19.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.728 1.211 . . . . 0.0 109.458 -162.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.27 179.95 42.14 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.172 0.892 . . . . 0.0 110.921 170.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -139.23 146.59 40.65 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.656 0.782 . . . . 0.0 109.474 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -127.72 112.58 14.97 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.493 1.517 . . . . 0.0 107.655 -171.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -158.07 179.44 9.17 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.707 1.603 . . . . 0.0 107.349 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.5 mt -73.18 46.08 0.17 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.547 1.939 . . . . 0.0 112.636 -176.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.75 -140.48 30.13 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.135 1.35 . . . . 0.0 111.422 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.09 79.39 1.23 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 168.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 23.6 tpp -45.08 125.43 5.44 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.117 1.367 . . . . 0.0 108.573 165.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.7 -24.69 61.98 Favored 'Trans proline' 0 CA--C 1.545 1.058 0 C-N-CA 122.136 1.891 . . . . 0.0 112.921 -176.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 9.6 t80 71.02 8.95 6.66 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.192 2.197 . . . . 0.0 116.85 158.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 mtmp? -98.54 -84.66 0.39 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 121.061 1.755 . . . . 0.0 112.059 -172.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.58 103.33 0.6 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 124.704 1.145 . . . . 0.0 111.662 -169.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.7 m 52.62 31.77 10.7 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.039 0.936 . . . . 0.0 111.835 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.2 19.8 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 126.015 1.726 . . . . 0.0 111.968 -174.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 50.43 36.66 13.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.208 2.203 . . . . 0.0 113.989 167.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -144.31 177.13 8.84 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.461 1.904 . . . . 0.0 107.739 169.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -173.47 -100.59 0.14 Allowed Glycine 0 C--N 1.339 0.706 0 CA-C-O 118.918 -0.935 . . . . 0.0 111.267 -174.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.33 -29.74 69.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.811 0.805 . . . . 0.0 111.538 174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -63.28 118.79 8.49 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -147.47 80.5 1.51 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 171.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -150.67 156.33 41.11 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 122.813 0.445 . . . . 0.0 111.789 175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -146.71 -178.97 6.46 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.699 2.4 . . . . 0.0 107.59 176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.58 170.17 35.13 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 165.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.87 131.83 38.77 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -95.43 132.2 40.75 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.35 132.53 20.46 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.001 0.92 . . . . 0.0 108.786 175.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.23 142.75 19.64 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.665 -172.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.64 147.14 26.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.966 1.306 . . . . 0.0 108.512 165.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.516 ' HE2' ' CE1' ' A' ' 94' ' ' TYR . 81.2 tttt -143.52 135.17 26.34 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.375 1.47 . . . . 0.0 109.204 -165.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.8 tp -144.28 129.45 18.69 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 125.729 1.612 . . . . 0.0 107.394 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -139.73 179.13 19.16 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 117.965 0.348 . . . . 0.0 112.994 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -143.42 138.55 15.58 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.344 1.058 . . . . 0.0 109.298 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.45 117.08 4.05 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.798 2.332 . . . . 0.0 109.073 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.7 tt -90.86 -10.55 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 123.023 0.529 . . . . 0.0 110.78 -176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 48.3 m -151.05 -78.79 0.12 Allowed 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 158.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -152.54 -59.76 0.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 123.771 0.828 . . . . 0.0 109.369 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -78.29 1.47 21.61 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.202 1.801 . . . . 0.0 113.012 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.43 147.39 45.34 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 125.145 1.378 . . . . 0.0 110.213 171.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -132.36 136.56 46.91 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 126.678 1.991 . . . . 0.0 107.917 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.93 110.58 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CE1' ' HE2' ' A' ' 82' ' ' LYS . 10.4 m-85 -111.5 118.43 35.74 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 126.526 1.931 . . . . 0.0 110.613 -171.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 28.4 m -96.97 154.6 17.21 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.315 1.846 . . . . 0.0 108.183 171.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.98 165.05 35.86 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -174.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.4 tt -138.54 151.13 47.06 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.718 2.007 . . . . 0.0 107.552 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.35 -139.8 8.34 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 119.129 0.877 . . . . 0.0 111.21 176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 175.0 177.9 44.45 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 117.517 0.659 . . . . 0.0 112.448 172.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.2 108.37 19.54 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 125.012 1.325 . . . . 0.0 107.433 168.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.2 t -86.02 122.76 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -88.82 150.7 22.79 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -143.28 109.48 5.32 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.307 1.043 . . . . 0.0 109.706 171.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.51 170.61 11.75 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 161.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.73 165.86 19.57 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.74 0.781 . . . . 0.0 112.906 169.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 t -74.03 164.18 26.95 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.541 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 41.4 tttt 64.42 -50.23 0.3 Allowed 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 128.669 2.788 . . . . 0.0 114.707 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.6 t 58.32 -93.22 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -158.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -147.9 167.97 23.45 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 158.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.42 HG13 ' H ' ' A' ' 111' ' ' TYR 0.339 7.4 p 40.69 -107.13 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.021 1.728 . . . . 0.0 109.874 -159.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.42 ' H ' HG13 ' A' ' 110' ' ' VAL . 13.4 m-85 -117.52 17.05 14.6 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.707 1.603 . . . . 0.0 112.511 175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.02 -18.22 62.07 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.992 1.282 . . . . 0.0 115.707 -163.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -141.07 153.29 45.4 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.456 1.628 . . . . 0.0 110.929 167.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.64 -59.37 2.81 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.364 1.465 . . . . 0.0 108.045 169.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 170.92 -37.92 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 129.309 3.044 . . . . 0.0 106.762 -169.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 55.9 70.81 0.6 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.703 1.201 . . . . 0.0 110.256 158.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.1 t -141.02 153.43 45.53 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.592 0.757 . . . . 0.0 109.822 -175.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 130.71 -174.15 19.9 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.093 1.33 . . . . 0.0 110.628 -174.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 9.7 p -161.09 163.72 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.442 1.897 . . . . 0.0 106.664 161.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 16.5 m -68.37 128.32 93.12 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 161.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -67.04 148.14 81.04 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 121.639 1.559 . . . . 0.0 109.678 175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.8 169.8 19.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.521 1.128 . . . . 0.0 110.192 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -136.05 154.0 51.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.503 1.521 . . . . 0.0 107.128 168.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.94 171.47 18.29 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.103 0.961 . . . . 0.0 109.08 -174.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -152.63 161.94 29.73 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 169.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 171.19 -140.96 6.18 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -177.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.2 t -132.57 158.3 43.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-N 117.532 0.666 . . . . 0.0 109.738 -167.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -123.08 137.22 54.98 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 158.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -120.16 113.57 20.64 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.641 1.576 . . . . 0.0 107.624 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.0 81.58 1.89 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.855 1.262 . . . . 0.0 108.868 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.9 tp -70.53 -41.13 78.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 167.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.55 115.57 60.12 Favored Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 126.413 1.885 . . . . 0.0 106.486 161.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -59.1 -23.31 68.39 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 CA-C-N 121.021 1.4 . . . . 0.0 111.45 169.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 57.2 mp0 -68.03 -39.99 82.97 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 126.208 1.803 . . . . 0.0 112.895 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 17.9 tt -146.42 130.77 10.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 119.527 1.058 . . . . 0.0 108.468 -167.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.97 145.66 31.62 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 123.579 0.55 . . . . 0.0 109.525 -160.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 32.4 m -94.97 151.56 19.07 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.15 152.97 49.89 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 125.053 1.341 . . . . 0.0 109.803 173.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 pp -141.61 154.65 45.54 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.191 1.396 . . . . 0.0 108.824 163.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -145.68 155.46 43.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.678 1.591 . . . . 0.0 108.92 171.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -133.68 149.35 51.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.946 1.698 . . . . 0.0 107.733 166.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -135.12 167.81 20.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.454 1.502 . . . . 0.0 108.857 167.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -83.82 160.56 21.16 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 168.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.61 -26.62 2.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.385 1.074 . . . . 0.0 111.647 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.48 -32.46 0.1 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.711 2.404 . . . . 0.0 115.038 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 62.56 -23.97 0.05 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 130.613 3.565 . . . . 0.0 116.382 168.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.1 tt -64.38 122.1 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.698 1.199 . . . . 0.0 112.179 -163.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -146.48 146.44 16.43 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 106.354 -2.699 . . . . 0.0 106.354 162.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -157.99 177.53 11.22 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.33 -4.71 1.28 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.299 1.44 . . . . 0.0 113.262 176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -144.83 -26.03 0.5 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 119.536 1.062 . . . . 0.0 112.701 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 12.2 t -149.75 -150.04 0.33 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.945 1.298 . . . . 0.0 108.189 -171.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 43.3 pt -131.55 162.39 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 159.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 167.41 -23.62 0.12 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.58 -0.567 . . . . 0.0 112.927 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 11.6 m -69.53 98.6 1.15 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.202 1.401 . . . . 0.0 108.406 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -81.81 144.02 51.26 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -160.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -77.74 40.8 0.9 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 125.293 3.996 . . . . 0.0 112.108 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -60.44 -30.77 69.86 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -164.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -134.04 173.07 11.98 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.552 1.168 . . . . 0.0 111.474 -159.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -109.49 165.31 12.41 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 113.593 -1.64 . . . . 0.0 109.314 163.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 18.5 ttt -104.64 148.06 26.96 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 169.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.8 pp -130.64 160.81 33.13 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.334 0.654 . . . . 0.0 111.4 -176.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.39 158.11 44.92 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.589 1.155 . . . . 0.0 108.531 163.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.4 pp -149.54 156.03 41.29 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.326 1.451 . . . . 0.0 108.712 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.16 175.19 40.29 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 112.271 -0.332 . . . . 0.0 112.271 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 13.7 p -139.25 145.07 27.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 170.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.8 p -154.18 151.66 29.47 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.275 0.943 . . . . 0.0 110.743 -177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -106.15 149.83 26.41 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.342 1.857 . . . . 0.0 108.961 175.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.12 156.13 46.69 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 127.211 2.204 . . . . 0.0 109.949 171.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -66.93 151.65 47.2 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 159.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -113.99 -111.66 2.97 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -86.26 -33.84 20.57 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.326 1.05 . . . . 0.0 108.639 160.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -121.86 -172.06 14.16 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.759 1.647 . . . . 0.0 110.463 169.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.59 -26.25 66.83 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.07 -0.665 . . . . 0.0 110.661 170.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -140.38 161.14 38.42 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.446 2.299 . . . . 0.0 106.082 158.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.377 1.471 . . . . 0.0 111.776 -168.8 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 118.582 -0.723 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -60.77 167.67 8.18 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.604 2.869 . . . . 0.0 111.738 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.06 17.15 17.97 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -161.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.25 -28.4 53.06 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.431 0.693 . . . . 0.0 112.206 170.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.491 ' ND2' ' H ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -46.32 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 129.97 3.308 . . . . 0.0 112.047 176.162 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.5 p -154.13 161.59 41.77 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.516 1.926 . . . . 0.0 109.226 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -134.86 149.37 50.31 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.385 1.474 . . . . 0.0 107.462 174.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -134.85 144.77 47.75 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.79 2.036 . . . . 0.0 108.802 -174.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 92.0 m -150.08 135.16 17.88 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.906 -1.121 . . . . 0.0 108.682 171.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -173.09 -155.42 11.53 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 123.717 0.675 . . . . 0.0 112.748 -160.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.77 162.88 33.64 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.843 1.257 . . . . 0.0 111.0 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -139.5 142.22 37.3 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.76 1.624 . . . . 0.0 108.83 -177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mp -125.1 139.32 53.88 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 126.512 1.925 . . . . 0.0 106.524 174.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.92 148.27 19.0 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 124.615 1.102 . . . . 0.0 111.43 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -137.78 129.44 28.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 127.012 2.125 . . . . 0.0 107.493 -167.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.3 t -142.01 -176.94 4.99 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 171.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -50.11 -45.16 52.6 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.864 2.066 . . . . 0.0 112.182 -159.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -140.69 -21.52 0.81 Allowed 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 159.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.584 ' CG ' ' H ' ' A' ' 20' ' ' ASP . 32.5 t60 170.1 -127.98 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 131.146 3.778 . . . . 0.0 104.386 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.584 ' H ' ' CG ' ' A' ' 19' ' ' HIS . 5.2 p-10 -54.78 -31.89 59.41 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 126.026 1.731 . . . . 0.0 112.364 174.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 36.69 90.36 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 129.466 3.106 . . . . 0.0 114.207 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.82 52.78 1.64 Allowed Glycine 0 CA--C 1.537 1.438 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 160.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . 0.309 45.8 p90 -36.38 -98.55 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 130.355 3.462 . . . . 0.0 115.86 -158.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 8.4 tp -65.96 -22.88 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.531 1.059 . . . . 0.0 111.728 -169.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -76.57 -47.77 21.43 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.891 -0.576 . . . . 0.0 111.699 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.2 -0.31 0.69 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -168.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.43 -9.12 4.16 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.177 1.353 . . . . 0.0 112.758 -167.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.48 133.6 6.34 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.553 1.549 . . . . 0.0 109.483 -172.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -58.44 -32.19 95.78 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.606 2.204 . . . . 0.0 112.428 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . 0.282 1.3 m 54.27 -153.41 0.29 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.672 1.989 . . . . 0.0 111.036 173.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -146.34 -32.67 0.33 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 -163.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.412 1.3 pt-20 109.15 121.32 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 131.381 3.872 . . . . 0.0 112.923 175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -154.26 -19.54 0.13 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.286 1.034 . . . . 0.0 113.632 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -161.83 137.56 7.67 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 120.415 1.462 . . . . 0.0 110.013 -163.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -137.19 -58.13 0.71 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 166.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.41 -169.59 42.6 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.9 170.55 18.54 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.371 1.068 . . . . 0.0 108.741 173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.36 -179.14 43.02 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.67 159.09 15.23 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 173.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -144.16 156.65 44.42 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.287 0.635 . . . . 0.0 111.113 -162.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.15 171.9 39.83 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 170.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.12 166.3 39.38 Favored Glycine 0 C--N 1.331 0.261 0 CA-C-N 117.778 0.789 . . . . 0.0 111.546 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -148.8 133.37 17.72 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.022 0.929 . . . . 0.0 109.318 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -121.76 154.84 36.42 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -155.37 -54.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.835 -172.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.69 152.48 93.51 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 125.35 1.46 . . . . 0.0 108.289 174.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -57.3 118.48 5.36 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.004 1.803 . . . . 0.0 109.731 174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.6 m-30 62.83 14.76 7.65 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.152 2.181 . . . . 0.0 114.943 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.1 t -139.91 133.65 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 120.53 1.513 . . . . 0.0 110.596 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.48 -161.43 11.47 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 125.082 1.325 . . . . 0.0 112.163 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -136.44 155.83 49.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.696 1.198 . . . . 0.0 109.021 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -147.38 149.06 32.02 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.72 1.208 . . . . 0.0 108.223 -169.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 73.3 mtp -151.16 171.9 16.64 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.995 0.918 . . . . 0.0 110.898 -162.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.51 179.02 40.13 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-O 119.523 -0.598 . . . . 0.0 111.959 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -148.42 149.54 31.91 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.047 1.739 . . . . 0.0 110.29 -175.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -132.49 146.12 51.68 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.418 1.487 . . . . 0.0 110.853 169.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -141.17 86.1 2.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.576 2.35 . . . . 0.0 105.927 160.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 40.8 tp -55.7 132.27 48.69 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.45 -41.57 2.15 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -169.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.08 -24.35 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 130.278 3.431 . . . . 0.0 117.615 167.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 25.4 ttt -58.0 121.71 52.64 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.218 1.407 . . . . 0.0 110.216 -174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.08 58.9 6.34 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.312 2.675 . . . . 0.0 110.126 174.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -63.74 109.0 1.57 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -148.2 156.58 42.74 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.96 1.304 . . . . 0.0 107.843 -170.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.27 9.93 85.35 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 120.016 -0.325 . . . . 0.0 112.972 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.5 m -163.82 178.93 7.44 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.679 1.992 . . . . 0.0 107.361 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.1 m -118.77 172.25 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.377 1.471 . . . . 0.0 107.929 170.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.24 171.02 17.99 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 168.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -69.62 166.84 18.18 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.044 2.138 . . . . 0.0 109.828 167.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 172.28 172.51 38.18 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 171.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.81 160.45 42.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.817 1.647 . . . . 0.0 107.497 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 64.98 164.91 0.16 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.061 2.144 . . . . 0.0 113.07 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -177.19 176.15 1.41 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.2 1.8 . . . . 0.0 108.676 175.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 58' ' ' LEU . . . -139.76 155.79 47.12 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 158.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -141.71 142.68 33.31 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -162.1 172.89 38.34 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.853 -0.689 . . . . 0.0 113.849 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.9 m -146.15 164.7 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.819 2.047 . . . . 0.0 110.058 173.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -120.62 146.4 46.41 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 163.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -145.54 116.54 7.82 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.289 1.436 . . . . 0.0 108.518 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.84 145.67 27.61 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.809 -0.557 . . . . 0.0 110.376 -169.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.48 22.69 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.967 0.907 . . . . 0.0 108.978 169.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.535 ' HE2' ' CE1' ' A' ' 94' ' ' TYR . 86.7 tttt -142.16 138.31 31.48 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.752 1.221 . . . . 0.0 108.69 -170.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -142.89 146.55 34.17 Favored 'General case' 0 C--N 1.335 -0.052 0 C-N-CA 123.113 0.565 . . . . 0.0 109.505 169.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.5 170.22 32.91 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 118.409 0.549 . . . . 0.0 113.623 -174.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -157.97 157.2 29.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 124.285 1.034 . . . . 0.0 111.607 -166.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.01 131.12 13.92 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.463 2.775 . . . . 0.0 110.521 172.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.1 pt -73.68 38.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.511 1.125 . . . . 0.0 112.865 -178.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 64.7 p 63.45 -37.32 0.17 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.622 2.769 . . . . 0.0 113.488 -167.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -69.15 167.04 16.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.768 0.794 . . . . 0.0 108.902 159.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -75.98 16.23 0.45 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.408 2.283 . . . . 0.0 113.983 -173.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.6 tp -102.06 125.46 48.75 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.674 1.19 . . . . 0.0 108.596 176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -106.85 111.9 24.62 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.244 1.018 . . . . 0.0 108.531 -170.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.4 HG22 HG12 ' A' ' 127' ' ' VAL . 10.1 pt -109.66 143.91 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 121.85 -0.531 . . . . 0.0 110.002 -166.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.535 ' CE1' ' HE2' ' A' ' 82' ' ' LYS . 77.5 m-85 -137.89 158.86 43.48 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.707 0.765 . . . . 0.0 112.869 -166.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.7 m -124.43 147.09 48.52 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 128.429 2.692 . . . . 0.0 106.179 166.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.28 144.22 31.38 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 124.059 0.944 . . . . 0.0 108.996 -171.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.1 tt -149.07 147.48 28.56 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.339 1.056 . . . . 0.0 109.188 176.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.9 -140.68 7.68 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -150.19 176.42 28.83 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-O 122.222 0.901 . . . . 0.0 112.789 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -140.0 157.44 45.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.31 1.044 . . . . 0.0 109.087 169.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.5 t -130.26 128.29 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -150.72 110.11 3.98 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.48 105.06 15.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.26 112.19 21.14 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 170.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -83.51 103.63 13.01 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.1 p -105.51 16.02 26.15 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 126.165 1.786 . . . . 0.0 110.134 175.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 62.39 -29.04 0.07 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.843 2.457 . . . . 0.0 113.569 -172.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 64.0 m -158.67 178.88 9.64 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.934 2.094 . . . . 0.0 108.174 168.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -72.76 83.29 1.18 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.539 0.736 . . . . 0.0 110.092 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 111' ' ' TYR . 4.2 p -72.23 -178.72 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 125.019 1.327 . . . . 0.0 109.826 169.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.464 ' H ' HG22 ' A' ' 110' ' ' VAL . 14.6 t80 -59.19 25.53 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 129.786 3.234 . . . . 0.0 115.766 176.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -54.64 160.51 5.06 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 120.63 -1.294 . . . . 0.0 111.215 168.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -124.5 -156.02 0.7 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.934 0.893 . . . . 0.0 110.404 -164.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -72.51 2.17 6.8 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.181 0.993 . . . . 0.0 113.502 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -70.17 172.1 8.63 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.359 1.064 . . . . 0.0 109.818 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' OD2' ' OG ' ' A' ' 120' ' ' SER . 2.6 m-20 -53.09 142.28 20.6 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.143 0.977 . . . . 0.0 110.697 173.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.5 t -144.92 43.49 1.34 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 170.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 154.94 -87.95 0.13 Allowed Glycine 0 C--N 1.336 0.578 0 N-CA-C 108.564 -1.814 . . . . 0.0 108.564 -170.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.43 154.68 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.009 1.323 . . . . 0.0 109.3 -172.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.409 ' OG ' ' OD2' ' A' ' 116' ' ' ASP . 71.3 p -145.62 156.83 52.55 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.713 1.205 . . . . 0.0 110.268 167.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.43 155.76 36.54 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.76 2.307 . . . . 0.0 110.086 166.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.8 124.54 2.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 124.913 1.285 . . . . 0.0 108.288 169.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -133.35 145.86 50.76 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 167.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -157.89 170.78 21.57 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.923 0.889 . . . . 0.0 110.468 -164.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -126.34 165.2 19.63 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 161.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.16 175.5 43.5 Favored Glycine 0 C--N 1.331 0.299 0 CA-C-N 118.149 0.974 . . . . 0.0 113.187 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.4 HG12 HG22 ' A' ' 93' ' ' ILE . 18.0 m -133.44 140.64 46.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.242 1.417 . . . . 0.0 107.43 175.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.422 ' CD ' ' HE ' ' A' ' 138' ' ' ARG . 40.4 mt-10 -136.63 148.01 47.21 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 124.591 1.157 . . . . 0.0 108.092 -169.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -149.97 166.14 30.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.917 0.887 . . . . 0.0 110.385 -168.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.82 143.81 51.11 Favored 'General case' 0 C--N 1.338 0.098 0 C-N-CA 125.159 1.383 . . . . 0.0 109.603 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.56 -26.81 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 123.012 0.525 . . . . 0.0 110.104 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 91.0 m 139.06 -64.46 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.776 1 C-N-CA 132.894 4.478 . . . . 0.0 106.879 176.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -67.35 179.81 2.27 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.833 1.689 . . . . 0.0 109.943 159.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -52.81 -3.84 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 130.542 3.537 . . . . 0.0 117.914 -165.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 68.5 mt -87.61 138.08 19.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.95 161.52 34.07 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.719 0.808 . . . . 0.0 109.682 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 75.5 m -135.28 148.91 49.68 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.474 1.509 . . . . 0.0 107.799 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.422 ' HE ' ' CD ' ' A' ' 128' ' ' GLU . 33.5 mtp-105 -135.32 146.13 48.14 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.708 1.203 . . . . 0.0 108.928 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 96.4 mt -128.6 125.66 38.67 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 105.494 -2.039 . . . . 0.0 105.494 164.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -140.01 123.58 17.2 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -169.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -120.68 138.03 54.16 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.149 1.78 . . . . 0.0 109.842 -172.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.14 114.97 16.99 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.621 1.968 . . . . 0.0 107.867 -167.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -132.07 162.21 31.36 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.422 1.089 . . . . 0.0 109.346 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.8 m 62.89 -43.96 0.2 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 127.691 2.397 . . . . 0.0 113.22 -171.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -59.74 116.33 3.99 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.971 0.909 . . . . 0.0 108.775 168.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -158.45 176.27 12.64 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.473 1.109 . . . . 0.0 108.504 -167.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.406 HG13 ' H ' ' A' ' 147' ' ' ILE . 13.2 mt -46.73 -38.28 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 126.249 1.82 . . . . 0.0 109.966 163.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 123.76 22.16 2.28 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.901 1.715 . . . . 0.0 111.992 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -78.67 126.72 31.12 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.79 1.295 . . . . 0.0 113.024 -171.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.85 21.67 1.61 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.339 1.456 . . . . 0.0 110.413 159.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -77.95 -9.36 59.05 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -159.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 29.3 p -148.21 168.6 22.06 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.158 0.983 . . . . 0.0 110.132 -165.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.8 pt -127.75 161.71 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 124.705 1.202 . . . . 0.0 108.038 169.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 144.58 -161.72 28.0 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 107.855 -2.098 . . . . 0.0 107.855 -167.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 20.1 m -69.75 96.69 1.0 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -108.0 96.58 18.18 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 124.285 1.034 . . . . 0.0 109.957 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -82.35 -25.31 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.407 2.738 . . . . 0.0 111.91 170.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 33.82 51.45 0.38 Allowed 'General case' 0 CA--C 1.531 0.247 1 C-N-CA 131.792 4.037 . . . . 0.0 113.618 168.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -55.38 -37.94 68.21 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.388 1.475 . . . . 0.0 111.972 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.72 -112.33 3.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -167.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -152.44 141.83 21.6 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.965 0.883 . . . . 0.0 109.391 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.0 tp -118.82 154.33 33.05 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.553 1.941 . . . . 0.0 107.484 173.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.9 p -153.77 162.1 41.52 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.299 -0.875 . . . . 0.0 111.785 178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 7.0 tt -132.52 149.82 52.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.192 2.197 . . . . 0.0 106.767 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -144.01 162.77 27.8 Favored Glycine 0 CA--C 1.52 0.393 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 170.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 55.6 t -139.79 142.75 31.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 8.0 t -151.46 167.92 26.49 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.711 0.687 . . . . 0.0 110.734 -167.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -115.81 127.71 55.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.016 2.126 . . . . 0.0 106.303 167.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -89.63 137.59 32.2 Favored 'General case' 0 C--N 1.337 0.063 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 170.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 5.3 m-30 -63.14 115.95 4.95 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 173.14 -179.04 44.83 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.404 1.478 . . . . 0.0 111.287 -165.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -149.19 0.51 0.52 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.874 1.27 . . . . 0.0 113.83 -166.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 74.51 -53.54 2.38 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.932 1.253 . . . . 0.0 112.537 -175.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -60.7 155.59 18.78 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.532 1.933 . . . . 0.0 110.522 173.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -111.86 -16.5 13.13 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.06 1.344 . . . . 0.0 112.829 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 116.48 -1.724 . . . . 0.0 111.294 167.638 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . 0.342 . . . . . . . 0 CA--C 1.546 0.811 0 CA-C-O 115.083 -2.389 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.03 173.52 10.2 Favored 'Trans proline' 0 C--N 1.354 0.828 0 CA-C-N 124.717 2.72 . . . . 0.0 111.964 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.0 tmtt? -57.44 127.59 32.74 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.681 1.192 . . . . 0.0 108.384 169.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -68.9 133.97 48.96 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.726 0.81 . . . . 0.0 109.865 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.99 125.41 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.768 2.427 . . . . 0.0 113.925 -172.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 86.2 m -121.71 155.32 35.47 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.11 1.364 . . . . 0.0 108.795 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -121.37 129.6 53.14 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.294 1.438 . . . . 0.0 108.01 -173.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -113.13 143.34 44.52 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.993 1.317 . . . . 0.0 107.95 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 t -150.35 158.2 43.89 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.384 0.993 . . . . 0.0 111.514 159.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.04 -141.59 6.41 Favored Glycine 0 C--N 1.337 0.6 0 C-N-CA 125.4 1.476 . . . . 0.0 110.041 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.67 155.29 44.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.95 0.375 . . . . 0.0 111.606 -164.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.44 159.81 41.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.144 0.978 . . . . 0.0 111.617 -174.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp -109.75 158.96 17.58 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.204 1.802 . . . . 0.0 106.411 164.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -129.89 165.35 22.36 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 124.966 1.27 . . . . 0.0 109.933 174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -148.3 148.34 30.31 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 173.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.4 t -162.88 96.42 0.91 Allowed 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 171.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -159.3 157.96 31.51 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -121.3 -75.47 0.59 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 101.749 -3.426 . . . . 0.0 101.749 158.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -122.33 -165.75 1.32 Allowed 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 158.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 27.38 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 128.644 2.778 . . . . 0.0 115.923 172.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 p -70.68 67.09 0.36 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.403 -0.81 . . . . 0.0 109.848 166.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.01 116.91 1.98 Allowed Glycine 0 CA--C 1.531 1.061 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -163.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -45.04 108.8 0.13 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.099 1.76 . . . . 0.0 111.624 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.53 -23.66 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -159.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -61.23 -18.8 60.18 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.957 0.798 . . . . 0.0 112.871 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.04 -25.97 1.98 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.613 1.165 . . . . 0.0 112.885 171.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.434 ' CG ' ' H ' ' A' ' 28' ' ' GLY 0.252 8.0 t-20 48.22 -172.78 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.951 2.9 . . . . 0.0 113.092 -168.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.434 ' H ' ' CG ' ' A' ' 27' ' ' ASN . . . 145.6 81.77 0.05 OUTLIER Glycine 0 CA--C 1.529 0.915 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -166.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -73.92 -173.23 1.32 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.448 2.765 . . . . 0.0 111.391 -176.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -151.32 155.83 39.54 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.49 1.516 . . . . 0.0 107.653 -177.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -63.26 -19.61 64.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.683 1.193 . . . . 0.0 113.862 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -129.96 109.78 11.15 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 159.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.19 135.98 16.28 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 61.52 -81.17 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -158.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -112.58 171.23 7.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.015 1.326 . . . . 0.0 110.447 173.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -160.2 175.68 36.95 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.841 2.162 . . . . 0.0 109.127 170.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.03 166.3 32.88 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.026 0.93 . . . . 0.0 110.399 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.37 175.69 44.84 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.482 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -100.81 157.34 16.78 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.635 1.174 . . . . 0.0 107.883 164.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -151.44 166.2 31.8 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.729 0.776 . . . . 0.0 111.796 175.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.25 171.85 39.9 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -167.62 166.2 39.18 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -121.06 119.84 33.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 173.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.13 160.34 25.29 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.414 0.685 . . . . 0.0 109.428 -176.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 78.7 t -69.08 -27.67 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 124.364 1.066 . . . . 0.0 111.387 -170.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 135.19 -45.31 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.49 1 C-N-CA 132.24 4.216 . . . . 0.0 111.366 -177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.97 -87.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 121.899 1.733 . . . . 0.0 111.178 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -153.72 20.15 0.53 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.565 1.075 . . . . 0.0 113.316 -168.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.5 t -129.09 142.27 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 -176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 177.14 -162.3 30.38 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 118.756 0.707 . . . . 0.0 113.695 -173.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -126.68 155.3 42.85 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.997 1.319 . . . . 0.0 108.113 166.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -149.16 158.12 43.93 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.863 1.265 . . . . 0.0 108.455 -169.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.0 mtt -146.1 152.56 39.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.124 1.77 . . . . 0.0 108.731 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -136.73 157.69 23.79 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -136.4 115.78 12.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 103.183 -2.895 . . . . 0.0 103.183 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -123.09 150.53 43.06 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.558 0.743 . . . . 0.0 111.677 -158.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.1 t80 60.33 -177.34 0.1 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.021 1.728 . . . . 0.0 111.666 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -96.8 0.97 50.2 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.353 -0.842 . . . . 0.0 112.542 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 42.83 -93.1 0.01 OUTLIER Glycine 0 CA--C 1.531 1.077 0 C-N-CA 127.49 2.471 . . . . 0.0 114.04 175.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.01 22.9 3.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.816 1.246 . . . . 0.0 112.64 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 53.6 mtt -55.97 -49.04 95.35 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 116.858 -1.544 . . . . 0.0 113.528 178.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.78 69.51 7.34 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.404 2.069 . . . . 0.0 111.205 -174.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 65.72 -34.98 0.2 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 128.72 2.808 . . . . 0.0 113.935 -177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.2 pttt -152.97 -169.35 3.31 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.115 2.166 . . . . 0.0 108.625 168.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.05 -128.29 2.86 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 170.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.8 p -71.97 173.33 8.53 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 122.038 0.923 . . . . 0.0 111.892 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.2 m -65.47 -25.75 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 -161.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 7.6 pm0 -64.97 -20.61 66.57 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 -162.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.67 177.52 7.82 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 120.525 1.511 . . . . 0.0 112.083 -164.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -138.17 172.25 23.02 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 126.839 2.161 . . . . 0.0 108.199 170.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 61.21 -56.69 0.1 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.071 2.148 . . . . 0.0 111.727 -162.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 1.3 t80 63.06 87.26 0.11 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 127.484 2.313 . . . . 0.0 114.236 159.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -69.89 152.52 44.42 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.329 1.052 . . . . 0.0 110.038 166.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.9 168.9 24.25 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.853 0.861 . . . . 0.0 109.737 167.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -147.2 158.98 44.14 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 126.736 2.014 . . . . 0.0 106.886 162.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -174.48 76.97 0.08 OUTLIER Glycine 0 C--N 1.335 0.494 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.3 m -143.43 163.05 16.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 123.138 0.575 . . . . 0.0 110.33 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -147.29 155.97 42.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.564 1.145 . . . . 0.0 109.808 172.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.8 pp -143.73 144.44 31.84 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.238 1.415 . . . . 0.0 107.797 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 t -154.03 153.16 31.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.588 0.709 . . . . 0.0 111.401 -169.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -84.71 151.67 24.26 Favored 'General case' 0 C--O 1.245 0.846 0 N-CA-C 104.843 -2.28 . . . . 0.0 104.843 158.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -135.74 135.46 40.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.303 1.441 . . . . 0.0 108.622 -171.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.3 tp -133.52 168.29 18.9 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 128.023 2.529 . . . . 0.0 107.478 -176.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.53 -176.9 39.71 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.431 ' CG ' ' HD2' ' A' ' 86' ' ' PRO . 64.8 t80 -143.8 142.21 20.15 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 168.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 85' ' ' TYR . 63.8 Cg_endo -75.42 157.58 40.96 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.053 1.835 . . . . 0.0 112.909 -161.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.7 mp 16.37 68.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 131.447 3.899 . . . . 0.0 110.637 162.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 27.1 m -86.47 54.56 3.2 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 42.8 t0 60.99 133.84 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 129.714 3.206 . . . . 0.0 111.41 -158.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.7 t70 49.43 -60.39 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 129.193 2.997 . . . . 0.0 115.383 -164.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.35 167.44 16.96 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.383 1.873 . . . . 0.0 112.41 -160.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -86.97 148.3 25.38 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 tp -90.91 144.04 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 167.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -137.09 134.91 36.98 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.694 1.598 . . . . 0.0 108.519 -164.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.8 m -137.62 147.18 44.78 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -151.67 142.78 23.19 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.881 -0.512 . . . . 0.0 110.687 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.7 mp -141.59 140.29 33.33 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.518 1.127 . . . . 0.0 108.826 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -176.96 -150.27 8.22 Favored Glycine 0 C--N 1.337 0.587 0 CA-C-N 117.757 0.253 . . . . 0.0 113.006 -164.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.83 161.63 24.34 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.653 1.12 . . . . 0.0 112.017 170.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 26.6 ptm -141.6 149.67 41.03 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 125.567 1.547 . . . . 0.0 109.973 175.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.4 t -141.1 127.06 19.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 C-N-CA 125.295 1.438 . . . . 0.0 107.664 -167.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -138.47 135.68 35.41 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 117.789 0.268 . . . . 0.0 110.504 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -143.48 152.15 41.15 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.174 0.99 . . . . 0.0 109.515 172.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -148.75 165.25 31.98 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 162.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -95.73 116.59 29.1 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.466 0.575 . . . . 0.0 110.106 -167.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 57.1 m 60.25 -36.2 0.08 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 127.839 2.455 . . . . 0.0 114.0 -165.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt 73.93 165.07 0.29 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 128.659 2.784 . . . . 0.0 111.201 174.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 99.6 p -68.03 94.13 0.47 Allowed 'General case' 0 C--O 1.241 0.648 0 O-C-N 121.799 -0.563 . . . . 0.0 109.904 -175.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -73.13 71.01 1.13 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.728 1.611 . . . . 0.0 110.391 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.84 170.58 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 158.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -57.98 -36.99 73.4 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.792 -1.193 . . . . 0.0 112.863 -168.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -97.26 2.57 61.26 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 118.136 -1.369 . . . . 0.0 114.217 175.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.2 mptt 56.52 141.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 130.135 3.374 . . . . 0.0 115.516 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -66.25 82.14 0.09 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.524 1.13 . . . . 0.0 109.935 167.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -73.28 -16.62 61.38 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -173.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -65.22 15.69 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 -161.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t -77.0 151.33 35.66 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 120.722 -1.236 . . . . 0.0 109.759 175.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 178.83 176.5 46.73 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 121.572 0.54 . . . . 0.0 112.595 177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.82 114.74 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 100.461 -3.903 . . . . 0.0 100.461 159.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.95 158.22 52.9 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.538 -158.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -72.14 167.18 27.5 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.8 2.334 . . . . 0.0 109.925 164.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.5 p -147.25 153.24 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 165.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -143.37 152.34 41.49 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.465 1.506 . . . . 0.0 106.986 169.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -163.92 168.64 19.16 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.142 0.577 . . . . 0.0 110.051 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -156.12 164.46 32.36 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 170.79 -133.21 2.71 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 -173.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.73 162.21 35.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 118.471 1.135 . . . . 0.0 111.615 -171.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -139.93 144.57 37.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 126.136 1.774 . . . . 0.0 109.048 -176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -153.17 164.68 37.62 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.132 0.573 . . . . 0.0 110.925 -173.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -136.41 143.06 43.76 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 161.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.7 tp -113.07 -2.93 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 124.18 0.992 . . . . 0.0 111.084 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.8 m -161.58 136.97 5.66 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 102.806 -3.035 . . . . 0.0 102.806 168.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.72 -23.93 69.25 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 121.894 1.729 . . . . 0.0 113.905 -161.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.68 -2.07 49.13 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 36.5 pt -127.38 163.39 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.87 0.868 . . . . 0.0 109.79 173.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -140.61 169.22 18.05 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.882 0.873 . . . . 0.0 109.127 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 98.1 m -149.46 138.69 21.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 54.3 mtt180 -137.91 145.89 42.65 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 124.852 1.261 . . . . 0.0 107.63 178.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.91 140.15 25.45 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 167.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -136.42 161.09 36.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.95 1.3 . . . . 0.0 110.803 -177.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -136.51 152.35 50.43 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 127.279 2.232 . . . . 0.0 108.995 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -141.86 148.33 38.62 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 127.438 2.295 . . . . 0.0 107.35 172.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -138.13 159.9 40.83 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 125.503 1.521 . . . . 0.0 107.617 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.6 p -80.46 177.83 8.73 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.262 0.554 . . . . 0.0 110.821 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -73.09 4.3 4.52 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 167.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 48.81 68.34 0.72 Allowed 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.867 2.467 . . . . 0.0 112.745 -177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 16.9 tt -70.37 71.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.542 1.137 . . . . 0.0 109.717 169.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.9 -58.3 1.0 Allowed Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.282 1.896 . . . . 0.0 111.894 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.1 t70 59.66 -95.79 0.06 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 128.055 2.542 . . . . 0.0 111.682 -174.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -76.55 73.18 3.27 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.273 1.029 . . . . 0.0 110.743 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -70.44 72.12 0.48 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.621 1.568 . . . . 0.0 110.24 177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 86.3 m -154.27 88.59 1.23 Allowed 'General case' 0 CA--C 1.531 0.246 0 O-C-N 120.214 -1.554 . . . . 0.0 109.175 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.71 HG22 ' H ' ' A' ' 154' ' ' GLY . 20.0 mt 60.94 -169.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 124.768 1.227 . . . . 0.0 108.502 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.71 ' H ' HG22 ' A' ' 153' ' ' ILE . . . -71.84 40.06 0.66 Allowed Glycine 0 CA--C 1.534 1.243 0 O-C-N 120.2 -1.562 . . . . 0.0 113.318 176.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 7.6 t -69.79 158.58 35.19 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 117.944 0.872 . . . . 0.0 109.445 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -95.68 112.33 58.72 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.17 167.34 26.46 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.844 2.362 . . . . 0.0 111.329 174.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -160.48 140.22 11.08 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 103.88 -2.637 . . . . 0.0 103.88 159.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -159.61 96.58 1.27 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 127.294 2.238 . . . . 0.0 108.326 -168.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -161.97 -178.34 35.79 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-O 121.993 0.774 . . . . 0.0 113.205 -176.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 54.5 ttm -144.67 151.67 39.31 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.143 1.777 . . . . 0.0 107.558 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 3.9 pp -139.68 162.41 35.17 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.128 0.971 . . . . 0.0 110.04 174.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 11.1 m -139.16 155.93 47.49 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.774 0.829 . . . . 0.0 109.741 165.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 16.1 tp -149.96 119.3 6.85 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 126.708 2.003 . . . . 0.0 107.4 -173.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -152.89 171.22 31.96 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-O 121.718 0.621 . . . . 0.0 114.26 -178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.08 160.38 33.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 C-N-CA 126.278 1.831 . . . . 0.0 109.282 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 46.0 m -152.46 161.99 41.82 Favored 'General case' 0 CA--C 1.52 -0.181 0 O-C-N 121.52 -0.738 . . . . 0.0 111.504 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -97.49 152.45 18.98 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.062 1.745 . . . . 0.0 107.365 161.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.83 116.18 27.55 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.21 1.004 . . . . 0.0 110.485 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -57.62 156.52 8.24 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.522 1.129 . . . . 0.0 113.154 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 114.36 -16.17 19.83 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.325 1.44 . . . . 0.0 114.36 162.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -157.54 171.87 19.57 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.018 1.327 . . . . 0.0 108.483 172.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 61.73 42.05 99.69 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.933 -0.467 . . . . 0.0 111.933 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -135.98 148.28 48.38 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.735 1.614 . . . . 0.0 107.295 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -158.65 174.07 15.62 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.599 1.56 . . . . 0.0 108.373 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.982 0 C-N-CA 127.202 2.201 . . . . 0.0 106.39 168.837 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -71.73 157.01 56.44 Favored 'Trans proline' 0 C--N 1.353 0.765 0 CA-C-N 121.248 1.481 . . . . 0.0 110.946 164.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 120.16 9.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.313 1.445 . . . . 0.0 108.372 171.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.83 162.67 2.26 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.563 2.345 . . . . 0.0 114.596 -164.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.42 159.91 40.61 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.641 1.576 . . . . 0.0 107.245 163.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.6 m -117.7 124.51 48.69 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -104.14 156.42 17.9 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -142.71 156.94 45.09 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.944 1.698 . . . . 0.0 109.131 -177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.0 t -150.27 158.64 44.38 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 118.89 0.768 . . . . 0.0 111.519 162.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 170.65 -134.34 3.1 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 124.105 0.86 . . . . 0.0 112.296 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.09 147.74 50.54 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.236 1.014 . . . . 0.0 110.627 -172.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -129.36 139.52 51.68 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.0 mp -115.12 159.5 20.81 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.472 1.909 . . . . 0.0 107.311 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.77 157.52 27.31 Favored Glycine 0 C--N 1.334 0.443 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 170.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -138.35 149.85 46.0 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.537 1.135 . . . . 0.0 108.358 -176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.6 p -138.44 126.3 22.42 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.0 1.32 . . . . 0.0 108.248 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -65.89 148.08 52.35 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.743 2.017 . . . . 0.0 110.17 -178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -132.93 65.8 1.58 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.407 ' CE1' HG21 ' A' ' 155' ' ' THR . 0.4 OUTLIER -74.26 98.05 3.12 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 103.396 -2.816 . . . . 0.0 103.396 158.135 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -64.44 134.15 53.94 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 169.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 p -70.46 -30.36 67.16 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.671 0.389 . . . . 0.0 111.701 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -94.52 66.1 1.46 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 171.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -71.06 48.72 0.12 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.199 1.8 . . . . 0.0 113.446 -174.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.4 mt -55.7 -47.45 79.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 162.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -69.22 103.5 1.95 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 158.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -68.86 23.62 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.381 1.472 . . . . 0.0 113.639 177.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -155.45 174.8 14.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 128.989 2.915 . . . . 0.0 106.771 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -106.89 42.92 1.8 Allowed Glycine 0 CA--C 1.536 1.397 0 CA-C-O 117.106 -1.941 . . . . 0.0 115.976 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -66.08 -9.73 24.52 Favored 'Trans proline' 0 C--N 1.355 0.887 0 CA-C-N 122.485 3.143 . . . . 0.0 113.033 -173.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.0 m -55.84 80.02 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.145 2.578 . . . . 0.0 109.072 161.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.7 m80 77.86 -17.91 0.54 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 129.241 3.017 . . . . 0.0 113.146 -174.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 46.86 54.21 9.37 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.991 1.716 . . . . 0.0 112.373 -172.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 71.15 67.45 0.17 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.903 1.681 . . . . 0.0 110.319 163.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -151.7 173.46 14.67 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.423 1.889 . . . . 0.0 109.213 -167.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 54.3 tp -152.77 -61.05 0.15 Allowed 'General case' 0 C--N 1.342 0.272 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.306 175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 167.2 -167.26 39.74 Favored Glycine 0 C--N 1.343 0.921 0 CA-C-N 119.584 1.084 . . . . 0.0 113.625 -174.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.07 169.22 19.12 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.154 1.382 . . . . 0.0 109.908 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.41 170.21 38.74 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.072 0.844 . . . . 0.0 112.048 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.46 143.76 26.52 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 171.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -144.97 165.2 28.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -175.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.76 152.56 20.33 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 127.309 2.385 . . . . 0.0 109.322 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.89 151.93 19.21 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -148.35 105.72 3.65 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 -172.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -122.59 142.14 50.95 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 118.743 0.701 . . . . 0.0 111.097 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 p -126.66 -16.54 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.812 0.845 . . . . 0.0 112.24 -164.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -159.68 167.92 13.17 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 126.454 1.902 . . . . 0.0 107.174 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -71.68 -11.4 27.88 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 121.672 1.581 . . . . 0.0 114.414 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -87.83 -38.68 15.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.651 1.114 . . . . 0.0 111.65 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.88 147.87 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-O 122.178 0.99 . . . . 0.0 112.03 -169.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.55 -166.9 18.55 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 127.663 2.554 . . . . 0.0 109.087 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -135.53 163.66 29.59 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.171 1.388 . . . . 0.0 108.886 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -148.04 152.38 37.32 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.364 1.066 . . . . 0.0 108.304 164.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 50.4 mtt -149.49 157.11 42.99 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.534 1.134 . . . . 0.0 108.068 -169.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -169.47 176.52 43.4 Favored Glycine 0 C--N 1.333 0.404 0 CA-C-N 119.06 0.846 . . . . 0.0 113.08 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -141.72 151.31 42.82 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.572 1.549 . . . . 0.0 109.376 -172.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -129.05 145.78 51.18 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.092 1.357 . . . . 0.0 109.318 170.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -141.18 120.4 12.98 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 164.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 39.1 mt 54.83 18.98 2.37 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.657 1.983 . . . . 0.0 114.933 172.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.08 58.14 1.61 Allowed Glycine 0 C--N 1.341 0.82 0 CA-C-N 119.686 1.13 . . . . 0.0 110.388 -174.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 50.56 37.57 16.45 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.522 1.929 . . . . 0.0 112.289 -176.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 52.0 ttp -127.36 115.64 21.44 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.219 1.408 . . . . 0.0 108.278 -170.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.85 -26.36 44.66 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.687 2.258 . . . . 0.0 114.222 -164.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -154.94 167.44 30.32 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 164.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -75.19 66.97 1.77 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.72 -95.36 0.22 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -168.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.1 t -156.83 172.24 18.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.198 1.799 . . . . 0.0 106.99 169.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.27 17.8 m 39.59 -125.27 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.855 1.662 . . . . 0.0 110.122 -166.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 65.9 -54.52 0.37 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 127.803 2.441 . . . . 0.0 114.565 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -159.52 -174.74 4.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 173.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 176.31 -24.49 0.06 OUTLIER Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.418 1.961 . . . . 0.0 110.9 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.35 -64.45 0.86 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.866 0.833 . . . . 0.0 109.15 166.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -65.9 162.88 18.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.722 0.809 . . . . 0.0 110.672 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.88 165.52 18.18 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 125.716 1.607 . . . . 0.0 108.531 170.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -136.67 134.38 37.2 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 160.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -157.89 161.12 38.25 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.54 1.136 . . . . 0.0 108.041 -165.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.8 168.25 41.26 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 121.146 -0.971 . . . . 0.0 112.146 171.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.7 p -143.87 148.5 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -132.05 130.23 41.05 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.386 1.874 . . . . 0.0 107.013 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 6.4 mp -120.38 150.32 40.95 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 159.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -154.98 132.24 11.05 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 120.598 -1.314 . . . . 0.0 109.08 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -85.12 140.03 31.27 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 164.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.2 ttmt -117.72 114.36 23.22 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -136.21 136.64 40.09 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 118.867 0.758 . . . . 0.0 110.176 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.93 -148.53 17.14 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-O 118.582 -1.121 . . . . 0.0 110.634 -166.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.401 ' CG ' ' HD2' ' A' ' 86' ' ' PRO . 1.6 t80 -159.32 157.43 27.24 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 118.508 1.154 . . . . 0.0 112.415 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 92' ' ' ASP . 37.5 Cg_endo -62.33 153.54 69.73 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.323 2.682 . . . . 0.0 111.911 161.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.5 mt -111.36 -34.87 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.832 1.253 . . . . 0.0 108.5 171.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 52.2 m -157.56 167.44 30.14 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 168.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.43 -21.41 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.945 1.298 . . . . 0.0 113.107 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -77.75 -34.34 52.53 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.286 1.835 . . . . 0.0 113.456 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.1 pp -155.75 155.16 32.6 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 119.977 1.262 . . . . 0.0 114.341 -170.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 86' ' ' PRO . 1.1 m-20 -134.93 164.02 28.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 127.024 2.13 . . . . 0.0 109.544 -172.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.39 129.2 73.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 125.657 1.583 . . . . 0.0 106.899 173.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -137.98 153.36 49.44 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.085 0.945 . . . . 0.0 111.768 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 51.9 m -96.9 132.41 42.69 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 159.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -99.31 108.93 21.59 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 167.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tt -98.96 107.53 19.99 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 173.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -104.07 142.01 15.39 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.113 0.863 . . . . 0.0 112.502 -164.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -121.66 95.48 0.56 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 105.929 -2.868 . . . . 0.0 105.929 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 25.1 ptp -134.23 157.04 47.29 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.275 0.63 . . . . 0.0 110.304 -171.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.2 p -148.25 150.38 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -117.62 156.17 28.6 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.602 1.961 . . . . 0.0 107.319 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 46.2 ttp85 -143.18 146.0 33.31 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.378 0.671 . . . . 0.0 109.698 175.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -144.48 122.02 11.75 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.115 0.966 . . . . 0.0 109.798 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -71.42 103.96 3.07 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.3 p -145.31 146.49 31.65 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.173 0.989 . . . . 0.0 109.076 -166.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -71.79 -21.12 61.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 119.038 -0.506 . . . . 0.0 112.005 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.8 t 55.6 -165.36 0.12 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.429 1.491 . . . . 0.0 112.679 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -66.6 -50.66 62.33 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.669 1.188 . . . . 0.0 108.605 164.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.269 0.4 OUTLIER 76.64 -39.68 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.998 2.519 . . . . 0.0 112.503 177.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -67.21 -37.23 83.26 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 158.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -82.78 93.08 1.65 Allowed Glycine 0 C--N 1.34 0.764 0 N-CA-C 107.148 -2.381 . . . . 0.0 107.148 159.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -73.31 69.8 1.14 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.34 1.456 . . . . 0.0 110.229 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -149.35 178.46 8.76 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.223 1.809 . . . . 0.0 108.237 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 58.42 78.11 0.26 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.417 2.287 . . . . 0.0 112.817 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -133.01 -72.36 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 1 N-CA-C 100.087 -4.042 . . . . 0.0 100.087 158.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.2 t -65.38 159.84 23.21 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.187 1.795 . . . . 0.0 109.849 158.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -172.77 179.6 44.15 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 127.488 2.471 . . . . 0.0 109.465 176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.489 HG12 ' H ' ' A' ' 120' ' ' SER . 52.0 t 62.47 176.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 124.818 1.247 . . . . 0.0 109.849 -168.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.489 ' H ' HG12 ' A' ' 119' ' ' VAL . 79.8 p -153.77 174.89 3.37 Favored Pre-proline 0 C--O 1.236 0.393 0 O-C-N 120.696 -1.253 . . . . 0.0 110.109 -168.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.5 158.08 24.6 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.019 1.146 . . . . 0.0 109.708 158.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 8.2 p -167.24 -178.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 126.192 1.797 . . . . 0.0 107.752 -172.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -139.01 164.8 28.8 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 120.596 -1.315 . . . . 0.0 109.694 163.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -144.77 160.6 40.99 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.199 1.8 . . . . 0.0 108.403 172.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -124.36 145.94 16.04 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 179.24 -162.37 29.15 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 117.915 0.857 . . . . 0.0 114.615 -169.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.97 158.51 30.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 127.301 2.24 . . . . 0.0 108.38 -169.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -135.56 146.55 48.12 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.157 1.383 . . . . 0.0 107.568 165.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -150.16 122.88 8.63 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.811 0.844 . . . . 0.0 110.077 -162.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -135.75 82.43 1.95 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.787 2.035 . . . . 0.0 109.201 -172.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 20.5 tt -55.64 -31.27 28.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.129 0.972 . . . . 0.0 112.931 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.0 p -136.65 155.08 76.95 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 124.972 1.309 . . . . 0.0 107.832 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.05 60.76 6.99 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 124.152 3.234 . . . . 0.0 111.33 -174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -148.07 -33.54 0.24 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.468 2.307 . . . . 0.0 111.395 -177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.16 149.58 21.66 Favored 'Isoleucine or valine' 0 C--N 1.342 0.268 0 C-N-CA 127.21 2.204 . . . . 0.0 108.131 -166.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -143.0 109.12 5.24 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 119.138 0.881 . . . . 0.0 108.871 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.65 149.03 21.57 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.435 1.894 . . . . 0.0 106.99 178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.6 157.75 46.04 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 119.277 0.944 . . . . 0.0 110.592 168.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 37.7 tp -154.44 119.52 5.0 Favored 'General case' 0 N--CA 1.46 0.064 0 C-N-CA 125.67 1.588 . . . . 0.0 107.266 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -141.34 156.45 45.84 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.365 1.066 . . . . 0.0 111.423 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -134.01 152.96 52.06 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.474 1.51 . . . . 0.0 109.801 -173.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -145.15 158.34 43.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.555 1.542 . . . . 0.0 109.915 175.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -146.2 163.54 35.1 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.089 1.755 . . . . 0.0 107.372 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 18.7 m 43.49 66.17 0.86 Allowed 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.502 1.521 . . . . 0.0 110.745 -172.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -67.48 167.24 13.13 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.627 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -78.62 62.46 3.19 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.523 1.129 . . . . 0.0 110.068 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.6 tp -151.22 164.01 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.385 1.474 . . . . 0.0 108.402 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.41 -161.47 44.84 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -178.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -144.6 177.03 8.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.408 1.483 . . . . 0.0 109.022 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -118.95 12.28 12.77 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.956 1.302 . . . . 0.0 113.033 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.3 -23.79 10.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.073 1.349 . . . . 0.0 111.216 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.2 t -62.95 168.9 3.63 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.753 1.221 . . . . 0.0 111.626 172.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 17.7 tt -151.58 163.21 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.37 1.468 . . . . 0.0 108.206 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 157.41 -147.33 15.31 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -176.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . 0.407 HG21 ' CE1' ' A' ' 19' ' ' HIS . 9.0 t -69.56 158.54 35.05 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 166.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -68.8 113.0 13.12 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.08 -43.49 6.4 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.537 1.491 . . . . 0.0 109.841 -179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 37.71 47.39 0.82 Allowed 'General case' 0 C--N 1.341 0.235 0 C-N-CA 128.57 2.748 . . . . 0.0 111.795 173.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -89.68 108.09 19.48 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.427 1.491 . . . . 0.0 108.281 -176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -83.35 167.11 44.66 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 171.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -140.96 157.76 44.89 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 pp -140.22 162.37 35.42 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.434 0.694 . . . . 0.0 111.136 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 58.3 m -135.02 155.85 50.05 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 160.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.31 158.64 44.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 169.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -163.6 170.14 38.85 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.25 136.78 41.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.5 p -144.43 166.78 24.14 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -117.21 154.07 31.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 166.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 -89.76 158.65 17.43 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.221 0.534 . . . . 0.0 111.56 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -54.49 139.64 36.98 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.92 161.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.05 29.3 0.28 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.151 1.357 . . . . 0.0 111.627 174.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -69.4 110.75 4.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.14 -33.32 3.07 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 126.458 1.98 . . . . 0.0 110.711 -166.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -90.45 -42.36 10.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.777 1.231 . . . . 0.0 108.54 165.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -123.53 -159.17 0.84 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.759 2.424 . . . . 0.0 107.865 169.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 116.772 -1.585 . . . . 0.0 106.842 172.222 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -69.88 159.69 52.39 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.14 1.894 . . . . 0.0 110.207 172.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -79.49 36.57 0.31 Allowed 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.952 0.901 . . . . 0.0 111.534 -176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -75.83 42.67 0.24 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.139 1.776 . . . . 0.0 111.36 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.48 100.3 1.64 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.254 1.421 . . . . 0.0 108.828 169.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 25.5 m -130.94 122.13 26.39 Favored 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 165.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 11.4 m95 -102.13 157.99 16.49 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -146.16 159.8 42.81 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.117 1.367 . . . . 0.0 109.253 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -149.86 161.58 41.99 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 159.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 165.37 -151.41 20.15 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.06 158.75 42.79 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.307 0.643 . . . . 0.0 110.543 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HE3' ' CZ ' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -136.66 150.38 48.47 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 171.026 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -136.79 162.85 32.07 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.812 1.645 . . . . 0.0 107.957 175.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -131.38 157.52 22.34 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-O 119.198 -0.779 . . . . 0.0 112.105 -170.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -144.11 152.23 40.66 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.906 1.282 . . . . 0.0 110.902 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.9 p 67.88 -132.66 0.11 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.669 2.388 . . . . 0.0 112.023 173.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 62.19 -27.87 0.06 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.063 2.545 . . . . 0.0 116.385 -165.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 50.7 t80 65.84 -42.15 0.36 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.91 2.084 . . . . 0.0 115.111 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.11 171.92 14.19 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.659 2.384 . . . . 0.0 109.006 178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -156.42 -176.21 5.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.375 1.87 . . . . 0.0 106.65 159.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.6 p -61.09 -166.92 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 130.992 3.717 . . . . 0.0 112.078 158.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.53 -96.6 0.84 Allowed Glycine 0 C--N 1.339 0.717 0 N-CA-C 105.41 -3.076 . . . . 0.0 105.41 -159.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -162.74 168.62 21.23 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.461 1.104 . . . . 0.0 108.5 158.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 29.5 mm -134.04 142.41 41.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 105.175 -2.157 . . . . 0.0 105.175 168.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -129.3 -99.02 0.35 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 105.285 -2.116 . . . . 0.0 105.285 161.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -87.79 90.56 8.43 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 162.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 56.88 -169.34 0.1 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.636 1.175 . . . . 0.0 110.043 -163.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -162.03 174.2 38.46 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 120.923 -1.111 . . . . 0.0 113.011 175.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.71 -10.14 27.8 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 123.538 2.826 . . . . 0.0 113.691 -175.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -63.9 -11.26 26.32 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.409 1.004 . . . . 0.0 112.897 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.3 t-160 69.24 -69.13 0.17 Allowed 'General case' 0 C--N 1.343 0.316 0 C-N-CA 127.189 2.196 . . . . 0.0 112.066 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -67.04 76.84 0.13 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.317 1.847 . . . . 0.0 108.983 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.73 17.79 2.34 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.924 2.49 . . . . 0.0 109.559 177.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 171.21 -54.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 130.203 3.401 . . . . 0.0 107.977 -171.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.79 167.96 27.31 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 125.109 1.364 . . . . 0.0 110.099 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -147.11 167.79 28.34 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 123.568 0.604 . . . . 0.0 112.167 175.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.3 153.44 29.05 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.641 1.576 . . . . 0.0 110.078 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.79 163.4 32.34 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.298 1.427 . . . . 0.0 111.253 168.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.4 140.34 49.22 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.011 1.724 . . . . 0.0 108.574 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -134.66 158.91 42.85 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -159.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -123.99 143.39 14.83 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 127.302 2.382 . . . . 0.0 107.801 160.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.38 161.65 26.51 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 117.931 0.866 . . . . 0.0 112.102 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -149.1 143.97 26.36 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.067 1.347 . . . . 0.0 109.771 -171.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -122.04 123.21 41.08 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 158.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.8 p -143.69 -3.29 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -158.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.56 166.96 14.01 Favored Pre-proline 0 C--O 1.237 0.446 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 173.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.1 107.47 0.56 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.526 2.151 . . . . 0.0 110.501 -172.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 63.22 26.17 15.09 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.716 2.006 . . . . 0.0 112.6 -176.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.2 t -130.82 138.23 54.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.143 0.977 . . . . 0.0 109.632 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -150.48 -179.57 26.37 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.009 0.814 . . . . 0.0 111.805 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -145.25 163.27 34.98 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 125.533 1.533 . . . . 0.0 108.835 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -151.82 159.94 43.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 162.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 77.6 mtm -143.44 156.39 44.64 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -155.4 170.68 33.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.878 -0.201 . . . . 0.0 112.608 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -141.48 159.18 42.76 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.483 1.113 . . . . 0.0 110.027 176.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -83.54 167.66 17.16 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.229 1.812 . . . . 0.0 111.797 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -73.01 51.57 0.3 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.569 1.148 . . . . 0.0 110.246 160.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.9 tp -8.95 79.08 0.0 OUTLIER 'General case' 0 C--N 1.342 0.24 0 C-N-CA 130.672 3.589 . . . . 0.0 114.151 -159.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 52.95 25.07 22.59 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 117.548 -1.695 . . . . 0.0 115.38 171.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 76.8 mtt-85 89.92 12.4 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 128.52 2.728 . . . . 0.0 113.017 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 53.9 ttp -46.61 135.16 7.81 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 119.467 1.031 . . . . 0.0 109.885 170.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.02 5.59 2.54 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.515 2.81 . . . . 0.0 115.005 -171.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 43.6 p90 46.86 27.19 0.67 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.776 2.43 . . . . 0.0 115.04 173.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.3 tttm -144.41 157.52 44.21 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.656 1.983 . . . . 0.0 106.998 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -71.43 68.93 0.92 Allowed Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 172.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.2 m -164.81 79.18 0.35 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.011 1.724 . . . . 0.0 107.881 -176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 t 65.36 47.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 123.146 1.451 . . . . 0.0 108.261 -166.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -53.86 -24.87 17.22 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 128.974 2.91 . . . . 0.0 112.428 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -142.74 158.04 44.04 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 162.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -148.17 14.86 1.3 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.918 1.723 . . . . 0.0 112.478 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -127.24 157.93 38.52 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.792 1.637 . . . . 0.0 110.921 -172.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -69.86 -61.52 1.75 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 118.535 -0.745 . . . . 0.0 109.602 165.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.276 0.0 OUTLIER -146.13 61.05 1.24 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 176.131 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.19 130.22 41.47 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 158.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -147.84 168.37 22.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.048 0.939 . . . . 0.0 109.001 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.59 57.12 0.19 Allowed Glycine 0 C--N 1.338 0.661 0 CA-C-O 117.618 -1.657 . . . . 0.0 114.03 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.83 155.36 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 118.983 1.392 . . . . 0.0 110.934 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -133.75 148.26 51.39 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.968 2.107 . . . . 0.0 108.178 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 pp -143.14 152.11 41.44 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.209 1.003 . . . . 0.0 110.961 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 m -155.68 152.07 28.18 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.706 1.202 . . . . 0.0 112.36 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.23 136.08 54.85 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.717 2.407 . . . . 0.0 106.975 159.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -118.56 153.54 34.06 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.977 0.911 . . . . 0.0 110.147 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.14 133.47 52.81 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 161.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.7 164.98 10.11 Favored Glycine 0 CA--C 1.52 0.4 0 N-CA-C 110.516 -1.033 . . . . 0.0 110.516 -167.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -161.24 168.87 10.73 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.142 -163.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -62.96 95.46 0.16 Allowed 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 124.154 3.236 . . . . 0.0 110.74 168.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.7 tt -68.01 -44.04 85.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.077 0.551 . . . . 0.0 110.895 -172.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.0 t -177.16 176.51 1.36 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 129.555 3.142 . . . . 0.0 105.518 175.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 54.09 28.76 9.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.984 1.714 . . . . 0.0 113.721 161.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 60.2 26.1 15.51 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.876 2.47 . . . . 0.0 114.047 -178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.7 mt -101.85 110.47 22.46 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.071 1.349 . . . . 0.0 109.244 173.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -86.72 111.79 21.03 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 166.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.6 137.17 41.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -153.5 166.73 31.79 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 122.551 1.167 . . . . 0.0 113.784 -170.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 9.6 t -129.73 153.45 48.16 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 158.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.28 155.73 41.68 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.996 -0.44 . . . . 0.0 110.34 -166.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 9.6 tt -127.8 138.12 52.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.13 -160.1 15.13 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -170.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -178.99 176.38 47.93 Favored Glycine 0 CA--C 1.521 0.448 0 CA-C-O 121.341 0.412 . . . . 0.0 112.299 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -116.33 144.64 43.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.238 1.815 . . . . 0.0 107.699 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.1 t -129.28 94.17 2.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 160.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -129.13 138.73 51.97 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -169.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -143.34 136.46 27.92 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.767 -0.583 . . . . 0.0 110.867 -174.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.55 161.81 18.35 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 105.933 -1.876 . . . . 0.0 105.933 158.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -81.58 148.6 29.03 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 118.192 -1.403 . . . . 0.0 112.041 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 41.5 p -148.94 93.3 2.09 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.629 1.571 . . . . 0.0 107.238 172.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.11 -38.35 51.33 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.954 0.883 . . . . 0.0 109.249 164.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.0 m -145.98 151.2 37.4 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 159.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 -85.48 74.18 10.38 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -173.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . 0.338 29.7 m 51.48 -76.62 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 128.124 2.57 . . . . 0.0 111.266 -158.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -117.11 -12.02 10.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.318 1.447 . . . . 0.0 112.417 175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -83.77 138.64 17.75 Favored Glycine 0 C--N 1.339 0.701 0 O-C-N 121.105 -0.997 . . . . 0.0 111.298 -175.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -77.68 -20.87 52.97 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 170.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -74.25 108.85 7.29 Favored 'General case' 0 C--N 1.342 0.272 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -49.32 161.87 0.16 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.237 1.815 . . . . 0.0 114.234 173.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -59.18 131.66 51.68 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.199 159.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t -153.51 94.71 1.83 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.21 1.404 . . . . 0.0 111.245 -170.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -89.79 76.14 1.74 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 172.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 p -109.57 100.81 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.3 p -143.01 127.2 9.57 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.353 0.661 . . . . 0.0 110.05 -166.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -79.28 168.89 19.64 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.931 2.42 . . . . 0.0 110.74 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.4 t -136.33 139.86 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.087 1.355 . . . . 0.0 107.879 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -127.77 118.69 24.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.711 2.004 . . . . 0.0 106.307 160.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.11 166.47 24.56 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.661 -0.649 . . . . 0.0 111.909 -168.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -120.75 158.51 15.65 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.444 -1.863 . . . . 0.0 108.444 166.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.79 175.23 47.43 Favored Glycine 0 C--N 1.336 0.555 0 CA-C-N 118.361 1.081 . . . . 0.0 113.412 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.7 m -138.97 135.35 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.463 1.105 . . . . 0.0 108.73 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -105.83 110.74 23.14 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.534 2.734 . . . . 0.0 105.347 169.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.91 110.46 22.13 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -74.16 81.46 1.79 Allowed 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 171.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 47.1 pt -69.36 -3.62 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.154 0.982 . . . . 0.0 112.632 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 45.0 m -154.43 149.71 20.78 Favored Pre-proline 0 CA--C 1.54 0.565 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 163.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.54 -7.8 9.62 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.306 2.004 . . . . 0.0 115.855 -171.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -111.49 -12.54 13.96 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.16 1.384 . . . . 0.0 113.577 174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.8 pp -139.34 147.94 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 121.764 2.075 . . . . 0.0 111.379 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -137.7 161.1 37.4 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.38 0.672 . . . . 0.0 109.293 -175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 73.9 m -130.96 135.97 48.13 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.451 ' CZ ' ' HE3' ' A' ' 12' ' ' LYS . 6.0 ptp180 -122.19 159.54 27.03 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 pp -135.02 145.06 47.69 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 125.112 1.508 . . . . 0.0 107.311 159.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -152.54 162.08 41.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.884 1.274 . . . . 0.0 109.664 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -154.56 154.84 33.73 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 123.12 0.568 . . . . 0.0 111.118 -165.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -138.22 160.05 40.45 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.301 1.84 . . . . 0.0 107.288 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -137.16 134.84 36.78 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.953 1.301 . . . . 0.0 108.455 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 147' ' ' ILE 0.251 26.0 m 39.22 47.95 1.49 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.492 2.317 . . . . 0.0 113.216 171.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -52.76 131.38 34.98 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.073 0.949 . . . . 0.0 111.377 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 55.36 4.1 0.09 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.826 2.05 . . . . 0.0 114.779 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.422 ' HA ' HG22 ' A' ' 144' ' ' THR . 44.5 mt 64.28 -55.97 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.76 2.024 . . . . 0.0 111.166 -164.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 75.83 -48.3 2.3 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.778 1.656 . . . . 0.0 112.001 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -19.35 65.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.116 1.366 . . . . 0.0 112.958 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . 52.24 25.77 3.56 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.246 1.818 . . . . 0.0 113.556 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . 0.309 2.9 m-70 51.06 52.19 15.49 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 127.452 2.301 . . . . 0.0 112.649 -169.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.2 m -69.9 -36.89 75.77 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.475 158.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.772 HG22 ' H ' ' A' ' 154' ' ' GLY 0.271 31.2 mm 60.4 -172.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 126.634 1.973 . . . . 0.0 109.907 -179.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.772 ' H ' HG22 ' A' ' 153' ' ' ILE . . . 78.84 -52.07 3.88 Favored Glycine 0 CA--C 1.527 0.824 0 O-C-N 120.246 -1.533 . . . . 0.0 110.038 -164.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' THR . . . . . . . . . . . . . 33.2 p -132.16 158.47 41.61 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.236 1.414 . . . . 0.0 108.748 166.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 85.6 mtm-85 -130.5 154.2 81.57 Favored Pre-proline 0 C--O 1.232 0.14 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 158.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -74.96 -18.17 19.05 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.295 1.33 . . . . 0.0 111.141 167.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 31.49 74.39 0.05 OUTLIER 'General case' 0 C--N 1.346 0.451 0 C-N-CA 128.428 2.691 . . . . 0.0 111.643 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -63.61 71.88 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.364 1.866 . . . . 0.0 111.291 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -114.93 119.49 4.66 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.852 1.691 . . . . 0.0 110.999 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 7.7 ptt? -105.65 159.28 16.09 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.042 0.937 . . . . 0.0 110.034 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.73 117.37 17.75 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 164.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 1.2 m -129.39 160.86 31.77 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.6 pp -144.39 167.08 23.31 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.941 1.296 . . . . 0.0 110.294 -170.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -164.63 175.24 40.65 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.917 -0.659 . . . . 0.0 113.814 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 15.8 m -131.32 148.93 32.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 124.592 1.157 . . . . 0.0 108.484 163.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 70.8 m -145.6 118.69 8.84 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -169.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -82.57 123.83 29.58 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 171.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -90.14 124.95 35.25 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.82 1.648 . . . . 0.0 106.74 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -59.09 115.79 3.41 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.591 0.756 . . . . 0.0 110.858 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 170.97 163.37 24.89 Favored Glycine 0 CA--C 1.533 1.172 1 C-N-CA 130.876 4.084 . . . . 0.0 105.037 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.411 HE21 ' HA ' ' A' ' 172' ' ' GLN . 0.0 OUTLIER -156.65 122.08 4.74 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-N 119.242 1.521 . . . . 0.0 111.135 176.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 66.96 30.71 76.41 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -96.37 179.01 5.18 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 122.945 0.498 . . . . 0.0 112.005 -163.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . 57.3 -164.75 0.16 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.434 1.894 . . . . 0.0 112.372 -173.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 C-N-CA 127.805 2.442 . . . . 0.0 106.398 176.916 . . . . . . . . 0 0 . 1 stop_ save_